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For many years the cervix was considered by clinicians to play a
passive role in child birth. They assumed the expulsive forces applied
to the fetus at term by the uterine musculature resulted in the forced
dilatation of the cervix as the child was pushed through the birth
canal. Few felt it necessary to investigate the subject any deeper.
However, in recent years we have come to realise that there are major
alterations in the structure of the cervix associated with pregnancy,
especially during the latter stages. This is cervical ripening.
It has been shown that prostaglandins applied to the cervix can
promote cervical ripening and they are now regarded as significant
factors in the process. Hormonal alterations may also be important,
with particular interest focusing on progesterone since the
introduction of drugs with anti-progestogenic properties.
The consensus of opinion is currently that the activity taking
place within the ripening cervix is very similar to an inflammatory
reaction, involving white blood cells, hormonal control and very likely
inflammatory mediators such as the cytokines.
A cell culture system was developed to study the production of
prostaglandins by cervical cells from late pregnant guinea pigs. This
permitted the examination of the influence of various substances on
/
the synthesis of the prostaglandins, including progesterone and the
anti-progesterone drug RU486 (Mifepristone/RU38486). RU486 has
been found to promote cervical ripening in humans and guinea pigs. It
is thought to increase the sensitivity of the uterus to prostaglandins
and thereby promote muscle activity. It is licensed in the United
Kingdom as an abortifacient. Since this antiprogestin can provoke
iv
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cervical ripening alone an accessible source of tissue from an animal
with a similar physiology to the human seemed to be an appropriate
starting point from which to investigate the effects of this steroidal
derivative and how it may affect prostaglandin production.
The results show that prostaglandin output can be provoked in
vitro by agents such as lipopolysaccharide and phorbol ester. The
observed effects of RU486 were mixed. Giving the animals RU486
prior to sacrifice did not produce any measurable change in the
response to most of the compounds examined, there were, however,
some instances where a significant increase was detected, apparently
associated with the calcium ionophore A23187, and others where
there appeared to be a reduction. The inclusion of RU486 in the
culture medium with other treatments did not produce any significant
differences compared to the treatment on its own, and alone RU486
only produced a significant difference where the animal had been
given the drug in vivo.
The cytokine/chemokine interleukin-8 was also examined. This
peptide is a neutrophil chemoattractant and activator and thus is
important in inflammatory reactions. The detection of interleukin-8 in
the culture medium from the guinea pig cultures was not possible.
However, maintaining cervical biopsy material from women using a
tissue culture system it was possible to study this inflammatory
mediator. Tissue was obtained from women hospitalised for surgical
termination, hysterectomy or dilatation and curettage.
This work showed for the first time that human cervix was
capable of producing interleukin-8 in vitro and that the level of
production could be increased by the addition of various compounds
to the culture medium. The tissue was obtained from different groups
v
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of women and the results suggest that there may be a differential
response related to the hormonal state of the patients, such as
whether they were pre- or postmenopausal.
Basic immunohistochemical work appeared to show the
presence of interleukin-8 in the connective tissue of the cervix which
may be an indication that this peptide could attract cells to that area
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Current Understanding of the Cervix and Cervical Ripening
Introduction
Throughout gestation the developing fetus must be protected
from the harsh outside environment and as it grows it must be
prevented from leaving the uterus. The cervix is a crucial element in
accomplishing these requirements and therefore in maintaining the
pregnancy. It does this by retaining its closed, rigid structure, acting
in a sphincter-like manner.
When the fetus is mature the cervix experiences dramatic
alterations in its function to allow the contents of the uterus to pass
into the birth canal, culminating in the delivery of the child. In order
for this to occur the cervix must dilate; however, it has become clear
that the cervix is not a muscular sphincter and cannot merely relax. It
is composed predominantly of connective tissue which must undergo
fundamental changes to allow dilatation to take place. These changes
are highly complex and are not fully understood. The process of
change from a closed, rigid barrier to a soft, dilated ring of tissue are
what we call cervical ripening.
Over one hundred years ago the cervix was shown to be an
organ with a fundamentally fibrous structure (Hofmeier, 1886) but
this idea was apparently overshadowed because the majority of
workers regarded it as predominantly muscular in nature and
therefore muscular in structure (Danforth, 1947). However, a few
individuals pursued the notion that the cervix was constructed
mainly of connective tissue (Stieve, 1927; Novak, 1944; Stander,
1945) and in 1947 Danforth (Danforth, 1947) published an article
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which provided more widely accepted evidence of the fibrous character
of the cervix. His work is often referred to and is seen by many as the
real origin of the modern day view that the cervix is not a muscular
sphincter and might be regarded as an organ in its own right.
For many years it was thought cervical ripening was a passive
process that was dependent on the mechanical forces the cervix was
subjected to by the action of the contracting uterus (Conrad and
Ueland, 1983), despite the clinical observations that the cervix could
ripen in the absence of uterine contractions or remain rigid and
unyielding under their influence (Liggins, 1978). In sheep, cervical
ripening was shown to occur even when the uterus and cervix were
mechanically isolated from each other (Stys et al., 1978; Ledger et al.,
1985).
The apparent lack of cervical smooth muscle meant that no
major function for it was considered likely (Schwalm and Dubrauszky,
1966) and it was only relatively recently that a consensus was reached
and the scientific community agreed that cervical ripening should be
explained in terms of connective tissue biology (Danforth et al., 1980).
Although the cervix may be able to ripen without the
contractions of the uterus it is obvious that the stresses they put on
the cervix must in some way affect the connective tissue of the
ripening cervix (Liggins, 1978; Calder, 1980; Hillier and Coad, 1982).
Recently, following Liggins* proposals, cervical ripening has
been considered by most to be some form of inflammatoiy reaction
(Liggins, 1981).
Since it is now clear that the cervix actively participates in
parturition a great deal of work has been carried out in an effort to
manipulate it and improve our understanding of its functioning.
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As well as the intrinsic value of understanding the processes
that take place during cervical ripening the knowledge gained has
potentially useful clinical applications. As with all biological functions
parturition and cervical ripening do not always adhere to anticipated
patterns. In fact around 10% of pregnancies are complicated by a lack
of cervical ripening at term and in a further 10% induction of labour
and cervical ripening are required because of other indications
(Ulmsten, 1988b; Ulmsten, 1988a). The need to promote cervical
ripening is not the only clinical problem. In some women the cervix
ripens and dilates relatively early in gestation and may be the cause of
loss of the pregnancy through spontaneous abortion or premature
delivery. This complication is known as cervical incompetence and
current practice is to suture the cervix to keep it closed. Thus a fuller
understanding of what processes underlie ripening may also permit
pharmacological intervention in such cases.
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The Cervix
The following pages detail cervical structure and the changes that are
associated with cervical ripening.
Cervical Anatomy
The cervix is the lower most part of the uterus and in women is
normally about 3cm long and approximately 2.5cm in outer diameter.
It is anchored within the pelvic girdle by the pubocervical fascia,
uterosacral and transverse cervical (or cardinal) ligaments (Uldbjerg
and Ulmsten, 1990; Danforth, 1983).
Cervical Structure
Unlike the corpus of the uterus the uterine cervix is not a
muscular organ but is predominantly composed of connective tissue
with comparatively little smooth muscle (Danforth, 1947). It has been
shown that, beginning at the uppermost reaches where it joins the
myometrium, the amount of smooth muscle in the cervix decreases
from around 29% to as little as 6% (Rorie and Newton, 1967) and
generally it is accepted as being in the region of 10-15% (Danforth,
1983; Schwalm and Dubrauszky, 1966). The main cellular component
of the cervix is the fibroblast (Junqueira et al., 1980) which is a cell
type capable of the production of collagen, glycosaminoglycans and
collagenase.
Around 75-80% of the cervix is water (Uldbjerg et al., 1983b;
Danforth et al., 1974; Kleissl et al., 1978).
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Most of the connective tissue of the cervix is collagen (Danforth,
1947; Junqueira et ah, 1980) and around 70% of this is type I
collagen, the remainder being type III (Danforth et al., 1974; Ito et al.,
1979). However, Minamoto's group found type IV collagen associated
with smooth muscle fibres and vascular basement membrane in
human cervix (Minamoto et al., 1987). Elastin has been reported in
small quantities (Danforth, 1947; Leppert et al., 1982) but there is
disagreement about its significance (Danforth, 1983). The other main
components of connective tissues are proteoglycans. They form a
ground substance of protein and disaccharides in which the collagen
is embedded (Uldbjerg et al., 1983c).
Collagen
Collagen is the most abundant protein in the body and there are
at least seven genetically different forms (Uldbjerg et al., 1983c;
Bornstein and Sage, 1980). Native collagen is found as fibrils (or
fibres) and is built up from tropocollagen, each molecule of which
consists of three collagen molecules twisted into a helical structure.
The tropocollagen helices specifically congregate to produce collagen
fibrils 60nm in diameter which are held together by cross links
between hydroxyamino acids in the non helical end regions of the
tropocollagen and hydroxyamino acids in the helix of adjacent
tropocollagen molecules (Challis and Olson, 1988). Collagen is
relatively rich in the amino acids hydroxyproline and hydroxylysine,
and it is the quantification of hydroxyproline that is generally used to
assess collagen concentration (Uldbjerg et al., 1983c; Uldbjerg and
Ulmsten, 1990). As it matures the number of cross links within the
fibrils increases (Uldbjerg et al., 1983c; Challis and Olson, 1988), as
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does the stability of the protein. It is thought that more recently
produced collagen is degraded more easily because of its simpler
structure.
The collagen fibrils are embedded in a network of proteoglycans
and the overall structure gives cervical connective tissue a high tensile
strength (Conrad and Ueland, 1983) and it has been claimed that
while smooth muscle does confer some contractile function on cervical
tissue it could not contribute to its strength in any significant manner
(Uldbjerg and Ulmsten, 1990; Schwalm and Dubrauszky, 1966;
Danforth and Evanston, 1954). The histological appearance of the
cervix is of an orderly, regimented structure where the collagen fibres
are arranged in neat, tightly packed bundles (Danforth et al., 1960).
Proteoglycans
Proteoglycans are networks of protein covalently bound to
glycosaminoglycans (GAGs). GAGs are large, unbranched chains of
disaccharide units which have an amino sugar (hexosamine,
glucosamine or galactosamine) and usually uronic acid, glucuronic
acid or iduronic acid (Danforth et al., 1974; Uldbjerg and Ulmsten,
1990; Lindahl and Hook, 1978). They vary in the exact composition of
the sugar residues and are often sulphated e.g. dermatan sulphate,
chondroitin sulphate. Figure 1.1 shows a simplified representation of
the proteoglycan structure.
As many as one hundred GAG chains bind to a glycoprotein
core and the glycoproteins themselves associate with another large
glycosaminoglycan, hyaluronic acid, probably through linking
proteins. There may be between fifty and one hundred proteoglycans
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non-covalently bound to each hyaluronic acid molecule (Uldbjerg and
Ulmsten, 1990; Danforth et al., 1974; Uldbjerg et al., 1983c).
Proteoglycan Protein Core
S Linking Protein Between Hyaluronic Acid and Proteoglycan Core
Glycosaminoglycan
Figure 1.1 Representation of a section of proteoglycan complex
While the exact function of the proteoglycans is not clear it has
been shown that the protein core of dermatan sulphate develops a
relationship with collagen fibres and binds to them at specific points
at 64nm intervals (Scott and Orford, 1981), corresponding to the
banding of collagen fibres seen histologically. The GAG sidechains are
also able to interact with the collagen or with other sidechains and
appear to coat the collagen fibres binding them together to form large
bundles of collagen (Uldbjerg and Danielsen, 1988). Thus the collagen
is embedded in a network of protein and carbohydrate and it seems
that the function of the proteoglycans may be to coordinate the
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orientation of collagen fibres (Lindahl and Hook, 1978) and thus to
increase the strength of the connective tissue matrix.
The proteoglycans are also able to interact with other
macromolecules and the small amount of elastin that is present is
bound into the ground substance in association with the collagen and
GAGs (Lindahl and Hook, 1978).
Smooth Muscle
After Danforth published his findings in 1947 (Danforth, 1947)
claiming to have observed a fibrous tissue with comparatively little
smooth muscle, relative to the uterine corpus, Hughesdon
(Hughesdon, 1952) claimed that the technique was at fault and that
the muscular portion was lost when dissecting the tissue. Danforth
then refuted these claims (Danforth and Evanston, 1954). While
others have shown that the cervix does contain smooth muscle, in
varying proportions between its proximal (vaginal) and distal (uterine)
regions, and that it does confer some contractile properties on the
cervix, its function is unclear (Rorie and Newton, 1967; Uldbjerg and
Ulmsten, 1990; Schwalm and Dubrauszky, 1966; Hillier and Karim,
1970). It is considered insufficient to affect significantly the resistance
of the cervix to dilatation. It may, however, have a role in returning
the cervix to the nonpregnant state after delivery.
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Changes in the Cervix Associated with Pregnancy
Physical Changes
During pregnancy there are changes in the cervix that are
obvious to the clinician. Early on there may be some hypertrophy, it
becomes vascularised and takes on a blue colour but remains
relatively firm (Liggins, 1978; Calder, 1981; Danforth, 1983).
Johnstone and colleagues (Johnstone et al., 1974) demonstrated an
increase in the diameter of the cervical lumen in the first few weeks
and this may be evidence that the cervix is enlarged. During the
second half of pregnancy the cervix softens but retains its closed
structure and remains resistant to forced dilatation (Liggins, 1978).
Gestation
Figure 1.2 Representation of the changes in the cervix in relation to
the uterus. Towards the end of the pregnancy the distinction between
the uterine corpus and the uterine cervix becomes progressively less
obvious as the cervix is "taken up."
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There is then little outward change in appearance until the last few
weeks of pregnancy when the early stages of ripening become evident.
The tissue becomes softer and distensible and begins to efface, that is,
it shortens and becomes less obvious as a separate entity as if the
endocervical lumen opens to become part of the uterine cavity,
following the contours of the uterus (Calder, 1981); this is represented
diagrammatically in figure 1.2. When the cervix is ripe it is completely
effaced and subsequently dilates to 10cm or more in order that the
fetus can be expelled.
Histological Changes
Histologically, the changes in the cervix are every bit as radical
as those required of it physically. This is hardly surprising in light of
the fact that the cervix is not merely relaxing as a muscular sphincter
would.
There are dramatic changes in the connective tissue the most
obvious of which is the reorganisation, or more correctly the
disorganisation, of the collagen fibres. In the nonpregnant and early
pregnant cervix many collagen fibres with the same orientation are
arranged in tightly packed bundles (Uldbjerg and Ulmsten, 1990;
Uldbjerg et al., 1983b; Rath et al., 1988b; Junqueira et al., 1980;
Pariy and Ellwood, 1981). These associations between the collagen
fibres are considered to give the cervix its great strength and rigidity.
The dissolution of the regimented collagen bundles is central to the
ripening of the cervix and the conversion to the resulting soft,
dilatable organ.
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Pany and Ellwood studied the cervical connective tissue of the
sheep and showed that even at 130 days gestation the cervix still had
a highly organised collagen fibre network (gestation in the sheep in
their study was 137-145 days) and that in parturient animals the
collagen became completely disorganised with large interfibrillar
spaces. Their work also showed that the connective tissue quickly
began to return to its previous regimented state with obvious
associations between collagen fibres as early as five days postpartum
(Parry and Ellwood. 1981).
In human cervix the situation is the same, spaces between the
collagen fibres appear at term and the fibres become irregular and
fragmented (Junqueira et al., 1980; Rath et al., 1988b; Minamoto et
al., 1987; Kokenyesi and Woessner, 1990; Ulmsten, 1988b).
Estimations of the collagen content of the cervix have been carried out
by Junqueira using picrosirius red staining. The stain is said to
specifically detect polymerised collagen when using a polarised light
source (Junqueira et al., 1979). The results showed that there was a
massive reduction in the level of similarly oriented collagen fibres, the
intrapartum tissue possessing only 8.3% of the degree of organisation
found in the nonpregnant specimens (Junqueira et al., 1980). A
reduction in the diameter of the collagen fibres was also noted and the
appearance of an amorphous material between them was suggested to
be due to the products of degradation.
Other microscopically observed events include the activation of
the cervical fibroblasts and the infiltration of the cervix by
polymorphonuclear leucocytes at term. Basset found fibroblasts to be
more active in sheep cervix (Basset, 1958) as did Parry (Parry and
Ellwood, 1981) and Liggins suggested that cervical ripening depends
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on changes in the functioning of fibroblasts (Ligglns, 1981; Liggins,
1978). While there is some debate over the role the fibroblasts play in
changing the state of the connective tissue, it is apparent that
clinically used methods of promoting cervical ripening also promote
fibroblast activity (Rath et al., 1988b; Uldbjerg et al., 1981).
Several reports ofwhite blood cell infiltration of the cervix have
been made. Junqueira's team observed that the fibroblast was the
most abundant cell in the human cervix but that during labour there
was an increase in cell numbers with the appearance of mast cells
and macrophages but predominantly neutrophilic polymorphonuclear
leucocytes (Junqueira et al., 1980). They found that once within the
cervical tissue these neutrophils degranulated and the collagen fibres
surrounding them disappeared. The function of the mast cells is
unclear but they have been shown to stimulate collagenase secretion
by fibroblasts (Dabbous et al., 1986). Two peptides of eosinophilic
origin are said to modulate proteoglycan metabolism in vitro. These
have been found in human, term cervix but not in nonpregnant or
early pregnant tissue. It has been suggested that this indicates that
eosinophils may also be involved in cervical ripening (Uldbjerg and
Ulmsten, 1990) and they have been found in rat and guinea pig cervix
at term (Luque and Montes, 1989; Liggins, 1981).
Minamoto et al. have shown that polymorphonuclear leucocytes
invade the cervix at term. They observed them in clear spaces between
the collagen fibres, possibly indicating degradation of the surrounding
collagen (Minamoto et al., 1987). Another group has also seen
leucocyte infiltration of the cervix during dilatation and parturition
(Rath et al., 1988b) and found cells devoid of granules which they
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suggest indicated that enzymes had been released into the cervical
stroma.
A team from Japan found fat droplets in fibroblasts at term and
less so earlier in pregnancy, but whether this signifies increased
activity in these cells is not clear. They also claim to have observed
leucocyte infiltration at term but only in the glandular tissue, at the
same time showing general collagen dispersal in the cervix (Yoshida
and Manabe, 1990).
Finally, a French group has extracted leucocytes from maternal
blood, stimulated them and then, using a stereotactic device to
accurately locate a syringe needle, they injected the woman's own
cells into her cervix in an effort to bring about cervical ripening. They
appear to have obtained a success rate of about 40% (Michelet et al.,
1986).
Biochemical Changes
The biochemical alterations which accompany the histological
changes are many and varied and some are still in dispute.
Collagen
Cervical collagen has been assessed by many different workers,
not only in terms of the amount of collagen but also the ease with
which it is degraded.
Various different parameters have been used to determine the
changes that occur in collagen concentration in the cervix. It has been
expressed in terms of the wet weight of the tissue, in terms of the dry
weight and also in terms of the defatted, dry weight.
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As a percentage of cervical protein collagen constitutes 82% in
nonpregnant human tissue and only 52% of pregnant cervix (Danforth
and Buckingham, 1973). Ito showed that the amount of collagen in
defatted, dried cervical tissue was almost 50% lower in term cervix
than in nonpregnant cervix (Ito et al., 1979). The level of collagen, as a
fraction of the wet weight, has been shown to fall in pregnancy
(Ulmsten, 1988b), the same author showing that as a fraction of the
dry weight there was also a reduction in collagen concentration.
Uldbjerg's group showed that the collagen content was significantly
reduced as early as ten weeks into pregnancy, when measured as a
percentage of the wet weight (Uldbjerg et al., 1983b; Uldbjerg et al.,
1985). Kleissl et al. found an overall reduction in the concentration of
cervical collagen per unit weight of protein (Kleissl et al., 1978). In the
mouse it has also been shown that the cervical collagen concentration
drops during pregnancy, reaching its lowest at term (Rimmer, 1973)
with a similar situation in rats (Kokenyesi and Woessner, 1990).
Another study in rats equated the fall in collagen concentration with
the reduction in tensile strength and increase in extensibility of the
cervix (Zarrow and Yochim, 1961). Findings supporting the same
circumstance in the human have been made, the proportion of
collagen being higher in women in labour with unripe cervices
compared to those in labour with favourable cervices (Uldbjerg et al.,
1983b; Ekman et al., 1986). In fact it was shown that the lower the
concentration of collagen the faster the dilatation of the cervix
proceeded (Uldbjerg et al., 1983b).
Von Maillot and Zimmerman could not find a significant change
in the amount of collagen when expressed as a fraction of the dry
weight of the cervical tissue (von Maillot and Zimmermann, 1976).
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Despite the difficulty of assessing the mass of the whole human cervix
at term, Ito et al. claim that they found the total collagen in the
pregnant cervix to be similar to that in the nonpregnant cervix (Ito et
al., 1979).
Although the bulk of the evidence suggests that the
concentration of cervical collagen falls in pregnancy it has been
reported that the absolute quantity of collagen in the cervix increases
in the sheep, the rat and the mouse (Fosang and Handley, 1988;
Golichowski, 1980; Kokenyesi and Woessner, 1990; Rimmer, 1973).
The changes in the concentration of collagen are accompanied
by changes in solubility and changes in its structural integrity.
The proportion of collagen soluble in aqueous solution has been
shown to increase from about 30% of the total collagen in the
nonpregnant cervix to over 50% in the pregnant cervix (von Maillot
and Zimmermann, 1976). Danforth found that the water soluble
fraction of the solid material in human cervix was raised from 5% in
nonpregnant tissue to 84% postpartum (Danforth et al., 1974), and
that the proportion of insoluble collagen in the solid extract of the
cervix fell dramatically between the nonpregnant and the postpartum
samples. Kleissl et al. did not find a difference between term pregnant
and nonpregnant women with regard to the percentage of collagen,
relative to the total protein, found in the soluble fraction of the
cervical tissue. In the same fraction, however, they did observe a
greater degree of collagen breakdown products in the samples from
pregnant patients (Kleissl et al., 1978). They also noted that the
amount of collagen in the insoluble fraction of the cervical tissue fell
from 75% of the total protein to 35%. Although Ito observed very little
solubility in acetic acid his group found that the proportion of the
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total collagen appearing in an acetic acid solution containing pepsin,
was almost 94% in term pregnant women compared with only 51% in
nonpregnant controls (Ito et al., 1979), and that the degree of
insoluble collagen was much lower at term. Uldbjerg's group obtained
similar results, little extractability in acid but large increases in the
presence of pepsin, and a significant reduction in the fraction of
collagen that was insoluble (Uldbjerg et al., 1983b). In a subsequent
publication Uldbjerg found no difference in the extractability of
cervical collagen in acetic acid plus pepsin as the result of pregnancy,
and no change in the proportion of the collagen that was intact
(Uldbjerg et al., 1985) despite the reduction in total collagen,
mentioned above, that they reported in this paper. He suggested this
indicated that the collagen lost was removed rapidly once degraded,
however this is at variance with the findings of Kleissl et al.
The crosslinks within the collagen are important in terms of
stability (Veis, 1980) and the fewer there are the more easily degraded
the collagen. Old collagen contains more crosslinks than new and is
therefore less soluble (Uldbjerg and Ulmsten, 1990). This suggests
that the reduction in the level of insoluble collagen is due to the
replacement of old collagen with new collagen. Examination of the
crosslinks has shown that the material containing the most crosslinks
persists longest in term cervix, the collagen with fewer crosslinks
probably having been digested (Kleissl et al., 1978). The lower the
number of crosslinks the more susceptible the protein is to
collagenase digestion (Veis, 1980).
Fosang and Handley studied collagen synthesis in the sheep as
the conversion of 3H-proline to hydroxyproline and found that
although as a whole the term cervix doubled its capacity for collagen
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synthesis compared with nonpregnant, when measured relative to the
wet weight or the dry weight there was no difference (Fosang and
Handley, 1988).
Proteoglycans
Glycosaminoglycan levels in the cervix have been shown to
increase dramatically in pregnancy. Danforth et al. measured the
concentration of hexosamine, present in all GAGs, in relation to the
dry weight of the tissue and found substantially more GAGs in
postpartum cervix than nonpregnant cervix (Danforth et al., 1974).
The proportions of different GAGs changed, chondroitin sulphate and
dermatan sulphate approximately doubling but keratan sulphate
seemingly increasing 8-fold (Danforth et al., 1974). However, keratan
sulphate was not determined directly but by assuming that the
fraction of GAGs that did not contain uronic acid was keratan
sulphate, since this glycosaminoglycan is known to be uronate free.
The same group also observed the appearance of an unidentified
component and proposed that it may have been another GAG since its
degradation products were rich in sugar residues (Danforth et al.,
1974). An increase in the proportion of hyaluronate was reported in
the human cervix at term and postpartum by von Maillot et al., who
also showed an increase in the proportion of keratan sulphate and a
decrease in chondroitin sulphate and dermatan sulphate (von Maillot
et al., 1979). They saw no change in unsulphated chondroitin. Others
have not even been able to demonstrate the presence of keratan
sulphate (Uldbjerg et al., 1983a).
Golichowski assessed GAGs by measuring uronate levels. He
did so because uronic acid is only found in significant quantities in
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GAGs whereas hexosamine is also found in glycoproteins. Keratan
sulphate does not contain uronate but he suggests that the cervix is
unlikely to contain this GAG (Golichowski, 1980) because other
similar connective tissues do not. A large increase in uronate per
cervix was measured in rats as pregnancy developed but the
concentration of glycosaminoglycan (uronate) in terms of the dry
weight of the tissue did not change. He also found that there was an
increase in the proportion of hyaluronic acid to total GAG during
pregnancy. Assessment of collagen levels allowed him to show that
the ratio of collagen to GAG fell slightly during pregnancy (i.e.
proportionately more GAG to collagen) (Golichowski, 1980). A study in
rats showed that the concentration of dermatan sulphate increased
relative to collagen as pregnancy continued (Kokenyesi and Woessner,
1990) and von Maillot's work also revealed a similar trend in human
cervix, the GAG to collagen ratio showing an increase in favour of the
GAGs (von Maillot et al., 1979).
Junqueira measured GAGs in human cervix using
electrophoresis and found a small increase in the proportion of
chondroitin sulphate but a decrease in dermatan sulphate and no
change in heparan sulphate (Junqueira et al., 1980). Uldbjerg
assessed hexosamine to quantify GAGs and observed a drop in the
concentration of sulphated glycosaminoglycans, in terms of tissue wet
weight, in late pregnancy with similar results for hyaluronic acid
(Uldbjerg et al., 1983b). However, from his results it is apparent that
the concentration of collagen fell by a greater proportion than did the
GAGs, thereby making the ratio of GAGs to collagen increase.
Danforth measured the total hexosamine levels then isolated
the GAGs and assessed the hexosamine values once more. He then
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assumed that the difference between the two figures constituted the
level of glycoprotein that was present since hexosamine is also
associated with these proteins (Danforth et al., 1974). The results
indicated that there was a drop in the amount of glycoprotein present
in pregnant tissue (per mg diy, defatted weight). Others have also
indicated that the level of glycoproteins increases in the pregnant
state (Uldbjerg and Ulmsten, 1990).
Cervical tissue from sheep was incubated with 35S-sulphate in
order to examine its incorporation into sulphated proteoglycan. The
results indicated that at term there was far greater proteoglycan
synthesis than in the early pregnant and nonpregnant ovine cervix
(Fosang and Handley, 1988). The same group carried out similar
experiments using 3H-glucosamine to assess hyaluronate synthesis
and once again found that term cervix produced much more
hyaluronic acid than nonpregnant tissue.
While it may not be altogether clear what is actually happening
with regard to the glycosaminoglycans it is obvious that some changes
are occurring. Additionally, the plasma concentration of an enzyme
that is capable of degrading GAGs, (3-D-N-acetylglucosaminidase, has
been shown to increase with gestation and to increase slightly more
just before term in humans (Takenaka et al., 1991). This supports the
idea that remodelling of the cervical tissue occurs throughout
pregnancy and that there may be a significant increase in connective
tissue degradation just prior to delivery.
It is suggested that hyaluronate's hydrophilic properties, its
relatively low level of interaction with protein and its extended
structure may promote the appearance of large gaps between the
collagen fibres (Golichowski, 1980). Chondroitin sulphate has been
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shown to bind to collagen and much more strongly than keratan
sulphate (Obrink, 1973), thus lower levels of chondroitin sulphate and
higher levels of keratan sulphate may result in loosening of the
connective tissue.
Water
Danforth et al. found the nonpregnant cervix to be
approximately 74% water and the postpartum cervix to be 78% water
(Danforth et al., 1974). Uldbjerg et al. measured the water content of
nonpregnant cervix as almost 81%, the late pregnant cervix as 86%
and postpartum tissue as 87% water (Uldbjerg et al., 1983b). Both
these groups assessed the water content by the difference in the wet
weight and the dry weight (dried to a constant weight). Kleissl weighed
the wet tissue and extracted the collagen followed by lyophilisation of
the collagen extract and residual tissue. This revealed 73% of the
nonpregnant cervix to be water and 80% of the intrapartum cervix to
be water (Kleissl et al., 1978). Thus it appears that there is a small
increase in the proportion of the cervix that is water.
Collagenolysis
The breakdown of collagen requires the action of collagenase or
leucocyte elastase as intact collagen molecules are resistant to general
proteolysis. However, once the site-specific cleavage is performed by
collagenase the products can denature at body temperature and the
collagen is amenable to digestion by other proteases present in the
tissue (Uldbjerg and Ulmsten, 1990).
Collagenase has been reported in the human cervix as free,
active enzyme, inactive enzyme complexed with a2-macroglobulin or
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as an inactive form bound to an unidentified low molecular weight
fragment (latent collagenase) (Kitamura et al., 1979; Kitamura et al.,
1980). A procollagenase has also been described and it is therefore
likely that this form also exists in the cervix (Rajabi et al., 1991;
Uldbjerg and Ulmsten, 1990; Clark and Cawston, 1989).
Measurement of collagenase activity has been carried out using
synthetic polypeptides. These, however, are liable to degradation by
other enzymes and also by collagenase complexed with
a2-macroglobulin (Kitamura et al., 1979; Rath et al., 1987). It is
therefore more appropriate that collagen be used as the substrate and
many investigators are now doing this.
Kitamura et al. (Kitamura et al., 1979), relating their results to
the wet weight of the tissue, found an increase in the degradation of a
synthetic peptide (DNP-peptide) in extracts of pregnant human cervix
compared to nonpregnant. Collagenase-a2-macroglobulin complex
activity and free enzyme activity increased but latent collagenase
activity was unchanged (latent enzyme was activated with
aminophenylmercuric acetate). Free, active collagenase was also
shown to increase using collagen itself as the substrate, and there
was no change in latent collagenase. Uldbjerg's group used
DNP-peptide to assess the overall collagenolytic activity of human
cervix and found it increased from the nonpregnant to the term state
(Uldbjerg et al., 1983b). Rath has studied collagen breakdown by
extracts from human cervix and found that collagenolytic activity was
higher postpartum than in early pregnant or nonpregnant women and
that there was no difference between the latter two groups (Rath et al.,
1988a; Rath et al., 1987). He subsequently published more material
showing that human cervical extracts contained collagenase activity,
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but that any increase was not evident even in the early stages of
labour (2-3cm dilatation). However, a significant increase had
occurred by the time the cervix had dilated to 6-8cm. This paper also
showed collagenase activity to have dropped again to prelabour levels
immediately after delivery (Osmers et al., 1990).
Another group has looked at the collagenase activity at term in
women using biopsies taken at caesarean section. They were from
women in labour with dilated cervices (4-8cm) or women not in labour
with closed cervices (0-2cm). These workers collected cervical and
lower uterine segment tissue and found no differences in enzyme
activity in each in the absence of labour, suggesting that both may
behave similarly during labour. In the group of patients in active
labour, lower uterine segment biopsies were regarded as safer and
easier to obtain. The results produced using those samples showed
that there was a thirteen fold increase in the level of degradation of
the collagen substrate associated with labour and cervical dilatation
(Rajabi et al., 1988).
It is apparent that there is an increase at the end of pregnancy
in collagenase/collagenolytic activity. Since the fibroblast is the major
cellular component of the cervix and is known to produce collagenase
(Clark and Cawston, 1989; Osmers et al., 1992) it was considered the
most likely candidate to provide this collagenase. However, a study on
the origins of the collagenase detected in the cervix has been carried
out recently, using in situ hybridisation and immunohistochemical
techniques. Cervical tissue was treated to extract the mRNA, which
was then probed for fibroblast procollagenase mRNA but this in situ
hybridisation did not reveal the presence of any such messenger
molecules. The immunohistochemical part of the study used an
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antibody specific for human leucocyte collagenase that was previously
shown did not cross react with fibroblast collagenase. This provided
evidence that the polymorphonuclear cells that infiltrated the cervix
contained granules incorporating collagenase and also showed the
presence of collagenase in the connective tissue, outwith the cells
(Osmers et al., 1992). Okamura et al. showed an increase, with
gestation, in the activity of polymorphs in cervical mucus (Okamura et
al., 1988). These results lend support to the observations of Junqueira
who found polymorphs in the cervix with the surrounding tissue
apparently dissolved (Junqueira et al., 1980). Uldbjerg examined
leucocyte elastase by radioimmunoassay and observed an increase
during pregnancy which appeared to continue postpartum (Uldbjerg
et al., 1983b). A Japanese group studied elastase activity in human
cervical mucus and also the histological localisation of this enzyme in
the cervix during pregnancy. They found elastase levels rose during
pregnancy, especially at term, and showed, using
immunohistochemistry, that it was not present in the cervical stroma
of unripe cervix but was present at term (Kanayama and Terao, 1991).
Additionally, polymorph collagenase has been shown to
selectively degrade type I collagen over type III, type I making up 70%
of the cervical collagen. Fibroblast collagenase degrades each type of
collagen equally (Horwitz et al., 1977).
Mammalian collagenases are unable to degrade the protein core
of proteoglycans (Poole, 1980). Therefore, in order to breakdown the
connective tissue there must be other enzymes to digest these
structures. Tissue proteinases have been shown to have this ability,
elastase, cathepsins and metalloproteinases among them (Roughley
and Barratt, 1977; Roughley, 1977; Keiser et al., 1976; Dingle et al.,
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1977; Sapolsky et al., 1974; Sapolsky et al., 1976). It is generally
accepted that proteinases are secreted in an inactive form (Poole.
1980) and there is evidence that the latent enzyme is activated by
limited proteolysis, collagenase being a good example (Vaes, 1972;
Eeckhout and Vaes, 1977; Werb et al., 1977; Horwitz et al., 1976).
Thus, the proteases may perform the dual functions of activating
collagenase, or other latent enzymes, and breaking down the partially
degraded collagen and connective tissue matrix.
Rath has studied protease activity in human and guinea pig
cervix and although protease activity was detected there was no
measurable increase in pregnancy. Guinea pigs in late pregnancy
showed no increase compared to nonpregnant animals (Rath et al.,
1989), and human cervix from first trimester patients showed no
increase over nonpregnant values (Rath et al., 1987). He has,
however, shown that there is significantly more protease activity in
samples from human cervix taken after normal spontaneous deliveries
(Rath et al., 1988a). Others have also shown that there are proteases
in the extracts of human cervical tissue (Ito et al., 1980; Mori et al.,
1981) and that activity may be increased postpartum (Hutchins and
Parkin, 1981).
There is evidence that enzyme inhibitors are produced by
cervical cells in sheep (Raynes et al., 1988b) and rabbits (Sakyo et al.,
1986b) and by many human tissues (Vater et al., 1979; Stricklin and
Welgus, 1983; Murphy et al., 1981; Welgus and Stricklin, 1983; Dean
and Woessner, 1984; Mercer et al., 1985) therefore they may also have
a role to play in the complex processes of collagenolysis.
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Summary
The following table (Table 1.1) summarises the changes that
have already been described.











Replacement of old collagen with new collagen
(fewer cross-links).
Increased concentration of GAGs (GAG:Collagen
ratio increased in favour of GAGs).
Alterations in the proportions of individual GAGs.
Increase in concentration of large GAG hyaluronate.
Increased collagenase.
increased Elastase.
Increased proteases (samples taken postpartum).
Increased water content (may be due to hydrophilic
properties of hyaluronate).
Fibroblast activation: source of new collagen, GAGs
and collagenase and proteases.
Infiltration of cervix by leucocytes: source of
collagenase, elastase and proteases.
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Methods Used Clinically to Promote Cervical Ripening and Labour
— Clues to Local Mechanisms Involved in Cervical Ripening
Membrane Stripping
The placing one or two fingers inside the uterine cavity and
separating the fetal membranes from the lower part of the uterus by
sweeping the fingers through a full circle has been employed to induce
labour and cervical ripening. This is not a particularly useful method
of cervical ripening when the cervix is totally unripe and the patient is
nulliparous, the cervix being insufficiently dilated to make it possible.
Where the patient is multiparous and effacement of the cervix has
begun it is often more successful, although the success rate is
inconsistent (Trofatter, 1992). The theory as to its efficacy as a
method of inducing the required changes in cervical state relies on the
release of endogenous prostaglandins (Porto, 1989) from the
membranes, decidua or the cervix itself, or possibly all three, and is
based on the fact that prostaglandin levels measured in plasma
increase following vaginal examination or amniotomy (Mitchell et al.,
1977; Sellers et al., 1980) presumably through mechanical
disturbances. Hillier and Coad have shown that stretching the human
cervix can cause the release of PGE2 and PGF2a (Hillier and Coad,
1982).
Amniotomy
This deliberate rupturing of the membranes is often used to
promote labour (Shime et al., 1984; Gibb et al., 1982; Hauth et al.,
1980). However, this is only appropriate where the cervix is already in
a favourable condition because the mother is then committed to
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deliver and if the cervix is unripe when amniotomy is performed
maternal and fetal complications may ensue (Satin and Hankins,
1989; Calder, 1980; Calder, 1990).
Foreign Body Mediated Dilatation
The insertion of objects into the cervical canal in order to dilate
it is claimed to have been mentioned in the writings of Hippocrates
400 years BC (Trofatter, 1992; Johnson, 1989). However, there are
problems associated with using mechanical force to increase the
diameter of the cervix. These are mainly concerned with damaging the
tissue, by tearing it (Hulka and Higgins, 1961; Hulka et al., 1974),
which can result in permanent injury (Johnstone et al., 1976) leading
to cervical incompetence and a higher risk of abortion or preterm
delivery in future pregnancies (Margolis and Goldsmith, 1972;
Pnatelkis et al., 1973; Papaevangelou et al., 1973; Pickering and
Forbes, 1985).
In the past many items have been used in attempts to dilate the
cervix including fingers, sponges, bark and canvas, but probably the
best known were derived from seaweed (Johnson, 1989). The
seaweeds in question were Laminaria japonica or digitata and the
basis of their action seems to rely on the absorption of fluid and
subsequent expansion, resulting in a gradual increase in diameter
(Margolis and Goldsmith, 1972). These dilators are referred to as
tents, a term defined medically as a conical expansile plug of soft
material used for dilating an orifice or for keeping a wound open
(Johnson, 1989).
The use of such dilators has not been particularly popular in
Britain but they are used by American, Japanese and Scandinavian
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clinicians (Johnson, 1989). The reasons for not using them stem from
the fear that by introducing foreign bodies into the endocervix and
leaving them in situ for prolonged periods there is an increased risk of
infection, however the risk does seem to be minimal, when properly
handled, and with the introduction of synthetic dilators the sterility of
the products can be guaranteed (Killick et al., 1985; Johnson, 1989;
Porto, 1989).
Apart from Laminaria tents there are also available Dilapan and
Lamicel tents. Dilapan tents were designed to act like Laminaria but
to be free of the stigma of infection and lack of consistent action. They
are made of a hydrophilic polymer and expand as they absorb water
in a predictable manner. Lamicel is a polyvinyl alcohol sponge
impregnated with magnesium sulphate. It does not exert enough force
to dilate the cervix and its mode of action is not clear (Johnson, 1989).
Although it is commonly believed that it may partially depend on
dehydrating the tissue this is disputed by Johnson.
In general, the mechanism behind the dilatation caused by
cervical tents is unclear. Laminaria have been shown to result in an
endocervical lumen with a greater diameter than the expanded dilator
itself (Stubblefield, 1980). Thus, there must be some additional factor
involved and the main contenders appear to be the prostaglandins
that are released by virtue of the mechanical disturbance (Olund et
al., 1984; Ye et al., 1982) or by the presence of a foreign body that
provokes an inflammatory reaction (Johnson, 1989) similar to that
considered to take place in natural cervical ripening (Liggins, 1981).
Lamicel contain magnesium sulphate, which is known to cause
relaxation of smooth muscle (Johnson, 1989), but the smooth muscle
content of the cervix is considered to be negligible. Even though there
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have been reports of muscular/contractile function in cervical tissue
the level was minimal and would be very unlikely to participate to any
significant degree in dilatation of the cervix (Hillier and Karim, 1970;
Najak et al., 1970; Uldbjerg and Ulmsten, 1990; Danforth and
Evanston, 1954).
So, even now it is still unclear how these dilators bring about
their effects but their use continues and it is interesting that in a trial
comparing PGE2 and laminaria for the dilatation of the cervix prior to
termination up to 16 weeks of pregnancy, the laminaria tents
appeared to produce better results (Killick et al., 1985).
The use of a Foley catheter to bring about cervical dilatation has
also been examined. The catheter, with a balloon attached, is passed
through the cervix into the uterine cavity and the balloon inflated. The
catheter is then fastened to the thigh with tape in order to produce a
downward force to pull it through the cervix and this has been shown
to cause dilatation of the cervix (Porto, 1989). Calder et al. established
a technique of combining the Foley catheter with prostaglandin
therapy (Calder et al., 1976).
A group working in this area have designed a device consisting
of two balloons one of which sits inside the uterus and one
intravaginally, (i.e. one at either end of the cervix). Their device is
intended to close off the cervix in order to retain an application of
prostaglandin containing gel administered through the catheter, so
that the effects of the PG are confined to that organ. The balloons
were inflated, the gel passed into the endocervix and the catheter
taped to the patients thigh. They found that cervical ripening occurred
and that the double balloon device on its own may have produced the
ripening effect (Atad et al., 1991). Observations have been made which
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suggested that the presence of the gel only (with no prostaglandin) in
the endocervical canal may produce cervical ripening (Keirse et al.,
1983).
Pharmacological Techniques
The use of pharmacological agents will be discussed in the next
section.
Summary
The induction of cervical ripening is not a modern problem and
some of the methodology employed today dates back centuries. The
most obvious technique is that of inserting expanding plugs into the
cervix and is still in use. However, there are now products with
predictable physical (swelling) characteristics that the clinician can be
sure are sterile and therefore less likely to cause infection. Some of
these dilators have been shown to be too weak to stretch the cervix or
shown to cause dilatation of the cervix to a greater diameter than
themselves. Membrane stripping, amniotomy and the dilators are all
considered to rely to some extent on the endogenous production of
prostaglandins, mechanical disturbance of the tissue resulting in
prostaglandin production. The role of prostaglandins will be more fully
discussed in the next section.
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Control of Cervical Ripening
The factors controlling the changes that occur in the cervix
during pregnancy are complex and not fully understood. Hormones,
including oestrogen, progesterone and relaxin, have been implicated
as have the products of arachidonic acid metabolism, principally the
prostaglandins.
The following outlines what is known about those factors and
their effects on the cervix and cervical ripening.
Prostaglandins
Prostaglandins were first discovered in the 1930s in human
seminal fluid and in extracts of,the accessory sex glands of the ram.
They were found to have a stimulatory action on isolated uterine and
intestinal smooth muscle but to cause a drop in blood pressure
following intravenous injection and it was von Euler, working in
Sweden, who identified the active component as lipid soluble and
introduced the term prostaglandin (Kurzrok and Lieb, 1930; Von
Euler, 1935; Bowman and Rand, 1980).
Prostaglandins are derived from 20 carbon, polyunsaturated
fatty acids and are included in the group of biological factors known
as the eicosanoids (Smith, 1986). The main precursor of the
prostaglandins is arachidonic acid, a major fatty acid found in cell
membranes and abundant in reproductive and fetal tissue (Crawford,
1983; Keirse, 1978) within lipid pools such as the phospholipids,
cholesterol esters or glycerol esters (Irvine, 1982; Blackwell and
Flower, 1983).
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Because of their low serum concentrations (<10-nM), the lack of
a specific organ for their synthesis and the fact they are produced by
many tissues, the occurrence of catabolic mechanisms in the lung,
liver and kidney which prevent prostanoids from building up in the
circulation and because they have been found to act both on the cells
in which they are synthesised and often on the cells which lie in the
surrounding area, the prostaglandins are regarded as local hormones
(Smith, 1986).
Prostaglandin Synthesis
The first stage in prostaglandin synthesis involves the release of
arachidonic acid from the membrane stores and the enzymes
responsible for this are the phospholipases (phospholipase Ai, A2, C
and D) (Blackwell and Flower, 1983; Stryer, 1980; Dennis, 1987; Van
den Bosch, 1980). Once free, the arachidonic acid can be metabolised
via three pathways 1) by cyclooxygenase to prostaglandins, 2) by
lipoxygenase to leukotrienes or 3) by epoxygenases to epoxides. The
element considered in this thesis is the first of these.
The original naming of the prostaglandins was based on their
partitioning into ether (PGE series) or into phosphate buffer (PGF
series, from the Swedish fosfat) and the numbers that are included in
the identification of prostaglandins indicate the number of double
bonds contained in the carbon chains attached to the cyclopentyl
portion of the molecules (Bowman and Rand, 1980). Figure 1.3
represents prostaglandin E2. The E group of prostaglandins is now
defined as those which possess a keto group at position 9 and a
hydroxyl group at position 11.
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0
Figure 1.3 Prostaglandin E2
Cyclooxygenase (prostaglandin endoperoxide synthase or
PGH-synthase) converts arachidonic acid to the prostaglandin
endoperoxide PGH2 which is further metabolised to various different
products by several enzymes (Smith, 1986; Kulmacz, 1987; Coleman
et al. 1990). The prostaglandins that have been most important in
cervical ripening are PGE2 and PGF2a (Keirse, 1979; Ulmsten, 1986;
Calder, 1986), however, PGF2a is much less potent than PGE2 and
would only be used in clinical situations where PGE2 is unavailable
(Calder, 1990).
PGH2 is converted to PGE2 by PGH-PGE isomerase and to
PGF2a by a reduction process that was originally thought only to
occur without the involvement of an enzyme, enzyme inhibition or
absence resulting in PGF2C1 formation (Bakhle, 1983; Smith, 1986). It
has been shown that PGF2a synthesis does take advantage of enzymic
catalysis also (Lin and Jarabak, 1978; Watanabe et al., 1985). PGH2
can also converted to prostacyclin (PGI2) and to thromboxane (TXA2)
by specific isomerases (Smith, 1986).
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Prostaglandin Receptors
Prostaglandins act via receptors in cell membranes. Different
receptors exist for each of the prostaglandins and several types can be
found on the same cell (Feigen and Chapnick, 1979; Coleman et al.,
1980; Coleman et al., 1984; Carsten and Miller, 1980; Kennedy et al.,
1982; Kennedy et al., 1983). Once the PG is bound to a receptor a
second messenger system is brought into operation, both the
adenylate cyclase and the phosphatidylinositol pathways having been
found to be involved (Kozawa et al., 1992; Elgendy and Hausman,
1990; Goureau et al., 1992; Toriyama et al., 1992). In fact, it has been
shown that PGE2 can activate both mechanisms and it has been
proposed that there are two distinct PGE2 receptor subtypes, one
linked to each of these two second messenger systems (Kozawa et al.,
1992; Goureau et al., 1992; Toriyama et al., 1992). PGF2a appears to
be linked to the phophatidylinositol pathway and both it and PGE2
increase intracellular calcium ion levels (Goureau et al., 1992;
Toriyama et al., 1992; Toriyama et al., 1990). Inhibition or stimulation
of cAMP can occur depending on the tissue and the prostaglandin.
Regulation of the action of PGs also depends on the up and down
regulation of receptor numbers, the activity of other molecules in the
cell membranes and on modification of intracellular calcium
concentrations (Robertson, 1986).
Prostaglandin Degradation
In the main, metabolism of prostaglandins to their inactive
metabolites occurs via the enzyme 15-hydroxy-prostaglandin
dehydrogenase (PGDH) which reduces the hydroxyl group attached to
the 15th carbon atom to a ketone group. This is regarded as the rate
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limiting step in PG catabolism and results in the loss of most of the
activity of the prostaglandins. The 15-keto-prostaglandin is then
further reduced and oxidised by different enzymes (Hansen, 1976).
The lungs liver and kidneys are rich in PGDH and prostaglandins in
the circulation are metabolised on their passage through these organs
(Bowman and Rand, 1980).
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The Cervix and Prostaglandins
Clinical Experience
For some time the ripening effects of prostaglandins on the
cervix have been recognised (Shepherd et al., 1976; Calder et al.,
1977), first becoming apparent to obstetricians using them for the
induction of labour at term. Since the mid 1970s there have been
many reports of cervical ripening associated with the use of
prostaglandins and they are now widely used in obstetrical and
gynaecological procedures to promote cervical softening and dilatation
(MacLennan and Green, 1979; MacKenzie and Embrey, 1977; Wiqvist
et al., 1986; Ulmsten, 1988a; Elder, 1988; Lyndrup et al., 1991;
Brindley and Sokol, 1988; Rath et al., 1982; MacLennan, 1981).
PGE2 and PGF20C are the prostaglandins used to improve the
status of the cervix but PGE2 is by far the more commonly adopted of
the two because it is more potent, shows greater specificity and is
toxicologically more acceptable (Calder, 1990; MacKenzie and Embrey,
1979; Brindley and Sokol, 1988). Much of the work on PGF2a has
been carried out by MacLennan in Australia because of legal
restrictions on the use of PGE2 (MacLennan, 1981).
The prostaglandins employed clinically are either synthetic
analogues, such as Cervagem™ (16,16-dimethyl-trans-A2-PGE, methyl
ester), or the naturally occurring prostaglandins. Because of the
metabolism of the endogenous prostaglandins analogues were
developed to prolong their activity and allow lower doses to be
administered. However, the use of prostaglandins for cervical ripening
is restricted in term pregnancies to the natural forms because of a
lack of knowledge with regard to the effects of the analogues on the
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fetus. The synthetic derivatives are only used at term in cases of
stillbirth.
Various routes of administration have been used over the years
with varying degrees of success. In early work using prostaglandins
for the induction of labour, the stimulant effect on the uterus was the
desired effect. They were given intravenously, orally and as vaginal
pessaries. Gastrointestinal problems (nausea, vomiting and
diarrhoea), pyrexia and a painful inflammatory reaction at the site of
the intravenous infusion were common side effects (Barr and
Naismith, 1972; Karim and Sharma, 1971; Embrey et al., 1974).
However, this procedure was intended to activate uterine contractions
and was actually only useful in cases where the cervix was ripe.
Current practice for the promotion of cervical ripening tries to limit
the stimulation of uterine activity, ideally not provoking any response
until the cervix is ripened. To this end the best route of administration
seems to be the instillation of the prostaglandin endocervically
(Calder, 1990; Ekman et al., 1983), however, because siting of the PG
within the cervical canal and its retention there can be problematical
(Ulmsten, 1988a) the vaginal route is often used. This requires a
higher does of prostaglandin (Ekman et al., 1983) and because of
greater systemic absorption may result in a slight increase in side
effects (Ekman et al., 1983; O'Brien et al., 1986; Ulmsten et al., 1983).
Prostaglandin Production by the Cervix
It has been shown that the cervix does have the capacity for
eicosanoid synthesis, in vitro at least. Ellwood and co-workers
demonstrated that the ovine cervix was capable of prostaglandin
synthesis (Ellwood et al., 1979) and then went on to show similar
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findings in the human (Ellwood et al., 1980). They found that
pregnant human cervix in a perfusion system produced PGE2, PGF2C1.
PGFM (the metabolised form of PGF2«) and prostacyclin (PGI2, as
determined by stable metabolite levels) but little thromboxane.
Another group, from Sweden, incubated human cervix with
radiolabeled arachidonic acid and observed its conversion to PGE2,
PGF2a and thromboxane but did not detect any prostacyclin
metabolite. They did find evidence of the production of two unknown
compounds which they claimed were higher in term pregnant tissue
compared to first trimester tissue, but they found no correlation
between either the unknown compounds and cervical ripening or the
prostaglandins and cervical ripening (Christensen et al., 1985).
Tanaka et al. observed, predominantly, prostacyclin synthesis by
human cervical homogenates incubated with arachidonic acid and
noted increased activity in postpartum tissue compared with
nonpregnant (Tanaka et al., 1981). They also found small amounts of
PGE2 but no changes were detected. Wallis and Hillier measured
PGE2, PGF2cx and prostacyclin production by nonpregnant human
cervix and found E and F to dominate, at similar levels, with a lesser
degree of prostacyclin output (Wallis and Hillier, 1982). Although
Ellwood found PGFM to be produced by the human cervix (Ellwood et
al., 1980) there is no direct evidence, such as an immunohistological
study, for the presence of PGDH in this tissue.
Human cervical strips have been shown to produce
prostaglandins in response to passive mechanical stretching and the
authors suggest that this could also be the case in vivo when uterine
contractions pull the cervix (Hillier and Coad, 1982). Anderson and
Turnbull showed that the uterus is contracting, whether or not the
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mother is aware of it, several weeks before the onset of labour
(Anderson and Turnbull, 1969). This provides a potential mechanism
whereby the physical forces exerted by the uterus could stimulate
prostaglandin production by the cervix and therefore play a part in
prostaglandin induced remodelling of the cervical connective tissue.
Human cervix incubated with arachidonic acid has also been
shown to produce HETEs (hydroxyeicosatetraenoic acid) (Saeed and
Mitchell, 1982b; Flatman et al., 1986) products of the lipoxygenase
pathway. However, it has been shown that their precursors HPETEs
(hydroperoxyeicosatetraenoic acid) can also be produced by PGH
synthase (cyclooxygenase) (Hecker et al., 1987). Other researchers
have also established that HETE production occurs in human cervical
biopsy material (Heidvall et al., 1992).
There is evidence that receptors for PGE exist in the cervix
(Giannopoulos et al., 1985). It is not known whether the numbers
increase at term but it has been suggested that women who do not
respond to prostaglandin therapy may have a receptor deficiency
(Ulmsten, 1988a).
The non steroidal anti-inflammatory aspirin is an inhibitor of
prostaglandin synthesis and has been found to prolong pregnancy
and labour in humans (Lewis and Schulman, 1973). Indomethacin,
another prostaglandin synthesis inhibitor, has been shown to
suppress contractions of the uterus provoked by stretching (Manabe
et al., 1983). It has been suggested the habitual use of such agents
during pregnancy, as reported by Collins and Turner (Collins and
Turner, 1975), may be a contributing factor in cases of an unripe
cervix at term (Calder, 1980). Ledger et al. found that inhibiting
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prostaglandin synthesis with mefenamic acid prevented cervical
ripening from taking place in the sheep (Ledger et al., 1984).
Prostaglandins in Amniotic Fluid
The production of prostaglandins by tissues closely allied to the
cervix may also have an influential effect on its state. An association
between PGE2 and PGF2a levels in amniotic fluid and the ripeness of
the cervix has been observed by Calder, higher concentrations of the
prostaglandins coinciding with a riper cervix (Calder, 1980). Other
workers have also observed that arachidonic acid and prostaglandins
appear in larger quantities in the amniotic fluid in the last stages of
pregnancy. This is suggested to be due to an increase in PG synthesis
rather than a decrease in catabolism since the level of the inactive
metabolites as well as the active prostaglandins increases (Keirse et
al., 1974; Keirse et al., 1977b; Keirse et al., 1977a; Reddi et al., 1984).
There have also been reports of increased levels of lipoxygenase
products in the amniotic fluid during gestation and in preterm labour
(Romero et al., 1987a; Romero et al., 1987b; Romero et al., 1989d).
Study of amniotic fluid and its ability to influence prostaglandin
synthesis has suggested that there are substances in it able to
stimulate and inhibit PG production and that the occurrence of these
compounds changes during pregnancy (Cohen et al., 1985;
Rehnstrom et al., 1983; Saeed et al., 1982).
Prostaglandins from the Fetus and Membranes
Prostaglandins found in the amniotic fluid could be derived
from the amnion and the chorion. The chorion possesses PGDH
(prostaglandin dehydrogenase) activity to a greater degree than any
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other tissue whereas the amnion has little or no capacity for enzymic
prostaglandin metabolism (Keirse et al., 1978; Okazaki et al., 1981).
Both have been found to produce prostaglandins and HETEs and
though different researchers reported differing results it seems that
PGE2 is certainly produced by the amnion and the chorion, with some
debate over prostacyclin (Dembele-Duchesne et al., 1981; Casey et al.,
1984; Skinner and Challis, 1985; Olson et al., 1983a; Christensen
and Green, 1983; Saeed and Mitchell, 1982a).
The fetus itself is also a source of prostaglandins (Falkay et al.,
1980). Fetal prostaglandins have been measured in the first voided
urine of neonates (urine collected immediately following delivery,
therefore produced in utero) and shown to be greater during labour
than in caesarean sections in the absence of labour (Casey et al.,
1983a). Human neonatal urine has also been found to contain
inhibitors and stimulants of in vitro PG synthesis (Strickland et al.,
1983; Casey et al., 1983b).
The placenta is another tissue which has been shown to be
capable of producing cyclooxygenase and lipoxygenase derived
products (Duchesne et al., 1978; Dembele-Duchesne et al., 1981;
Saeed and Mitchell, 1982a; Walsh et al., 1985; Mitchell and
Grzyboski, 1987), as is the decidua (Okazaki et al., 1981; Mitchell and
Grzyboski, 1987). Some work has suggested that prostaglandin
production by decidual tissue may rise in labour (Skinner and Challis,
1985), however, other reports have not shown any differences
(Okazaki et al., 1981; Olson et al., 1983b).
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Summary
Thus the prostaglandins that are most commonly detected in
significant quantities are PGE2 and PGF2a and these are probably the
most important PGs in cervical ripening. The source of these
prostaglandins is likely to be the cervix itself and cells of the immune
system involved in the inflammatory response. However, the initiation
of PG production may be provoked by the production of PGs by the
fetus and fetal membranes, which may continue to contribute to PGs
present in the cervix. The uterine body may also be a source of PGs
for cervical ripening.
Mechanism of Prostaglandin Action on the Cervix
The effects of prostaglandins on cervical tissue have been
studied in order to probe the mechanisms whereby they promote
cervical ripening.
While the muscular content of the cervix is low it has been
shown that it can respond to PGE2 and PGF2a- Hillier and Karim
found PGE2 inhibited spontaneous contractile activity and observed
inconsistent stimulatory and inhibitory responses to PGF201 (Hillier
and Karim, 1970; Najak et al., 1970). The significance of this is
unclear; however, it is possible that the relaxing properties of PGE2
may play a minor role in cervical dilatation.
The ripening effect of PGE2 has been shown to be unaffected by
the use of agents that suppress uterine contractions (Insull et al.,
1989; Goeschen et al., 1985) which supports the findings that the
uterine musculature is not an essential element in cervical ripening
(Liggins, 1978).
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It has been suggested that exogenously delivered prostaglandins
stimulate endogenous prostaglandin production (Uldbjerg and
Ulmsten, 1990). Green at al. observed uterine contractions in women
following administration of PGF20C to induce the termination of
pregnancy and found that they continued and increased, even when
the plasma levels of the prostaglandin were falling. They also looked at
PGEM and PGFM plasma levels following PGF2a administration and
found both increased (Green et al., 1981). They suggest that early
uterine activity, and presumably cervical ripening, were due to the
administered prostaglandin and subsequently endogenous production
took over. The inhibition of cyclooxygenase has been shown to
increase the time between PGF2a treatment and abortion (Souka et
al., 1983), supporting the theory that stimulation of endogenous PGs
takes place.
Prostaglandin Actions on Cervical Connective Tissue
Prostaglandins have been shown to affect the connective tissue
of the cervix. Biopsies taken from first trimester human cervices
before and after treatment with PGE2 showed marked disruption of
the regular collagen fibres only fifteen hours after intracervical
application of the prostaglandin (Uldbjerg et al., 1981). These same
workers also noted an increase in GAGs, and in vesicle enrichment
and migration to the plasma membrane of fibroblasts. MacLennan's
group (MacLennan et al., 1985) obtained similar results with PGF2a in
rabbits. They also observed the infiltration of "giant cells" which they
were unable to identify but found they were multinuclear and stained
basophilic on hematoxylin and eosin staining. This may be a different
cell type to those found by Junqueira (Junqueira et al., 1980) and
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Rath (Rath et al., 1988b), possibly indicating a general inflammatory
cell influx.
The production of hexosamine-containing substances
(GAGs/proteoglycans) by a rat fibroblast cell line was shown to
increase under the influence of PGF2a (Murato et al., 1977).
Hyaluronic acid was the most abundant stimulated component found
by these authors and therefore hyaluronic acid synthetase was
examined. The activity of this enzyme was also seen to increase and
the effect of PGF2a was blocked by actinomycin D (blocks mRNA
transcription), suggesting that the prostaglandin was inducing the
enzyme.
A study by Cabrol et al. used hysterectomised and
ovariectomised rats with the cervix left in situ. They found that
treatmentwith PGE2 caused an increase in hyaluronic acid in relation
to the dry weight. This was also the case when the animals were given
oestrogen and progesterone supplements. Additionally, they observed
that there was an overall increase in the level of hyaluronate, heparan
sulphate, dermatan sulphate and chondroitin sulphate in the animals
on steroid supplements compared to the others (Cabrol et al., 1987). A
later study by Cabrol's team, using intact, near term rats, examined
the effects of a cyclooxygenase inhibitor, a lipoxygenase inhibitor and
a dual cyclooxygenase/lipoxygenase inhibitor (Cabrol et al., 1990). All
three resulted in an increase in the water content of the cervix, a
factor indicative of cervical ripening. Inhibition of only prostaglandins
resulted in an increase in hyaluronic acid, leading the authors to
suggest that this indicated that lipoxygenase products may have been
responsible for the increase. The sum total of all the GAGs was
reduced in the presence of the dual inhibitor only, suggesting that
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both cyclooxygenase and lipoxygenase derived material is involved in
GAG control. They saw a drop in heparan sulphate levels when
prostaglandin synthesis was inhibited but not lipoxygenase activity,
and no effect on dermatan sulphate of dual inhibition but increased
dermatan sulphate concentration when each enzyme pathway was
inhibited selectively.
Norstrom found opposing effects of PGE2 in first trimester tissue
and term tissue (Norstrom, 1982). In early pregnant human cervical
tissue PGE2 promoted collagen synthesis but inhibited proteoglycan
synthesis, and in later pregnancy collagen synthesis was reduced and
proteoglycan synthesis increased.
Comparisons of postpartum cervical samples from 1) women
with unripe cervices, given PGE2, 2) women with unripe cervices but
who spontaneously laboured and were not given PGE2 and 3) women
who spontaneously laboured and had ripe cervices, indicated that in
the PGE2 treated group the collagen content was similar to the
spontaneously delivering women and lower than those with unripe
cervices (Ekman et al., 1986). This work also appeared to show a
higher level of non extractable collagen in the untreated, unripe
cervices, possibly signifying a greater degree of connective tissue
remodelling in the presence of PGE2.
As mentioned previously cervical tissue can produce products of
arachidonic acid metabolism other than prostaglandins. A study on
the effects of arachidonic acid and prostanoids on collagen dissolution
[in vitro) in human cervix explants, showed that addition of
prostaglandins to the cultures had no effect on hydroxyproline
release (a measure of collagen breakdown) into the culture medium
but that arachidonic acid caused an increase. These authors found
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that when they used high levels of arachidonate (10 5M) there was no
effect on collagen breakdown but they only examined the effects of
PGs at similar, high concentrations and did not look at the effects of
lower levels of prostaglandins. Inhibition of PG synthesis also
inhibited collagen breakdown but did not affect the stimulatory
properties of arachidonic acid. The amount of hydroxyproline released
into the medium was reduced in the presence of a phospholipase
inhibitor (Wallis and Hillier, 1982). These results suggest that while
prostaglandins are involved, other arachidonate metabolites are
probably acting within the cervix to promote the degradation of the
connective tissue matrix.
Experiments with rats showed that treatment in vivo with
PGF201 or arachidonic acid, towards the end of pregnancy, both
resulted in a greater degree of collagen solubility than measured in
control animals (Hillier and Wallis, 1981). The increase in collagen
solubility and the appearance of hydroxyproline in culture medium is
thought to indicate increased collagenolytic/proteolytic activity.
In contrast, work on rabbit cervical fibroblasts provided
evidence of a stimulatory action of PGE2 and PGF20C on collagenase
activity but this did not show a similar response to arachidonic acid,
both in the presence and absence of indomethacin (cyclooxygenase
inhibitor). This paper also showed that prostacyclin did not have a
significant effect on collagenase activity (Goshowaki et al., 1988). The
lack of a response to arachidonic acid in these experiments may
indicate a requirement for other cell types, such as macrophages or
neutrophils, that may have been present in the explants of cervical
tissue but absent from the fibroblast cultures. However, the purity of
these fibroblast cultures is questionable since the cells were in
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primaiy culture derived from rabbit cervix (Sakyo et al., 1986a) and
not a cell line. The authors suggest that the lack of an effect of
arachidonic acid and indomethacin indicates that endogenous
prostaglandins are not involved in cervical ripening (Goshowaki et al.,
1988).
Collagenase activity and DNP-peptide hydrolytic activity
(DNP-peptide is a substrate for collagenase) have also been reported to
be increased in samples of cervical tissue taken postpartum from
women given PGE2 compared to samples taken from women that were
not given the prostaglandin (Uldbjerg et al., 1983c).
Rath's group could not detect an increase, or decrease, in
collagenolytic or general proteolytic functions when they examined
biopsies taken from human cervix that were pretreated with the PGE
analogue sulprostone (Rath et al., 1987). Similarly, they could not find
any change in collagenase or proteolytic activity in the cervices of
guinea pigs after intracervical application of sulprostone (Rath et al.,
1989). In both these publications the authors found no evidence of
collagen breakdown products using electrophoretic analysis.
Uldbjerg observed an 80% increase in the activity of
collagenolytic/proteolytic enzymes in human cervical tissue following
treatment with a local application of PGE2, however, they did not find
any change in the level of elastase in the tissue (Uldbjerg et al.,
1983c).
Since the process of cervical effacement and dilatation begins
with the relaxation of the tissue nearest the uterine body, the
endocervix, it is possible that the contradictions found experimentally
lie, at least in part, in differing techniques for obtaining tissue. This
could, for example, mean that as the dilatation progresses down the
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cervix and more and more of the organ becomes integrated into the
contours of the uterus, that samples obtained at a slightly later stage
are in effect closer to the most active regions of the cervix and may
themselves be becoming more active with regard to the ripening
process. Thus some workers may find little or no evidence of some
processes while others find them to be strongly active, simply because
they have taken their samples from different parts of the organ.
Summary
From the work described it is evident that the cervix is capable
of producing prostaglandins in its own right and that there is a link
between the eicosanoids and cervical ripening. The cells responsible
for PG production within the cervix have not been identified but the
fibroblast must be the most likely source. The tissues surrounding the
cervix also possess the machinery for eicosanoid synthesis, so a
plentiful supply of endogenous prostaglandins is readily available to
participate in the ripening process. The facts that cervical tissue has
the ability to produce eicosanoids and that prostaglandins have been
shown to have fundamental, restructuring effects on the connective
tissue suggests that they are intimately involved in cervical ripening
whether through direct or indirect mechanisms. An autocrine function
is possible since fibroblasts are producers of collagen, GAGs and
collagenase. The prostaglandin receptors must have some function
lending support to a role for endogenous prostaglandins. The part
played by other eicosanoids may also be crucial in cervical ripening.
Another question which is raised when studying cervical
ripening is what the initial stimulus for increased PG synthesis is.
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Since the fetus is the best judge of its maturity it is most likely to be a
fetal product, related to gestational age and maturity.
1.
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The Cervix and Progesterone
Progesterone Withdrawal Hypothesis
Progesterone levels in women have been shown to rise as
pregnancy develops, early in gestation the principal source being the
corpus luteum and by the end of the first trimester production has
shifted to the placenta (Buster and Simon, 1989; Liggins, 1983; Csapo
et al., 1972). In some species the corpus luteum remains as the main
source of progesterone and an essential element for the continuation
of pregnancy, for example in rabbits, goats and rats (Liggins, 1983),
its removal resulting in the ending of gestation.
In humans there is not considered to be a significant fall in
serum progesterone levels prior to parturition (Anderson et al., 1985;
Smit et al., 1984; Hanssens et al., 1985), despite findings showing
such a trend (Turnbull et al., 1974) and the strong adherence to this
idea by Csapo (Csapo, 1975). Turnbull's group observed an increase
in the plasma oestradiol/progesterone ratio (Turnbull et al., 1974).
The importance of progesterone in pregnancy maintenance is not
disputed and has led others to suggest that local regulation of
hormone levels may be involved. Such changes may be undetectable
when studying peripheral blood levels (Milewich et al., 1977; Gibb et
al., 1978; Mitchell et al., 1982). Some work has shown that a
progesterone withdrawal effect may be produced locally via the
production of oestrogen by placental and fetal tissue, which was
found to inhibit the formation of progesterone (Gibb et al., 1978;
Mitchell et al., 1982; Das et al., 1985; Townsley, 1975; Grimshaw et
al., 1983). Challis et al. found progesterone synthesis capabilities to
be greater in human chorion and decidua from women at term, not in
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labour (caesarean sections), than in the same tissues from women
with spontaneous, term labour (Challis and Vaughan, 1987). They did
not find significant differences in the ability of amnion, chorion and
decidua from the two groups of women to synthesise oestrone, but
their results may indicate a slightly greater capacity in tissue from
spontaneously labouring patients. Their results lend support to a
paracrine regulatory mechanism rather than a systemic one.
Inhibition of progesterone synthesis in pregnant ewes, using
inhibitors of 3(3-hydroxysteroid dehydrogenase, has been shown to
precipitate labour and delivery (Taylor et al., 1982) and to cause an
increase in the level of PGF201 without affecting oestrogen. In a study
on cervical ripening in sheep Ledger et al. inhibited progesterone
synthesis and observed an increase in prostaglandins E and F
metabolites in blood drawn from the utero-ovarian vein and no change
in oestrogen concentration (Ledger et al., 1984). They observed an
increase in uterine activity and significant cervical ripening.
Furthermore, they administered an inhibitor of prostaglandin
synthesis to one group of animals, concurrently with the progesterone
synthesis inhibitor, and found that prostaglandin levels did not rise to
the same extent and that the change in uterine activity and cervical
ripening did not occur either (Ledger et al., 1984).
A study on hormone levels in women undergoing induction of
labour did not detect any difference in the presence of progesterone in
the circulation between those with unripe and those with ripe cervices
(Zuidema et al., 1986), nor in the ratio of progesterone to oestrogen.
Prostaglandin synthase (PGS) mRNA was examined in the
endometrium of ewes. Throughout the oestrus cycle and in early
pregnancy no differences were seen in PGS mRNA concentrations. In
1.51
Chapter 1 Perspective On Cervical Ripening
ovariectomised animals treatment with oestradiol caused a fall in
mRNA levels whilst progesterone did not. Treatment with both
steroids did not cause a reduction in mRNA content either, so
although progesterone did not appear to have any effect alone it did
block the effect of oestrogen (Salamonsen et al., 1991).
Human cervical tissue in culture (nonpregnant) has been shown
to release hydroxyproline into the medium (a measure of collagen
breakdown) and this activity can be reduced by the inclusion of
progesterone in the culture system (Wallis and Hillier, 1981).
Cervical cells from pregnant rabbits were found to produce an
inhibitor of collagenase and progesterone added to the culture
medium resulted in an increase in the output of this inhibitor (Sakyo
et al., 1986b).
Rajabi et al found high concentrations of progesterone
(10 3-10'4M) to inhibit collagenolytic activity in medium from cultured,
pregnant guinea pig cervix cells (Rajabi et al., 1991), in agreement
with other studies on progesterone (Halme and Woessner, 1975;
Jeffrey et al., 1971). However, at lower levels (10-7-10"9M) they
observed a stimulatory effect. The in vitro work mentioned previously
used 106-10"8M progesterone. Procollagenase mRNA levels in the
guinea pig cells were raised by as much as four fold in the presence of
the lower concentrations of progesterone (optimum stimulation at 10"
8M), with no apparent effect at higher concentrations (Rajabi et al.,
1991). In addition, this team found that the stimulatory effect of
oestradiol on procollagenase mRNA could be blocked by the inclusion
of progesterone (104M) in the culture medium.
The state of pregnancy is that of an essentially foreign body
inside the mother and there is therefore a need to suppress the
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immune system to prevent rejection. Progesterone has
immunosuppressive properties (Stites and Siiteri, 1983) and there is
evidence that high local concentrations can reduce inflammation and
rejection of grafted tissue (Siiteri et al., 1977) while systemic
administration may not (Krohn, 1954; Medawar and Sparrow, 1956;
Simmons et al., 1968; Watnick and Russo, 1968).
The lack of severe, general immunosuppression in pregnancy
may indicate that there is local suppression of rejection by high
concentrations of progesterone in the direct vicinity of the
reproductive organs. Cervical ripening and parturition being regarded
as inflammatory type processes (Liggins, 1981) lends support to this
idea, since they would be suppressed by locally raised progesterone
levels. The observation of progesterone withdrawal in some species
and the theory that local hormone regulation may be crucial in
humans fits in well with this, so that at term the immunosuppression
would disappear and parturition would ensue, following the rapid
softening and dilatation seen in the last stages of cervical ripening.
Progesterone withdrawal has been shown to permit the
infiltration of the pregnant ovine uterus by leucocytes (Staples et al.,
1983), a strong indication of an inflammatory reaction, and a similar
infiltration has been observed naturally in the human cervix at term
(Junqueira et al., 1980).
Evidence from the Progesterone Antagonist RU486
In recent years the development of drugs with actions
antagonistic towards those of progesterone has led to the development
and licensing ofRU486 for termination of first trimester pregnancy.
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There are several of these compounds, often called
antiprogestins, and they are steroidal derivatives (Kelly, 1988),
thought to reversibly antagonise the effects of progesterone at the
receptor level (Baulieu, 1989; Baulieu, 1987). RU486 also binds to
glucocorticoid receptors, with antiglucocorticoid effects, but has no
affinity for mineralocorticoid receptors (Baulieu, 1989). Studies have
shown the existence of progesterone receptors in the human cervix.
The levels did not vaiy during the menstrual cycle (Sanborn et al.,
1976; Sanbom et al., 1978). The antiprogestins have been shown to
cause abortion in guinea pigs (Elger et al., 1987a; Batista et al.,
1991), rats (Bosc et al., 1987; Garfield et al., 1987), and women
(Baulieu, 1989; Couzinet et al., 1986; Ulmann and Dubois, 1989),
with greater efficacy apparent in early pregnancy. Some of these
steroids have been shown to make the uterus highly sensitive to
prostaglandin treatment (Bygdeman and Swahn, 1985; Swahn and
Bygdeman, 1988; Cameron et al., 1986; Haluska et al., 1987) and
combinations of the two chemicals have been found to improve the
treatment-expulsion time and to permit lower dosing of each than
would be required if used alone (Elger et al., 1987a).
In cycling guinea pigs the corpus luteum is destroyed by PGF2a
(Horton and Poyser, 1973; Poyser, 1976) if conception does not occur,
and serum progesterone levels drop. In guinea pigs given
antiprogestins but not mated, the expected fall in serum progesterone
at the end of the luteal phase did not occur (Elger et al., 1987a; Elger
et al., 1987b) and it was suggested that the antiprogestins blocked
stimulation of uterine prostaglandin production in vivo (Elger et al.,
1987a). Others have observed a stimulatory effect of antiprogestins
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on uterine prostanoid production in vitro using human and rat tissue
(Kelly et al., 1986b; Kelly et al., 1985).
Apart from the use of RU486 as a method of medical
termination of pregnancy, as opposed to surgical termination, there
are now studies being carried out to determine its value as a method
of postcoital contraception or a once a month contraceptive pill. In
women given the antiprogestin on the day prior to the date of expected
menstrual bleeding this has already been shown to result in
suppression of (3-hCG in 80% ofwomen (Dubois et al., 1988; Ulmann
and Dubois, 1989).
However, this thesis is concerned with cervical ripening and
examining the ripening action of antiprogestins on this process
(Chwalisz and Elger, 1986; Chwalisz et al., 1987; Frydman et al.,
1988).
It has been shown that the human cervix becomes easier to
dilate following RU486 treatment (R&destad et al., 1988; Heidvall et
al., 1992), with similar results in the rat (Stiemer and Elger, 1990)
and guinea pig (Elger et al., 1987a). In the guinea pig the cervix was
more compliant at 60 days gestation following antiprogestin
treatment than it was at 44 days (Elger et al., 1987a), which may
indicate the triggering of a process associated with the rapid changes
seen in the cervix at term as opposed to those which are involved in
the general remodelling in the earlier stages of pregnancy. The
endocervical diameter has been shown to increase in early pregnant
women pretreated with RU486 (Lefebvre et al., 1990), with no
apparent influence of parity, which may again indicate that the
antiprogestin activates/permits the mechanisms of rapid change to
function in the cervix, since it has been suggested that the
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restructuring of the cervix in earlier pregnancies may in some way be
retained.
Stiemer and Elger observed a slight increase in the water
content of the pregnant rat cervix (day 18) following antiprogestin
treatment, similar to the levels they found in the untreated, late
pregnant (day 20) rats (Stiemer and Elger, 1990). Cabrol, likewise,
detected an increase in the water content of the rat cervix following
RU486 treatment (Cabrol et al., 1991). Stiemer also observed a
swelling of the cervix when examined histologically and considered
there to be an increase in the percentage of collagen in the sections
from animals treated with antiprogestin compared with the controls
(Stiemer and Elger, 1990).
A histological study in the guinea pig using the antiprogestin
ZK98.299 showed several similar changes in the cervical
ultrastructure consistent with intrinsic cervical ripening (Hegele-
Hartung et al., 1989). They observed an increase in oedema/ground
substance associated with dissociation of the regularly arranged
collagen fibres. Fibroblast activation was noted as was the infiltration
and activation of leucocytes. Neutrophils, macrophages and mast cells
were described and the neutrophils appeared to degranulate while the
macrophages were rich in phagocytosed material. Their observations
in late pregnant, antiprogestin treated animals were so similar to their
control animals at term that they described them as one.
Experiments using pregnant guinea pig cervical cells in culture
provided results opposite to those expected from the above work. They
showed that progesterone caused a slight increase in collagenase
activity and found that RU486 blocked this stimulation but also that
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it reduced the collagenase activity to a level significantly lower than
the control value (Rajabi et al., 1991).
The only significant difference in rat cervical GAGs was seen in
the hyaluronic acid content, which showed a slight increase in RU486
treated animals compared with their control counterparts. Heparan,
dermatan and chondroitin sulphates were also measured but did not
show any changes under the influence of the antiprogestin (Cabrol et
al., 1991). To examine the effect of prostaglandins on antiprogestin
induced cervical ripening Cabrol et al. administered the
cyclooxygenase inhibitor diclofenac to rats as well as RU486. They did
not detect any effect of prostaglandin inhibition on RU486 induced
hydration of the cervix or the increase in hyaluronic levels (Cabrol et
al., 1991), but did find that in the dual treatment group there was a
drop in the cervical concentration of heparan sulphate. However, they
did find that the blockade of prostaglandin synthesis prevented the
preterm delivery they observed following RU486 treatment alone.
Chwalisz et al. gave guinea pigs the antiprogestin ZK98.299 plus
indomethacin (prostaglandin synthesis inhibitor) and did not detect
any interference with the ripening effect of the antiprogestin (Chwalisz
et al., 1987).
The prostaglandin output of human cervical tissue in vitro was
found to be unaffected by oral pretreatment with RU486 (R&destad et
al., 1990), and a study of plasma PGEM and PGFM indicated that
their concentrations did not change in RU486 treated women either
(Hill et al., 1990). Cabrol's work with rats and the dual treatment of
antiprogestin plus prostaglandin synthesis inhibitor did not show up
any effect of RU486 on serum PGE2 or leukotriene B4. They did show
that the prostaglandin output was significantly reduced by diclofenac
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and that the leukotriene was unchanged In its presence (Cabrol et al.,
1991).
In terms of softening and dilatation of the cervix Stiemer and
Elger found RU486 to be the most effective of the antiprogestins that
they tested (Stiemer and Elger, 1990).
Recently, RU486 (mifepristone) was granted a product license
for clinical use in the United Kingdom. It is licensed to be issued on a
named patients only basis for the induction of medical termination
and is used in conjunction with a prostaglandin. Further studies are
being carried out to evaluate its usefulness as a method of
contraception, for example, as a 'once a month pill' and for cervical
ripening at term.
Summary
The immunosuppression produced by progesterone and the
increased levels associated with pregnancy have led to the conclusion
that it is important to the maintenance of the pregnancy. The
termination of gestation by the antiprogestin RU486 supports this,
despite the fact that circulating progesterone levels remain high in the
human throughout pregnancy and do not fall at term as observed in
other species. The softening of the cervix following treatment with
RU486 suggests that progesterone is a significant factor in cervical
ripening. The role progesterone plays is not clear, but it may act
through inhibition of any of the mediators of an inflammatory
response, such as the prostaglandins or any of the cytokines involved.
It is also possible that progesterone has direct effects on the cells of
the cervix. The steroid has been reported to affect collagenase
production by the cervix which may indicate a direct action on the
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fibroblasts. Progesterone may also have indirect effects on the cervix
through actions on the myometrium, maintaining its quiescence and
thereby reducing the mechanical stresses on the cervix which in turn
may reduce stimulation of prostaglandin production.
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The Cervix and Oestrogen
The serum levels of the oestrogens (oestrone, oestradiol-17|3 and
oestriol) have been shown to increase during pregnancy (Buster and
Simon, 1989; Turnbull et al., 1974; Tulchinsky et al., 1972). A
distinct, rapid increase in amniotic fluid oestrogen levels has been
claimed in the last two to three weeks of pregnancy (Challis and
Olson, 1988). It has been shown that in primigravid women with a
deficiency in placental sulphatase there is little serum oestrogen
(France and Liggins, 1969), and that the pregnancy can be prolonged
and cervical ripening may not take place (France et al., 1973).
However, in multigravid women with the same sulphatase deficiency
low serum oestrogen does not necessarily mean that cervical ripening
and labour do not occur and these patients may proceed to a normal
vaginal delivery. This has been explained by suggesting that some of
the changes that take place in the cervix during previous pregnancies
are retained in some way and permit normal functioning at term
(Liggins, 1978), thus implying that the oestrogens' role is in the
remodelling process that occurs throughout gestation. Treatment of
pregnant macaques with dexamethasone, which inhibits the
production of oestrogen, results in an increase in the length of
gestation (Novy and Walsh, 1983). Also noteworthy is the fact that in
hypertensive women , where oestrogen levels may be low, ripening of
the cervix can occur prematurely (Liggins, 1978).
Several authors claim to have observed a ripening effect of
oestradiol on the cervix or to have shown that it causes changes in
cervical tissue consistent with the softening seen at term (Gordon and
Calder, 1977; Pinto et al., 1964; Pinto et al., 1965; Tromans et al.,
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1981; Gordon, 1981; Stewart et al., 1981). In the rat it has been
associated with an increase in water content and weight of the cervix
(Zarrow and Yochim, 1961), and in the sheep intravenous infusion of
oestradiol has been shown to cause cervical softening (Fitzpatrick and
Dobson, 1981).
Other researchers have found oestradiol to have no effect or to
be inhibitory. Given vaginally, it did not promote ripening of early
pregnant human cervix (Anthony et al., 1984) and two further groups
could not find any benefit in the use of oestradiol with an
unfavourable cervix (Thiery et al., 1978; Pedersen et al., 1981). Luther
did not find that intramuscular administration improved the state of
the cervix prior to prostaglandin treatment (Luther et al., 1980) nor
did Williams' group observe any improvement with direct application
to the cervix (Williams et al., 1988).
In the rat oestrogen caused inhibition of collagenase activity in
the uterus (Woessner, 1979) but in culture it did not have any effect
on enzyme biosynthesis (Jeffrey et al., 1971). Explants of human
cervix were seen to exhibit a reduction in collagenolysis in oestradiol's
presence (Wallis and Hillier, 1981). Rabbit cervical cells in culture
produced greater amounts of a collagenase inhibitor under its
influence (Sakyo et al., 1986b) but the same group also found
oestradiol did not affect collagenase production or general protein
synthesis (Sakyo et al., 1987). In guinea pigs, Rajabi and co-workers
found that collagen breakdown increased in cervical tissue treated in
culture with oestradiol (Rajabi et al., 1991). They also found that
oestradiol could stimulate procollagenase production by guinea pig
cervical cells (Rajabi et al., 1991). This effect was blocked by the
cyclooxygenase inhibitor indomethacin and by the anti-oestrogen
1.61
Chapter 1 Perspective On Cervical Ripening
tamoxifen. In addition, production of the mRNA molecule for
procollagenase was shown to be stimulated by oestradiol when it was
included in the culture medium of cells from day 50 pregnant guinea
pigs (Rajabi et al.t 1991).
Receptors for oestrogen have been found in the cervix (Sanborn
et al., 1975; Sanborn et al., 1978), and this steroid has been shown to
cause changes in the numbers of other membrane receptors,
increasing the level of expression of those for oxytocin (Soloff, 1975;
Nissenson et al., 1978; Fuchs et al., 1983b). Oestrogen may also raise
a-adrenergic and reduce (^-adrenergic receptor numbers (Roberts et
al., 1981). In women there was no change in PGE2 and PGF2a
receptors throughout the menstrual cycle but in ovariectomised
hamsters given oestradiol supplements there was a decrease in
prostaglandin receptors (Wakeling and Wyngarden, 1974). In
ovariectomised ewes given oestrogen there was a reduction in the
concentration of prostaglandin synthase mRNA in endometrial tissue
(Salamonsen et al., 1991).
Indirect Actions of Oestrogen
Although uterine activity has been shown not to be necessary
for cervical ripening to take place it is likely that the stresses it places
on the cervix play some part in the process. Oestrogen has been
shown to promote the synchronisation of uterine muscle activity by
stimulating the formation of gap junctions between myometrial cells
(Bosc et al., 1987). Prostaglandin production by human amnion and
decidua has been shown to be stimulated by oestrogen (Olson et al.,
1983a; Kelly and Abel, 1980; Kelly and Abel, 1981) and it has been
suggested that oestrogen may cause uterine stimulation by diverting
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PG synthesis from the inhibitory prostaglandin prostacyclin to the
stimulatory prostaglandins such as PGE2 and PGF20C (Challis and
Olson, 1988).
Oestrogen has been shown to inhibit the production of
progesterone by human chorion (Mitchell et al., 1982) and it has been
suggested that this could be important in altering the
progesterone/oestrogen ratio, the two steroids having opposing effects
to each other in the uterus (Challis and Olson, 1988).
DHAS and Oestrogen Synthesis in Pregnancy
The androgen dehydroepiandrosterone sulphate (DHAS) is
produced by both the fetus and the mother (Mochizuki and Tojo,
1980) and converted to oestrogen by the placenta (Gant et al., 1971).
At term the conversion of .DHAS to oestradiol from each source is
thought to be similar (Siiteri and MacDonald, 1966; Tulchinsky and
Korenman, 1971), with the level of DHAS in umbilical cord blood
(Parker et al., 1982) and maternal circulation increasing towards the
end of pregnancy (Madden et al., 1976).
Plasma hormone levels in women undergoing induction of
labour with ripe cervices have been compared to levels in women
undergoing induction of labour where the cervix was not ripe and
have shown that circulating oestradiol and oestriol levels were the
same in each group, but that the level of DHAS was significantly
higher in blood from women with ripe cervices (Zuidema et al., 1986).
In rhesus monkeys there is a rise in DHAS with gestation and
this is augmented further near term (Seron-Ferre et al., 1983),
similarly there is an increase in DHAS in baboon serum which
shadows gestational age (Townsley and Pepe, 1977).
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Over a prolonged period (2-3 weeks) Mochizuki administered
DHAS to women, intravenously and on repeated occasions (Mochizuki
and Tojo, 1980) and noted that cervical ripening in the treated women
was improved when compared to the control subjects. His work also
involved measuring hormone and collagenase levels and showed that
oestradiol concentration increased in the cervix, to a greater degree
than in the blood, and there was a significant increase in collagenase
activity in the medium taken from cultured explants of cervix. DHAS
has been shown to increase collagenase and gelatinase released from
rabbit cervical cells in culture (Sakyo et al., 1986a; Sakyo et al., 1987;
Mori et al., 1981) but the same effect was not observed with
dehydroepiandrosterone (DHA) or oestradiol (Sakyo et al., 1986a).
Sakyo also showed that DHAS and oestradiol did not affect collagen
synthesis (Sakyo et al., 1987).
Interestingly, there appear to be a large number of specific
DHAS binding sites in the plasma membrane of human cervical
fibroblasts (Ohno et al., 1991) which may represent receptors for
DHAS. The same paper claims that DHAS induces the mobilisation of
the prostaglandin precursor arachidonic acid.
Summary
Thus, the oestrogens would appear to have some role in the
mechanisms of cervical ripening probably through actions on the
cervix itself where it promotes collagenase activity and collagen
breakdown, but also indirectly by coordination of uterine muscle
contractions and stimulation of prostaglandin production by the fetal
membranes. It is not clear which of the oestrogens is most important
but oestradiol and fetal DHAS must be contenders.
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The Cervix and Relaxin
Cervical Ripening
Relaxin has also been implicated as a participant in cervical
ripening. It is a polypeptide hormone first discovered in 1926 and
identified in 1930 and considered to have a similar structure to
insulin (Sherwood, 1988). In women it is produced by the corpus
luteum, placenta and decidua (Weiss et al., 1976; Fields and Larkin,
1980b; Bigazzi et al., 1980), and levels are highest in the first
trimester of pregnancy (Eddie et al., 1986). Unlike other species there
is no surge prior to parturition in the human (Quagliarello et al.,
1980).
Relaxin has been shown to cause softening of the pubic
symphysis in guinea pigs (Frieden and Hisaw, 1951) and mice
(Steinetz et al., 1965), and to cause cervical dilatation in several
species with an apparent requirement that the tissue is first primed
with oestrogen (Zarrow et al., 1956; Zarrow and Yochim, 1961; Fields
and Larkin, 1980a). As a method of inducing cervical ripening in
humans it was not studied until relatively recently because it was not
available in a pure enough form, most work having been done with a
crude extract of porcine ovary (Larkin et al., 1983). More recently
porcine relaxin has been purified and used in clinical experiments in
order to examine its effects on human cervix.
Much of the human work has been done by MacLennan
(MacLennan et al., 1980; MacLennan, 1981; MacLennan et al., 1986).
His groups found that women given purified porcine relaxin showed a
greater improvement in cervical score than the controls over a 15 hour
period. They observed that 2mg of relaxin, given vaginally, produced
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similar ripening to 25mg of intravaginal PGF20C and that intracervical
application of relaxin provided no advantage over intravaginal
application. Treatment of rabbits with vaginal gel containing PGF201 or
relaxin provided histological evidence that the relaxin significantly
affected the connective tissue structure and that these changes in the
connective tissue were similar to those seen under the ripening
influence of the prostaglandin (MacLennan et al., 1985). The collagen
bundles appeared to break down and the ground substance to
increase.
Evans' group found that a 2mg dose of porcine relaxin,
intracervically, resulted in a greater degree of ripening of the cervix
than observed in control women, but a 4mg dose did not (Evans et al.,
1983), the reasons for which are not clear. In pigs, relaxin has been
shown to cause increased cervical extensibility and an increase in the
wet weight (O'Day et al., 1989).
Hwang et al. observed the effects of administering a monoclonal
antibody against relaxin to rats on days 20-22 of pregnancy. They
found that the animals where relaxin had been inhibited by the
antibody had lower cervical wet weight, dry weight and water content,
and they were also less compliant than the control cervices (Hwang et
al., 1989).
It is interesting to note that relaxin (porcine and human
extracts) has been found to have a restraining effect on the uterus,
apparently inhibiting contractions (McCarthy et al., 1957; Eichner et
al., 1958; Downing and Sherwood, 1985; Szlachter et al., 1980).
However, in a study on both human and rat myometrial tissue,
recombinant human relaxin blocked the contractile activity of rat
myometrium in an organ bath, in a dose dependent manner, but had
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no effect on spontaneous or induced contractile function in human
tissue (Petersen et al., 1991), which was in agreement with other
findings (Decker et al., 1958; Kelly and Posse, 1956; McGaughey et
al., 1958). The differing effects may be due to the relaxin extracted
from tissue being relatively impure and therefore containing
contaminants which caused the observed effects. It seems paradoxical
that relaxin should inhibit uterine activity towards the end of
pregnancy while at the same time promoting cervical ripening.
However, in rats and pigs there is a drop in serum levels of relaxin
following the peak near term which would allow uterine activity to
increase (Downing and Sherwood, 1985; Gooneratne et al., 1983) and
delivery to follow.
Mechanisms Involved
Relaxin has been found to inhibit the in vitro incorporation of
tritiated proline by cervical tissue from women (Wiqvist et al., 1984),
and this was taken to be an indication of reduced collagen synthesis.
In ovariectomised rats given progesterone and oestrogen supplements
there is an increase in collagen solubility associated with relaxin
treatment, as well as increases in the total of individual GAGs in the
cervix and a fall in the collagen concentration (Downing and
Sherwood, 1986).
Relaxin treatment of guinea pigs has been found to increase the
water solubility of proteoglycans in the pubic symphysis (Sherwood,
1988) and the charge density of connective tissue was reduced
following relaxin treatment (Joseph et al., 1952), suggesting that there
were changes in the proteoglycan structure. Hwang's experiments
with a monoclonal antibody directed against relaxin also showed the
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level of GAGs to be lower in the cervices from treated rats than from
the control animals (Hwang et al., 1989)
Relaxin has been shown to activate mouse cervical fibroblasts
(Leppi and Kinnison, 1971) and to increase proteolytic activity in the
pubic symphysis, including that of collagenase (McDonald and
Schwabe, 1982; Steinetz and Manning, 1967; Sherwood, 1988).
Human amnion and chorion in culture have been shown to release
increasing amounts of plasminogen activator and collagenase into the
medium when incubated with relaxin (Koay et al., 1986; Koay et al.,
1983). The infiltration of rabbit cervical tissue by unidentified giant
cells occurred following treatment with relaxin which may be similar
to the leukocytic infiltrate seen during labour (MacLennan et al.,
1985).
Indomethacin has been shown to block relaxin induced
reduction in cervical tone in rats, which implies a role for
prostaglandins in its action (Kennedy, 1976)
The mode of action of relaxin is unclear but high affinity binding
sites for the porcine derived material have been found in pig, guinea
pig and rat cervical tissue (Mercado-Simmen et al., 1982; Gates et al.,
1981; Weiss and Bryant-Greenwood, 1982). In vitro it has been
shown to raise cAMP levels in rat and human cervix (Cheah and
Sherwood, 1980; Norstrom and Wiqvist, 1985).
Obviously it would be preferable to study the effects of relaxin
using the purified, human form of the protein. It has now been
identified and is produced by Genentech. Currently there is relatively
little information on the effects of recombinant human relaxin in
humans and it may be some time before there are enough data to
draw any conclusions about its role in cervical ripening and
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parturition in women. However, such studies are now being carried
out in Edinburgh, Glasgow and Oxford.
Summary
Relaxin extracts have been reported to promote cervical ripening
clinically, biochemically and histologically. However, preliminary
results from the recent clinical study in Edinburgh, using
recombinant human relaxin suggest that it has no effect on cervical
ripening (A Calder, Pers. Comm.). While this requires fuller
examination it may indicate that the active agent in earlier studies
was a contaminant or artifact of the extraction process.
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The Cervix and Oxytocin
Oxytocin has been used in obstetrics for many years to induce
and augment labour (Faris and Kahlenberg, 1954; Embrey and
Anselmo, 1962). It is a neurohypophysial peptide hormone of nine
amino acids (some regard it as an octapeptide because its two
cysteine residues oxidise to form cystine). It is a highly potent uterine
stimulant and lends its name to a class of drugs with similar uterine
effects (oxytocic agents), including prostaglandins. The contraction of
the uterus and the ejection of milk from the breast are the main
functions associated with oxytocin (Bowman and Rand, 1980).
Receptors for this peptide hormone have been identified by
several researchers in rat, sheep, rabbit and human uterus (Fuchs et
al., 1983b; Crankshaw et al., 1982; Auron et al., 1984; Fuchs et al.,
1982). Fuchs et al. have also provided evidence of their presence in
fallopian tubes and cervix (Fuchs et al., 1984), the levels they reported
in the cervix being less than 1% of those in the uterus. The uterine
receptor concentration has been shown to rise during gestation
(Fuchs et al., 1984), peaking during early labour (Fuchs et al., 1982;
Fuchs et al., 1984). The sensitivity of the myometrium to oxytocin also
rises during pregnancy (Bowman and Rand, 1980). Since, oestrogen
has been shown to promote an increase in oxytocin receptor numbers
(Soloff, 1975; Nissenson et al., 1978; Fuchs et al., 1983b) it is
suggested that a shift in the oestrogen/progesterone ratio may be
involved in permitting oxytocin derived contractions and increasing
the sensitivity of the uterus to the hormone (Brindley and Sokol,
1988; Bowman and Rand, 1980).
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Prostaglandins increase uterine sensitivity to oxytocin (Calder,
1990), reports having been made of PGF2a potentiating oxytocin-
induced contractions (Gillespie, 1972; Husslein et al., 1981; Fuchs et
al., 1983a). In addition, there is evidence that oxytocin itself can
stimulate the production of PGs by uterine tissue (Fuchs et al., 1982;
Roberts et al., 1976; Mitchell et al., 1975; Fuchs et al., 1981; Husslein
etal., 1981; Husslein et al., 1983).
Fuchs et al. studied plasma PGFM in women given oxytocin and
found that in those in whom the induction was successful PGFM
levels rose and the cervix dilated, but in those where it was
unsuccessful the prostaglandin level did not rise, and despite uterine
contractions the cervix failed to dilate (Fuchs et al., 1983a; Husslein
etal., 1981).
The clinical use of oxytocin is primarily concerned with causing
uterine contractions and it does not appear to have a direct effect on
cervical ripening (Wiqvist et al., 1986; Valentine, 1977; Wilson, 1978;
Auron et al., 1984). An in vitro study using human cervical tissue
showed that oxytocin was able to cause contraction of the cervix, an
effect that was reversed by the addition of PGE2 to the tissue bathing
fluid (Najak et al., 1970).
Any ripening of the cervix that does occur during the induction
of labour using oxytocin is likely to be due to the increased
myometrial activity rather than a direct effect of oxytocin on the cervix
(MacKenzie, 1981).
Clinicians regard attempts to induce the birth process with
oxytocin when the cervix is in an unfavourable condition as unwise
(Calder, 1990; Owen and Hauth, 1992) and recommend the prior use
of prostaglandins and amniotomy (Calder, 1990).
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Summary
The function of oxytocin in the uterus is primarily on the
myometrium, producing contractions. It may thus indirectly cause
physical stresses in the connective tissue of the cervix and play a
minor role in ripening the cervix. Oxytocin cannot be regarded as a
primary inducer of cervical ripening.
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Techniques Employed in the Study of the Cervix
The Guinea Pig as a Model
The guinea pig was selected for the work presented in this
thesis because of its similarities to the human in terms of its
physiology during pregnancy.
This animal undergoes a luteoplacental shift whereby the
production of progesterone, and therefore the continuation of
pregnancy, does not depend on the corpus luteum (Elger, 1979;
Illingworth and Challis, 1973; Heap and Deanesly, 1964), similar to
women. In addition, the guinea pig also delivers its young in the
presence of high circulating levels of progesterone (Hegele-Hartung et
al., 1989; Elger and Hasan, 1985).
Pharmacologically the human and guinea pig show similar
trends, oestrogen failing to cause abortion (Bacic et al., 1970; Elger
and Hasan, 1985) and different prostaglandins showing similar
potency profiles when used to induce the termination of pregnancy
(Elger, 1979). The rat showed a significantly different abortifacient
response to various prostaglandins when compared to the guinea pig
while the rhesus monkey was similar to the guinea pig (Elger, 1979),
which indicates that the rat may not be a good choice of model for
comparison with humans. A primate model would probably be most
analogous to the human situation, however, on a practical and cost
basis this is inappropriate.
Another indication of the similarity among human, primate and
guinea pig was shown by Rot who assessed the effect of human
interleukin-8 on the chemotaxis of neutrophils from various species
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(Rot, 1991). This work indicated that an optimal response from
monkey and guinea pig neutrophils required approximately three
times the concentration of human IL-8 needed with human
neutrophils, but that rat cells required one hundred times that of the
human cells.
Other Species and Techniques
Many different species have been used in experiments studying
the cervix and the data obtained from them can give an insight into
the processes that take place during the transformation of the cervix,
but it should always be borne in mind that the human situation
cannot necessarily be extrapolated from such studies.
Problems arise when the overall physiology of the animal in
question is compared to that of the human and it becomes obvious
that there are fundamental differences, such as the drop in plasma
progesterone levels prior to parturition known to occur in sheep and
rats (Taylor et al., 1982; Bassett et al., 1969; Stiemer and Elger,
1990), but which does not occur in humans (Anderson et al., 1985).
Even within the same species different approaches have been
used. For example the guinea pig cervix has been studied by in vivo
treatment with various drugs, such as steroids and prostaglandins
and the effects assessed on the biochemical, physical and histological
alterations they induce in the tissue. Other work has been done with
primary cell culture or tissue culture techniques in order to examine
the effects on cellular metabolism. These techniques have also been
applied to other animals including humans.
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Histological Characteristics
The pioneering work carried out by Danforth, examining the
histological structure and delineation of the cervix, reopened the
discussion about its intrinsic nature, muscular or fibrous, the former
being the accepted option at that time (Danforth, 1947). Danforth's
improved fixation and staining procedure indicated a predominantly
fibrous organ and since then the cervix has come to be regarded as
being fibrous in nature (Danforth and Evanston, 1954; Danforth,
1983; Uldbjerg and Ulmsten, 1990). The use of histological
methodology, including immunohistochemistry, has been employed to
reveal the underlying changes that occur during cervical ripening
which permit the physical characteristics to alter so significantly.
Such techniques are valuable tools in the elucidation of how the
manipulations the clinician may carry out, physical or
pharmacological, affect the structure of the cervix (Junqueira et al.,
1980; Rath et al., 1988b; Yoshida and Manabe, 1990; Saito et al.,
1981; MacLennan et al., 1985; Hegele-Hartung et al., 1989; Minamoto
et al., 1987). One of the difficulties with such work is that the
composition of the cervix is not uniform and changes as the uterine
body is approached, the degree of musculature increasing with
proximity to the corpus. This latter effect provoked heated literary
discussions between Danforth and Hughesdon in the early 1950's
(Hughesdon, 1952; Danforth and Evanston, 1954). Thus, the results
obtained from material taken from a cervix for study may depend on
the region from which it was dissected.
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Physical Characteristics
The mechanical properties of the cervix are the most obvious
indicators of ripening. Models employed in such avenues of research
have involved the measurement of the physical characteristics of the
cervix, how they can be affected by drugs and also how physical
manipulations of cervical tissue can affect it. For example, work has
been done looking at the ability of the cervix to contract (Najak et al.,
1970). These authors detected contractile activity in strips of cervix in
an organ bath, both spontaneous and drug induced. Conrad and
Ueland (Conrad and Ueland, 1983) and Koob and Ryan (Koob and
Ryan, 1980) have reviewed the ways in which some have attempted to
quantify the changes in the mechanical attributes of the cervix that
occur with pregnancy by examining the ability of isolated tissue [in
vitro) to stretch and determining the point at which the resistance of
the material to deformation is lost, and also by looking at the changes
in elasticity of the cervix in vivo by assessing the degree to which it
allows the passage of a measuring probe. Ledger et al. studied the
effect of the contracting uterus on the mechanical functions of cervical
ripening by surgically isolating the cervix from the uterine body while
leaving both in situ in a pregnant sheep (Ledger et al., 1985), as did
Stys et al. but, on this occasion, by subduing the uterine activity
chemically (Stys et al., 1978). Stiemer and Elger (Stiemer and Elger,
1990) examined the forces required to dilate the rat cervix in their
assessment of antiprogestins and endocrine hormones and their role
in cervical ripening, as well as utilising histological methodology and
thus combining more than one technique. Also in this area of cervical
study there has been work done to examine the response of the cervix
2.4
Chapter 2 Techniques Employed in the Study of the Cervix
to stretching (in vitro) in terms of prostaglandin production (Hillier and
Coad, 1982).
Biochemical Characteristics
As well as the histological and physical studies of the cervix
there have been studies concerned with the biochemical composition
and biochemical output of the cervix at various different times, for
example nonpregnant, early pregnant and late pregnant. In such
studies different approaches have been used which serve to introduce
further complications, making the analysis of the results difficult.
This can be illustrated by the following examples. Some authors have
assessed the degree of hydration of cervical tissue, an apparently
simple measurement. However, on studying the literature there are
differences in the way the results are reported, for example, as the
lyophilised weight (Stiemer and Elger, 1990), as the oven dried weight
(Uldbjerg et al., 1983b) or as the dried and defatted weight (Danforth
et al., 1974). As well as water there are many reports on the amount
of collagen in the cervix. The difficulties arise in this work because of
the different processes used to extract the collagen. The degree of
solubility of the collagen has been reported as its dispersal into acetic
acid (Kleissl et al., 1978), into acetic acid plus digesting enzyme
(Uldbjerg et al., 1983b), and into sodium chloride or guanidine
chloride (Danforth et al., 1974). The picture is then obscured even
more by the lack of consistency of authors in quoting the amounts of
material they have detected, be it collagen or GAGs or other proteins,
in terms of the wet weight of the tissue or the diy weight of the tissue.
There have been studies that examined biochemical factors associated
with tissue that had been sampled and examined immediately. There
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have also been studies of cervical tissue maintained In culture for
several days, looking at how differing culture conditions have affected
the production of such substances. In addition, biochemical
measurements have been made to assess the effects on tissue placed
under physical stress while maintained in vitro for a few hours (Hillier
and Coad, 1982), thus bringing together the two methodologies,
mechanical and biochemical. Reports of collagenase output by
explants of cervix maintained in culture have been made (Wallis and
Hillier, 1981; Raynes et al., 1988a) but so have reports of collagenase
extracted from biopsied material not sustained in culture (Rajabi et
al., 1988; Rath et al., 1988a; Osmers et al., 1990; Kitamura et al.,
1979), and to add further to the confusion there have been reports of
collagenase activity in the medium of cultured cells derived from the
cervix (Rajabi et al., 1991; Sakyo et al., 1986a; Goshowaki et al.,
1988).
One of the problems of the experimental methods used is the
sampling procedure. To obtain cervix tissue from women at term of
pregnancy or in labour is ethically difficult and presumably not of
great interest or significance to the delivering mother. The risk to the
fetus also makes it unlikely that novel pharmacological manipulations
will be carried out just for scientific research, the use of such
intervention being restricted to cases where no alternative options are
available or where a pregnancy is being terminated. Thus, human
models for studying the cervix have most often been in nonpregnant
women, early pregnant women or just after the birth, with severe
limitations regarding the examination of the effects of drug treatments
on cervical constitution prior to the disruptive passage of the fetus.
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Cell Culture
The use of cell culture has become more and more popular In
recent years, not least because of pressure to reduce the number of
experiments on animals. The absolute value of such work, however,
still requires to be confirmed in living creatures and we must not
become solely reliant on it, since a living system rarely, if ever,
operates in such an isolated manner, many factors influencing its
normal functioning. As far as the cervix is concerned the first cell line
that was ever developed was the HeLa cell line which was derived from
the cervix of an American woman in the 1950s. Worth remembering is
the fact that the very nature of a cell line is its transformed state
which allows it to go on dividing continually, and that many,
including HeLa, were produced from excised tumour material. The
final point concerning cell lines derived from cervical tissue is that
although there are several in existence there is a distinct lack of a line
with its origins in the stromal tissue, those available being of
epithelial origin and thus likely to be of limited use in studying the
changes that occur in the connective tissue of the cervix.
Until a cell line is produced from stromal tissue and it retains
the characteristics of its origins it would appear that the best lines of
enquiry will involve human or animal material, both in primary
culture systems or as part of the whole animal. Any results generated
from cell lines will require to be confirmed using such alternatives as
already outlined. Thus, there will always be a place in this type of
research for animal and human models.
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Current Understanding, Aims and Objectives
Thus in conclusion the cervix and cervical ripening are complex
in nature. The cervix itself is composed predominantly of a connective
tissue matrix consisting of collagen embedded in a network of
proteoglycans. The main cellular component of this organ is the
fibroblast, a collagen and glycosaminoglycan (GAG) producing cell
type. There are also smooth muscle cells present but the numbers are
so low that they are not thought to play a significant role in cervical
function.
The nonpregnant cervix is rigid and closed, having a highly
organised histological appearance where the collagen fibres tend to
run in large parallel bundles held together by the proteoglycan
network.
Cervical ripening is the process by which the normally
unyielding cervical tissue softens to permit the passage of the fetus.
Current thinking regards cervical ripening as an inflammatory based
process. The histological changes are dramatic. The connective tissue
becomes less regimented in its organisation and there is an
infiltration of leucocytes. Collagen concentration in the ripening cervix
falls as does the number of crosslinks between the fibres, thought to
indicate the gradual replacement of older collagen with new collagen.
The overall concentration of glycosaminoglycans increases. Those
species of glycosaminoglycan which proffer less rigidity showing an
increase while those which endow the connective tissue with greater
tensile strength showing a reduction. An increase in the large,
hydrophilic GAG hyaluronic acid is thought to increase the water
content of the cervix. The leucocytes that infiltrate the cervix appear
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to be the source of collagenase found in the ripening cervix, this
enzyme being essential for the degradation of collagen.
Prostaglandins are undoubtedly important factors in cervical
function, their ability to promote cervical compliance having been
recognised in the 1970s. PGE2 and PGF2a are the prostaglandins in
clinical use; PGE2 is the most potent. It has been shown that the
cervix itself is capable of producing prostaglandins and that inhibition
of prostaglandin synthesis can prevent cervical ripening taking place.
The presence of prostaglandins in the surrounding tissues (i.e. the
uterus, fetal membranes and amniotic fluid) may also influence the
cervix. PGE2 and PGF20C have been shown to produce histological and
biochemical changes in the cervix consistent with cervical ripening,
for example, increased GAG synthesis, alterations in collagen
solubility (indicative of replacement of old collagen with new collagen
which is amenable to rapid breakdown) and increased collagenolytic
activity.
Progesterone is crucial to the continuation of pregnancy. In
several species parturition is preceded by a fall in serum
progesterone, however, in the human there is no significant reduction
in circulating progesterone at term. Progesterone is considered to be
an anti-inflammatory steroid and it is likely that the concentration of
progesterone in and around the reproductive tissues is even higher
than in the circulation during gestation. Progesterone has been
associated with reduced collagen breakdown and the inhibition of
progesterone synthesis has been found to result in increased
prostaglandin production, as measured in the circulation and in blood
drawn form the utero-ovarian vein in the sheep. Significantly, the
development of drugs with actions antagonistic to those of
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progesterone (antiprogestins) has led to the introduction of
Mifepristone (in combination with prostaglandin therapy) for the
induction of medical terminations. This drug acts on both the uterus
and the cervix. It has been found to soften the human cervix. In
animal studies antiprogestins have been shown to increase hydration
of the cervix and increase hyaluronic acid production. Histologically
the cervix takes on characteristics similar to those seen in natural
cervical ripening. Following progesterone withdrawal Leucocyte
infiltration of the uterus has been observed and antiprogestins have
been linked to an increased presence of active fibroblasts and white
cells.
Oestrogen levels in serum rise during pregnancy. This steroid
possesses generally opposing effects to those of progesterone. While
some workers have observed cervical ripening effects others have not,
both in human and animal studies, and cervical ripening can take
place in conditions where the serum oestrogen concentration is low.
The role of oestrogen may be in the coordination of uterine
contractions through the stimulation of gap junction formation and
prostaglandin synthesis. Such uterine activity while not essential to
cervical ripening is probably beneficial. DHAS levels rise at term,
around half originating from the fetus. DHAS is converted to
oestrogen by the placenta but it has been found to promote cervical
ripening and stimulate the release of arachidonic acid through a
direct action.
Relaxin causes softening of the pubic symphysis in guinea pigs
and activates mouse cervical fibroblasts and enzyme production in the
pubic symphysis. It has been shown to be involved in cervical ripening
in several species but the results in human studies have been less
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conclusive. The most recent studies, using recombinant human
relaxin, have again found no evidence of a ripening effect of relaxin in
humans (A Calder, Pers. Comm.).
The neurohypophysial peptide oxytocin, while an important tool
to the obstetrician in stimulating uterine contractions and inducing
delivery of the fetus, appears to have little or no direct effect on
cervical ripening.
The most important factors in cervical ripening seem to be
progesterone withdrawal and the action of prostaglandins. Related to
these and to the perception of cervical ripening as an inflammatory
process it is inevitable that other mediators of inflammation would be
significantly involved in the changes that take place in the cervix.
The development of the antiprogesterone drugs has lead to the
introduction of RU486 (mifepristone) for the induction of early
terminations. This drug is now used in the UK in conjunction with
PGE as the efficacy of the treatment is significantly improved by this
combination. RU486 promotes cervical ripening and this project was
designed to examine the relationship between progesterone and the
prostaglandins, and to study other factors that may be important in
cervical ripening and therefore influenced by the antiprogestin. To do
this tissue from as near to term as possible was necessary and an
animal model was required, the availability of human cervical material
at this stage of gestation being very restricted. The guinea pig was
chosen for this purpose because of its similarities to the human. The
aim was to develop a culture system using cells derived from the
guinea pig cervix using material from control animals and from
animals pretreated with RU486. These cultures would then permit the
in vitro manipulation of the environment in which the cells would be
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maintained. Such manipulations would provide information on the
capacity of the cervix to produce prostaglandins, the mechanisms
involved and any influence RU486 may have.
The infiltration of the cervix at term by leucocytes reinforces the
inflammatory nature of the ripening process and the interleukin IL-8
is a chemotactic factor likely to be involved as it possesses strong
attraction and activation properties towards neutrophils. Therefore, it
was intended that available human material would be used to produce
tissue cultures to permit the examination of the ability of the human
cervix to produce this chemokine. In addition, human cervical tissue
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Tools for the Analysis of the Involvement of Cytokines and
Second Messengers in Cervical Ripening
This chapter reviews the cascades involved in inflammatory,
and other, cell activation and in the actions of their products,
including cytokines.
Accounts are given of agents that provoke or otherwise interfere
with these cascades, thus making them useful experimental tools.
They will be used to study the prostaglandins and their relationship
with the cervix by incorporating them into the guinea pig culture
system described in the next chapter.
Nonspecific Activation of the Immune System
Endotoxin is a lipopolysaccharide(s) (LPS) (Westphal, 1984) and
represents a group of compounds composed of lipid and sugar
residues found associated with the surface membrane of gram
negative bacteria (Raetz, 1990). LPS nonspecifically activates the
immune system (Morrison and Ryan, 1987) and activates the
complement cascade (Vukajlovich et al., 1987). LPS has been found to
provoke the release of prostaglandins and leukotrienes (Morrison and
Ryan, 1987), interleukin-8 and other cytokines and inflammatory
mediators, mainly from monocytes and macrophages but also from
keratinocytes, endothelial cells and choriodecidual cells (Matsushima
et al., 1992; Kelly et al., 1992; Strieter et al., 1989; Doebber et al.,
1985).
The component of LPS that is responsible for its stimulatory
actions is lipid A, a molecule unique to gram negative bacteria
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(Galanos et al., 1985) and there are suggestions that some form of
receptor for lipid A exists. The evidence for this relies on the ability of
a naturally occurring form of lipid A (from R. sphaeroides) to act as an
antagonist to LPS (Takayama et al., 1989) but not provoke a response
itself (Strittmatter et al., 1983), and work showing that genetic
mutations in mammalian cells can affect the response to LPS and
lipid A (Morrison, 1986; Hopkins-Sibley et al., 1988). Some evidence
exists which shows a saturable and apparently specific binding of a
radiolabeled lipid IVA probe, a precursor of lipid A produced in E. coll
These findings indicated that the probe binds to macrophages but not
to fibroblasts (Hampton et al., 1988), however, the protein responsible
for this association has not been identified. Because of competition for
the binding sites observed between the lipid IVA and acetylated-LDL
(low density lipoproteins), which binds to a scavenger receptor (Brown
and Goldstein, 1983), it has been suggested that this may in fact be a
defensive mechanism whose function is to remove LPS from the
circulation (Raetz, 1990). Specific LPS binding sites have been
identified (Lei and Morrison, 1988). LPS is also claimed to activate G
protein (Daniel-Issakani et al., 1989). Since all known situations
where G protein activation occurs are via a membrane receptor
linkage (Stiyer and Bourne, 1986) this supports the existence of a
specific LPS receptor (DeFranco, 1987). LPS is claimed to inhibit the
enzyme adenylate cyclase through its stimulation of G protein
(DeFranco, 1987).
Because of its fatty acid component it has been suggested that
LPS may not act solely through a receptor but become an integral part
of the cell membrane by inserting its hydrophobic region into the
membrane (DeFranco, 1987), similarly to its natural position in the
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bacteria from which It is derived. Such an action may allow it to
interact with other molecules associated with the membrane and
affect intracellular events.
While the details of how LPS stimulates cells are not well
understood it is apparent that it can promote cellular activity. It has
also been found, in some instances, to have a priming effect on cells
allowing them to respond to phorbol esters by making certain proteins
more susceptible to phosphorylation by protein kinase C (Rosen et al.,
1989; Aderem et al., 1988). It is suggested that lipid A in some way
mimics an endogenous mediator or directly affects a signal
transduction cascade having been found to activate
phosphatidylinositol turnover and protein kinase C and to affect G
protein (Rosoff and Cantley, 1985; Wightman and Raetz, 1984;
Daniel-Issakani et al., 1989). One difficulty associated with the
receptor molecule being the same or related to that of acetylated LDL
is that acetylated LDL does not possess the same actions as LPS
(Raetz, 1990), however, neither does the lipid A molecule from R.
sphaeroides which appears to bind to a receptor and block the effects
of LPS.
So, it is apparent that LPS has a stimulatoiy activity in cells of
the immune system but less clear is such activity in other cell types,
particularly the main cell type found in the cervix, the fibroblast. It is
also clear that LPS is able to induce the release of inflammatory
mediators such as prostaglandins and cytokines.
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The Protein Kinase C Pathway
PKC is dependent on calcium and phospholipids for its
phosphorylative action (Takai et al., 1979a) and is activated
endogenously by diacylglycerol (DAG), following cell surface receptor
binding and activation of the phosphatidyl inositol signal transduction
system (Takai et al., 1979b; Kishimoto et al., 1980). DAG has been
found to increase the affinity of PKC for calcium making an increase
in intracellular calcium levels unnecessary for its activation
(Kishimoto et al., 1980). Phosphatidylserine is essential in PKC
activation (Kaibuchi et al., 1981; Takai et al., 1979b). Synthetic forms
of DAG are also capable of inducing PKC activation in vitro, bypassing
the membrane receptor molecules and the breakdown of phosphatidyl
inositol. The DAG molecules are thought to intercalate into the cell
membrane (Kaibuchi et al., 1982; Kaibuchi et al., 1983; Kishimoto et
al., 1980).
Phorbol myristate acetate (PMA) belongs to a group of similar
compounds (phorbol esters) which have tumour promoting properties
and are often used to stimulate cells in culture.
Phorbol esters are thought to act at the cell surface (Nishizuka,
1984) and have been shown to activate the enzyme protein kinase C
(PKC) (Castagna et al., 1982; Yamanishi et al., 1983).
The phorbol esters have also been shown to be dependent on
the presence of calcium and phospholipid in order to bind to and
activate PKC (Kikkawa et al., 1983; Ashendel et al., 1983; Sando and
Young, 1983; Leach et al., 1983). In intact cells the phorbol esters are
thought to intercalate into the membrane and mimic DAG, having a
similar structure (Nishizuka, 1984). Unactivated PKC is a soluble
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enzyme, however, when Intact cells are treated with phorbol ester and
the cells disrupted the PKC is found strongly associated with the
membrane (Nishizuka, 1984; Kraft et al„ 1982).
Thus the phorbol esters are thought to interact with protein
kinase C, resulting in its activation and the propagation of cellular
signal transduction via this pathway. The measured effects of such an
action may give an insight into the mechanisms which control those
factors endogenously.
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Protein Dephosphorylation
Phosphatases are intracellular enzymes which control processes
as diverse as metabolism, cell division, contractility and membrane
transport and secretion. They are classified as protein phosphatase 1
and protein phosphatase 2, depending on their preference for the a or
(3 subunit of phosphorylase kinase, then further subdivided primarily
by their dependence on divalent cations (Cohen, 1989). Their function
is to remove phosphate groups from other intracellular proteins, the
removal of phosphate often resulting in a change in the function of the
protein in question from its active state to its inactive state or vice
versa (Cohen, 1989; Alberts et al., 1983).
Okadaic acid is a relatively new tool in biochemical analysis. It
was first isolated from marine sponges, from which it derives its name
[Halichonria okadaii) (Tachibana et al., 1981), and has been a major
cause of gastrointestinal disturbances through the consumption of
contaminated shellfish.
This molecule has a polyether fatty acid structure and was
found to promote tumour growth in mouse skin (Cohen et al., 1990).
It has been shown to be an inhibitor of protein phosphatase activity
(Takai et al., 1987; Bialojan and Takai, 1988).
Okadaic acid is a specific inhibitor of protein phosphatase 1
(PP1) and protein phosphatase 2A (PP2A) (Bialojan and Takai, 1988;
Haystead et al., 1989), and has been found to posses little or no effect
on other phosphatases and protein kinases, including protein
kinase C (Takai et al., 1987; Bialojan and Takai, 1988; Haystead et
al., 1989; Suganuma et al., 1988).
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The mechanism through which it exerts its effects is unclear
but it is hydrophobic and thought to enter cells relatively easily, and it
has been suggested that okadaic acid may interact with the
C-terminus of PP1 and PP2A rather than the catalytic centre (Cohen
et al., 1990; Bialojan and Takai, 1988).
Thus okadaic acid is a tool which may be used to examine the
role protein phosphorylation plays in cellular functioning and the
effects attributable to exogenously applied materials.
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Calcium Tnflmr
Calcium is an important factor in many physiological processes
including neurone membrane depolarisation, the efficient functioning
of enzymes, muscle contractions and as a second messenger in
membrane receptor signal transmission.
Most of the available evidence shows a stimulatory effect of the
calcium ionophore A23187 on the production of prostaglandins (Hsu
and Goetz, 1993; Ibe and Raj, 1992; Houmbard et al„ 1991; Cabre et
al., 1993). This molecule causes an increase in intracellular calcium
concentration. However, experiments carried out using human tissue
(fetal membranes/placenta) and A23187 revealed an inhibitory effect
of the ionophore (R Leask, Pers. Comm.). The role of calcium in
prostaglandin production therefore required further investigation and
in addition, the role of calcium on the effects of the other materials
employed in this study were examined.
The name ionophore was the generic term given to molecules
that bind cations and transport them across membranes (Pressman et
al., 1967). There are families of ionophores with differing selectivity
towards the biologically active cations and A23187 belongs to the
family of carboxylic ionophores (Pressman, 1976). This particular
ionophore has a specificity for divalent cations (i.e. Ca2+ and Mg2+)
over the monovalent cations (i.e. Na+ and K+) (Reed and Lardy, 1972;
Pfeiffer et al., 1974) and will not therefore alter the balance of sodium
and potassium ions across the plasma membrane (Pressman, 1976).
The action ofA23187 is thought to depend on its reduced form being
lipid soluble and able to pass across the lipid bilayer of the cell. When
it reaches the edge of the membrane the polar environment results in
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the loss of the hydrogen ion and traps the ionophore in the polar-
nonpolar interface. Calcium in the intercellular fluid binds to the
ionophore which changes its properties and permits it to move back
into the polar membrane. It can then cross to the internal surface of
the cell membrane where the calcium is released and replaced with
hydrogen which restarts the cycle (Pressman, 1976). Thus A23187 will
swap two H+ ions for each Ca2+ (Alberts et al., 1983). A23187 will also
allow the flux of calcium ions from membrane bound intracellular
stores and the cytoplasm (Reed and Lardy, 1972).
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Indomethacin
Prostaglandins were discussed in Chapter 1. Their synthesis
depends on the enzyme cyclooxygenase, also known as prostaglandin
synthetase, and its catalysis of the conversion of arachidonic acid to
the prostaglandin endoperoxide PGH2. Therefore the role of
prostaglandins or stimulants of their synthesis can be examined
through the inhibition of the enzyme cyclooxygenase.
Indomethacin is a non steroidal anti-inflammatory drug
(NSAID). This group of drugs are well known for their
anti-inflammatory, antipyretic and analgesic properties and includes
aspirin (acetylsalicylic acid) and ibuprofen (Bowman and Rand, 1980).
Indomethacin is a potent inhibitor of cyclooxygenase and
therefore prevents the production of prostaglandins (Bowman and
Rand, 1980). Indomethacin is over one hundred times more potent,
with regard to cyclooxygenase inhibition, than aspirin (Horuk, 1994).
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Summary
The following table (Table 3.1) summarises the action of the
drugs already described (LPS, PMA OA, A23187 and indomethacin).







Activation of immune system cells.
Protein kinase C activation via substitution for
DAG (DiAcylGlycerol).
Phosphatase inhibitor resulting in maintenance of
phosphorylated state of cellular proteins.
Increases free calcium by transporting calcium into
the cytosol.
Inhibitor of PGH-synthase (cyclooxygenase)




Chemical Tools and Cytokines
Cytokine is the generic name given to molecules such as the
interleukins, tumour necrosis factors and interferons. They are
chemical mediators which generally act close to their site of synthesis
to coordinate immune/inflammatory responses to tissue damage or
the invasion of the host by foreign antigens. Their influence on the
cervix is of interest as it may provide further evidence that
inflammatory processes could be the mainstay of cervical ripening.
Interleukin-1
IL-1 is a polypeptide of approximately 31,000 Da (Daltons)
which is cleaved to give an active molecule of 17,500 Da. It exists in
two forms IL-la and IL-1(3 (Dinarello et al., 1973; March et al., 1985).
IL-ip is the predominant form measured in blood and body fluids,
while IL-la appears to be embedded in the cell membrane (Dinarello,
1988; Kurt-Jones et al., 1985). Although the two show only 26%
amino acid homology in the human they are both composed of
p-folded sheets (Dinarello, 1988) and are both recognised by the same
IL-1 receptor (Kilian et al., 1986; Dower et al., 1986). There is one
section of the molecules, where the amino acid homology is high, that
is thought to contain the receptor recognition site (Dinarello, 1988).
IL-1 is produced by a variety of cell types including fibroblasts,
lymphocytes, macrophages/monocytes and polymorphonuclear cells.
It is a major player in inflammatory reactions and was originally called
endogenous pyrogen because of its ability to cause fever (Dinarello,
1988; Atkins, 1960). It is also produced by cells in the brain and is
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thought to promote sleep (Dinarello, 1988), presumably accounting for
tiredness associated with illness and activation of the immune
system, Interleukin-1 has many and varied actions (Tabibzadeh,
1991b; Dinarello, 1988), mostly concerned with inflammation and
tissue repair (Krane et al„ 1985; Evequoz et al., 1984; Dayer et al„
1986).
IL-1 has been shown to stimulate prostaglandin E synthesis by
rat glomerular mesangial cells and human lung fibroblasts
(Pfeilschifter et al., 1989; Elias, 1988; Elias et al., 1987). The rat cells
also showed increased phospholipase A2 release (Pfeilschifter et al.,
1989). IL-ip was more potent than IL-la in stimulating both PGE2
synthesis and PLA2 in rat mesangial cells (Pfeilschifter et al., 1989),
but in lung fibroblasts the effect of each on prostaglandin output was
similar (Elias et al., 1987). Prostacyclin synthesis by human
endothelium was stimulated by both forms of IL-1, again to a similar
degree (Endo et al., 1988).
Interleukin-1 and the Reproductive Tract
Interleukin-1 is thought to stimulate collagenase and proteolytic
enzymes production by rabbit cervical cells (Goshowaki et al., 1988;
Ito et al., 1987) and by other cell types (Krane et al., 1985; Evequoz et
al., 1984; Dayer et al., 1986).
IL-1 has also been shown to have chemotactic and activating
effects on cells of the immune system (Dinarello, 1988; Hunninghake
et al., 1987; Klempner et al., 1978; Klempner and Dinarello, 1979;
Sauder et al., 1984), however, there is now evidence that this cytokine
has the ability to stimulate the production of another interleukin,
IL-8, (Larsen et al., 1989b; Matsushima et al., 1988; Strieter et al.,
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1989) which exerts strong chemotactic/activating functions,
particularly on neutrophils, and that such properties attributed to
IL-1 may in fact have been the result of contamination by IL-8 (Peveri
et al., 1988; Matsushima et al., 1988). Streiter et al. claim to have
observed no significant chemotactic activity with culture medium
containing recombinant IL-1 p (Strieter et al., 1989), and Yoshimura's
group reported similar findings using purified, natural IL-1 (a and (3
forms) and their recombinant counterparts (Yoshimura et al., 1987a).
Hyaluronic acid in the cervix has been shown to increase during
pregnancy (Fosang and Handley, 1988) and it has been reported to
stimulate IL-1 production by human monocytes (Hiro et al., 1986).
Hyaluronic acid has itself been found to have a chemotactic effect on
neutrophils as has the exudate from hyaluronic acid conditioned
monocytes. The authors suggested that the monocytes released a
neutrophil chemotactic factor into the conditioning medium (Mazzone
et al., 1986). This may have been IL-1, which subsequently stimulated
IL-8 release.
The proinflammatory actions of interleukin-1, whether direct or
indirect, may be of importance in the process of cervical ripening if it
is assumed to be an inflammatory type reaction.
Human menstruation has also been likened to an inflammatory
reaction, showing similar characteristics (Tabibzadeh, 1991b). The
presence of IL-1 in plasma has been reported to vary during the
menstrual cycle and to peak in the secretory phase (Cannon and
Dinarello, 1985). IL-1 mRNA has also been identified in reproductive
tissue, both mouse and human uterine material showing its presence
with in situ hybridisation (Takacs et al., 1988; Kauma et al., 1990). A
bioassay identified the production of IL-1 by decidual cells (Romero et
3.14
Chapter 3 Chemical Tools and Cytokines
al., 1989c) and this cytokine has also been found in amniotic fluid
(Tamatani et al., 1988). Endometrial epithelium and stroma has been
shown to possess specific binding sites for interleukin-1 (Tabibzadeh
et al., 1990; Tabibzadeh, 1991a).
Interestingly, there is evidence that IL-1 is produced by
placental tissue obtained after vaginal delivery in much greater
quantities than placental tissue from elective caesareans (Taniguchi et
al., 1991). IL-ip was the predominant form measured in culture
medium in both groups. This suggests that IL-1 may be also be
involved in labour. The same group found a seventeen fold increase in
interleukin-1 output by tissue derived from women in labour but
where intrauterine infection was present. It has been suggested that
microbial invasion of the uterus may be involved in the precipitation
of preterm labour by the instigation of an inflammatory response
(Taniguchi et al., 1991; Uldbjerg and Ulmsten, 1990; Romero et al.,
1988; Lamont et al., 1990; Romero et al., 1989a; Romero et al.,
1989b), the many factors produced, including prostaglandins and
cytokines, resulting in parturition.
This obviously supports the idea that cervical ripening is an
inflammatory based process, and there is evidence of interleukin
production by cervical tissue. Ito et al. claimed to have found IL-1
production in cervical explants from pregnant rabbits but no such
protein synthesising activity in nonpregnant animals (Ito et al., 1988).
They also showed that the IL-1 they isolated was capable of
stimulating collagenase production by rabbit cervical fibroblasts and
proposed that interleukin-1 was involved in cervical ripening and
dilatation.
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Tumour Necrosis Factor-alpha (TNF)
Tumour necrosis factor is another polypeptide that is associated
with inflammation and immunoregulation (Tabibzadeh, 1991b). It is
synthesised as a 26,000Da protein and processed to a mature form
with a molecular weight of 17,000Da (Jue et al., 1990). It is also often
referred to as cachectin or given the suffix "a", and is related to
lymphotoxin-a (also known as TNF(3) (Male et al., 1987). The two
tumour necrosis factors were shown, using a human cervical
carcinoma cell line, to share the same receptor (Aggarwal et al., 1985).
Where the acronym TNF is used in this text it refers to TNFa.
Although TNF was originally thought to be a macrophage
product there is now in situ hybridisation and immunohistochemical
evidence that it may be produced by other cell types, such as smooth
muscle (Barath et al., 1990), monocytes (Sariban et al., 1988; Ruco et
al., 1989), neutrophils (Vilcek and Lee, 1991), breast tissue (Spriggs et
al., 1987), lymphoid tissue (McCall et al., 1989) and epidermal cells
(Oxholm et al., 1988).
The name tumour necrosis factor may be slightly misleading
since this molecule has many other biological functions and they have
been found to overlap with those of IL-1 (Balkwill and Burke, 1989; Le
and Vilcek, 1987), such as the stimulation of granulocytes,
B-lymphocytes and T-lymphocytes and inducing fever.
The complex network of cytokines involved in
inflammatory-/immuno-modulation shows areas of overlap, as
mentioned above, but there also appears to be cooperation between
different components of this system resulting in synergistic responses
of greater magnitude than their simple sum.
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Fibroblasts have been shown to produce PGE2 in response to
TNF (Dayer et al., 1985), and a combination of both IL-1 and TNF was
shown to stimulate PGE2 production to a much greater extent than
anticipated by adding their effects together (Elias et al., 1987; Elias,
1988; Elias et al., 1988a). However, Elias also noted that fibroblast
proliferation was inhibited by the two cytokines in combination,
despite each individually stimulating proliferation (Elias, 1988; Elias
et al., 1988a). He found that inhibition of prostaglandin synthesis
blocked the inhibitory effects of IL-1 + TNF treatment (Elias, 1988;
Elias et al., 1988a) and suggested that the response of the cells may
indicate some involvement of these cytokines in the regulation of
fibrotic activity in inflamed tissue. This work also indicated that the
cytokines in question were not causing cell death. Pfeilschifter et al.
also observed PGE2 stimulation in rat mesangial cells treated with
TNF, plus an increase in the activity of phospolipase A2 (Pfeilschifter
et al., 1989). They also observed that the combination of IL-1 and TNF
resulted in greater stimulation than their individual effects added
together.
Prostacyclin synthesis by endothelial cells in culture has been
shown to increase following treatment with TNF (Endo et al., 1988;
Kawakami et al., 1986), and Endo et al. observed an additive increase
in prostaglandin synthesis when IL-1 and TNF were combined in the
same culture medium (Endo et al., 1988).
Fibroblasts have also been shown to produce collagenase in
response to TNF (Dayer et al., 1985) and to increase their synthesis of
glycosaminoglycans (Elias et al., 1988b). The GAG study found that
hyaluronic acid (HA) was the predominant molecule but also found
chondroitin sulphate, dermatan sulphate and heparan sulphate. TNF
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appeared to increase HA synthesis and decrease the production of the
other GAGs, possibly by promoting HA synthetase activity.
Indomethacin inhibition of prostaglandin synthesis did not affect the
GAG response to TNF (Elias et al., 1988b), thus indicating separate
control mechanisms.
As with IL-1, TNF has been shown to promote the synthesis of
mRNA for the chemotactic/stimulatory cytokine IL-8 (Matsushima et
al., 1988; Larsen et al., 1989b; Strieter et al., 1989)
TNF and the Reproductive Tract
In terms of reproductive biology the analogy ofmenstruation to
an inflammatory reaction (Tabibzadeh, 1991b), and similarly
parturition, has led to studies of TNF in reproductive tissue. TNF has
been found in human placental and decidual supernatants, as well as
in amniotic fluid and decidual tissue itself (Casey et al., 1989; Jaattela
et al., 1988). Uterine tissue was shown to contain TNF mRNA and
placental cells to posses receptors for the cytokine (Tabibzadeh,
1991b; Eades et al., 1988). Thus, TNF's presence in such tissues
supports a role for it in reproductive physiology possibly through
inflammatory style processes that regulate menstrual function and
the mechanisms of parturition.
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Interleukin-8
IL-8 is a 72 amino acid peptide belonging to a supergene family
of peptides with potent leucocyte chemotactic properties. It has been
placed within the chemokine subgroup of the cytokine group of
mediators (Tanaka et al., 1993; Lindley et al., 1993). Structurally it
comprises a P-sheet and two a-helices (Clore and Gronenborn, 1992).
The family of proteins to which it belongs includes platelet basic
protein/connective tissue activating protein/p-thromboglobulin
(PBP/CTAP/P-TG), platelet factor 4 (PF4), growth regulated gene
product (GRO), and macrophage derived inflammatory protein-2
(MIP-2), (for a review see Baggiiolini et al. (Baggiolini et al., 1994)
Baggiolini and Sorg (Baggiolini et al., 1992), Matsushima and
Oppenheim (Matsushima and Oppenheim, 1989)).
The literature shows that interleukin-8 was initially identified
by several separate laboratories and given a different name by each
based on the experiments they carried out. The cells used to produce
the IL-8 were usually stimulated to do so with lipopolysaccharide and
some of the alternative names assigned to IL-8 include, Monocyte
Derived Neutrophil Chemotactic Factor (MDNCF) (Yoshimura et al.,
1987b), Neutrophil Activating Factor (NAF) (Peveri et al., 1988) and
Monocyte derived Neutrophil Activating/Attracting Protein/Peptide
(MONAP/NAP) (Schroder et al., 1987). Another peptide, T-Lymphocyte
Chemotactic Factor (TCF), has also been shown to have the same
amino acid sequence and properties as IL-8 (Larsen et al., 1989a).
Since it appears to be a multipotent compound, acting on several cell
types, agreement was reached that this compound should be renamed
interleukin-8 (IL-8) (Westwick et al., 1989).
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A receptor for interleukin-8 has been shown to exist and this
shows the binding characteristics of a single receptor type (Samanta
et al., 1989; Grob et al., 1990). However, another group has reported
the detection of a high and a low affinity binding site for IL-8 on
polymorphs (Besemer et al., 1989). Different authors have claimed
both a highly significant binding of IL-8 to red blood corpuscles
(RBCs) (Darbonne et al., 1991) and negligible binding of IL-8 to RBCs
(Besemer et al., 1989). Evidence is now available that the Duffy blood
group antigen is in fact the reported receptor for IL-8 on RBCs (Horuk,
1994). The prospect of RBCs sequestering IL-8 in the blood stream is
attractive since this would limit the activation of neutrophils to the
site of IL-8 production and also help to maintain the concentration
gradient that is considered essential to its chemotactic properties.
Several human cell types have been shown to produce IL-8,
among them monocytes/macrophages (Yoshimura et al., 1987b),
dermal fibroblasts and keratinocytes (Larsen et al., 1989b),
endothelial cells (Strieter et al., 1989) and possibly more relevant to
this thesis, chorion and decidual cells (Kelly et al., 1992). IL-8 has
been detected in amniotic fluid, greater quantities in fluid from
women at term, in labour than women at term but not in labour
(Romero et al., 1991). Romero's group also noted a further increase in
amniotic fluid IL-8 levels in term pregnant women with bacterial
infections detected in their amniotic fluid (Romero et al., 1991).
Bacterial endotoxins have been shown to inhibit the chemotactic effect
of IL-8 on neutrophils (Bignold et al., 1991), however, greater
numbers of neutrophils have been observed in the amniotic fluid of
women in whom microorganisms were detected in the same fluid
(Romero et al., 1991).
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As its various original names implied, interleukin-8 attracts
neutrophils and also causes them to release the contents of their
granules. The specific granules, which contain collagenase, are those
stimulated to become active by IL-8, however, it has also been shown
to stimulate the release of elastase from the azurophil granules,
under certain conditions (Peveri et al., 1988). The importance of IL-8
in cervical ripening has not been examined before, however, the view
that leucocyte collagenase is crucial in the breakdown of cervical
collagen (Osmers et al., 1992; Rath et al., 1988b) implies that some
factor must cause the observed leucocyte infiltration of the cervix
(Junqueira et al., 1980; Minamoto et al., 1987) and degranulation of
those leucocytes. Interleukin-8 presents itself as an excellent
candidate and there is now some evidence that a chemotactic
substance is produced by rabbit cervical cells, probably fibroblasts
(Uchiyama et al., 1992).
Interleukin-8's effects are thought to involve increased
intracellular calcium (Thelen et al., 1988; Bacon et al., 1989), an
inhibitory effect on cAMP and the activation of protein kinase C
(Bacon et al., 1989).
There is evidence that other cytokines may be involved in the
regulation of IL-8 synthesis. In particular, interleukin-1 and tumour
necrosis factor were shown by Matsushima et al. (Matsushima et al.,
1988), Larsen et al. (Larsen et al., 1989b) and Strieter et al. (Strieter
et al., 1989) to cause rapid induction of IL-8 mRNA expression.
Additionally, IL-8 and prostaglandin E2 have been found to act
cooperatively, PGE2 reducing the concentration of IL-8 required to
cause neutrophil invasion of rabbit skin (Colditz, 1990).
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If cervical ripening is regarded as an inflammation based
process, then the cytokines must be an integral part of that system
and IL-8 is an attractive candidate for a central role therein.
The Medical Research Council is currently pursuing the patent
rights for interleukin-8 with regard to its use in the promotion of
cervical ripening.
Overview
The process of cervical ripening is complex. The structural
changes require the coordination of the degradation and rebuilding of
the connective tissue, and this appears to rely on an inflammatory
type activity. The fibroblasts become active and produce collagen and
GAGs to replace the old highly structured material. They can also
produce the collagenase essential for the breakdown of collagen.
Similarly the cervix is infiltrated by polymorphonuclear cells
stimulated to produce the only two enzymes capable of initiating the
demise of the collagen molecule, collagenase and elastase. These cells
also contain other proteases that are able to complete the digestion of
the collagen molecules and also activate latent forms of collagenase.
The factors controlling cervical ripening are likely to be common
mediators of inflammation such as the prostaglandins and the
cytokines. These factors may be produced by constituent cells, such
as the fibroblasts, and by recruited leucocytes. An auto/paracrine
system may then be set up, under the ultimate control of hormonal
mediators produced by the fetus and related to the gestational age,
culminating in the rapid removal of the resistance of the cervical
connective tissue to dilatation as parturition progresses to the delivery
of the child.
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This thesis examined the prostaglandins and the regulation of
their production in the cervix, including the possible effects of
progesterone and the cytokines IL-1 and TNF, and the production and
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Materials and Methods
The reagents mentioned in this chapter are contained in
appendix I at the end of this thesis.
The Guinea Pig Study
Preparation of the Cervical Cells for in vitro Culture
The Guinea Pigs
Pregnant Duncan Hartley guinea pigs were sacrificed at forty
nine to fifty two days gestation (mean ± se, 50.4 ± 0.3 days). The
length of gestation was determined from the date of the previous litter
in conjunction with the weight change of the animal on a weekly
basis. Full term gestation in these animals is 65 days. Those animals
assigned to be treated in vivo with the antiprogestin RU486 were
given a standard injection of lOmg in 0.1ml ethyl oleate 24 hours
prior to being killed. The animals were killed by cervical dislocation.
Dissection
The dissection table was prepared by cleaning with disinfectant
solution and swabbing with 70% isopropanol (IPA). Several layers of
paper towelling were spread on the work surface and sprayed with
IPA. The guinea pig was weighed (1470 ± 32g) and placed on its back
on the dissection table, the abdomen was cleaned of any loose
material and sprayed with IPA.
Using equipment pretreated with disinfectant (Shield, as
directed by manufacturer) and washed with IPA the skin was removed
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from the guinea pig abdomen and the exposed muscle sheet cleared of
any fur. The muscle was cut and the abdomen covered with
aluminium foil. The uterus was removed through a hole in the foil and
a cut was made through the vagina ensuring that the cervix was
above the line of the incision.
The lower part of the uterus, including the cervix, was removed
and placed in 50ml cold tissue collection buffer (see later).
The remaining part of the uterus was opened and the fetuses
decapitated to ensure they were dead. The fetuses and the placentae
were counted and weighed. The mean (± sem) weight of the fetuses
was 184 ± 14g and of the placentae 22.4 ± 1.4g (n=21).
In a class II tissue culture cabinet the cervix was washed in
fresh PBS and the extraneous tissue removed using scissors. The
upper limit of the cervix was taken to be the point at which the
septum separating the two uterine horns began (see figure 4.1).
Enzyme Based Cervix Cell Dispersal
Trypsin Pre-Digestion
The minced cervix was placed in a trypsin solution for 15
minutes at room temperature with occasional mixing by shaking or
pipetting. The tissue was then centrifuged at 1400g (2,500rpm,
Sorvall RT6000B) for 10 minutes (4°C) and the supernatant
discarded.
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Figure 4.1 Diagrammatic representation of the guinea pig cervix.
The mean (± sem) weight of the cervices was 268 ± 24mg (n=7).
The cervix was then cut longitudinally using a scalpel blade and
chopped into a mince with scalpel blades to be
enzymatically/mechanically dispersed. The dispersal process was
based on that of Rajabi et al. (Rajabi et al., 1991).
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Main Digestion
After resuspending in 50ml prewarmed collagenase/DNAse
digestion medium the tissue was incubated at 37°C for 60 minutes. At
intervals during the incubation the tissue was forced through a large
bore pipette, several times, in order to dislodge any cells that were
loosened by the action of the enzymes. This accelerated the process of
dispersal and reduced the exposure time of the cells to the digesting
enzymes.
After an hour at 37°C the digesting tissue mixture was filtered
through a 150pm sterile nylon mesh. The enzymes in the cell
containing fraction, which passed through the mesh, were inhibited
by the addition of approximately 5ml FBS and centrifuged at
2,500rpm for 20 minutes (4°C). The cell pellet was resuspended in
5-10ml complete medium and kept on ice. The tissue captured by the
filter was placed in fresh, prewarmed digestion medium (50ml) and
incubated for a further hour as described previously. This process was
repeated until all the cervical tissue had been dispersed, usually
three, one hour long, incubations were sufficient.
Cell Quantification and Viability
The resuspended cell fractions were combined and the number
of cells quantified using a haemocytometer. The average (± sem)
number of cells released by this process was 22 x 106 ± 1.3 x 106
(n=16). Trypan blue exclusion was used to assess cell viability, which
was always greater than 80% in the cultures used.
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Guinea Pig Cervix Culture Development
Initial attempts at producing cultures of guinea pig cervical cells
were based on the idea that the main cellular component of the cervix
is the fibroblast, and that fibroblasts are relatively easily grown, being
renowned for contaminating cultures of dispersed tissues where they
are not the desired cell type but become the predominant one.
In the first instance the cervix of a guinea pig was finely minced
using scalpel blades then incubated in complete medium at 37°C
(95% air/5% CO2) for several days. The flasks were then examined for
signs of cellular outgrowths, emanating from the small pieces of
tissue. This method did show promise in the early stages and isolated
groups of cells grew in the culture vessels. After two weeks there were
30 x 106 cells in total spread out in several flasks. These cultures
were split by trypsinisation in an attempt to stimulate replication.
They were also plated out at 106 and 5 x 105 cells per well in cluster
plates precoated with collagen to determine whether or not this would
improve cell adherence and thus also encourage growth, however, this
offered no improvement over the uncoated polystyrene. The cells were
maintained in culture flasks for several weeks but they failed to divide
enough to produce confluent cultures suitable for experimental use.
Further attempts at maintaining guinea pig cervical tissue in
culture were based on both mechanical and enzymatic dispersal, until
the method finally used in the main experiments was developed.
Following on from the first method the cervix was again cut into
small pieces using scalpel blades but then treated with a digestion
medium containing collagenase and DNAse at 37°C for 40 minutes.
This technique was based on a digestion process used successfully by
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others in the Centre for Reproductive Biology (R Kelly, Pers. Comm.).
This technique was based on the method published by Jones et al.
(Jones et al., 1989).
The cells that were released from the cervix by this process were
permitted to grow in a culture flask in complete medium and early
results were encouraging as more cells seemed to adhere to the
culture flasks than with the previous method. Visually the cells were
fibroblast-like. Again, the difficulty encountered with this method
arose from the fact that although the cells were viable they did not
produce confluent cultures. Variations of this technique were
employed where the digestion time was increased to 60 minutes and
mechanical dispersal was encouraged by introducing continuous
stirring with a magnetic stirrer. This made little difference to the
results.
Since the methods described above were not producing enough
cells from the initial stages a Virtis 23 homogeniser was tested. This
piece of equipment basically consisted of a steel blade on the end of a
rotating spindle that pulverised the minced cervix into a soup of
exceptionally small fragments. A sonic homogeniser was avoided for
the purposes of this work since it would have destroyed the cells and
it was hoped that the cellular content of the cervix would remain
intact by using the Virtis homogeniser.
Because the soup produced by this method was already a fine
suspension of tissue no enzymes were used. Instead of trying to
produce cultures from which cells would be propagated, the cell
clumps were seeded directly into culture plates. Since there had only
been sparse adherence of cells previously different substrates were
tried in the wells in an effort to find a better growing surface. A
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protein blotting membrane, polypropylene capillary matting and a
synthetic lens tissue were used. The rationale was that a different
surface may have been more attractive to the cells and especially with
the capillary matting that the cells would have become attached
within the fine mesh and become better established. This would at
least have allowed these cultures to be used experimentally. However,
this method did not produce good results, the homogenisation
possibly being too violent and destroying too many cells, suggested by
the presence ofmany small fragments that were clearly not cells.
The next obvious step was to reduce the damage to the cells
caused by the homogenisation procedure, and this was done by
reducing the speed of the rotor and the length of time the cervical
tissue was exposed to it. Also at this stage the enzyme mixture was
reintroduced (40 minutes, 37°C). The mixture was agitated during
the digestion process and any undigested material was further
digested in fresh digestion medium. This did prove to be slightly more
successful as cells were found but still there remained many small
unidentified fragments and the different substrates did not offer any
improvements over the polystyrene surface of the culture dishes
themselves.
Abandoning the homogenisation completely, because of the
damage caused to the cells and the poor results, and placing the
minced cervix in a trypsin solution prior to the main digestion proved
to be a highly successful alteration. From such experiments it was
evident that to digest the minced cervix completely would have taken
4-5 hours and would presumably have been extremely harsh on the
cells, thus the removal of the released cells from the digestion mixture
and replacement of the undigested material in fresh digestion medium
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reduced the proteolytic damage, almost eliminated the mechanical
damage and gave excellent yields of cervical cells (approximately 20 x
106 cells per cervix). Another advantage of this method was that the
cultures were each representative of the cervix as a whole and were
not confined to fibroblasts, so any resident macrophages or other
white blood cells would be included in the experiments that followed.
Because the process was relatively severe, very likely to have removed
some of the surface molecules from the cells, and because the cells
were likely to have been stimulated to produce prostaglandins, at
least by the mechanical disruption, they were left to recover for 65-70
hours.
This last method was adopted for the guinea pig cultures
employed in the work for this thesis and is described in greater detail
elsewhere.
Guinea Pig Cervix Cell Culture Used Experimentally
Plating Out of Cells
The dispersed cells were seeded into 48 well culture plates
(Costar) at 105 cells per well in a volume of 1ml complete medium.
The 48 well format allowed for 8 different treatments per plate with 6
replicates of each. The plates were made of polystyrene, each had a lid
and was described by the manufacturer as of low evaporation design
which should have improved the accuracy of the system.
Progesterone Effect
Because of the high levels of progesterone in the pregnant
animal part of the study was designed to examine the role of
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progesterone. Therefore approximately half the total number of wells
were seeded with complete medium containing progesterone at a
concentration of 10"6M. This was done as soon as possible in order to
reduce the time during which the cells were in a progesterone free
medium to the minimum possible.
The culture plates were incubated at 37°C in a 95% air/5%
CO2, humidified atmosphere for approximately 65-70 hours. This
allowed time for the cells to adhere to the polystyrene dish and to
recover from the relatively harsh digestion procedure. Figure 4.2
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Figure 4.2 Guinea pig cervix cells in culture. The arrow on the right
indicates an example of a fibroblast, the arrow on the left indicates an
example of another cell type present in the cultures.
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They appear to adhere well to the plates. Fibroblast-like cells
constitute the majority, however, other types are evident. Some
clumps of cells are also present although which type they are and the
reason for clumping is not clear. It may be that the digestion did not
separate all cells, leaving small numbers together which went on to
produce small colonies within the whole culture.
Experimental Procedure
At the end of the recovery period the cells were used in
experiments to examine the effects of various treatments on the
production of prostaglandins. The medium was removed from each
well and the cells washed with 1ml sterile PBS (Northumbria
Biologicals). The PBS was removed and replaced with the medium
containing the compound being tested (treatment medium, 1ml/well).
The culture dishes were then returned to the incubator and a humid,
95% air/5% CO2 atmosphere at 37°C for a further 24 hours. The
treatments for cells seeded in 106M progesterone were made up in
medium which contained progesterone.
Each of the primary cultures comprised a control set of wells
where nothing was added to the medium, a control for the
progesterone containing wells where only progesterone was added to
the medium and a variety of different treatments (6 wells each).
4.10
Chapter 4 Materials and Methods
Cells Lost ByWashing
The number of cells lost by the removal of the original medium
and the washing process was examined by counting the number of
cells in the fluid removed from the wells. This fluid was centrifuged as
the original preparation had been and the number of cells found to be
equivalent to approximately 104 cells lost per well.
Cells Remaining at the End of the Experiment
To determine the number of cells in the final cultures, after
experimentation, the wells were washed with PBS and trypsin used to
free the cells from the culture dish and each other. This was not
particularly successful as many cells remained attached to the culture
plates which meant that the cells counted did not represent the
numbers in the wells. This continued to be the case even when a
strong solution of trypsin plus EDTA was employed. Attempts to
remove the cells from the plate mechanically were not successful.
Using a plastic scraper the surface of the well was scraped but there
were still cells apparently adhering to the plastic. This made assessing
cell numbers difficult, however, 7-8 x 104 cells were released per well
by these methods. While the actual number of cells in each well was
probably higher an accurate assessment was not possible.
Sample Storage
Following the experimental treatment incubation period the
medium was harvested. Half of it was mixed with methyloximating
solution (0.5ml medium + 0.25ml methyloximating solution) and the
methyloximation of the prostaglandins in the sample allowed to take
place at room temperature, overnight (samples treated in this way
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were said to have been 'moxed'). The moxed samples were stored at
4°C. The remainder of the medium was frozen and stored at -20°C. All
the samples from these cultures were stored in 1ml polypropylene
tubes in racks in a 96 well format and each tube was capped (Alpha
Laboratories).
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Standardisation ofAssayed Values of Prostaglandins
Estimation of the quantity of prostaglandins present was
carried out in the following way. The samples were assayed in aliquots
and for the purposes of this example a 20jil aliquot will be assumed.
The absolute figure obtained from the assay was a measure of the
quantity of PG (in picogrammes) in the aliquot (20jil). This was a
fraction of the moxed sample of 750|il (500pl medium plus 250jil
MOX), introducing a multiplication factor of 37.5 (750pl/20|il) to give
the amount of PG in 750pl moxed medium (which is the same as that
in 500|o.l of the unmoxed medium). To relate this to the total volume of
treatment medium, that is lOOOjil, a second multiplication factor of 2
was used (1000(il/500jil). So, in practice the absolute figure was
multiplied by 75 to give a measure of picogrammes of prostaglandin
per lOOOpl per 105 cells, using the seeding value for the number of
cell present. Where different aliquot volumes were used the
multiplication factors were adjusted accordingly.
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The Human Study
The aim of this study was to examine prostaglandin and
interleukin-8 production in vitro, by cells derived from the cervices of
women at different reproductive stages and following treatment with
and without prostaglandin and RU486 therapies.
Cervical Tissue
Human cervical explants were obtained from five groups of
women. Three groups were from pregnant women undergoing surgical
termination of pregnancy (including women treated with
prostaglandin or RU486), one was from postmenopausal women
hospitalised for dilatation and curettage to investigate uterine
bleeding, and the fifth group of tissues were obtained from
premenopausal women undergoing hysterectomy where there was no
disease of the cervix. The pregnant and post menopausal women's
cervices were biopsied using a Tru-Cut™ needle. This produced plugs
of cervix about 10-15mm in length and 2mm in diameter
(approximately 10-15mg). The hysterectomy tissue was obtained at
operation and cervical tissue not required for pathological
examination was available for study. Tissue samples were collected in
saline at 4°C by the operating theatre staff.
The division of the tissue was as follows,
Group 1 was from women given the prostaglandin E analogue
Cervagem™ (16,16-dimethyl-trans-A2-prostaglandin Ei, methyl ester)
prior to surgical termination. Cervagem was given as a lmg pessary 2-
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3 hours before surgery to aid cervical dilatation. These women were
nulliparous.
Group 2 was from parous women not given cervagem
pretreatment before surgical termination.
Group 3 was from the hysterectomy patients. These women
were premenopausal and were not pregnant. They were at various
stages of the menstrual cycle and there were insufficient data to
examine any stage specific differences.
Group 4 samples were from the postmenopausal women being
treated for unexplained uterine bleeding.
Group 5 were from women attending for surgical termination
that agreed to pretreatment with the antiprogestin RU486 48 hours
before the operation. Difficulties were encountered in obtaining needle
biopsies from these patients. A possible explanation is that the cervix,
which was not as rigid as in the other groups because of the effect of
the RU486, was more likely to slide round the needle rather than into
it, thereby often making the biopsies inadequately small.
Results from one of the human cervices were excluded because
of discrepancies in the tissue weights. A further biopsy was discarded
because bacterial contamination was evident after 24 hours
incubation. Such contamination is not unexpected in cervical tissue
as there are several opportunities for exposure to microorganisms to
occur. An obvious occasion would be between removal of the tissue
and dissection in the tissue culture cabinet while the other main
source of contamination would be from a vaginal infection.
This study had the approval of the local ethics committee.
RU486 (Mifepristone) is only available in the United Kingdom under a
named patient basis and only for medical terminations. Therefore, the
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use of RU486 in this study required the approval and cooperation of
the manufacturer (Roussel) who supplied the drug for experimental
use.
Culture Method Employed
All the biopsy material made available was dissected under
sterile conditions in a clean air cabinet within about an hour of
excision from the patient. Each tissue was rinsed in fresh PBS several
times and when necessaiy any blood clots that were attached to it
were gently removed in order to reduce contamination of the cultures
with cells other than those from the cervix itself.
The needle biopsy tissue, when large enough, was cut
longitudinally and one piece was placed in 4% formaldehyde fixing
solution for 24 hours. Then it was processed in a Shandon 2LE tissue
processor which sequentially moved the tissue through increasing
concentrations of ethanol (from 70% to absolute alcohol) to dehydrate
it, followed by immersion in histoclear (clearing agent, miscible -with
both alcohol and paraffin wax) to replace the alcohol. The histoclear
was then replaced with molten wax. Once the cervix was impregnated
with wax it was embedded in a wax block for later
immunohistochemical investigation. The remaining tissue was cut
into four pieces (approximately l-3mg each) and used in tissue
culture (see below), two of the pieces were assigned control medium
and the other two to a treatment medium, thus each cervix provided
enough material to examine the effects of only one treatment.
The hysterectomy tissue was cut into small pieces similar in
size to those obtained with the needle biopsies. However, because this
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sampling method resulted in a much larger piece of cervical tissue for
experimentation more than one treatment could be tested on each
individual cervix. Generally 16-20 small segments of tissue
(approximately 2-3mg each) were taken from the biopsy material and
four pieces were assigned to each treatment including the control.
With these tissues it was also possible to place a relatively large piece
in formaldehyde for fixation and wax embedding.
The experiments were carried out in 48 well plates as used for
the guinea pig cultures. The tissue was placed in the well with 250pl
of the appropriate medium. This was enough to cover the tissue but
still allow it to remain close to the fluid:air interface. The plates were
incubated in a humid atmosphere of 95% air/5% CO2 at 37°C for 24
hours and the spent treatment medium was then harvested and
replaced with fresh treatment medium. The plates were returned to
the incubator for a further 24 hour period. The medium was
harvested into two separate tubes one to be frozen and used in a later
interleukin-8 assay and one to be treated "with MOX for later
prostaglandin assay. The wet weight of the tissues was then recorded
using a Cahn 1200 electronic balance.
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Standardisation of Assayed Values of EL-8 and Prostaglandins
Microscopic examination of the cultures suggested that a degree
of tissue debris was present in the wells of the culture dishes,
therefore before assay the medium was centrifuged at 10,000g for 30
seconds in order to sediment any particulate material and reduce the
likelihood of interference in the assay. The medium was diluted prior
to assay by a factor of ten, using BSA/tween buffer, and 25-40jil
samples of this diluted culture medium (made up to lOOpl with PBGS)
were used for assay.
Calculation of the total quantity of IL-8 in the medium was
performed as follows. This example assumes an aliquot of 25jil of the
diluted medium. The absolute figure from the assay was a measure of
the quantity of IL-8/ml (in nanogrammes), taking into account the
fact that the sample was assayed in lOOpl. In effect, only 2.5(il of that
100(il was culture medium, thus introducing a multiplication factor of
40. To standardise the results the quantities of IL-8/ml were divided
by the mass of the tissue from which they were derived, giving a final
quantification in ng IL-8/mg tissue/ml.
Quantification of the PGE2 in the medium was performed as
follows. This example assumes an aliquot of 20gl of already diluted
medium (as for IL-8). The absolute figure from the assay was a
measure of the amount of PGE2 in the assayed aliquot (in
picogrammes). The aliquot effectively contained 1.33pl of the original
medium. Therefore, the figures obtained were multiplied by 750
(1000{il/1.33|il) to give pg/ml and divided by the weight of the tissue
(mg), resulting in units of pg/mg/ml. The results are presented in
ng/mg/ml.
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Assays
Prostaglandins and interleukin-8 were assayed by
radioimmunoassay (RIA), both utilising basically the same
methodology. These RIAs rely on competition between an antigen and
a radio labelled form of the same antigen for a specific antiserum. The
antibody/antigen complex is then bound by a second antiserum
directed against the immunoglobulins of the species in which the first
antiserum was raised, for example rabbit, and the excess antigen
(labelled and unlabelled) washed away. Depending on how much of
the antigen was in the sample being assayed the level of radioactivity
in the resulting complex will vary.
All RIAs were carried out in polypropylene tubes (Sarstedt) in
assay racks (Amersham). Separation of bound and free antigen was
effected by the addition of a magnetite-DAR (second antibody)
complex (magnetic particles coated with antiserum raised in donkeys
and directed against rabbit immunoglobulins) which was supplied by
Dr R.W. Kelly.
The magnetite was sedimented by placing the racks of tubes in
suitable magnets (Amersham).
The gamma radioactivity in each tube was measured using a
Nuclear Enterprises gamma counter (NE1600).
Assay results were calculated using a Macintosh computer and
Assayzap software (Biosoft, Cambridge, UK) written by Dr P. Taylor of
the MRC unit in which most of this work was carried out. Assayzap
used four parameter, weighted logistics to fit a curve to the standard
points.
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Prostaglandins
Assays for prostaglandins were established ones developed by
Dr R.W. Kelly (Kelly et al., 1986a; Kelly et al., 1989). The polyclonal
antisera were raised in rabbits against haptenised, methyloxime
derivatives of the various prostaglandins. Adding a methyloxime group
to the PG improves its stability and therefore reduces the likelihood
that the antisera will cross react with other prostaglandins or its own
metabolites. This introduced the requirement that the collected
samples were also treated with methyloximating solution (MOX) to
convert any prostaglandins contained therein to their Moxed form
(Figure 4.3). Another benefit of this process was that the samples were
then more stable when stored at 4°C.
Figure 4.3 Moxed form of PGE2
Prostaglandins were methyloximated and coupled to tyrosine
through an imide linkage. This conjugate was iodinated using
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Standard curves were reconstituted from freeze dried aliquots of
the relevant prostaglandins using PBGS. Serial dilutions were made to
produce the range of standards required (10 standards, lOpg/ml to
5120pg/ml). These solutions were prepared freshly, shortly before use
and were not stored in the reconstituted form.
Quality controls were made up from aliquots of moxed medium
containing known amounts of the prostaglandin in question.
The antiserum was stored freeze dried at -20°C and aliquots
were diluted 1:100 with PBGS and kept at 4°C. The working strength
used in assays was between 1:20,000 and 1:150,000 again diluted
with PBGS.
The stock iodine labelled PGs were stored in glass at 4°C and
diluted when required in PBGS to give approximately 20-25,000
counts per minute per lOOjil.
Samples of harvested medium were assayed in aliquots of
10-40|il made up to 100)il with PBGS. Dilutions were performed using
a Hamilton Microlab 1000. The medium from the human cervix
cultures required to be prediluted by a factor of ten using PBGS before
the samples were aliquoted using the Microlab.
The standard curve was constructed by adding 100|il of the
serial dilutions to the relevant assay tubes.
100|j.l of antiserum were added to all but the total counts and
the NSB (Non Specific Binding) tubes and 100(il of labelled PG were
added to every tube. The NSB tube had 200|il of PBGS to allow for the
dilution produced by the addition of antiserum and labelled PG in the
other tubes. The total binding (B0) tubes contained no PG other than
the radiolabeled form and therefore the sample volume of 100(il was
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replaced with PBGS. The contents of the tubes were thoroughly
mixed.
All samples, standards, total counts, NSBs and B0s were in
duplicate.
The assay mixture detailed above was incubated overnight at
room temperature.
Following incubation, 250jil of the second antibody preparation
was added to each tube and the tubes agitated to disperse the
magnetic particles evenly through the reaction mixture. The second
antibody was allowed to react for 30 minutes then the racks were
placed on the magnets to precipitate the magnetic particles (30
minutes). The rack (plus magnets) were then inverted to drain off the
excess buffer (antiserum and labelled PG) then the pellet resuspended
in 250(il ofwash buffer. The magnetic particles were precipitated once
more for 30 minutes followed by draining of the supernatant and 30
minutes inverted on several layers of absorbent paper to allow any
remaining buffer to drain out of the tubes.
The average binding capacity of the antiserum in these assays
was 19% and the non specific binding was 1%. The intra-assay
coefficient for the PGE2 assay was 6% (at lOOpg/ml) and the
inter-assay coefficient was 7.6% (n=32). PGF2a inter-assay coefficient
was 8.8% (n=32) and the intra-assay coefficient was 9.3% (at
lOOpg/ml). In both assays the sensitivity was 2pg/tube (100(il
sample/standard per tube).
4.22
Chapter 4 Materials and Methods
0 10 20 30 40 50 60
Expected Value (pg PGE2)
Figure 4.4 A typical curve from a prostaglandin assay produced by
Assayzap, using 4 parameter, weighted logistics to fit the line to the
duplicate data points.
Assay Interference
To examine the interference of hydrophilic factors contained in
the culture medium the following experiment was carried out with
PGE2.
Guinea pig culture medium, that had been stored at -20°C, was
pooled and a portion treated with MOX as described elsewhere. A
second portion (20ml) was run down a Sep-Pak™ C-18 cartridge to
remove lipophilic molecules, including prostaglandins. The cartridge
was pretreated by running 5ml methanol then 5ml of water down it.
This resulted in the particles of the cartridge being surrounded by a
layer of methanol. As the medium flowed past the methanol the
lipophilic molecules in the medium preferentially partitioned into the
alcohol phase. The phenol red pH indicator from the medium
remained in the column and the fluid flowing out was colourless. This
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was stripped medium. The column was next flushed with 2ml
methanol then 2ml water and these elutions pooled. This fraction
should have contained the molecules partitioned into the methanol
around the C-18 particles.
Stripped medium was spiked with PGE^ and diluted to produce
a range of concentrations. The spiked samples and some of the
unadulterated stripped medium were treated with MOX as was the
pooled medium.
The samples spiked with PGE2 correlated well with the expected
values (Figure 4.5) having a correlation coefficient (r) of 0.99
(p<0.001).
Expected Value (pg PGE2)
Figure 4.5 Correlation between the amount of PGE2 added to the
stripped medium and the amount detected in the radioimmunoassay.
Stripped medium did not contain any measurable PGE2, as
anticipated.
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The sample of moxed medium contained 628pg PGE2/ml and
the fluids eluted from the column after the stripping process
contained 279lpg PGE2/ml. Since this latter fraction was only 4ml,
derived from 20ml pooled medium, the equivalent value relative to the
moxed medium was 558pg PGE^/ml, which represented a recovery of
89%.
The correlation between spiked, stripped medium and the
expected values for those samples indicated that hydrophilic
molecules in the culture medium or released by the guinea pig cells
did not interfere with the assay. The stripping process was obviously
successful as witnessed by the fact that the material left on the
column contained almost as much PGE2 as the unstripped medium.
The slight loss may indicate that a larger volume of methanol and
water should have been used to clear the sep-pak, however, all the
phenol red appeared visually to be eluted by the method used.
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Interleukin-8
For the IL-8 radioimmunoassay a polyclonal rabbit antiserum
(ICN Flow) was used with recombinant interleukin-8 (Collaborative
Biomedical Products) labelled with iodine (125I, Amersham), using
chloramine T oxidation.
Standard curves were reconstituted from freeze dried aliquots of
recombinant IL-8 using standards buffer (50% PBGS and 50%
BSA/Tween buffer). Serial dilutions were made to produce the range
of standards required (9 standards, 0.097ng/ml to 25ng/ml). These
solutions were prepared freshly, shortly before use and were not
stored in the reconstituted form.
Quality controls were included in the assays and were prepared
from a stock medium containing IL-8.
The antiserum was stored at -20°C. Short term it was diluted
1:100 with PBGS and kept at 4°C. The working strength used in
assays was 1:1000 again diluted with PBGS.
The stock iodine labelled IL-8 was stored in glass at 4°C and
diluted when required in PBGS to give approximately 15-20,000
counts per minute per lOOpl.
The assay procedure was similar to that for the prostaglandins,
but there were some modifications. All but the total counts tubes
contained lOOpl of BSA/tween buffer and this was added before the
samples. The second antibody added was increased to 500|il and it
was found that the washing step could be omitted. Thus following the
30 minutes allowed for the second antibody to bind to the primary
antibody the tubes were drained of supernatant and inverted on
absorbent paper for a further 30 minutes.
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Samples of harvested medium were generally diluted by a factor
of ten with BSA/tween buffer and assayed in aliquots of 25-40|il made
up to lOOpl with PBGS. Dilutions were performed using a Hamilton
Microlab 1000. Before the initial dilutions were made the samples
were centrifuged for 30 seconds at high speed (10,000g) in a Biofuge
micro centrifuge. This was carried out to ensure that any particulate
matter from the cervical biopsies, that may have been taken up when
the medium was harvested, was excluded from the assay.
Figure 4.6 A typical curve from an interleukin-8 assay produced by
Assayzap, using 4 parameter, weighted logistics to fit the line to the
duplicate data points.
Where the difference between duplicates was greater than 10%
the sample was re-assayed. The average Bo of the antiserum in these
assays was 17% and the non specific binding was 1.6%. The
intra-assay coefficient for the IL-8 assay was 5.9% (at 3.12ng/ml) and
the inter-assay coefficient was 11.6% (n=9). For this assay the
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sequential dilution of culture medium from human cervix, up to 8 fold
dilution, gave a correlation with expected values of R=0.994 (p<0.01).
The sensitivity of the assay was determined as the point
distinguishable/separable from the B0 by two times the standard
deviation. The sensitivity was 0.195ng IL-8/ml and the value for
unused culture medium was below this.
Kit Elisa/RIA Comparison
Because the use of a kit to assay all the samples involved in this
work would have been prohibitively expensive the radioimmunoassay
described above was developed. In order to ensure that the
radioimmunoassay was in agreement with the ELISA kit (Quantikine)
with regard to the assay of IL-8 in the medium harvested from
cultures, samples were assayed by both methods and compared.
Correlation between the two sets of data was calculated and the
coefficient (r) was 0.968 (p<0.05), indicating that the two assay
methods do in fact produce parallel results.
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Statistical Analysis
Statistical analysis of the data was performed with the aid of a
Macintosh computer and software from Clear Lake Research (CLR
Anova). This program carried out between and within subject
comparisons of variance and follow up comparisons assigning
significance to the results using several optional tests. For this work
the Newman-Keuls test was used and in order to be consistent
throughout the same test was used in each analysis where such
testing was performed. This test reduces the likelihood of spurious
positive claims of significant differences. Statistical constraints permit
such follow up analyses when the anova is one-way only. Thus the
reported significances in initial presentation of the data do not involve
the Newman-Keuls test.
The comparisons between the different treatments used in the
guinea pig cultures were carried out using the differences between
each treatment and the control values for that treatment. This
approach was used because it eliminates the repeated use of the same
figures for the controls, a situation which arises because the different
treatments were often applied to cells cultured from the same animals
and would therefore be referenced back to the same control values.
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Immunohistochemistry
The immunohistochemical staining used in this work employed
the peroxidase anti-peroxidase (PAP) system. The principles of the
system are that a primary antiserum, in this case raised in rabbits
and directed against interleukin-8, binds to the antigen in the
sections and is then itself the target of a second antiserum (here
raised in swine and directed against rabbit immunoglobulins). The
second antiserum also reacts with the peroxidase antiserum complex
and a substrate for the peroxidase is exposed to the enzyme revealing
a brown colour if the primary antiserum is bound to its target.
Material from pregnant and nonpregnant women was fixed in
4% formaldehyde for 24 hrs then processed and embedded in wax for
sectioning. Wax embedded tissues were cut into 4pm sections using
an American Optical Corp 820 Spencer microtome, mounted on glass
slides and baked at 30°C overnight to attach them to the slides.
The slides were placed in xylene to dewax the tissue (10
minutes) then in pure ethanol for 60 seconds, followed by 95%
ethanol. The sections were then placed in a methanol/hydrogen
peroxide solution for 30 minutes to block endogenous peroxidase
activity. Next the slides were immersed in running water for 5 minutes
followed by 10 minutes in TBS with one change of the buffer after 5
minutes (the dishes used for the immersion of slides were agitated by
gentle motion on a rocking table).
The next few steps were all carried out in a slide box, designed
to maintain a moist atmosphere to prevent the tissue from drying out.
The buffer was drained off the slides and any excess fluid carefully
removed by capillary action through placing absorbent paper adjacent
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to the sections. Normal swine serum (1 part serum, 3 parts TBS) was
pipetted onto the sections and incubated at room temperature for 30
minutes. The NSS was then drained off and any excess removed. The
primary antibodies (raised in a rabbit and directed against IL-8) and
control immunoglobulins (normal rabbit serum. Both primary and
control sera used at a dilution of 1/25) were pipetted onto the
sections and incubated at room temperature for 30 minutes. The
control immunoglobulins were used to highlight any non specific
binding of rabbit immunoprotein to the tissue. The slides were then
rinsed in a stream of TBS (from a wash bottle) and immersed in TBS
as above (2x5 minutes) then any excess fluid removed. The second
antiserum was applied in the same way as the NSS and primary
antiserum and again incubated at room temperature for 30 minutes
(second antibody used at a dilution of 1/40). Rinsing in a stream of
TBS and two, 5 minute washes in TBS followed. The Peroxidase Anti-
Peroxidase (PAP, Used at a dilution of 1/100) complex was pipetted
onto the slides and incubated for 30 minutes (room temperature),
again followed by rinsing in a stream of TBS and two TBS washes.
Excess fluid removed, the DAB substrate was applied to the sections
and incubated in the dark for approximately 5 minutes, till the colour
developed enough to be seen by eye. The sections were then rinsed in
running water for several minutes and subsequently the nuclei
counterstained with hematoxylin for 30 seconds. The excess
hematoxylin was washed away in water and the slides placed in 1%
acid alcohol to differentiate the cytoplasm and nuclei. The slides were
washed in water then in Scott's water to blue up the nuclei, then
again in tap water. The final stage was to return the sections to xylene
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through increasing strengths of ethanol and mount coverslips on the
sections using Histoclear fixative.
4.32
Chapter 5
Regulation of Prostaglandin Production
by Guinea Pig Cervical Cells in Culture
Chapter 5 Guinea Pig Results
Regulation of Prostaglandin Production by Guinea Pig Cervical
Cells in Culture
The aim of this work was to examine prostaglandin production
by the pregnant guinea pig cervix and to test the effects of several
agents in order to develop a better understanding of the way in which
prostaglandin production by cervical cells may be regulated during
the process of cervical ripening.
The effect of treating the guinea pigs with the anti-progestin
RU486 was investigated since its action in promoting cervical ripening
may involve the prostaglandin pathways. The other experiments were
aimed at testing,
1) The effect of progesterone or its absence in vitro, both in otherwise
untreated cells and those challenged by the compounds listed
below.
2) The in vitro effect of the G-protein activator LPS.
3) The in vitro effect of the protein kinase C stimulant PMA.
4) The in vitro effect of the phosphatase inhibitor okadaic acid.
5) The in vitro effect of increased intracellular calcium availability
using the ionophore A23187.
6) The in vitro effect of the antiprogestin, RU486.
7) The in vitro effect of oestradiol.
8) Interactions which may have occurred between the above
compounds.
9) The effect RU486 may have had on the actions of the above
compounds.
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Prostaglandin Production de novo
In order to confirm that the prostaglandins measured were
being produced de novo by the guinea pig cells, cultures were
performed in the presence of indomethacin which inhibits the
synthesis of prostaglandins by blocking the action of cyclooxygenase.
It was found that the level of prostaglandins in the medium dropped
below detectable quantities when indomethacin was present at 5|iM.
Later in this thesis LPS will be shown to increase prostaglandin levels
in the guinea pig cultures, however, when the same concentration of
LPS was applied to cells in the presence of indomethacin it was
unable to raise PG values above those observed in the presence of
indomethacin alone.
In addition, samples were collected from some cultures after a
second and third 24 hour culture period in the presence of the
treatment media and there was still a significant output of
prostaglandin, the correlation coefficient between the first and second
harvests of 0.918 and a coefficient of 0.910 between the second and
third medium collection, indicating that the cells in different
treatments were maintaining their activity relative to each other.
These experiments indicated that prostaglandin synthesis was
occurring de novo and that the cells remained viable, certainly in
terms of their ability to produce prostaglandins, for several days in
culture.
Eicosanoids In Unused Medium
Samples of medium that were incubated in the absence of cells
were moxed, as described previously, and then tested for the presence
of eicosanoids and it was found that PGF2a and PGFM were
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undetectable. PGE2 was found but in very small quantities such that
the results could not be accurately read from the standard curve (that
is they were probably negligible) and PGEM was found to be present in
slightly greater quantities (approximately 300pg/ml) which were again
difficult to assess accurately from the standard curve and which
approached the values obtained in the assays of medium that had
been incubated with cells. Significant amounts of thromboxane (TxB2)
were found (around 2000pg/ml). Subsequent TxB2 assays were not
performed because this contaminating material was similar to the
amount measured in samples of medium that had been incubated
with cells. Cultured medium levels did not appear to show any
response to the treatments that had been found to affect other
prostaglandins, suggesting that the cells were not producing
thromboxane. The presence in the medium of these eicosanoids was
due to the fetal bovine serum used in the complete medium and since
thromboxane is involved in platelet aggregation and blood clotting it
was not unreasonable to find it in serum from dead bovine fetuses.
Fetal bovine serum was included in the culture system because
in its absence the level of prostaglandins found in the cultures was at
the lower end of the standard curve where the accuracy of the
readings was reduced. This also did not allow for any inhibitory
activity to be observed and indicated that while PG synthesis may
have been occurring de novo when FBS was absent, it also had some
requirement for an exogenous substrate supply.
Effect of DMF and Ethanol
Dimethylformamide (DMF) was the vehicle used for okadaic acid
and ethanol was the vehicle for PMA, progesterone, RU486, oestradiol
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and A23187. In other cases the vehicle used was saline or water.
Neither DMF nor ethanol was found to affect the control culture
values for PGE2, PGF2a. PGEM or PGFM when used at the same
concentrations as in the treatment media (0.05% DMF, 0.2% ethanol).
Effects of Progesterone and RU486 in vivo
Comparison of Basal Prostaglandin Output
A principal hypothesis was that progesterone would suppress
prostaglandin production, therefore progesterone was included in
these experiments. In the natural situation the cervix would be in an
environment where the progesterone concentration was high,
although this would be very difficult to determine, justifying the use of
10 6M progesterone. Because RU486 is considered to block receptors
for progesterone, this made it relevant to examine any effect the two
steroids may have had upon each other.
The figures in this section are divided into 4 blocks of results.
The first two blocks are derived from control animals (no RU486
treatment in vivo) and the third and fourth blocks are derived from
animals that were given RU486 in vivo . Thus, blocks one and three
represent the data from control wells (no progesterone) and the
second and fourth blocks represent data from progesterone containing
control wells.
PGE2 (Figure 5.1)
The control animals (those that did not receive RU486 in vivo)
showed a reduction in PGE2 output when their cells were cultured in
the presence of progesterone. The overall effect of progesterone was
significant (p=0.0092). Analysis of variance did not reveal a significant
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difference between the control and RU486 in vivo animals. Although
there appears to be a difference between the two groups of animals
the interaction between progesterone and RU486 in vivo treatment did
not reach significance (p=0.0526).
PGE2 Controls
H No RU486 in vivo
H RU486 in vivo
No P Prog No P Prog
No P Progesterone free cultures
Prog Progesterone conditioned cultures
Figure 5.1 Comparison of basal PGE2 production by guinea pig
cervix cells in culture. (Mean ± sem, No RU486 in vivo, n=14, RU486
in vivo, n=9).
Progesterone effect p=0.0092
PGF2a (Data not shown)
The effects of progesterone and RU486 in vivo on the output of
PGF2a were largely the same as for PGE2. They followed a similar
pattern suggesting an inhibitory effect of progesterone, however, there
was no significant effect of progesterone or ofRU486 in vivo.
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PGE2/PGF2a (Data not shown)
No significant differences were detected between the production
levels of the two prostaglandins at any level using analysis of
variance.
PGEM and PGFM (Data not shown)
Metabolites of PGE2 (PGEM) and PGF2a (PGFM) were also
examined, however, reproducibility of the assays for these was poor
and did not allow comparison to be made between individual assays.
For the PGEM assay the intra-assay variation was 18.2% and for
PGFM it was 20%. The values obtained for these prostaglandin
metabolites were highly variable because of the large error between
assays (<100pg/ml to approximately lOOOpg/ml) and were generally
low which introduced another factor that would have reduced the
accuracy of any analysis, since small changes in measured
prostaglandin levels would have had a disproportionately large effect.
Additionally, the medium itselfwas contaminated with PGEM before it
even made contact with the cells. Therefore the results from the
PGEM and PGFM assays were not suitable for analysis. If all the
samples had been measured in one assay then valid comparisons
could have been made between each treatment and each group of
animals, however, this would have involved an assay of approximately
15,000 tubes and was thus impractical.
In an attempt to gain some insight into the effects on PGEM of
RU486 in vivo and progesterone in vitro treatment, the following
assay was performed. Samples of the medium from control wells,
progesterone free and progesterone conditioned, from all but one of
the guinea pigs (lack of medium available) were measured for the
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prostaglandin metabolite. The results were compared but did not
show any differences between the animals treated in vivo with RU486
and the controls, nor did they show any effect of progesterone on the
level of PGEM.
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Format of Data Presentation
The results which follow were obtained from 14 control animals,
not treated with RU486, and from 9 animals given RU486 18-24
hours prior to being killed.
Each set of results (each figure) represents the information
from 10 batches of cells treated with each substance or combination
of substances (5 derived from control animals and 5 from animals
given RU486 in vivo). In some instances there were fewer than 5
results for each treatment and they will be identified in the text. The
graphs are divided into 4 blocks of results each relating to,
1) "Control"-the mean of the control values for the cultures
concerned (i.e. culture medium only),
2) "Control (Prog)"-the mean of the progesterone conditioned
cells (i.e. culture medium with progesterone added to act as
a progesterone-alone control),
3) "Treated"-the mean of the values obtained with the particular
treatment under examination (i.e. culture medium
containing the additive(s) being studied) and
4) "Treated (Prog)"-the mean for the same treatment as in '3'
but in the presence of progesterone (i.e. culture medium
containing both progesterone and the agent being
investigated).
Not all the data are represented graphically. However, they are
presented numerically in the tables at the end of each section. Where
there is no graph this will be marked by "Data not shown."
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Effect of Lipopolysaccharide Alone and in Conjunction with Other
Compounds on Prostaglandin Output by Cultured Guinea Pig
Cervical Cells
LPS
LPS (lipopolysaccharide) is a product derived from the surface of
gram negative bacteria. It is thought that in a proportion of cases of
preterm delivery the cause may be related to the presence of bacterial
infections in the upper genital tract (Taniguchi et al., 1991; Uldbjerg
and Ulmsten, 1990; Romero et al., 1988; Lamont et al., 1990; Romero
et al., 1989a; Romero et al., 1989b). In these experiments LPS was
used to examine the likelihood that the cervix could produce
prostaglandins under such circumstances. LPS has previously been
shown to be an effective stimulant in cell culture systems at a similar
concentration to that used here (Kelly et al., 1992; Strieter et al.,
1989).
PGE2 (Figure 5.2)
LPS at 4gg/ml had an obvious stimulatory effect on PGE2
output. The increase observed was significant (p=0.0002) with no
measurable effect of in vivo RU486 treatment or of progesterone.
PGF2(x (Data not shown)
LPS provoked a significant increase in PGF2a production
similarly to PGR2 (p=0.0005). Comparisons indicated no overall effect
ofRU486 treatment or of progesterone.
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PGE2/PGF2CC (Data not shown)
Comparison of PGE2 and PGF2a showed that less PGF2a than
PGE2 was produced (p=0.0027). The stimulatory effect of LPS was
greater on PGE2 synthesis (p=0.002). The two prostaglandins were not
differentially affected by pretreatment of the guinea pigs with RU486
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II RU486 in vivo
Figure 5.2 Effect of LPS (4pg/ml) on PGE2 production (mean ± sem).
LPS effect p=0.0002
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LPS + RU486 (in vitro)
LPS (4|ig/ml) and RU486 (l|iM) were combined in one treatment
medium and used to treat the cells. RU486 is known to promote
cervical ripening in the guinea pig and was tested in vitro as well as in
vivo in order to examine any role it may have in the production of
prostaglandins in the late pregnant cervix. Once excised from the
guinea pig the cervical tissue is no longer in contact with the
antiprogestin and it was therefore included in the medium to
determine whether or not this was relevant.
PGE2 (Figure 5.3)
LPS still stimulated prostaglandin production when RU486 was
added in vitro. As for LPS alone the only significant effect was that of
the treatment medium, LPS + RU486 (p<0.0001).
PGF2<x (Data not shown)
LPS + RU486 in vitro resulted in a significant increase in PGF2a
(p=0.0001). Progesterone did not affect production nor did in vivo
treatment with RU486.
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LPS + RU486
Figure 5.3 Effect of LPS (4|ig/ml) + RU486 (in vitro, ljuM) on PGE2
production (mean ± sem).
LPS + RU486 (in vitro) effect p<0.0001
PGE2/PGF2a (Data not shown)
Less PGF2oc than PGE2 was produced (p=0.0021). The
stimulatory effect of LPS + RU486 in vitro was greater on PGE2
synthesis (p=0.0009). The two prostaglandins were not differentially
affected by pre treatment of the guinea pigs with RU486 or the
inclusion of progesterone in the culture medium.
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LPS + A23187
A23187 is a calcium ionophore, thereby raising the intracellular
calcium concentration. In the majority of reported cases it is a
stimulant of prostaglandin synthesis (Hsu and Goetz, 1993; Ibe and
Raj, 1992; Houmbard et al., 1991; Cabre et al., 1993). R Leask (Pers.
Comm.) had observed an inhibitory effect of the ionophore and it was
therefore of interest to examine its effects in the late pregnant guinea
pig cervix to study the role of intracellular calcium in regulating
prostaglandin production. A23187 was used at 2|iM in conjunction
with LPS (4|ig/ml).
PGE2 (Figure 5.4)
A23187 appeared to inhibit the stimulation of PGE2 production
by LPS. The p-value for the LPS + A23187 v Control was 0.0519, close
to the accepted limit of significance, as is that for the interaction
between RU486 in vivo and LPS + A23187 (in vitro), p=0.056. Although
differences between the control and RU486 treated guinea pigs are
identifiable when the data are analysed separately such analyses are
more likely to produce spurious significance values as some of the
power of the analysis is reduced. The only significant effect detected
was an interaction between progesterone and the treatments applied
to the cells (control or LPS + A23187), p=0.0244, indicating that
progesterone affects the control wells differently to the LPS + A23187
wells. There appears to be a stimulatory effect of progesterone on the
effect of LPS + A23187.
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Figure 5.4 Effect of LPS (4|ig/ml) + A23187 (2jiM) on PGE2 production
(mean ± sem).
Progesterone x Treatment interaction p=0.0244
PGF2cc (Figure 5.5)
The results were similar to those for PGE2 in that there was no
overall effect of RU486 treatment of the animals or of progesterone
inclusion in the culture medium. Again the only detected interaction
was that between progesterone and the treatments applied to the cells
(p=0.0166), an apparent stimulation of prostaglandin production in
the LPS + A23187 containing wells.
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Figure 5.5 Effect of LPS (4|ig/ml) + A23187 (2|iM) on PGF2a
production (mean ± sem).
Progesterone x Treatment interaction p=0.0166
PGE2/PGF2CC (Data not shown)
On the whole less PGF2a than PGE2 was produced (p=0.001)
The response of the cells to the LPS + A23187 treatment again differed
in terms of PGE2 and PGF2a production (less F than E, p=0.0004).
The two prostaglandins were not differentially affected by
pretreatment of the guinea pigs with RU486 or the inclusion of
progesterone in the culture medium.
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LPS + PMA
The phorbol ester PMA is an activator of protein kinase C. It was
used to examine the involvement, if any, of the protein kinase C
pathway in the production of prostaglandins by cultured cells of the
guinea pig cervix derived from tissue excised in late pregnancy. It was
also used in conjunction with other drugs in order to explore the
independence/interdependence of the pathways involved. PMA was
tested alone and the results of that experiment are presented later in
this chapter (page 5.32)
PGE2 (Figure 5.6)
LPS (4|ig/ml) in combination with PMA (O.ljiM) provoked an
increase in PGE2 output (p=0.0002). The effect of combining LPS and
PMA resulted in greater prostaglandin production than LPS alone but
not significantly (see later). Neither RU486 in vivo nor progesterone
treatment had any significant effects.
PGF2cx (Data not shown)
The stimulation evoked by the treatment used here was highly
significant, p=0.0004. RU486 treatment in vivo and progesterone in
vitro had no significant effect on the results.
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Figure 5.6 Effect of LPS (4|j.g/ml) + PMA (0.1|iM) on PGE2 production
(mean ± sem).
LPS + PMA effect p=0.0002
PGE2/PGF2a (Data not shown)
The output of PGF2a was less than that of PGE2 (p=0.001). The
stimulatory effect of LPS + PMA was greater on PGE2 synthesis
(p=0.005). The two prostaglandins were not differentially affected by
pretreatment of the guinea pigs with RU486 or the inclusion of
progesterone in the culture medium.
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LPS + PMA + A23187
Since A23187 (2|iM) appeared to have an unexpected inhibitory
action in the experiments already described it was combined with LPS
(4pg/ml) and PMA (O.lpM) to determine if it reduced prostaglandin
synthesis in the presence of both stimulators. PMA was also tested
with A23187 only and those results are presented later (page 5.36).
A23187 had a less pronounced inhibitory action on PMA stimulated
PGE2 production than it did on LPS stimulated production, but it
affect both PMA and LPS similarly with regard to PGF2a-
PGE2 (Figure 5.7)
Despite the inclusion ofA23187 in the medium there was still a
significant stimulation of prostaglandin production, p=0.0013, similar
to the effect observed with PMA + A23187 (see later). This was the first
set of data to show a significant effect of the pretreatment of the
guinea pigs with RU486, p=0.0432. The RU486 treatment in vivo
resulted in a greater output of prostaglandin under the influence of
LPS + PMA + A23187. This interaction between the treatment applied
to the cells and the pretreatment of the animals with RU486 was
significant, p=0.0176, the RU486 appearing to reduce the inhibitory
effect of the A23187. From the figures in table 5.1-4 it is apparent
that the RU486 maintains the stimulation at levels similar to those
produced with LPS + PMA only.
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M No RU486 in uiuo
H RU486 in uiuo
^ , , Control rr, . A TreatedControl - Treated .
(Prog) (Prog)
LPS + PMA +A23187
Figure 5.7 Effect of LPS (4|ig/ml) + PMA (0.1|iM) + A23187 (2|iM) on
PGE2 production (mean ± sem).
RU486 in vivo effect p=0.0432
LPS + PMA + A23187 effect p=0.0013
RU486 in vivo x LPS + PMA + A23187 interaction p=0.0176
PGF2a (Figure 5.8)
Analysis of variance indicated that LPS + PMA + A23187 did not
significantly stimulate the production of PGF2a, and that RU486 in
vivo and progesterone in vitro did not have any overall effect. However,
significant interactions were detected 1) between the progesterone and
RU486 treatments (p=0.0135), 2) between the LPS + PMA + A23187
and RU486 treatments (p=0.0422), and 3) between the LPS + PMA +
A23187 and progesterone treatments (p=0.018). These interactions
show 1) that in animals treated with RU486 the response of the
cultures to progesterone was different to the control animals, the
former showing greater PGF201 production, 2) that in animals treated
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with RU486 the response of the cultures to LPS + PMA + A23187 was
different to the control animals, the former showing greater PGF2a
production, and 3) that the cultures treated with and without
progesterone differed in their response to LPS + PMA + A23187, the



















M No RU486 in vivo
U RU486 in vivo
„ , . Control „ , , Treated
Control . Treated >
(Prog) (Prog)
L J
LPS + PMA + A23187
Figure 5.8 Effect of LPS (4pg/ml) + PMA (O.lpM) + A23187 (2pM) on
PGF2a production (mean + sem).
RU486 in vivox. Progesterone interaction p=0.0135
LPS + PMA + A23187 x RU486 in vivo interaction p=0.0422
LPS + PMA + A23187 x Progesterone interaction p=0.018
5.20
Chapter 5 Guinea Pig Results
PGE2/PGF201 (Data not shown)
Comparison of PGE2 and PGF2a showed that less PGF201 than
PGE2 was produced (p=0.0003). The stimulatory effect of LPS + PMA +
A23187 was greater on PGE2 synthesis (p=0.0003). The two
prostaglandins were not differentially affected by progesterone or by
RU486 in vivo.
5.21
Chapter 5 Guinea Pig Results
Comparisons of Results Obtained from Experiments Involving
LPS
The data concerned are presented on pages 5.9 to 5.20. The
differences between the treatments and their controls were compared
using one way analysis of variance and the Newman-Keuls test to
make pairwise comparisons.
pge2
Table 5.1 No RU486 in vivo, no progesterone
PGEs A B c D E Mn Diff sem
(ng/105 cells)
A LPS X - s - - 7.3 2.2
B LPS+RU486 - X s - - 7.6 1.2
C LPS+A23187 - - X s - -0.5 1.1
D LPS+PMA - - s X s 12.6 2.7
E LPS+PMA+A23187 - - - s X corH00
'Mn Diff Mean difference between treated cells and their controls.
Left, lower triangle p<0.01, right, upper triangle p<0.05
's' indicates a significant difference.
Table 5.2 No RU486 in vivo, progesterone
PGE2 A B C D E Mn Diff sem
(ng/105 cells)
A LPS X - - - - 4.7 0.9
B LPS+RU486 X s 7.4 2.0
C LPS+A23187 X s 0.5 1.0
D LPS+PMA s X s 10.2 2.3
E LPS+PMA+A23187 - - - X 2.1 1.8
'Mn Diff Mean difference between treated cells and their controls.
Left, lower triangle p<0.01, right, upper triangle p<0.05
's' indicates a significant difference.
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'Mn Diff Mean difference between treated cells and their controls.
Left, lower triangle p<0.01, right, upper triangle p<0.05
's' indicates a significant difference.
Table 5.4 RU486 in vivo, progesterone
PGE2 A B C D E Mn Diff sem
(ng/105 cells)
A LPS X 4.3 0.5
B LPS+RU486 X 5.5 0.8
C LPS+A23187 - X s s 3.0 0.7
D LPS+PMA X 8.6 2.0
E LPS+PMA+A23187 X 9.2 1.8
'Mn Diff Mean difference between treated cells and their controls.
Left, lower triangle p<0.01, right, upper triangle p<0.05
's' indicates a significant difference.
The four tables contain the data from the cells exposed to
treatment media with and without progesterone from both groups of
animals.
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Summary of Key Findings
In the progesterone free cultures:
1) LPS + A23187 treatment of control animal cells was shown to result
in significantly less PGE2 production than the LPS alone, LPS +
RU486 [in vitro) and LPS + PMA treatments.
2) LPS + PMA provoked greater stimulation than LPS + PMA +
A23187.
3) In the RU486 pretreated animals both LPS + PMA and LPS + PMA +
A23187 caused greater stimulation of PGE2 output than LPS +
A23187.
In the presence of progesterone:
1) LPS + A23187 treated cells from control animals produced less
PGE2 than LPS + RU486 [in vitro) and LPS + PMA treated cells.
2) LPS + PMA + A23187 caused a smaller increase than LPS + PMA.
In the RU486 pretreated animals both LPS + PMA and LPS +
PMA + A23187 caused greater stimulation of PGE2 output than LPS +
A23187.
The pretreatment of the guinea pigs with RU486 appeared to
block the effects of A23187 especially when used in conjunction with
PMA.
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PGF20C
Table 5.5 No RU486 in vivo, no progesterone
PGF2a A B c D E Mn Diff sem
(ng/105 cells)
A LPS X - s s s 3.6 1.0
B LPS+RU486 - X s s s 3.3 0.3
C LPS+A23187 - - X s - -1.9 1.2
D LPS+PMA - - s X s °0CO00
E LPS+PMA+A23187 - - - s X -1.1 1.3
'Mn Diff Mean difference between treated cells and their controls.
Left, lower triangle p<0.01, right, upper triangle p<0.05
*s' indicates a significant difference.
Table 5.6 No RU486 in vivo, progesterone
PGF2a A B C D E Mn Diff sem
(ng/105 cells)
A LPS X 3.1 1.1
B LPS+RU486 X 5.1 2.2
C LPS+A23187 X s -1.1 1.0
D LPS+PMA X s 7.5 2.3
E LPS+PMA+A23187 X -0.9 1.1
'Mn Diff Mean difference between treated cells and their controls.
Left, lower triangle p<0.01, right, upper triangle p<0.05
's' indicates a significant difference.
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Table 5.7 RU486 in vivo, no progesterone
PGF20C A B c D E Mn Diff sem
(ng/105 cells)
A LPS X - s s - 2.9 0.5
B LPS+RU486 - X s s - 3.1 0.3
C LPS+A23187 - - X s - 0.4 0.3
D LPS+PMA - - s X s 5.8 1.2
E LPS+PMA+A23187 - - - s X 1.5 0.5
'Mn Diff Mean difference between treated cells and their controls.
Left, lower triangle p<0.01, right, upper triangle p<0.05
's' indicates a significant difference.
















s - 0.8 0.3
X - 5.0 1.0
X 2.9 0.8
'Mn Diff Mean difference between treated cells and their controls.
Left, lower triangle p<0.01, right, upper triangle p<0.05
's' indicates a significant difference.
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Summary of Key Findings
In the absence of progesterone:
1) LPS + PMA was found to provoke greater stimulation of PGF2a than
the other four treatments for both the control and the RU486 in vivo
animals.
2) The production of PGF2a under the influence of LPS + A23187 was
significantly less than LPS alone and LPS + RU486 (in vitro) for both
the control and the RU486 in vivo animals.
3) The control animals (no RU486 in vivo) also showed lesser PGF20C
output than LPS alone and LPS + RU486 (in vitro).
In the presence of progesterone:
1) Both the control and the RU486 in vivo animals produced
significantly less PGF2a under the influence of LPS + A23187 than
under the influence of LPS + PMA.
2) The control group (no RU486 in vivo) also showed a significant
reduction in stimulation between the LPS + PMA and the LPS + PMA +
A23187 treatments.
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Summary of Data Involving LPS
The following tables summarise the statistically significant
results already described.
Effects on PGE2 Production
This table summarises how PGE2 output was affected by the
treatments applied to the animals and the cultures.
Table 5.9
RU486 Prog
Treatment Media in vivo in vitro Treatment Interactions
LPS NS NS Increase NS
LPS+RU486 NS NS Increase NS
LPS+A23187 NS NS NS PxT
LPS+PMA NS NS Increase NS
LPS+PMA+A23187 Increase NS Increase RxT
NS No significant effect or interaction.
Increase Significant increase in prostaglandin synthesis.
R RU486 pretreatment of guinea pigs.
T Treatment applied to cells.
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Effects on PGF2a Production
This table summarises how PGF2a output was affected by the
treatments applied to the animals and the cultures.
Table 5.10
RU486 Prog
Treatment Media in vivo in vitro Treatment Interactions
LPS NS NS Increase NS
LPS+RU486 NS NS Increase NS
LPS+A23187 NS NS NS PxT
LPS+PMA NS NS Increase NS
LPS+PMA+A23187 NS NS NS RxP, RxT, PxT
NS No significant effect or interaction.
Increase Significant increase in prostaglandin synthesis.
R RU486 pretreatment of guinea pigs.
P Progesterone applied to cells.
T Treatment applied to cells.
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Comparison of the Effects on PGF2CC and PGE2 Production
This table summarises how PGF2a and PGE2 outputs were









NS No significant difference or interaction.
F<E Significantly less PGF2a than PGE2 produced.
Overview
The only direct effect of giving the guinea pigs RU486 in vivo
was observed in the LPS + PMA + A23187 treatment set, where the
antiprogestin produced an increase in PGE2 output. Significant
interactions were found between RU486 treatment in vivo and the LPS
+ PMA and the LPS + PMA + A23187 treatment sets, with regard to
PGE2 production, but only for the latter treatment set with regard to
PGF2a- RU486 raised the production of prostaglandins above the
levels observed in its absence.
For none of the in vitro treatments did progesterone produce any
significant effects on the production of either prostaglandin. The only
significant result of progesterone inclusion in the medium was an
RU486 Prog Other
in vivo in vitro Treatment Interactions
NS NS F<E NS
NS NS F<E NS
NS NS F<E NS
NS NS F<E NS
NS NS F<E NS
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interaction between it and the LPS + A23187 treatment and the LPS +
PMA + A23187 treatment on PGF2a- In both cases progesterone
appeared to have a stimulatory effect on the treated cells. In the latter
treatment set progesterone also showed a significant interaction with
RU486 pretreatment of the animals, the RU486 treated guinea pigs
showing evidence of a stimulatory response.
Overall, each of the treatments resulted in an increase in PGE2
production with the exception of the LPS + A23187 treatment. PGF2a
showed a similar response pattern. However, both media containing
A23187 (i.e. LPS + A23187 and LPS + PMA + A23187) failed to
produce a significant increase in this prostaglandin. Comparing the
treatments with each other revealed an inhibitory effect of A23187. It
also showed that combining LPS and PMA resulted in greater
stimulation of PGF2a production, but that this effect was not
significant on PGE2 production. This effect appeared to be lost or at
least reduced when the guinea pigs were pretreated with RU486.
Comparison of the two prostaglandins revealed a trend of less
stimulation of PGF2a production than PGE2 but no overall effect of
progesterone. RU486 treatment of the guinea pigs caused a
measurable effect in only one treatment set, LPS + PMA + A23187,
where it had an inhibitory effect on PGF2a. This same comparison
revealed an interaction between both in vitro progesterone and in vivo
RU486 and the LPS + PMA + A23187. The RU486 and the
progesterone appeared to permit the production of PGE2 to be
significantly greater than PGF2a.
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Effect of Phorbol Myristate Acetate Alone and in Conjunction
with Other Compounds on Prostaglandin Output by Cultured
Guinea Pig Cervical Cells
PMA
The phorbol ester PMA is an activator of protein kinase C. It was
used in the experiments described in this thesis to examine the
involvement, if any, of the protein kinase C pathway in the
production of prostaglandins by guinea pig cervix cells sustained in
culture and derived from tissue removed towards the end of
pregnancy. It was also used in conjunction with other drugs in order
to explore the independence/interdependence of the pathways
involved in prostaglandin production by those cells.
PGE2 (Figure 5.9)
PMA at a concentration of O.ljiM stimulated PGE2 production
by guinea pig cervix cells from both the control and RU486 pretreated
animals (p=0.0001). Progesterone in the culture medium had a small
but significant inhibitory effect (p=0.0201). However, pretreatment
with RU486 in vivo had no effect.
PGF20C (Data not shown)
The response of PGF2a to PMA was the same as PGE2
(PcO.OOOl), but no effect of progesterone was observed or of RU486
pretreatment of the guinea pigs.
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PGE2/PGF2C1 (Data not shown)
PGE2 and PGF2a were produced in similar quantities and were
not differentially affected by RU486 in vivo or progesterone in vitro.
The only significant effect was a greater inhibitory action of
progesterone on PMA stimulated PGE2 than on PGF2a. he. a
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PMA + RU486 (in vitro)
Guinea Pig Results
Since the excised tissue was no longer in an environment
containing RU486 and this was one of the main objects of the
experiments performed, the antiprogestin was included in the culture
medium to study its effects on prostaglandin synthesis.
PGE2 (Figure 5.10)
Cells were treated with PMA plus RU486 in vitro, at 0. lfiM and
lpM respectively.
An obvious stimulation of PGE2 output occurred with PMA +
RU486 in vitro (p=0.0002). Progesterone did not affect PGE2 nor did
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Control lr. . Treated ^(Prog) (Prog)
1 1
PMA + RU486 in vitro
Figure 5.10 Effect of PMA (0.1|iM) + RU486 [in vitro, lpM) on PGE2
production (mean ± sem).
PMA + RU486 in vitro effect p=0.0002
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PGF2a (Data not shown)
Again treatment with PMA + RU486 (in vitro) produced a
significant increase in PGF2a output (p=0.001), and progesterone and
RU486 in vivo had no effect on the results.
PGE2/PGF2C1 (Data not shown)
Comparison of the two prostaglandins indicates that they were
produced in similar quantities. No effect of progesterone or RU486 (in
vitro) was found.
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PMA +A23187
Since A23187 was found to inhibit the stimulation of
prostaglandin production by LPS, its effects on PMA stimulation were
examined. PMA activates protein kinase C and it has been shown to
require calcium for this to take place. IfA23187 blocked the action of
PMA this would suggest an inhibitory action of increased free
intracellular calcium downstream of the PMA interaction with the cell
membrane and protein kinase C.
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PGE2 (Figure 5.11)
A23187 did not block the stimulatory effect of PMA. Thus,
PMA (0.1 fiM) + A23187 (2jiM) provoked an increase in PGE2 output,
(p=0.0011). The inclusion of A23187 did appear to reduce the
effectiveness of the PMA but the reduction was not significant (see
tables 5.12-14). Progesterone did not influence the results, nor did
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PMA + A23187
Figure 5.11 Effect of PMA (0.1gM) + A23187 (2pM) on PGE2
production (mean ± sem).
PMA + A23187 effect p=0.0011
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PGF2a (Figure 5.12)
A23187 blocked the stimulatory effect of PMA (see tables
5.15-18), PMA + A23187 treatment not producing any significant





H No RU486 in vivo
U RU486 in vivo
Figure 5.12 Effect of PMA (O.lpM) + A23187 (2pM) on PGF2a
production (mean ± sem).
PGE2/PGF2a (Data not shown)
The overall trend was for less PGF2a production than PGE2
(p=0.0109) and the difference in the effect of the PMA + A23187
treatment on the two prostaglandins was highly significant (less F
than E, p=0.001). No effect of progesterone or RU486 in vivo was
detected.
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PMA + Okadaic Acid
Okadaic acid is an inhibitor of phosphatases and therefore
prevents the dephosphorylation of intracellular proteins. It was
examined to determine if such an action would increase the effect of
the PKC activator by maintaining the phosphorylated state of
intracellular proteins. Okadaic acid alone was found to stimulate
prostaglandin production by guinea pig cervical cells in culture (see
later page 5.51). Cells were treated in vitro with PMA (O.ljiM) and
okadaic acid (OA, 50nM).
PGE2 (Figure 5.13)
PGE2 synthesis was increased on exposure to PMA + OA,
(p=0.0192). OA did not, however, potentiate the action of PMA (see
tables 5.12-14). Neither progesterone in the culture medium nor
RU486 in vivo had any significant effects on the outcome of the
experiments.
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Figure 5.13 Effect of PMA (O.lpM) + Okadaic Acid (50nM) on PGE2
production (mean ± sem).
PMA + OA effect p=0.0192
PGF2a (Data not shown)
The response of PGF2a was similar to that of PGE2, the
stimulatory action of PMA + OA producing the only significant change
(p=0.0021). Again there was no significant difference between the
PMA + OA and the PMA alone treatments (see tables 5.15-18).
PGE2/PGF20C (Data not shown)
Comparison of the two prostaglandins once again indicated that
they were produced in similar quantities, and that both progesterone




PMA + LPS and PMA + LPS + A23187
Guinea Pig Results
These are the same results as in the LPS section under LPS +
PMA and LPS + PMA + A23187 (Figures 5.6-8). They are included in
the following analyses because they include data from experiments
where PMA was used.
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Comparisons of Results Obtained from Experiments Involving
PMA
The data concerned are presented on pages 5.26 to 5.41.
pge2
Table 5.12 No RU486 in vivo , no progesterone
PGEa A B c D E F Mn Diff sem
(ng/105 cells)
A PMA X - - - s - 4.4 0.4
B PMA+RU486 - X - - s - 5.9 1.3
C PMA+A23187 - - X - s - 2.1 1.0
D PMA+OA - - - X s - 5.6 3.4
E PMA+LPS - - s - X s 12.6 2.7
F PMA+LPS+A23187 - - _ - s X 1.8 1.4
'Mn Diff Mean difference between treated cells and their controls.
Left, lower triangle p<0.01, right, upper triangle p<0.05
's' indicates a significant difference.
Table 5.13 No RU486 in vivo , progesterone
PGEa A B c D E F Mn Diff sem
(ng/105 cells)
A PMA X - - - s - 3.9 0.7
B PMA+RU486 - X - - s - 5.0 1.0
C PMA+A23187 - - X - s - 2.5 0.7
D PMA+OA - - - X s - 3.8 1.7
E PMA+LPS - - - - X s 10.2 2.3
F PMA+LPS+A23187 - - - - s X 2.1 1.8
'Mn Diff Mean difference between treated cells and their controls.
Left, lower triangle p<0.01, right, upper triangle p<0.05
's' indicates a significant difference.
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Table 5.14 RU486 in vivo
No Progesterone Progesterone









B PMA + RU486
C PMA + A23187
D PMA + OA
E PMA + LPS








'Mn Diff Mean difference between treated cells and their controls.
No significant differences were detected.
Summary of Key Findings
In the presence and absence of progesterone the cells from
control animals:
1) Produced significantly more PGE2 in response to challenge with
PMA + LPS than all the other PMA group treatments.
2) While A23187 inclusion was found to have a significant inhibitory
effect on the PMA + LPS stimulation, its effect on PMA alone did not
reach significance.
3) Okadaic acid did not potentiate the effect of PMA.
In the group of animals pretreated with RU486 there were no
statistically significant differences between the various PMA
containing treatments with regard to PGE2 synthesis. The previously
observed inhibitory effect ofA23187 on PMA + LPS was lost.
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PGF2CC


































'Mn Diff Mean difference between treated cells and their controls.
Left, lower triangle p<0.01, right, upper triangle p<0.05
's' indicates a significant difference.































'Mn Diff Mean difference between treated cells and their controls.
Left, lower triangle p<0.01, right, upper triangle p<0.05
's' indicates a significant difference.
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Table 5.17 RU486 in vivo , no progesterone
PGF2a A B C D E F Mn Diff sem
(ng/105 cells)
A PMA X - s 4.0 1.1
B PMA+RU486 - X s 4.5 1.0
C PMA+A23187 - X s s -0.2 0.5
D PMA+OA - - - X - - 4.4 1.4
E PMA+LPS s - X s 5.8 1.2
F PMA+LPS+A23187 ----- X 1.5 0.5
'Mn Diff Mean difference between treated cells and their controls.
Left, lower triangle p<0.01, right, upper triangle p<0.05
's' indicates a significant difference.
Table 5.18 RU486 in vivo , progesterone
PGF2a A B C D E F Mn Diff sem
(ng/105 cells)
A PMA X - s - - - 3.7 0.4
B PMA+RU486 - X s - - - 4.0 0.9
C PMA+A23187 - - X s s s 0.2 0.2
D PMA+OA - - - X - - 3.4 0.8
E PMA+LPS - - s - X - 5.0 1.0
F PMA+LPS+A23187 ----- X 2.9 0.8
'Mn Diff Mean difference between treated cells and their controls.
Left, lower triangle p<0.01, right, upper triangle p<0.05
's' indicates a significant difference.
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Summary of Key Findings
In the control animal group (no RU486 in vivo):
1) In the absence of progesterone, A23187 Inhibited the stimulation of
PGF2(x production provoked by PMA alone and by PMA + LPS.
2) In the presence of progesterone the inhibitory effect ofA23187 was
only significant on the response to PMA + LPS, both PMA + LPS +
A23187 and PMA + A23187 producing less prostaglandin than
PMA + LPS. The difference between PMA and PMA + A23187 was not
significant.
Cells from guinea pigs given RU486 in vivo, in the absence of
progesterone:
1) Produced less PGF2a under the influence of PMA + A23187
compared with the other treatments, except PMA + LPS + A23187.
2) PMA + LPS + A23187 was only significantly different to PMA + LPS,
showing an inhibitory effect ofA23187.
With progesterone present in the medium the inhibitory effect of
A23187 was again evident. PMA + A23187 resulted in less stimulation
of PGF2a than all of the other treatments.
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Summary of Data Involving PMA
The following tables summarise the statistically significant
results already described.
Effects on PGE2 Production
This table summarises how PGE2 output was affected by the






in vitro Treatment Interactions
PMA NS Decrease Increase NS
PMA+RU486 NS NS Increase NS
PMA+A23187 NS NS Increase NS
PMA+OA NS NS Increase NS
PMA+LPS NS NS Increase NS
PMA+LPS+A23187 Increase NS Increase RxT
NS No significant effect or interaction.
Increase Significant increase in prostaglandin synthesis.
Decrease Significant decrease in prostaglandin synthesis.
R RU486 pretreatment of guinea pigs.
T Treatment applied to cells.
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Effects on PGF2a Production
This table summarises how PGF2a output was affected by the
treatments applied to the animals and the cultures.
Table 5.20
RU486 Prog
Treatment Media in vivo in vitro Treatment Interactions
PMA NS NS Increase NS
PMA+RU486 NS NS Increase NS
PMA+A23187 NS NS NS NS
PMA+OA NS NS Increase NS
PMA+LPS NS NS Increase NS
PMA+LPS+A23187 NS NS NS RxP, RxT, PxT
NS No significant effect or interaction.
Increase Significant increase in prostaglandin synthesis.
R RU486 pretreatment of guinea pigs.
P Progesterone applied to cells.
T Treatment applied to cells.
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Comparison of the Effects on PGF20C and PGE2 Production
This table summarises how PGF2CC and PGE2 outputs were




Treatment Media in vivo in vitro Treatment Interactions
PMA NS NS NS ExPxT
PMA+RU486 NS NS NS NS
PMA+A23187 NS NS F<E NS
PMA+OA NS NS NS NS
PMA+LPS NS NS F<E NS
PMA+LPS+A23187 NS NS F<E NS
NS No significant difference or interaction.
F<E Significantly less PGF2« than PGE2 produced.
E Prostaglandin E or F.
P Progesterone applied to cells
T Treatment applied to cells.
Overview
RU486 treatment in vivo only affected the PMA + LPS + A23187
conditioned cultures and there it resulted in increased prostaglandin
synthesis. The results for LPS containing cultures will obviously be
the same as highlighted in the previous section.
Progesterone produced an overall decrease in PGE2 synthesis
in the PMA alone treatment, but had no such effect on any of the
other cultures or on PGF2a-
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In general, both PGE2 and PGF2a were stimulated similarly by
the PMA-containing media employed in this section. The exceptions
were A23187 containing media which did not have any significant
effect on PGF2a- Comparing the treatments with each other revealed
an inhibitory effect ofA23187. It also showed that combining LPS and
PMA resulted in a significantly greater stimulation of prostaglandin
production, particularly PGE2. This effect appeared to be lost when
the guinea pigs were pretreated with RU486.
Progesterone had no effect, nor did RU486 in vivo.
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Effect of Okadaic Acid Alone and in Conjunction with Other
Compounds on Prostaglandin Output by Cultured Guinea Pig
Cervical Cells
Okadaic Acid
Okadaic acid is an inhibitor of protein phosphatases and
therefore prevents the dephosphorylation of intracellular proteins. It
was examined to determine the effect of maintaining the
phosphoiylated state of basally phosphoiylated proteins in the late
pregnant guinea pig cervix. Okadaic acid (OM) was used to treat cells
at a concentration of 50nM.
PGE2 (Figure 5.14)
OA increased PGE2 synthesis (p=0.0058). There was no
significant effect ofRU486 in vivo or progesterone in vitro.
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Okadaic Acid
Figure 5.14 Effect of Okadaic Acid (50nM) on PGE2 production
(mean ± sem).
Okadaic Acid effect p=0.0058
PGF2cx (Figiure 5.15)
OA treatment resulted in an increase in PGF2a output
(p=0.0048). Neither RU486 in vivo nor progesterone had an individual
effect, however, there was a significant interaction between them
(p=0.0241). This indicates that RU486 treatment of the guinea pigs
blocked and possibly reversed a slight inhibition produced by
progesterone.
PGE2/PGF2a (Data not shown)
The two prostaglandins were produced in similar quantities.
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Figure 5.15 Effect of Okadaic Acid (50nM) on PGF2a production
(mean ± sem).
Okadaic Acid effect p=0.0048
RU486 in vivo x Progesterone interaction p=0.0241
5.53
Chapter 5 Guinea Pig Results
Okadaic Acid + RU486 (in vitro)
Since the excised tissue was no longer in an environment
containing RU486 and this was one of the main objects of the
experiments performed, the antiprogestin was included in the culture
medium to study its effects on prostaglandin synthesis.
PGE2 (Figure 5.16)
Okadaic acid (50nM) and RU486 in vitro (ljiM) combined
stimulated PGE2 (p=0.0012), however, there were no significant effects
produced by RU486 in vivo or progesterone. The effect of okadaic acid
+ RU486 (in vitro) was not significantly different to that of okadaic acid
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Okadaic Acid + RU486
Figure 5.16 Effect of Okadaic Acid (50nM) + RU486 (in vitro, lpM) on
PGE2 production (mean ± sem).
Okadaic Acid + RU486 (in vitro) p=0.0012
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PGF2(x (Data not shown)
Significant stimulation of PGF2a synthesis occurred under the
influence of OA + RU486 in the culture medium (p=0.006). Treatment
of the guinea pigs with RU486 did not result in any significant
changes in PGF20c synthesis, nor did progesterone in the culture
medium.
PGE2/PGF2a (Data not shown)
PGE2 and PGF2a were produced in similar quantities and this
was not significantly affected by progesterone or pretreatment of the
guinea pigs with RU486 in vivo.
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Okadaic Acid + A23187
Since A23187 was found to inhibit the stimulation of
prostaglandin production by LPS, its effects on okadaic acid
stimulation were also examined. Okadaic acid is a relatively new
biochemical tool and it was also appropriate to examine the role
calcium may play in its activity.
Cells were therefore exposed to okadaic acid (50nM) and the
calcium ionophore (A23187, 2|iM). This set of results contains
information from only nine guinea pigs, five from control animals and
four from those given RU486 in vivo.
PGE2 (Figure 5.17)
A23187 appeared to block the stimulatory action of OA and
statistically OA + A23187 did not induce any changes in PGE2
synthesis. Despite this, comparison of the different treatments (see
table 5.22-23) did not show the effect of OA alone to be significantly
different to that of OA + A23187. Neither RU486 in vivo nor
progesterone in vitro had significant effects on the results.
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Figure 5.17 Effect of Okadaic Acid (50nM) + A23187 (2gM) on PGE2
production (mean ± sem).
PGF2a (Data not shown)
Again, A23187 appeared to have an inhibitory effect on OA
stimulation and the OA + A23187 did not cause any significant
change in prostaglandin synthesis when compared to the control. As
observed with PGE2 the difference between OA alone and
OA + A23187 was not significant. RU486 in vivo and progesterone in
vitro did not significantly affect the results.
PGE2/PGF2a (Data not shown)
Comparison of PGE2 and PGF2a showed they were produced in
similar quantities. Progesterone in the culture medium and RU486
given to the animals had no significant effect.
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Okadaic Acid + PMA
These are the same results as in the PMA section under
PMA + Okadaic Acid (Figure 5.13). They are included in the following
analyses because they contained Okadaic Acid.
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Comparisons of Results Obtained from Experiments Involving
Okadaic Acid
The data concerned are presented on pages 5.51 to 5.58.
pge2
Table 5.22 No RU486 in vivo
No Progesterone Progesterone
PGEa Mn Diff sem Mn Diff sem
(ng/105 cells) (ng/105 cells)
A Okadaic acid 3.1 1.2 1.9 0.6
B Okadaic acid + RU486 1.4 0.5 1.2 0.5
C Okadaic acid + A23187 -0.8 1.0 0.2 0.6
D Okadaic acid + PMA 5.6 3.4 3.8 1.7
'Mn Diff Mean difference between treated cells and their controls.
No significant differences were detected.
Table 5.23 RU486 in vivo
PGE2
A Okadaic acid
B Okadaic acid + RU486
C Okadaic acid + A23187















'Mn Diff Mean difference between treated cells and their controls.
No significant differences were detected.
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Summary of Key Findings
Statistically no differences between PGE2 synthesis in the
presence of the various OA group treatments were significant.
However, examination of the data suggests additional stimulation in
the presence of PMA and once again an inhibitory action associated
with A23187.
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PGF2a
Table 5.24 No RU486 in vivo, no progesterone
PGF2CC
A Okadaic acid
B Okadaic acid + RU486
C Okadaic acid + A23187














'Mn Diff Mean difference between treated cells and their controls.
Left, lower triangle p<0.01, right, upper triangle p<0.05
's' indicates a significant difference.
Table 5.25 No RU486 in vivo, progesterone
PGE2 Mn Diff sem
(ng/105 cells)
A Okadaic acid 2.4 0.8
B Okadaic acid + RU486 2.0 1.2
C Okadaic acid + A23187 -0.7 0.7
D Okadaic acid + PMA 3.5 1.2
'Mn Diff Mean difference between treated cells and their controls.
No significant differences were detected.
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Table 5.26 RU486 in vivo, no progesterone
PGF2CC A B c D Mn Diff sem
(ng/105 cells)
A Okadaic acid X - - - 2.0 0.9
B Okadaic acid + RU486 - X - - 2.4 0.4
C Okadaic acid + A23187 - - X s 0.3 0.3
D Okadaic acid + PMA - - - X 4.4 1.4
'Mn Diff Mean difference between treated cells and their controls.
Left, lower triangle p<0.01, right, upper triangle p<0.05
's' indicates a significant difference.
Table 5.27 RU486 in vivo, progesterone
PGEa Mn Diff sem
(ng/105 cells)
A Okadaic acid 1.8 0.7
B Okadaic acid + RU486 2.4 0.6
C Okadaic acid + A23187 0.6 0.4
D Okadaic acid + PMA 3.4 0.8
'Mn Diff Mean difference between treated cells and their controls.
No significant differences were detected.
Summary of Key Findings
For PGF2a the inhibitory effect of A23187 was significant but
not on the effect of OA. While the influence of PMA did not produce a
significant increase in prostaglandin synthesis over okadaic acid alone
it did make the difference between OA + A23187 and OA + PMA
significant. This latter effect was only seen in the absence of
progesterone, but did occur in both groups of animals.
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Summary of Data Involving Okadaic Acid
The following tables summarise the statistically significant
results already described.
Effects on PGE2 Production
This table summarises how PGE2 output was affected by the






in vitro Treatment Interactions
Okadaic acid NS NS Increase NS
Okadaic acid + RU486 NS NS Increase NS
Okadaic acid + A23187 NS NS NS NS
Okadaic acid + PMA NS NS Increase NS
NS No significant effect or interaction.
Increase Significant increase in prostaglandin synthesis.
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Effects on PGF2a Production
This table summarises how PGF2a output was affected by the






in vitro Treatment Interactions
Okadaic acid NS NS Increase RxP
Okadaic acid + RU486 NS NS Increase NS
Okadaic acid + A23187 NS NS NS NS
Okadaic acid + PMA NS NS Increase NS
NS No significant effect or interaction.
Increase Significant increase in prostaglandin synthesis.
R RU486 pretreatment of guinea pigs.
P Progesterone applied to cells.
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Comparison of the Effects on PGF2a and PGE2 Production
This table summarises how PGF2a and PGE2 outputs were










Okadaic acid NS NS NS NS
Okadaic acid + RU486 NS NS NS NS
Okadaic acid + A23187 NS NS NS NS
Okadaic acid + PMA NS NS NS NS
NS No significant difference or interaction.
Overview
RU486 treatment of the guinea pigs had no direct effect on the
synthesis of either prostaglandin. Its significant effect was its
interaction with progesterone on the set of cultures treated with
okadaic acid alone, and then only affecting PGF2a-
The only detected effect of progesterone was its interaction with
RU486 mentioned above.
Overall, PGE2 and PGF2a both showed a tendency to increase
output over control in the presence of OA except for OA + A23187
where there was no significant change. A23187 appeared to have an
inhibitory action. The comparison of treatments showed that they
generally did not result in significantly different effects in the cultures.
The only differences found were between OA + A23187 and OA + PMA,
in the absence of progesterone and only on PGF2a-
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Both prostaglandins were produced in similar quantities and
were not differentially affected by the different treatments or RU486 in
vivo or progesterone. The interaction between RU486 in vivo and
progesterone detected on PGF2a production under the influence of
okadaic acid alone was strong enough to produce an interaction
between the these two factors at this level also.
5.66
Chapter 5 Guinea Pig Results
Effect of RU486, A23187 and Oestradiol-17(3 on Prostaglandin
Output by Cultured Guinea Pig Cervical Cells
RU486 (l|iM)
RU486 is know to promote cervical ripening in the guinea pig
and was tested in vitro as well as in vivo in order to examine any role it
may have in the production of prostaglandins in the late pregnant
cervix. Once excised from the guinea pig the cervical tissue is no
longer in contact with the antiprogestin and it was therefore included
in the medium to determine whether or not any action that may have
been attributable to it was dependent on its continued presence.
Cells were exposed to lpM RU486 in vitro.
PGE2 (Figure 5.18)
RU486 in vitro had a stimulatory effect on PGE2 synthesis
(p=0.0030), as did RU486 in vivo (p=0.0389). There was also an
interaction between these two forms of RU486 treatment (p=0.0188),
RU486 in vivo augmenting the effect of RU486 in vitro. Progesterone
did not directly affect prostaglandin production but it did interact with
RU486 in vivo (p=0.0375), the RU486 blocking and possibly reversing
an inhibition of prostaglandin synthesis in the presence of
progesterone.
PGF2a (Data not shown)
The response of PGF2a was largely the same as that for PGE2.
RU486 in vitro stimulated output (p=0.0006), RU486 in vivo
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stimulated output (p=0.0044) and there was a similar interaction
between RU486 in vivo and progesterone (p=0.0413).
PGE2/PGF2CC (Data not shown)
Comparison of PGE2 and PGF2a showed that overall both were
produced in similar quantities. There was a significant three way
interaction with RU486 in vivo, RU486 in vitro and the two
prostaglandins (p=0.0483). The RU486 in vivo produced an increase in
prostaglandin production by control cells and RU486 in vitro treated
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Figure 5.18 Effect of RU486 (in vitro, lpM) on PGE2 production (mean
± sem).
RU486 in vitro effect p=0.0030
RU486 in vivo effect p=0.0389
RU486 in vivo x RU486 in vitro interaction p=0.0188
RU486 in vivox Progesterone interaction p=0.0375
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RU486 in vivo x Progesterone interaction p=0.0375
RU486 (10|iM, Data not shown)
RU486 was also used in vitro at a concentration of 10(iM.
When the results from this treatment were compared with those
from cells conditioned with RU486 in vitro at IjiM there were no
significant differences found between the two concentrations of
antiprogestin.
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A23187
A23187 is a calcium ionophore, consequently raising the
intracellular calcium concentration. In the majority of reported cases
it is a stimulant of prostaglandin synthesis (Hsu and Goetz, 1993; Ibe
and Raj, 1992; Houmbard et al., 1991; Cabre et al., 1993). R Leask
(Pers. Comm.) had observed an inhibitory effect of the ionophore with
human fetal membranes and it was therefore of interest to examine its
effects in the late pregnant guinea pig cervix to study the role of
intracellular calcium in regulating prostaglandin production. A23187
was used at 2pM.
PGE2 (Figure 5.19)
A23187 did not significantly affect PGE2 production. However,
RU486 in vivo did result in an overall increase in output (p=0.0118).
There was no overall effect of progesterone on PGE2 synthesis, but the
analysis did show an interaction with A23187 (p=0.0341), the
progesterone blocking a mild inhibitory action of A23187 which was
not large enough to be significant when analysed as an individual
factor.
5.70























H No RU486 in vivo
ElRU486 in vivo
Figure 5.19 Effect of A23187 (2|iM) on PGE2 production (mean ±
sem).
RU486 in vivo effect p=0.0118
Progesterone x A23187 interaction p=0.0341
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PGFaa (Figure 5.20)
A23187 had an inhibitory effect on PGF2a synthesis (p=0.0010).
RU486 treatment of the guinea pigs did not affect the synthesis of this
prostaglandin, nor did progesterone. However, there was an
interaction between progesterone and A23187 (p=0.0171), again
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Figure 5.20 Effect of A23187 (2(iM) on PGF2a production (mean ±
sem).
A23187 effect p=0.0010
Progesterone x A23187 interaction p=0.0171
PGE2/PGF2a (Data not shown)
Overall the analysis did not detect a difference in the production
of the two prostaglandins. A significant interaction between A23187
and the two PGs (p=0.0130) showed that A23187 inhibited PGF2a
production to a greater extent than PGE2.
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Oestradlol-173
Some authors have attributed cervical ripening effects to
oestrogens, however, there are others have found no such effect.
There are also reports of cultured fetal membranes producing
increased amounts of prostaglandin when challenged by oestrogens.
Thus, it was relevant to examine the effect oestradiol-17{3 would have
on prostaglandin synthesis by cultured cells from the late pregnant
guinea pig cervix.
Cells were cultured with oestradiol at a concentration of lOnM.
This set of results was made up from five control animals and four
given RU486 in vivo.
PGE2 (Figure 5.21)
The small reduction caused by oestradiol was significant
(p=0.0080). There were no significant overall effects of RU486 in vivo
and progesterone in vitro. Progesterone and RU486 in vivo did show a
significant interaction (p=0.0278), where the RU486 appeared to block
and possibly reverse an inhibitory action attributable to progesterone.
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Figure 5.21 Effect of Oestradiol (lOnM) on PGE2 production
(mean ± sem).
Oestradiol-17(3 effect p=0.0080
RU486 in vivo x Progesterone interaction p=0.0278
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PGF2a (Figure 5.22)
For this prostaglandin no significant effect of oestradiol was
found. RU486 in vivo did, however, result in an increase in output
(p=0.0104). Progesterone alone did not significantly alter the synthesis
of PGF2a but did interact with RU486 in vivo in a similar manner to
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Figure 5.22 Effect of Oestradiol (lOnM) on PGF2a production
(mean ± sem).
RU486 in vivo effect p=0.0104
RU486 in vivo x Progesterone interaction p=0.0080
PGE2/PGF2(x (Data not shown)
Overall, PGE2 and PGF2a were produced in similar quantities. A
significant interaction between the two PGs and progesterone
(p=0.0477) indicated a stimulatory effect of progesterone on PGF2a
which was not detected on PGE2 synthesis.
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Medroxy Progesterone Acetate (MPA, lpM, Data not shown)
MPA was included in the experiments as an analogue of
progesterone. Four control animal cultures were treated but only two
from the RU486 in vivo group.
Neither PGE2 nor PGF2a production showed any response to
MPA.
The cultures from control animals produced less PGF20C than
PGE2. The other results showed no difference but only two animals
were involved in that analysis.
Serum Free Cultures (Data not shown)
Some cultures were carried out without FBS in the medium. As
stated previously the basal production of prostaglandins in its
absence lay at the lower end of the standard curve and this made the
values obtained less reliable.
However, examination of the effects of LPS, PMA and OA
indicated that they were all still capable of stimulating prostaglandin
synthesis but to a much lesser degree than in the presence of FBS.
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Summary of Data from RU486 in vitro, A23187 and Oestradiol
The following tables summarise the statistically significant
results already described.
Effects on PGE2 Production
This table summarises how PGE2 output was affected by the
treatments applied to the animals and the cultures.
Table 5.19
RU486 Prog
Treatment Media in vivo in vitro Treatment Interactions
RU486 (lpM) Increase NS Increase RxP, RxT
A23187 Increase NS NS PxT
Oestradiol NS NS Decrease RxP
NS No significant effect or interaction.
Increase Significant increase in prostaglandin synthesis.
Decrease Significant decrease in prostaglandin synthesis.
R RU486 pretreatment of guinea pigs.
P Progesterone applied to cells.
T Treatment applied to cells.
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Effects on PGF2a Production
This table summarises how PGF2a output was affected by the
treatments applied to the animals and the cultures.
Table 5.20
RU486 Prog
Treatment Media in vivo in vitro Treatment Interactions
RU486 (IjiM) Increase NS Increase RxP
A23187 NS NS Decrease PxT
Oestradiol Increase NS NS RxP
NS No significant effect or interaction.
Increase Significant increase in prostaglandin synthesis.
Decrease Significant decrease in prostaglandin synthesis.
R RU486 pretreatment of guinea pigs.
P Progesterone applied to cells.
T Treatment applied to cells.
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Comparison of the Effects on PGF2a and PGE2 Production
This table summarises how PGF2CC and PGE2 outputs were




Treatment Media in vivo in vitro Treatment Interactions
RU486 (l(iM) NS NS NS RxExT
A23187 NS NS F<E NS
Oestradiol NS F>E NS NS
NS No significant difference or interaction.
F<E Significantly less PGF2a than PGE2 produced.
F>E Significantly more PGF2a than PGE2 produced.
R RU486 pretreatment of guinea pigs.
E Prostaglandin E or F.
T Treatment applied to cells.
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Effect of Interleukin-1(3 and Tumour Necrosis Factor-a on
Prostaglandin Output by Cultured Guinea Pig Cervical Cells
Interleukin-1 and tumour necrosis factor are important
regulators of inflammatory responses. They can be produced by a
variety of cell types, including macrophages/monocytes and
polymorphs, and have been shown to stimulate fibroblasts to produce
prostaglandins and collagenase. Since the main cell type in the cervix
is the fibroblast it may be expected that these cytokines may be
involved in the regulation of cellular functions, including the
production of prostaglandins. As well as responding to IL-1,
fibroblasts can produce it themselves and may therefore influence
their own activity.
As mentioned earlier some experiments were carried out using
serum free medium (culture medium with no fetal bovine serum
added to it). PMA has already been shown to stimulate the production
of prostaglandins in the guinea pig cultures used in this work where
FBS was included. Other experiments with PMA using serum free
medium were also performed and yielded similar results, a marked
increase in prostaglandin synthesis being evident. As part of those
experiments interleukin-1 (3 (IL-1) and tumour necrosis factor-a (TNF)
were also tested.
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PGE2 (Data not shown)
The results of this work relate only to cells derived from control
animals.
IL-1 (up to 200units/ml, 23pM) had no effect on the production
of PGE2, nor did TNF (up to 200units/ml, 0.6nM) or a combination of
the two cytokines.
No differences were detected between the three treatment
conditions.
PGF20C (Data not shown)
PGF2a production was also found to be unaffected by treatment
with IL-1, TNF or IL-1 + TNF. Again there were no differences between
the three treatments.
PGE2/PGF2(x (Data not shown)
Comparison of these two prostaglandins indicated that overall
more PGF2a was produced than PGE2 in the cultures (IL-1 set
p=0.0249, TNF set p=0.0290, IL-1 + TNF set p=0.0295) but that the
IL-1 and TNF did not affect the comparison.
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Problems Encountered with Interleukin-1 and TNF
EL-1
Interleukin-1 has been reported by several authors to stimulate
prostaglandin production (Pfeilschifter et al., 1989; Elias, 1988; Elias
et al., 1987), however, in the experimental work for this thesis no
such effect was observed. Concurrent experiments using the same
stock of IL-1 (British Biotechnology), also showed no response to the
cytokine (I A Greer, Pers. Comm.). The IL-1 used in those experiments
was dissolved in a protein free, physiological salt solution and used in
sheep. Ovine and human IL-1 [3 show 62% amino acid homology, ovine
and murine IL-1 (3 show 58% amino acid homology, all three show the
same processing characteristics required of human IL-1 [3 for biological
activity (Mclnnes, 1993), and the ovine form has been shown to be
similar enough to the mouse form that it can stimulate murine cells
(Andrews et al., 1991). Thus it is probable that recombinant human
IL-1 would be active in sheep.
The possibility that the IL-1 required the presence of other
proteins to reduce the likelihood of it adhering to the storage tube was
considered and a new supply of IL-1 was made up in 5% BSA/PBS
solution or as before. The two stocks of IL-1 were then compared but
once again no differences in prostaglandin output were observed.
Further experiments with IL-1 purchased from another supplier
(Boehringer Mannheim) also failed to show any stimulatory, or
inhibitory, effects of the cytokine, suggesting that human IL-1 may
not be active in guinea pigs. However, Rajabi et al. have shown that
procollagenase mRNA levels can be raised following conditioning of
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guinea pig cervical cells with recombinant human IL-1 (Rajabi et al.,
1991).
TNF
TNF has also been shown by other workers to stimulate
prostaglandin synthesis (Pfeilschifter et al., 1989; Elias, 1988; Elias et
al., 1987). The experiments carried out during this work did not find
evidence of such in the guinea pig cell cultures but did uncover a mild
stimulatory effect of the same stock of TNF on human cervical
explants. This indicates that the TNF that was used was not
biologically inactive or lost in handling as considered for IL-1.
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IL-8 Production by Guinea Pig Cervical Cells in Culture
The cytokine interleukin-8 is known to be chemotactic for
neutrophils and also to stimulate their degranulation. The presence of
leucocytes in the ripe cervix may therefore be under the influence of
IL-8, and for this reason the portion of guinea pig culture medium
that was stored at -20°C (without methyloximation) was examined for
its presence.
Samples of culture medium were selected on the basis of their
response to stimulatory compounds. Medium from cells that showed
an increase in prostaglandin production was assayed for IL-8 using
antibodies directed against recombinant human IL-8.
There was no evidence of interleukin-8 production either in
control medium or in that from stimulated cells. However, this may
have been because the antibodies were directed against the human
cytokine and not the guinea pig form.
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Results Obtained Using the HeLa Cell Line
An experiment was carried out using the HeLa cell line as these
cells were derived from a human cervix. This cell line was produced in
the 1950s, was the first cell line developed and has been maintained
ever since.
The response to challenge by LPS was examined. The cells were
plated out at 105 cells per well and LPS included in the culture
medium at 4(ig/ml (as for the guinea pigs) and also at ten times that
concentration (40|ig/ml). In neither of the treatments was there any
effect of LPS on the output of PGE2.
HeLa cells are thought to originate from epithelial cells of the
cervix and this suggested that the PGE2 produced by the guinea pig
cervices probably did not come from any epithelial cells in the
cultures.
The effect of PMA on HeLa cells was examined at 0.1 |iM and at
0.01|J,M. Both concentrations caused stimulation of PGE2 synthesis
that was greater than the highest standard. This indicated that
epithelial cells in the guinea pig cultures may, at least in part, have
been the source of this prostaglandin when challenged by PMA.
The effect of OA on HeLa cells was examined at 50nM and
caused stimulation of PGE2 synthesis that was greater than the
highest standard. This indicated that epithelial cells in the guinea pig
cultures may, at least in part, have been the source of this
prostaglandin produced in response to okadaic acid.
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Guinea Pig Study Discussion
The following pages examine and discuss the preceding results
obtained from the guinea pig work.
The cultures used in this work were derived from and
representative of the whole, late pregnant, guinea pig cervix. Therefore
there would have been a variety of different cell types present,
including fibroblasts, smooth muscle, epithelial and endothelial cells,
constituent macrophages and mast cells, and possibly other
leucocytic cells. The cervix at this stage of gestation would have
undergone certain changes associated with pregnancy, such as
replacement of older collagen with newer, less cross-linked collagen
and alterations in the GAG composition. Thus, it would be different
from the nonpregnant cervix and also be primed for the last stages of
cervical ripening
Thus, the results obtained, while not identifying the cell type
responsible, give an indication about the capabilities of the guinea pig
cervix as an organ ofmixed cellularity, and therefore resembles the in
vivo situation.
There is of course the disadvantage that the blood supply is
lost, which means that any infiltration or effect of leucocytes is not
accounted for. However, this applies equally to most in vitro studies.
There is also a loss of geometric distribution of the various cell types,
those that may not normally be in close contact with each other lying
together, and vice versa.
This technique of tissue digestion and the release of cells has
the advantage over simply incubating small pieces ofmaterial in that
the bathing fluid comes into intimate contact with each of the cells
6.1
Chapter 6 Guinea Pig Discussion
and the Individual wells will show greater homogeneity, since such
small pieces of tissue may be from different parts of the cervix. The
tissue can also be distributed more evenly, between greater numbers
of wells and therefore treatments, by virtue of the fact that the
dissection of any material by hand is relatively crude and produces a
wide range of sizes. In addition, the use of cell culture can allow time
for the cells to become accustomed to their new environment and the
subsequent removal of any cell debris prior to the commencement of
the experiment. With tissue culture the material is generally
incubated as soon after excision as possible and any necrotic tissue,
which may affect the results, cannot be removed.
Prostaglandins
Although prostaglandins are not considered to be stored within
cells, except for some neurones, the prostaglandin synthesis inhibitor,
indomethacin, was used to confirm the synthetic capabilities of the
cells being studied and did so, its addition to medium containing LPS
blocking the stimulatory effect of that agent. The cells were also able
to maintain prostaglandin synthesis for several days, an unlikely
situation if this was due to the release of prepackaged stores.
Because the medium contained FBS it was examined for the
presence of endogenous prostaglandins. No PGF2a or PGFM were
detected and negligible amounts of PGE2, however, there was slightly
more PGEM and very high levels of thromboxane B2. The latter
component's presence may be explained in terms of the clotting that
would undoubtedly have taken place in the fetal blood. TxA2 is an
integral part of the clotting process and platelet aggregation, and
quickly breaks down to TxB2. The reason for the presence of PGEM in
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the FBS is less clear, and surprising, since the level of PGE2 measured
was negligible and it seems unlikely that all of it would have been
converted to the metabolised form. It is possible that this was due to a
contaminant that cross reacted with the antiserum, however, its
identification would involve extensive separation and purification of
the constituent parts of the FBS and testing of them in the assay.
The inclusion of the bovine serum in the medium was justified
by the low basal output of prostaglandins in its absence, which would
have meant the results were read from the lower end of the standard
curve which was less sensitive and thus less accurate giving less
reliable results. In addition, this would not have allowed for the
detection of any inhibitory effects on prostaglandin synthesis.
PGE2 and PGF2a were selected for assay because they represent
the prostaglandins consistently identified by others as the
predominant prostanoids produced by cervical tissue and therefore
the most likely to play a significant role in cervical biology. In
addition, human clinical experience has shown that PGE2 and PGF20C
are effective ripening agents, PGE2 being the prostaglandin of choice.
The assay system used in this work relied on the conversion of
the prostaglandins in the harvested medium to their methyloxime
derivative. This process protects the PGs from dehydration and
therefore makes them more stable. The development of antisera is
improved because the methyloxime derivative of the prostaglandin in
question persists in vivo for longer, presenting a greater antigenic
challenge, and there are also no endogenous methyloximated
prostaglandins to bind to the antibodies produced and thus result in
the loss of those antibodies from the circulation (Kelly et al., 1989).
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Treatments
RU486 is now available to clinicians in the UK for the
termination of early pregnancy. It was the first drug of its type to
reach clinical trials and is the only antiprogestin to be given a product
license in Britain.
RU486 was shown to be effective in producing cervical ripening
several years ago (Lefebvre et al., 1990). It is thought to act at the
receptor level as an antagonist to progesterone which implies that
progesterone may be important in inhibiting the process of cervical
ripening. As progesterone may have inflammation suppressing
properties (Stites and Siiteri, 1983; Siiteri et al., 1977) this
antagonism of the steroid supports the hypothesis that the changes
that occur in the cervix are the result of an inflammatory style
reaction. RU486 has also been shown to interact with prostaglandins
and to increase the sensitivity of the uterus to administered PGs, as
well as allowing spontaneous contractions to develop (Bygdeman and
Swahn, 1985; Swahn and Bygdeman, 1988).
This work on guinea pigs was carried out in an attempt to find
out more about the effects of RU486 on the endogenous
prostaglandins and how other agents' in vitro activity may be affected
by the antiprogestin. The aim of these experiments was to improve
understanding of how RU486 produces cervical ripening and how it
may be interacting with the natural ripening mediators. The dosage of
RU486 was set at lOmg because it has been found to be effective in
previous work with the guinea pig (Elger et al., 1987a).
It was also hoped that the production of interleukin-8 could be
examined in the same preparations, but unfortunately the cytokine
was undetectable in the assay system used. This may have been
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because there was none, or very little, produced or because the guinea
pig form of IL-8 was not recognised by the antiserum. One possible
solution was to freeze dry the samples and reconstitute them in a
smaller volume. However, with only 500(il available and no IL-8
detected in one fifth of that volume, it is unlikely that the minor
degree of concentration that could have been produced (approximately
4 to 5 fold) would have been sufficient. Even if IL-8 was detected, at
such low levels the results would have been in the lower range of the
assay where the curve is relatively insensitive.
The study of interleukin-8 was thus confined to the medium
harvested from the human biopsy material (see chapter 7).
The vehicles used for the agents employed in this work in vitro
were dimethylformamide (DMF) or ethanol, which were found not to
affect the quantities of prostaglandin produced by cells incubated in
control medium containing only the vehicle as an additional
component. Water and saline were also used as solvents.
RU486
The comparison of the combined basal production figures from
each group of animals, showed that RU486 treatment of the animals
did not have a significant effect on the output of either PGE2 or
PGF2a.
Because of the large variation between each PGEM assay, a
single assay was performed incorporating medium from all the
controls and from all the progesterone conditioned controls in order to
give some indication ofwhat effect RU486 may have had on the basal
levels of this metabolite, thus allowing a comparison of those with and
without RU486 pretreatment and those with and without progesterone
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conditioning. This showed that RU486 in vivo did not affect the
generation of PGEM.
From the results obtained for PGE2 and PGF2« under the
influence of the other in vitro treatments it was found that giving
guinea pigs RU486 prior to sacrifice had no effect on the stimulation
caused by LPS, PMA, OA or combinations of these agents. The most
obvious effect was generally associated with the media that contained
the calcium ionophore, A23187, in conjunction with LPS and PMA. In
these cases the ionophore appeared to have an inhibitory effect on
prostaglandin synthesis, but in the cultures from animals pretreated
with RU486 the effect of the ionophore was reduced. PMA or OA
combined with A23187 did not show any significant effect of such
RU486 treatment, suggesting that the effect may have been on the
action of LPS. However, there did appear, based on the figures, to be a
small increase in the synthesis of both prostaglandins in the PMA +
A23187 treated cells when RU486 pretreatment had been given.
The experiment with A23187 alone showed a stimulatory effect
of the antiprogestin on PGE2 production, but here both the control
and ionophore treated cells produced more prostaglandin. The output
of PGF2CX was similarly greater from cells treated with A23187, the
effect on the control cells being less than for PGE2. RU486 did not
significantly affect the action ofA23187 itself.
Results obtained with cells in the oestradiol incubation group
indicated that some stimulation of PGF20C had occurred as a
consequence of pretreatment of the animals with RU486. The
antiprogestin did not affect the action of oestradiol. The significant
interaction between RU486 and progesterone observed in this set of
data appears to show an inhibitory effect of progesterone in the
6.6
Chapter 6 Guinea Pig Discussion
absence of RU486 and a stimulatory effect of progesterone in the
presence ofRU486, for both prostaglandins.
In the cultures where additional RU486 challenge of the cells
was provided by in vitro antiprogestin, a general stimulatory effect of
in vivo RU486 was found, similarly to the A23187 set of data. This
effect was apparent for both prostaglandins. RU486 interacted with
progesterone in the same way as it did with oestradiol, again for both
prostaglandins, but it also produced a significant increase in the
stimulatory effect of the RU486 in vitro.
RU486 combined in vitro with LPS or PMA or OA did not show
any significant effects of pretreatment with RU486 in vivo.
On the whole, the effect of RU486 in vivo was limited. In a few
instances it caused a general increase in prostaglandin synthesis and
in particular when associated with LPS and A23187 resulted in the
blockade of an inhibitory effect of the calcium ionophore. Why RU486
interacts in this way is not clear. The results suggest a calcium
dependent factor in the action of RU486 on LPS, since RU486 did not
affect the action of LPS in the absence of A23187. It is possible that
RU486, or a product of its action, requires calcium to amplify the
effects of LPS rather than block the action of A23187. If the action of
RU486 was on A23187 itself then the effect would also have been
observed in the experiment using PMA.
If RU486 induces cervical ripening, at least in part, through an
action on prostaglandins then the effect observed with A23187 (alone
and with PMA) suggests that calcium may not be a significant factor
in any increase in PG synthesis that occurs following administration
of the antiprogestin.
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Progesterone
The effect of progesterone inclusion in the culture medium was
examined. Progesterone receptor levels in the cervix have been shown
to be unchanged during the menstrual cycle (Sanborn et al., 1976;
Sanborn et al., 1978), which suggests that they may not be strongly
influenced by progesterone or oestrogen levels. The concentration of
progesterone in the cervical tissue in vivo is difficult, if not
impossible, to determine. However, the production of this steroid in
reproductive tissues during pregnancy is high and increases with
gestation (Buster and Simon, 1989; Liggins, 1983; Csapo et al., 1972)
which means that the local concentration may well be high and
justifies the use of 1(T6M progesterone in the culture medium.
From the comparison of the combined control values for all the
guinea pigs in both groups, it is apparent that progesterone caused a
modest fall in the synthesis of PGE2 by cells derived from control
animals. The same pattern was seen for PGF2a. but the reduction was
not significant. No significant effect of RU486 in vivo on progesterone
action was detected for either prostaglandin. The PGEM assay of the
control and progesterone controls indicated that progesterone did not
affect the generation of PGEM. It appears that inclusion of
progesterone in the culture medium throughout the culturing period
did not have a strong influence on the production of prostaglandins.
The majority of the experiments carried out did not find
evidence of a direct effect of progesterone. The only set of data that
showed such an effect was that of PMA alone, where progesterone
produced an overall reduction in PGE2 output. The effect of
progesterone was more evident when looking at its relationships with
the treatments applied to the cells and the pretreatment of the guinea
6.8
Chapter 6 Guinea Pig Discussion.
pigs with RU486. The interactions with treatments (LPS + A23187,
LPS + PMA + A23187 and A23187 experiments) appear to show a
stimulatory effect of progesterone. The interactions with RU486 in vivo
(LPS + PMA + A23187, Okadaic acid, RU486 and Oestradiol
experiments) also suggest a stimulatory activity.
Overall the results suggest that progesterone probably played
little or no part in the control of prostaglandin synthesis in the guinea
pig cervix cultures but given the clinical evidence concerning the
ripening effects of the antiprogestins it seems likely that progesterone
is crucial in the process. Despite the lack of an anticipated inhibitory
function for progesterone with regard to the synthesis of
prostaglandins, this steroid may well be involved in the suppression of
the action of other inflammatory mediators such as the cytokines, for
example as seen with interleukin-8 (Kelly et al., 1992). It is also
possible that progesterone may prevent or at least delay cervical
ripening by inhibiting uterine activity and thereby the mechanical
stresses placed upon the cervix, such activity being likely to induce
mechanical disturbances in the cervix and thus promoting
prostaglandin production.
The RU486 and progesterone results taken together show
neither to have a significant role in the production of prostaglandins
by the late pregnant guinea pig cervix. Since progesterone did not
produce the inhibitory effect that was anticipated, an antagonistic
effect of RU486 was unlikely, and the results indicate that RU486 did
not stimulate PG synthesis in the absence of progesterone.
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Comparisons Between PGE2 and PGF2CX Production by the Same
Cells
Comparing the basal production levels of the two
prostaglandins revealed that similar quantities of each PG were
synthesised by the cells from RU486 treated and control animals and
that progesterone had no significant affect.
Most cases where a difference was found showed less PGF2a
than PGE2 production in the presence of the treatment medium.
Differences between PGE2 and PGF2a synthesis were not unexpected
since the effect of each compound on the synthesis of each PG need
not necessarily be identical. All the LPS containing media resulted in
greater production of PGE2 than PGF2a as did PMA + A23187 and
A23187 alone. The data from the PMA alone experiment showed that,
while the overall trend was for both PGs to be produced in similar
quantities, there was a greater inhibitory effect of progesterone on
PMA stimulation of PGE2 than of PGF2a. The RU486 in vitro
experiment showed there was a greater stimulation of PGF2a than of
PGE2, but again no overall difference in the output of the two
prostaglandins. The only other detected difference between the PGs
was in the oestradiol data set. Here progesterone stimulated PGF2a
synthesis under control and treated conditions but not PGE2
synthesis. Okadaic acid treated cultures showed no differences
between PGF2« and PGE2 production.
These figures suggest that okadaic acid stimulates the
production of PGF2a and PGE2 equally but that PMA, LPS, A23187
and RU486 preferentially induce PGE2 over PGF2a.
The conversion of arachidonic acid to PGH2 is common to both
PGE2 and PGF2a (Smith, 1986; Kulmacz, 1987; Coleman et al. 1990).
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Therefore it is possible that the effect of okadaic acid on the
conversion of PGH2 to PGE2 and PGF2a results from similar activity
towards the isomerase and reductase enzymes responsible for each
PG respectively (Smith, 1986; Kulmacz, 1987; Coleman et al. 1990)
and the other drugs result in greater stimulation of the PGE2
pathway. The enzyme prostaglandin E 9-keto reductase has been
shown to covert PGE2 to PGF201 in vitro, thus it is possible that a
differential effect could result form inhibition of this enzyme
producing a build up of PGE2 and a deficit in PGF2a- However, the
reaction kinetics suggest that this is unlikely to be operative at
physiological prostaglandin levels and that the enzyme has another
function in vivo (Kulmacz, 1987).
Effects of the Different Treatments on Prostaglandin Production
The response of the guinea pig cells to the different agents
employed in this work were varied but more usually provided evidence
of a stimulatory action on prostaglandin synthesis. Some did not
appear to affect PG synthesis and there were some cases where the
output of prostaglandins from cells exposed to the test substance was
lower than the control level. In most cases PGF2a and PGE2
responded with similar increases or decreases in output although, as
already mentioned, not necessarily to the same degree.
LPS was obviously capable of stimulating the cells in the cervix
cultures to produce prostaglandins E2 and F2a, as was PMA. Both
stimulated in the presence and absence of fetal bovine serum. The
oestradiol results on the other hand appeared to show a more
selective effect, inhibiting PGE2 production but not PGF2a- The
calcium ionophore, A23187, also seemed to show a selective tendency
6.11
Chapter 6 Guinea Pig Discussion
towards one of the PGs over the other, inhibiting PGF2a but not PGE2.
The antiprogestin, when used in vitro, stimulated both PGE2 and
PGF2CC- Medroxy progesterone acetate used in vitro with control
animal cells did not have any effect on the output of either
prostaglandin. In serum free cultures IL-1 and TNF were found to be
inactive.
Various combinations of the different agents were tested and
although they may individually have had a significant effect on
prostaglandin synthesis, there were obvious changes associated with
combined treatments that did not always reach a significant level
when compared to each substance on its own.
LPS and PMA were both found to stimulate PGE2 and PGF2a
synthesis but only PGF2a production, in the absence of progesterone,
showed a significant increase when the two stimulants were
combined, despite other apparent increases. Also, okadaic acid alone
acted as a stimulant but when combined with PMA failed to produce a
significant further increase in PG production. Comparison of the
degrees of LPS and PMA evoked stimulation revealed no differences
between the two. However, comparisons amongst LPS, PMA and OA
showed that LPS and PMA both stimulated PGE2 to a greater extent
than OA, but this effect was less apparent for PGF2a-
PMA + OA did not produce significantly more of either
prostaglandin than either stimulant alone, despite apparent increases
produced when compared with OA on its own.
The inclusion of A23187 with LPS, PMA or OA in the culture
medium appeared to cause a general inhibition of prostaglandin
synthesis. However, many of these apparent differences caused by the
presence or absence ofA23187 in those cultures were not shown to be
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significant. The most consistent factor with regard to the significance
of the reduction was the inclusion of LPS in the medium. The majority
of the LPS group results showed significant reductions associated
with the calcium ionophore and the effect appeared to more often
significant for PGF2a than for PGE2. The PMA group, despite similarly
showing apparent reductions in PG synthesis in response to
co-culture with A23187, showed fewer significant falls and those that
were significant were again more common for PGF2C0 No significant
differences were found between the cells treated with okadaic acid and
those treated with okadaic acid + A23187, even though the former
produced a significant increase in PG production and the latter did
not. The selective effect of A23187 on PGF20C concurs with the
previously mentioned activity ofA23187 alone, where it was shown to
inhibit PGF201 but not PGE2.
RU486 used on its own (in vitro) did produce an increase in PG
synthesis but the presence of RU486 in the culture medium with LPS
or with PMA did not show any additional stimulatory function of the
antiprogestin.
Hela Cell Line Experiment
A minor side experiment with the HeLa cell line was performed
with some of the agents used in the guinea pig cultures. This cell line
was derived from a human, cervical tumour in the 1950s and is of
epithelial origin. This experiment gave some qualitative data
suggesting that the PMA and OA were activators of epithelial cells but
implying that LPS was not, despite evidence that LPS can have
stimulatory actions on human vascular endothelial cells (Strieter et
al„ 1989).
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Action of the Substances Studied
G-Protein/Protein Kinase C/Phosphatase
The action of LPS is thought to involve G protein activation,
which supports the presence of a receptor for LPS since G proteins
appear to be associated with receptor mediated signal transduction
(Stryer and Bourne, 1986). For cells other than those involved in the
detection and removal of bacteria to possess such a receptor seems
unlikely, unless LPS is merely utilising a receptor for some other
endogenous molecule, such as that implied by the fact that it
competes with acetylated LDL for the same binding site (Raetz, 1990).
Such receptors for acetylated LDL were not found in significant
quantities on cell types other than macrophages, and were absent
from human fibroblasts (Brown and Goldstein, 1983). The effect of
LPS observed in the guinea pig work shows that the cervix is capable
of producing prostaglandins in response to the bacterium derived
material. The HeLa result and the finding by Hampton et al. (Hampton
et al., 1988) that fibroblasts may be deficient with regard to a binding
site for LPS, and thus may not be able to respond to it, suggests that
other cells of the cervix might be involved in LPS stimulated PG
synthesis, the likely candidates being macrophages and possibly other
resident white cells, or alternatively supporting the hypothesis that
LPS can also intercalate into the membrane and affect intracellular
activity in some way via that route.
Fibroblasts have been shown to produce prostaglandins (Elias
et al., 1987) and are the major cellular component of the cervix. Both
PMA and LPS were shown to be capable of producing similar increases
in PG output from guinea pig cervix cultures and to exclude the
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fibroblasts from the total cell population and their component of the
prostaglandins synthesised, a significant difference would have been
anticipated between the two stimulants, with LPS having far fewer
cells which possess LPS receptors and thus in which it could provoke
PG synthesis. This assumes that PMA would be active in any
fibroblasts present, a situation which seems likely since PMA does not
appear to act via a receptor in the cell membrane but by inserting
itself into the membrane.
The activation of G protein in the cell membrane by LPS also
suggests the involvement of a second messenger system. It has been
shown that LPS can stimulate protein kinase C (Wightman and Raetz,
1984) and it is thought to inhibit adenylate cyclase (DeFranco, 1987).
The stimulatory action of PMA shows that the cells of the
pregnant guinea pig cervix are able to respond to the phorbol ester,
indicating that at least some of the cell types present can be induced
to produce prostaglandins via protein kinase C, since PMA has a
direct PRC binding and activating function. Thus the subsequent
phosphorylation of intracellular proteins by PRC must be involved in
PG synthesis and OA, which blocks the dephosphorylative action of
phosphatases, would be expected to increase the stimulatory effect.
However, the lack of any additional effect of OA over PMA alone may
indicate that production of PGs in those cells stimulated through the
PRC pathway had reached a plateau. Lipocortin is an endogenous
inhibitor of prostaglandin production (Flower, 1988) and has been
shown to be inhibited itself when phosphorylated (Hirata, 1981).
Therefore, it is possible that PRC may promote prostaglandin
synthesis, at least in part, through the removal of this endogenous
homeostatic mechanism.
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Although PMA and LPS independently stimulated both PGs the
comparison between the two together and each alone showed mixed
results, the majority of comparisons revealing no significant
differences. This lack of a significant difference between the effect of
PMA or LPS alone and the two agents in combination may suggest
that they act via the same mechanism and this had reached a
maximal level. However, the data appear to show that there was an
increase in prostaglandin synthesis which was not detected
statistically, except in a few cases, and this may indicate an additive
effect through the same mechanism or alternatively through
differential pathways.
Okadaic acid was shown to cause an increase in PGE2 and
PGF2a synthesis. This shows that the basal production of PGs
involves the phosphorylation and dephosphorylation of intermediate
proteins/enzymes since OA inhibits the removal of phosphate groups,
thereby increasing the level of phosphorylated proteins. This may
result in the maintenance of an inactive state for molecular species
that would normally be involved in prostaglandin degradation or the
maintenance of an active state for other mediators which support
prostaglandin production.
Okadaic acid was examined in conjunction with PMA. Since
PMA acts through the activation of protein kinase C, and thereby the
phosphorylation of intracellular mediators, it would be expected that
inhibition of the natural reversal of that phosphorylation may increase
the effects associated with PMA. This was not the observed effect.
Okadaic acid was shown to raise the level of PG synthesis in its own
right, presumably by altering the basal control mechanism, but not to
affect the stimulation imposed by PMA. This may indicate that PMA
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induced prostaglandin production is not dependent on the
phosphorylative activity of PKC and that the effect of PMA is not
produced merely through the modulation of the basal synthesis
mechanism, or that PMA causes maximal, constant activation of
phosphorylation thereby removing any role for okadaic acid.
Calcium/A23187
The importance of calcium in cellular activity is well recognised.
The calcium ionophore, A23187, allows the concentration of calcium
ions in the cytosol to increase by swapping two H+ ions for each Ca2+
ion that flows down its concentration gradient (Alberts et al., 1983). In
these experiments A23187 appeared to have a predominantly
inhibitory effect on prostaglandin synthesis. The increase in Ca2+
seemingly having a greater effect on PGF2a than PGE2. This would
suggest that the two PGs have different control mechanisms that
differ in their sensitivity to calcium concentration. Calcium ions have
been found to bind to lipocortin (Schlaepfer and Haigler, 1987), a
protein which inhibits prostaglandin synthesis through the inhibition
of phospholipases (Blackwell et al., 1980; Blackwell et al., 1982;
Hirata, 1981; Hirata, 1983) and therefore a reduction in eicosanoid
pathway substrate availability, thus A23187 may have produced this
inhibitory action through an effect on lipocortin. It has been shown
that calcium is required for the eicosanoid inhibiting activity of
lipocortin (Cirino and Flower, 1987b; Cirino and Flower, 1987a) and
that calcium can also permit lipocortin to bind to the phospholipase
substrate molecules (e.g. phosphatidylethanolamine,
phosphatidylserine) (Davidson et al., 1987; Aarsman et al., 1987;
Rothhut et al., 1987). A reduction in substrate availability would have
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been more likely to affect all downline processes to the same extent
and this was not the observed effect.
The inhibition produced by A23187 was surprising. The bulk of
the available evidence indicates that the calcium ionophore is a
stimulant of prostaglandin production (Hsu and Goetz, 1993; Ibe and
Raj, 1992; Houmbard et al., 1991; Cabre et al., 1993). It has been
shown to increase PG output by the guinea pig uterus (Poyser and
Ferguson, 1993), and also shown to stimulate PGE2 production by
cells in culture at a concentration of ljiM (Ljunggren et al., 1993). The
concentration used in the experiments described in this thesis was
2|iM. There is also evidence of a stimulatory effect of the ionophore on
eicosanoid production at the higher concentration of 5pM (Ibe and
Raj, 1992). A Japanese group have shown that A23187 stimulates the
rabbit cervix to produce PGs (Okawa, 1990), and there is a report
showing a greater degree of PGF2a synthesis than PGE2 under the
influence of A23187 (Calderaro et al., 1991).The calcium ionophore
has been shown to increase PG output through a stimulatory action
on arachidonic acid release (Hsu and Goetz, 1993), and at the same
time these authors showed that A23187 did not affect the conversion
of arachidonic acid to prostaglandins. Potestio and Olson also
observed increased arachidonic acid release by cells cultured with
A23187, at concentrations as high as 5pM (Potestio and Olson, 1990).
In the work presented here A23187 co-cultured with PMA resulted in
apparent reductions in PG synthesis, although not always
significantly, however, this is in complete contrast to the findings of
Kellner and Van der Kraak (Kellner and Van der Kraak, 1992) who
showed that the two act synergistically to increase prostaglandin
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production. They also found that PGE was produced in greater
quantities than PGF.
While there is most definitely a larger body of evidence to
suggest that A23187 is a stimulant of prostaglandin synthesis there
is, however, some opposing evidence that it may posses inhibitory
actions. Gibb and Lavoie found that A23187 stimulated freshly
isolated human amnion cells to produce PGs but had the opposite
effect when co-incubated with dexamethasone, producing a greater
degree of inhibition than the dexamethasone on its own (Gibb and
Lavoie, 1990). A study on plasminogen activator showed that A23187
was inhibitory at concentrations up to lpM. It also found that PMA
could stimulate plasminogen activator production and that 0.05pM
A23187 produced a synergistic increase in that stimulation.
Interestingly they observed a blockade of the PMA induced stimulation
when the A23187 concentration was raised to 0.5 and IjiM (Tilly and
Johnson, 1990). Although the data presented in this thesis did not
show a consistent, significant reduction in the action of PMA when
co-incubated with A23187, they do appear to show a similar trend to
the observations ofTilly and Johnson. The picture is similar with LPS,
but there were more significant effects when both LPS and PMA were
present.
A recent report has claimed that the addition of A23187 to
gastric mucosa cells grown in culture caused cell death (Tepperman
and Soper, 1994). The authors used more than six times as much
(12.5jiM) of the ionophore than the experiments in this thesis and two
and a half times that used by Ibe and Raj (Ibe and Raj, 1992), who
found that it increased PG production. Taken together with the
observations in this thesis showing that A23187 did not produce the
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same effects on PGE2 synthesis and PGF2a synthesis it would appear
that cell death was not the reason for the fall in prostaglandin output,
since a consistent effect would then have been produced.
Another interesting feature of the A23187 containing cultures
was the fact that they appeared to permit in vivo RU486 treatment of
the guinea pigs to produce an increase in prostaglandin synthesis
when compared to the equivalent control animal cultures, especially
the LPS + PMA + A23187 treated cells. This implies that PG
stimulation by RU486 may be dependent on an increase in the
concentration of calcium in the cytosol, despite the observation that
the calcium ionophore appeared to have an inhibitory effect in
general. This may reflect differing utilisation of available calcium when
lipocortin stimulation is inhibited by the presence of RU486 in
glucocorticoid receptors (Peers et al., 1988).
The action of A23187 (and calcium) on PG synthesis in the
guinea pig cervix is obviously somewhat different to the often reported
stimulatory effect. In order to examine this further it would be of
interest to carry out similar experiments using calcium free media.
However, this would also affect other calcium dependent systems and
would probably have a deleterious effect on the adherence of the cells
to the culture dish. The use of calcium channel blocking drugs would
be of limited use since A23187 is considered to transport calcium
across the membrane by complexing with the cation itself (Pressman
et al., 1967).
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Oestrogen
Oestrogen has been shown to promote prostaglandin production
by decidua and amnion (Olson et al., 1983a; Kelly and Abel, 1980;
Kelly and Abel, 1981). In the guinea pig cervix cultures oestradiol
caused a reduction in PGE2 but not PGF2a synthesis. While the effect
on PGE2 was significant the magnitude of the change was small. The
opposing effects of progesterone and oestrogen (Challis and Olson,
1988) would also have been expected to become apparent in such
experiments, however no such interaction was detected. The lack of
any consistent effects of progesterone and RU486, or of a major effect
of oestradiol may be indicative of low numbers of steroid receptors.
However, the fact that RU486 has been shown to cause cervical
softening (Elger et al., 1987a) indicates that the cervix does contain
receptors for this steroid, in vivo, and work by Rajabi et al. (Rajabi et
al., 1991) showed that progesterone could influence collagenase
output and RU486 was able to block progesterone's actions.
Thus, the experiments carried out for this thesis suggest that
the steroid hormones do not play a significant role in the local control
of prostaglandin synthesis in the late pregnant guinea pig cervix and
may therefore not be involved in PG control in the latter stages of
cervical ripening. It is possible that these hormones can influence the
cervix by actions they have on surrounding tissues, most likely the
uterus. Activity in this organ may result in paracrine interactions
between the tissues, as they are physically a single entity.
Oestrogen's function in cervical ripening is not clear with
several reports of a ripening effect of exogenously applied oestrogen
(Gordon and Calder, 1977; Pinto et al., 1964; Pinto et al., 1965;
Tromans et al., 1981; Gordon, 1981; Stewart et al., 1981), others
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suggesting that it does not promote ripening (Thieiy et al., 1978;
Pedersen et al., 1981). There are also conflicting reports about the
effects oestrogen may have on biochemical events,
collagenase/collagenolytic activity having been found to both increase
(Rajabi et al., 1991; Rajabi et al., 1991) and decrease [Woessner,
1979; Wallis and Hillier, 1981). The work in this thesis showed that
oestradiol did not have any strikingly obvious effect on prostaglandin
synthesis by guinea pig cervix. This was despite the fact that where
oestrogen was found to produce an increase in procollagenase levels
(Rajabi et al., 1991), the results were obtained using guinea pig
cervical tissue and inhibition of cyclooxygenase resulted in the loss of
that effect of the oestrogen, suggesting that prostaglandins may be
involved in such an effect. Thus, the role of oestrogen remains open to
question, but it is suggested that it may be involved in the regulation
of gap junction formation in the myometrium (Bosc et al., 1987;
Garfield et al., 1980; Puri and Garfield, 1982) so it may also have a
similar effect in the cervix, allowing the individual cells to act in
concert with each other to produce the rapid ripening observed in
normal clinical situations.
Cytokines
Interleukin-1 and tumour necrosis factor have both been shown
to stimulate prostaglandin synthesis (Dayer et al., 1985; Elias, 1988;
Hammarstrom, 1989; Pfeilschifter et al., 1989). The lack of such an
effect by IL-1 in these experiments was surprising and initially
thought to be due to the preparation of the material but changes in
the preparation and in the supplier failed to show any difference.
Recombinant human IL-1, as used here, was found to stimulate
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guinea pig cells to produce mRNA for procollagenase (Rajabi et al.,
1991), which suggests that this human form of IL-1 can be active in
the guinea pig. Thus it seems that IL-1 may not be a stimulant of
cervical prostaglandin production. The biological inactivity of the TNF
used was discounted by later experiments with human tissue but
again introduces the question concerning the activity of recombinant
human material being bioactive in other species.
The stimulant effect of LPS on prostaglandin production lends
support to the proposals that the presence of intrauterine infection
may be a factor in cases of preterm labour (Platz-Christensen et al.,
1992; McGregor, 1988), possibly the result of the initiation of an
inflammatory response directed against the invading microorganisms.
However, this raises the issue of how the maternal immune system is
able to respond to the infection while unable to recognise the fetally
derived tissue. One possible solution to this problem lies in the fact
that some microorganisms are able to produce prostaglandins
themselves or produce enzymes, such as phospholipase A2, which
promote PG synthesis (McGregor, 1988; Lamont et al., 1990). The LPS
results also support the suggestions that parturition is an
inflammatory based function with cervical ripening and uterine
contractions being stimulated and controlled, at least in part, through
the actions of prostaglandins and cytokines. Even if the initiation of
the inflammatory response is supplied by a non-maternal source, that
is the fetus or an infection, or if these sources actually produce
prostaglandins themselves, it may still be relevant to examine the
ability of the late pregnant cervix to produce prostaglandins since
endogenous PG production has been observed following stimulation
with exogenous prostaglandin (Green et al., 1981).
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Although the results obtained with guinea pig tissue did not
provide evidence of an effect of the cytokines IL-1 and TNF on
prostaglandin synthesis and this may have suggested that they have
no function in the cervix, their central role in the process of
inflammation implies that they are very likely to be involved in cervical
ripening to some degree. The lack of response from the guinea pig
cervix may have resulted from the absence of cell types capable of
responding to those cytokines. However, the fact that human cervix
did respond to TNF (chapter 7) suggests that this was probably not
the reason as both tissue preparations would be expected to contain a
similar range of cells, the main differences being that of species and
the loss of any direct cell to cell interactions via gap junctions.
Summary
Cervical cells taken from late pregnant guinea pigs and
maintained in culture are capable of producing prostaglandins E2 and
F2a- A variety of drugs were shown to alter the degree of prostaglandin
output and the general trend was for greater amounts of PGE2 to be
produced than PGF2a- Production of PGs can be stimulated by
activation of G-protein linked second messenger pathways involving
protein kinase C and by preventing the dephosphorylation of
intracellular proteins. An induced increase in cytosol calcium levels
causes a reduction in prostaglandin synthesis. The antiprogestin
RU486 does not have a significant effect on prostaglandin production
by the late pregnant guinea pig cervix, nor do the endogenous sex
steroids progesterone and oestrogen have a role. The cytokines IL-1
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Human Cervix and Interleukin-8 Production
The remodelling of the pregnant cervix is primarily dependent
on the alteration of the connective tissue matrix. For this to occur the
original connective tissue must be broken down and replaced. One of
the enzymes crucial to this is collagenase, as it is one of only two
enzymes capable of the initiation of collagen degradation (the other
enzyme being elastase). It has been shown collagenase in the ripening
cervix is of polymorphonuclear cell origin. The chemokine (a
subdivision of the cytokines) interleukin-8 is a chemotactic factor for
neutrophils, a PMN with granules containing collagenase (elastase is
also found in neutrophils). Thus, the presence of IL-8 in the cervix
would be an ideal method for inducing neutrophil migration to the
cervical connective tissue, the subsequent degranulation and release
of collagenase and ultimately the breakdown of the highly crosslinked
collagen.
The initial aim of this section ofwork was to determine whether
or not the human cervix was capable of producing interleukin-8, and
if so to examine the influence of different in vitro treatments on that
production.
It was also intended that the effects of pretreatment with the
antiprogestin RU486 would be examined using biopsies from the
cervices ofwomen undergoing surgical termination of pregnancy.
The human cervical biopsies were derived from five separate
groups of women. The difficulty in obtaining biopsies from RU486
treated women (group 5) meant that there were no results from this
group.
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The following data were produced using tissue obtained from
the remaining four. Group 1 (P-Cgem) was from women given the
prostaglandin E analogue Cervagem prior to surgical termination.
These women were nulliparous. Group 2 (P-No Cgem) was from
parous women not given cervagem pretreatment before surgical
termination. Group 3 (NP) was from hysterectomy patients. These
women were premenopausal and were not pregnant. They were at
various stages of the menstrual cycle but there was insufficient
information to permit the determination of any stage specific
differences. Finally, group 4 (PM) samples were from the
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Production of IL-8 by the Human Cervix
Influence of PMA on Interleukin-8 Production (Figure 7.1)
PMA is an activator of protein kinase C (see chapter 3). It was
used to examine the involvement, if any, of the protein kinase C
pathway in the production of prostaglandins by human cervical tissue
sustained in culture.



















Figure 7.1 Effect of PMA (O.lgM) on IL-8 production by human
cervical tissue explants (mean ± sem).
Group 1- Pregnant, cervagem treated
Group 2- Pregnant, no cervagem treatment
Group 3- Nonpregnant
Group 4- Post menopausal
Tissue group effect p=0.0115
PMA effect p=0.0001
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The production of IL-8 by these four different tissues was not
equal. There was an obvious reduction in output of IL-8 by the group
4 (postmenopausal) cervix, p=0.0115.
PMA was included in the culture medium at a concentration of
0.1|iM. It caused a significant increase in the level of IL-8 in the
medium, p=0.0001.
While there appeared to be an interaction between the tissue
group and the treatment, that is that the group 4 tissues seemed to
respond differently to the PMA than the other tissues, the relationship
between group and treatment was not significant, p=0.1818. The lack
of significance may be attributed to the small number of results in
group 4 (only three samples).
Effect of Progesterone on Interleukin-8 Production (Figure 7.2)
Biopsies from nonpregnant patients (group 3) were larger than
those from the other groups and more experiments could therefore be
carried out with each one. This meant that four separate culture
conditions could be set up with tissue from the same patient and thus
allow direct comparison of the effect of progesterone on the basal and
PMA stimulated levels of IL-8.
Complete medium with and without progesterone at a
concentration of l|iM, and PMA containing medium (O.lpM PMA),
again with and without progesterone at lgM, were examined for their
effect on IL-8 output.
Once more, PMA caused a significant increase in the output of
IL-8, p=0,0132. Progesterone had no effect on the output of
interleukin-8. Despite the apparently lesser degree of stimulation of
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IL-8 production in the cultures containing progesterone the difference
















Figure 7.2 Effect of progesterone (l|iM) on IL-8 production by human
cervical tissue explants (mean ± sem).
Group 3- Nonpregnant
PMA effect p=0.0132
Effect of Okadaic Acid on Interleukin-8 Production (Figure 7.3)
Okadaic acid is an inhibitor of protein phosphatases and
therefore prevents the dephosphorylation of intracellular proteins (see
chapter 3). It was examined to determine the effect ofmaintaining the
phosphorylated state of basally phosphorylated proteins in the human
cervix.
Cultures were incubated with medium containing okadaic acid
at 50nM. For this treatment, group 1 (P-Cgem) and group 3 (NP)
tissue biopsies were available.
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The two groups of tissue showed no significant difference in
their production of IL-8, p=0.1442, and although there does appear to
have been some inhibitory effect of okadaic acid on the nonpregnant










H Group 1, n=6
□ Group 3, n=6
OA, 50nM
Control OA
Figure 7.3 Effect of okadaic acid (50nM) on IL-8 production by
human cervical tissue explants (mean ± sem).
Group 1- Pregnant, cervagem treated
Group 3- Nonpregnant
No significant differences
Effect of LPS on Interleukin-8 Production (Figure 7.4)
LPS (lipopolysaccharide) is a product derived from the surface of
gram negative bacteria and it is thought to activate G-proteins.(see
chapter 3). It is thought that in a proportion of cases of preterm
delivery the cause may be related to the presence of bacterial
infections in the upper genital tract. In these experiments LPS was
used to examine the likelihood that the human cervix could produce
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prostaglandins under such circumstances. It was tested at a
concentration of 4jig/ml on cultures of nonpregnant cervical explants.
LPS caused a significant increase in the output of interleukin-8
compared to the control, p<0.01. This analysis of variance was a one¬
way analysis and showed that a significant stimulation had taken
place, p=0.0003, thus permitting the follow up Newman-Keuls test.
Effect of TNF on Interleukin-8 Production (Figure 7.4)
TNF is a cytokine involved in the regulation of immune
responses and inflammation. It acts via specific receptors in the cell
membrane (see chapter 3). Cervical tissue from nonpregnant patients
was exposed to TNF at lOOunits/ml.
Again, an increase in IL-8 production was detected when
compared to the results from the control tissue, p<0.05.
Effect of DMF on Interleukin-8 Production (Figure 7.4)
DMF, the solvent in which okadaic acid was reconstituted, was
studied in tissue from nonpregnant women.
The results indicated that this vehicle, at 0.05%, did not
significantly affect the production of interleukin-8.
All of the results presented thus far concerning material from
nonpregnant patients and the effects of okadaic acid, DMF, LPS and
TNF were obtained from the same set of tissues and are therefore
displayed together in the same figure (Figure 7.4).
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Control DMF OA LPS TNF TNF 100 units/ml
H Group 3, n=6
OA, 50nM
LPS 4jig/ml
Figure 7.4 Effect of DMF, okadaic acid (50nM), LPS (4|ig/ml) and
TNF (lOOunits/ml) on IL-8 production by human cervical tissue
explants (mean ± sem).
Group 3- Nonpregnant
LPS greater than control, p<0.01
TNF greater than control, p<0.05
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A further set of tissue derived from nonpregnant women was
studied. These biopsies were exposed to PMA, PMA + A23187, TNF (at
a higher concentration than previously) and ethanol, the vehicle used
for progesterone, PMA and A23187.
Effect of Ethanol on Interleukin-8 Production (Figure 7.5)
Ethanol at a concentration of 0.2%, the maximum that would
have been present in any of the cultures, had no discernible effect on
IL-8 production.
Effect of PMA and PMA + A23187 on Interleukin-8 Production
(Figure 7.5)
O.lpM PMA and 2jiM A23187 were examined because early
work on the guinea pig suggested that the calcium ionophore
(A23187) may have had an inhibitory effect on prostaglandin
synthesis (see chapter 5).
PMA alone was included as an appropriate control for the PMA
+ A23187 treatment. There were significant effects (using one-way
anova p=0.0002). PMA treatment caused an obvious stimulation in
IL-8 output, p<0.01. A23187 had a significant inhibitory effect on the
action of PMA, p<0.05. The PMA treatment effect was also significantly
greater than that of TNF at 500 units/ml, p<0.05. Although PMA +
A23187 and TNF also raised IL-8 levels by apparently large amounts
their effects were not found to be significant.
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Effect of a Higher Concentration of TNF on Interleukin-8
Production (Figure 7.5)
TNF was tested at 500units/ml, as opposed to only
lOOunits/ml previously.
The TNF appeared to promote the production of IL-8 by the
nonpregnant cervical tissue but the increase over the control did not
reach significance. A comparison of TNF at 100 units with TNF at 500
units did not detect a difference between them. The comparison was
made using the difference between each TNF stimulated value and its
respective control.
Control EtOH PMA PMA TNF TNF' 500 units/ml
+
A23187
Figure 7.5 Effect of ethanol, PMA (O.lpM), PMA (O.ljiM) + A23187
(2|iM) and TNF (500units/ml) on IL-8 production by human cervical
tissue explants (mean ± sem).
Group 3- Nonpregnant
PMA greater than control, p<0.01
PMA greater than PMA + A23187 and TNF, p<0.05
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Maintenance of IL-8 Output
The data presented were derived from the medium harvested
after the first 24 hr incubation period. As an indication that the tissue
remained viable beyond this point, the cultures were maintained for a
second 24 hrs. The correlation coefficient produced by comparing the
results from each of the culture periods was 0.92 (p<0.001). This
strongly suggests that the tissue was still viable 48 hrs after excision
from the patient.
A limited number of cultures were continued for a third period
of 24 hrs. For those cultures the correlation between the first and
second harvests had a coefficient of 0.94 (p<0.001) and between the
second and third harvests a coefficient of 0.98 (p<0.001). While this
does not give an indication of the level of cell viability, it does indicate
that the tissue was behaving in a parallel manner on subsequent
days.
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Prostaglandin E2
As an adjunct to the interleukln-8 study PGE2 production by
the excised human cervical tissue was also examined. The use of
drugs employed in the guinea pig study may also show whether the
guinea pig and human respond in a similar manner.
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Production of PGB2 by the Human Cervix
Prostaglandin levels were determined in the medium harvested
from each group of tissues (figure 7.6).
For basal production no statistically significant differences were
found between the four groups of tissue, p=0.2741.
Influence of PMA on PGE2 Production (Figure 7.6)
PMA increased the level of PGE2 synthesis, p=0.0358. As
observed with IL-8 there was no significant interaction between the
grouping and the treatment, p=0.7405, despite the apparent lack of
















II Group 1, n=14
□ Group 2, n=9
11 Group 3, n=8
□ Group 4, n=3
PMA, 0.1pM
Control PMA
Figure 7.6 Effect of PMA (0. lpM) on PGE2 production by human
cervical tissue explants (mean ± sem).
Group 1- Pregnant, cervagem treated
Group 2- Pregnant, no cervagem treatment
Group 3- Nonpregnant
Group 4- Post menopausal
PMA effect p=0.0358
7.13
Chapter 7 Human Cervix
Effect of Progesterone on PGE2 Production (Figure 7.7)
The cervix of nonpregnant women was cultured in complete
medium and PMA containing medium (O.lpM PMA), in both cases
with and without progesterone at a concentration of 10'6M.
Again, PMA caused a significant increase in the output of the
prostaglandin, p=0.0403. Progesterone had no significant overall effect
on the output of PGE2, p=0.1542. However, there was an interaction
between the progesterone and the PMA treatment, p=0.0467, the
progesterone reducing the stimulation of PGE2 output by PMA.
Figure 7.7 Effect of progesterone (lpM) on PGE2 production by
human cervical tissue explants (mean ± sem).
Group 3- Nonpregnant
PMA effect p=0.0403
Progesterone x PMA interaction p=0.0467
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Effect of Okadaic Acid on PGE2 Production (Figure 7.8)
The group 1 (P-Cgem) and group 3 (NP) tissue biopsies
incubated with okadaic acid (50nM) showed a quite different response
to that of interleukin-8.
The two groups of tissue responded in a similar manner to
okadaic acid. Both produced the same basal quantities of PGE2 and
increased their output significantly and to the same degree when
cultured in the test medium. p=0.0146. This effect of okadaic acid is
distinctly different from the effect observed on IL-8 production. There
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OA, 50nM
Control OA
Figure 7.8 Effect of okadaic acid (50nM) on PGE2 production by
human cervical tissue explants (mean ± sem).
Group 1- Pregnant, cervagem treated
Group 3- Nonpregnant
Okadaic acid effect p=0.0146
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The effects of okadaic acid, DMF, LPS and TNF on group 3
tissue (NP) are again presented in the same figure (figure 7.9) since
they were all produced from common source material. The okadaic
acid results will not be discussed again at this point.
Effect of LPS on PGE2 Production (Figure 7.9)
The analysis of variance of these data obtained by studying
tissue from nonpregnant women revealed a significant stimulation of
PGE2 production, p<0.0001. The one-way anova was supplemented by
the Newman-Keuls test. LPS (4|j.g/ml) conditioning resulted in
significantly greater output of PGE2 than the control medium, p<0.05.
Effect of TNF on PGE2 Production (Figure 7.9)
The effect of TNF (lOOunits/ml) on PGE2 was also examined on
this cervical tissue from nonpregnant patients.
An increase in the production of the prostaglandin was detected
in the presence ofTNF at 100 units/ml, p<0.05.
Effect of DMF on PGE2 Production (Figure 7.9)
DMF did not affect the production of PGE2 by the tissue from
nonpregnant patients.
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Figure 7.9 Effect of DMF, okadaic acid (50nM), LPS (4|ig/ml) and
TNF (lOOunits/ml) on PGE2 production by nonpregnant human
cervical tissue explants (mean ± sem).
Group 3- Nonpregnant
LPS greater than control, p<0.05
TNF greater than control, p<0.05
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The following results are from another set of tissues derived
from nonpregnant women, as described in the previous section on
interleukin-8.
Effect of Ethanol on PGE2 Production (Figure 7.10)
Ethanol was tested as a vehicle control (0.2%). It had no
discernible effect on PGE2 production.
Effect of PMA and PMA + A23187 on PGE2 Production (Figure
7.10)
O.ljiM PMA and 2p.M A23187 were examined because early
work on the guinea pig suggested that the calcium ionophore
(A23187) may have had an inhibitory effect on prostaglandin
synthesis (see chapter 5).
The analysis of variance indicated that a significant increase in
PGE2 output had taken place, p=0.0062. PMA (O.lpM) treatment
caused an obvious stimulation of PGE2 output as did the combination
of PMA + A23187, however, only the latter difference reached
significance, p<0.05. Comparison of PMA treated cultures with PMA +
A23187 treated cultures did not detect any difference between the
two.
The quantity of PGE2 produced by this tissue under the
influence of these two treatments was higher than observed previously
for PMA, the mean value approximately three times the mean from
the data in first set of figures presented. There was no obvious reason
for this and all of the data lay within three standard deviations of the
mean.
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Again, as found with okadaic acid, the observed interaction
between PGE2 and PMA + A23187 is in contrast to that between IL-8
and PMA + A23187.
Effect of a Higher Concentration of TNP on PGE2 Production
(Figure 7.10)
500units/ml TNF appeared to promote the production of PGE2
by the nonpregnant cervical tissue but the difference between it and
the control medium did not reach significance. Comparing TNF at 100
units with TNF at 500 units did not detect a difference between their
effects.
50 n
Control EtOH PMA PMA TNF TNF' 500 units/ml
+
A23187
Figure 7.10 Effect of ethanol, PMA (O.lpM), PMA (O.lpM) + A23187
(2|iM) and TNF (500units/ml) on PGE2 production by human cervical
tissue explants (mean ± sem).
Group 3- Nonpregnant
PMA + A23187 greater than control, p<0.05
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Maintenance of PGE2 Output
The data presented were derived from the medium harvested
after the first 24 hr incubation period. As an indication that the tissue
remained viable beyond this point, the cultures were maintained for a
second 24 hrs. The correlation coefficient produced by comparing the
results from each of these two culture periods was 0.84 (p<0.001).
This tends to support the data obtained from the IL-8 results.
A limited number of cultures were continued for a third period
of 24 hrs and the correlation between the first and second harvests for
those cultures had a coefficient of 0.85 (p<0.001) and between the
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Human Cervix Discussion
Interleukin-8
This work shows for the first time that the human cervix is
capable of producing the neutrophil chemotactic and activating
cytokine interleukin-8, albeit in vitro. The four groups of tissue from
which results are presented produced IL-8 at similar basal levels,
although, from the data it is apparent that the base lines were
variable and suggests that the postmenopausal tissue produced less
than the others. The figures obtained from early experiments appear
to show generally higher basal output which may be related to
inexperience with a new technique and a greater degree of trauma to
the tissue. It seems possible that this may have provoked the
initiation of an inflammatory reaction.
In figure 7.1 the response of tissue from groups 1, 2 and 3
appeared to be identical when challenged by PMA, with comparatively
little effect on the post menopausal tissue (group 4). However, there
was no significant interaction between the tissue group and the
treatment and it is probable that this was due to the small number of
samples that were made available from this group ofwomen. The use
of human cervix for experimental work is fraught with such problems,
limited quantities being obtainable. The lack of homogeneity in the
human population produces relatively large variation between
patients which ultimately means that the statistically significant
differences will be difficult to detect with small numbers of samples. It
is nonetheless interesting that this tissue appeared not to respond to
the PMA in the same manner as the tissue from the other groups of
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women, and may indicate that there is an element of hormonal control
in the production of IL-8. However, there were no apparent differences
between the nonpregnant group and the two sets of tissue from
pregnant women, the hormonal environments being quite different in
the pregnant and nonpregnant groups but still under the influence of
substantially more ovarian hormones than postmenopausal tissue.
Figure 7.2 shows the effect of progesterone in vitro which did
not reveal any significant effect of the steroid despite the presence of a
glucocorticoid/progestin response element in the IL-8 gene (Mukaida
and Matsushima, 1992) and the inhibition of IL-8 production seen
with chorio-decidual cells in culture (Kelly et al., 1992). The reduction
in IL-8 levels seen in the PMA treated tissue co-incubated with
progesterone may not have reached a significant level due again to the
low number of patients involved, only five, and the fairly high
variation between patients. In these experiments on the effect of
progesterone, nonpregnant tissue was used because it allowed each of
the four treatments to be applied to tissue from each of the patients,
in the expectation that any differences would be more easily detected.
Despite the difficulties associated with using human cervix the
relevance ofwork on human tissue makes it a valuable tool, especially
where it can be used to confirm more extensive studies in animal or
cell culture models.
The similarity in the responses of the pregnant, cervagem
treated, pregnant but not treated with cervagem and the nonpregnant
tissues when cultured with PMA presents several interesting points.
Firstly it suggests that exogenous prostaglandin treatment used to
promote cervical softening does not do so by increasing the synthesis
of IL-8, although it may reduce the threshold concentration of IL-8
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that is required for it to exert its effects, as was seen in rabbit
experiments (Colditz, 1990). Secondly, the similarities between tissue
from pregnant and nonpregnant women may indicate that
nonpregnant material could be used as a model for the cervix. This
would be preferred since it is ethically more acceptable to obtain
tissue from organs removed at hysterectomy rather than interfere with
the intact cervices ofwomen of reproductive age. However, the results
obtained with okadaic acid (OA) suggest that the responses of the two
tissues may not be the same. In addition, this work does not address
the possible, or even probable, differences between the cervix of early
pregnant or nonpregnant women and that obtained from term
pregnant women.
The material from nonpregnant women was removed because of
uterine dysfunction and the cervix not used if it appeared to be in any
way abnormal. This was subsequently confirmed by routine histology.
The stage at which these women were in their menstrual cycle was not
always available because of the occurrence of almost constant
bleeding or amenorrhoea, which meant that it was not possible to
examine the results for any stage specific differences in IL-8
production that may have been present.
From the data obtained with PMA, LPS and TNF it is apparent
that the human cervix has the capacity to up regulate its output of
IL-8. The correlation between output in consecutive culture periods
indicates that it can maintain those higher levels for two to three days
at least. This latter point also implies that the IL-8 is not merely
released from intracellular stores but is being synthesised de novo.
The effect of OA on IL-8 production remains open to question.
In the pregnant tissue there was obviously no effect at the dose used,
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however, the response from nonpregnant cervix was more ambiguous.
The baseline was lower than that of the pregnant tissue in the first
place (insignificantly), the level upon treatment with OA seemed to
drop, but even then difference between the two groups of tissue when
challenged by OA did not reach significance. This disparity between
the groups of tissue may well be a real effect since PGE2 measured in
medium from the same cultures did not show the same pattern,
indicating that the effect was not a blanket one on cellular function.
Statistically no differences were detected between the two groups of
tissue anyway.
Prostaglandin E2
This study with human cervical tissue confirms its ability to
produce PGE2. Figure 7.6 shows the four groups of tissue and there
were no significant differences between the outputs of each. Despite
this, the pregnant, cervagem treated group does appear to produce
slightly more than others, both basally and following PMA stimulation,
which may indicate that the cervagem caused increased endogenous
prostaglandin synthesis, as suggested by Uldbjerg and by Green
(Uldbjerg and Ulmsten, 1990; Green et al., 1981). In a cross-reactivity
test 1 and lOng cervagem registered as 5 and 49pg PGE2 respectively.
Equating this to the assay of the human cervical tissue suggests that
to give lng/mg/ml there would have to be contamination of the
material at 0.2mg cervagem/mg tissue which seems unlikely since the
pessary used contained only lmg of cervagem and the PG analogue
would be distributed in a relatively large volume of tissue, probably
also being absorbed into the general circulation. The baseline PGE2
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levels from the cultures with OA were identical between nonpregnant
and pregnant, cervagem treated tissue which suggests that cervagem
did not contribute to any of the assayed prostaglandin.
Similarly to its effect on IL-8, PMA increased the synthesis of
PGE2 and the postmenopausal samples showed an apparently limited
response to it. Once more the small number of women recruited from
this group appeared to constrain the analysis, however, the data do
suggest that the postmenopausal tissue may be less able to respond
to PMA challenge.
There was generally a high degree of variability in the quantity
of prostaglandin produced. The nature of the samples and the fact
that it was human probably accounted for this. The biopsy material
was often supplied in more than one piece. This was due to the plug of
material coming apart when removed from the needle or because more
than one attempt was made to take a biopsy, resulting in more than
one piece of tissue. It was not possible to identify epithelial parts of
the biopsies therefore the proportion of stromal and epithelial material
in each well of the culture dish was variable. It is possible that this
would have affected the production of IL-8 and PGE2.
The prostaglandin response of nonpregnant group cervix to
progesterone was similar to that of IL-8 except that progesterone
interacted with the treatments differently, inhibiting the PMA
stimulated cells more than the controls. An inhibitory effect of
progesterone could be seen as contradictory to the situation with
postmenopausal tissue where its absence in vivo may have been
involved in the apparent lack of response to PMA.
An interesting result was obtained with okadaic acid. Both the
group 1 (pregnant, cervagem) and group 3 (nonpregnant) tissues
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responded the same in terms of PGE2, showing the same baseline
output and the same level upon exposure to OA, a significant
increase. However, this contrasts with the effect on IL-8 where there
was no change in the group 1 tissue but the suggestion of a reduction
in output by the group 3 cervix. This indicates a probable difference in
the mechanisms that control these two components.
LPS and TNF were shown to stimulate PGE2 production,
reinforcing the link with inflammation and its common mediators.
The last set of data from nonpregnant tissue was slightly
unusual. The level of PGE2 detected following PMA treatment was
much higher than in previous experiments with nonpregnant group
tissue but the IL-8 levels appeared to be similar to those observed
earlier. This effect seemed to be confined to PMA conditioned tissue as
the effect of TNF at 500 units/ml was comparable with TNF at 100
units/ml used in the other experiment with this tissue. The reason for
this effect on PMA is unknown, one possibility is the incorrect dilution
of the stock of PMA but this would presumably have affected the
results for IL-8 also. Since IL-8 and PGE2 seemed to respond in
parallel to PMA in the other experiments it also seems unlikely that
the tissue was in some way sensitised to the effects of PMA.
The calcium ionophore, A23187, seemed to inhibit the PMA
stimulation of IL-8 synthesis but once again there was a difference
between the IL-8 and PGE2 response. A23187 did not affect the level
of PGE2.
A point worth noting is that the same TNF which failed to
stimulate prostaglandin production by guinea pig cells in culture was
active in these experiments, both for PGE>2 and for IL-8. This may be
related to the fact that the cytokine was recombinant human TNF,
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although it has been shown to stimulate rat cells (Pfeilschifter et al.,
1989).
The correlation between prostaglandin synthesis on consecutive
days supports similar results with IL-8 and the conclusion that tissue
viability was maintained throughout the culture period.
General Discussion
As discussed in chapter 5, PMA activates protein kinase C and
OA is a phosphatase inhibitor that does not inhibit protein kinase C,
thus it is reasonable that they do not share the same spectrum of
activity. The results suggest that activation of protein kinase C causes
IL-8 production and the inhibition of protein dephosphoiylation does
not, and may in some circumstances be inhibitoiy.
The stimulation of IL-8 production by LPS and TNF agrees with
the findings of others (Matsushima et al., 1992; Strieter et al., 1989).
The calcium ionophore, A23187, is presumed to cause an
increase in intracellular calcium levels (Pressman, 1976; Reed and
Lardy, 1972; Pfeiffer et al., 1974). In many cellular events raised
intracellular calcium is associated with a stimulatory action. In the
nonpregnant cervix there appeared to be an attenuation of the
stimulation seen with PMA when A23187 was included in the culture
medium. This combination was examined because early experiments
with guinea pig material suggested it may have an inhibitory effect on
prostaglandin synthesis, and because of similar findings by others
(R Leask, Pers Comm.). There is disparity between the effect of
A23187 on IL-8 and PGE2 production in this human material which
tends to support the notion that the observed effect is real and that
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calcium inhibits the synthesis, or possible the release mechanism, of
IL-8.
The maintained output of IL-8, as measured by the correlation
coefficients, suggests that the tissue remained functional at least for
the period of the experiment.
Although there is little doubt that the human cervix is able to
produce interleukin-8 and to alter significantly that synthesis, the
physiological mechanisms which control it are unknown. It is known,
however, that in most cells examined there is a stimulatory effect of
IL-1 and that this induces detectable increases in IL-8 mRNA within
an hour of the initial challenge (Mukaida et al., 1994b). TNF has been
shown to produce a significant increase in IL-8 mRNA expression as
little as 30 minutes after initial contact (Kunkel et al., 1990). The
increase in IL-8 mRNA has been shown to be independent of de novo
protein synthesis (Mukaida et al., 1991; Mukaida et al., 1994b), and,
in relation to IL-1 and TNF induced stimulation, at least partly
dependent on the activation of transcription (Oliveira et al., 1992; Sica
et al., 1990; Mukaida et al., 1990; Kasahara et al., 1991). IL-1 has
also been shown to increase the stability of IL-8 mRNA (Kasahara et
al., 1991). The NF-IL6, NF-kB and AP-1 bindings sites in the IL-8 gene
are thought to be crucial in its activation (Mukaida et al., 1990;
Mukaida et al., 1994a; Okamoto et al., 1994; Yasumoto et al., 1992;
Mukaida et al., 1994b).
Once the IL-8 is synthesised, as a 99 amino acid protein
(Schmid and Weissmann, 1987; Matsushima et al., 1988), it is cleaved
by proteases to give variants of 69-77 amino acids in length
(Yoshimura et al., 1989; Lindley et al., 1988; Van Damme et al., 1989;
Baggiolini et al., 1994). There appears to be an increase in the
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biological activity of IL-8 as the N-terminal is shortened (Walz and
Baggiolini, 1990; Van Damme et al., 1990; Clark-Lewis et al., 1991).
The influence of LPS and TNF, and similar results from other workers
studying inflammatory mediators (IL-1, TNF, IL-3, IL-7, GM-CSF)
(Matsushima et al., 1988; Larsen et al., 1989b; Strieter et al., 1989;
Standiford et al., 1992; Takahashi et al., 1993), indicate that
inflammatory processes may be crucial elements in the control of IL-8
production and therefore likely to be involved in IL-8 regulation in the
ripening cervix.
These results may have significant clinical relevance. The failure
of the cervix to ripen normally or the need to promote such changes in
it before term have long been a problem for obstetricians. Similarly,
the question of premature ripening has dogged obstetrical practice,
neither situation being well understood or satisfactorily treated. It has
been considered that infection may be an important cause of preterm
cervical ripening and parturition (McGregor, 1988; Platz-Christensen
et al., 1992) and prostaglandins, leukotrienes and interleukin-8 have
been found in the amniotic fluid and cervical mucus in association
with microbial colonisation (Cherouny et al., 1992; Romero et al.,
1991; Platz-Christensen et al., 1992; Romero et al., 1987a). Thus the
possibility that IL-8, and prostaglandins, could be involved in preterm
delivery through the induction of an inflammatory reaction by
microorganisms in the reproductive tract is attractive and supported
by the response to the bacterium derived stimulant used in the
experiments for this thesis, LPS.
Dealing clinically with an unripe cervix often relied on
mechanical methods until more recently when prostaglandin and
antiprogestin therapies became available. Treatment of the
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incompetent cervix basically depends on the suturing of the organ in
such a way as to close or narrow the opening in order to prolong the
pregnancy and allow the fetus to mature for as long as possible. Thus,
fuller knowledge of how and why the cervix softens and dilates would
be a very useful addition to the obstetrician's repertoire.
Interleukin-8 may be an important part of the process of
cervical ripening as it has the ability to attract cells (Yoshimura et al.,
1987b; Peveri et al., 1988; Schroder et al., 1987; Larsen et al., 1989a)
with the capacity to degrade the connective tissue matrix (Osmers et
al., 1992), a seemingly integral part of cervical ripening as
demonstrated many times by histological studies. Collagenase has
been thought to be important in the degradation of the connective
tissue of the cervix for some time, generally presumed to originate
from the fibroblasts, the main cell type in the cervix. However, recent
work has provided evidence that the ripening cervix may not rely on
fibroblast derived collagenase but instead on leukocytic collagenase
(Osmers et al., 1992). This fits in well with the theory that IL-8
production in the cervix attracts and activates neutrophils, resulting
in tissue breakdown. It is also supported by the observations of
leukocytic infiltration of the cervix at term (Junqueira et al., 1980;
Rath et al., 1988b; Luque and Montes, 1989; Liggins, 1981).
This new work showing that the cervix can produce IL-8 and the
proven effects of prostaglandins on cervical ripening, together with the
ability of cytokines such as IL-1 and TNF to influence collagenase and
prostaglandin production simply serves to reinforce the proposals
published by Liggins (Liggins, 1981) that ripening of the cervix is
based on an inflammatory type of response.
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Further work in this area could pursue the effects of RU486.
The attempts thereat for this thesis were unsuccessful because of
problems associated with obtaining the biopsies. The patients in
question were first trimester surgical termination cases who had
agreed to participate, however, the Tru-Cut needle biopsy equipment
proved to be unsuitable as the biopsies produced were inadequate for
culturing. It seems likely that the cervical softening that resulted from
RU486 treatment allowed the tissue to slide around the needle rather
than enter it. Such work may then require the excision of a larger
piece of cervix by more direct methods, similar to the technique of
Uldbjerg (Uldbjerg et al., 1983b) who used a needle biopsy in early
pregnant women but scissors and forceps in term and post delivery
sampling. The fact that the cervix softened indicated an effect of
RU486. The increased sensitivity of the uterus to prostaglandins
following RU486 treatment leads to the consideration that the
reported cooperation between PGE2 and IL-8 (Colditz, 1990) may be
further enhanced by the antiprogestin through the same or a similar
mechanism to that which promotes prostaglandin responsiveness in
the uterus, and thus partially explain its cervical ripening effects.
Other studies could examine the effects of the sex steroids. The
work on postmenopausal material was very limited and should be
continued and extended. Comparisons could be made between women
taking hormone replacement therapy (HRT) and those not taking it. If
the results of the preliminary experiments described in this thesis are
confirmed it would of interest to know whether the cervix could be
conditioned once again to produce large quantities of IL-8. It would
also be prudent to examine the effects of other substances known to
stimulate IL-8 and PGE2 production by premenopausal cervix.
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Molecular biological techniques could be employed to examine
the tissue for evidence of activity at the IL-8 gene level, as already
shown in other tissues (Mukaida and Matsushima, 1992). This would
provide evidence of de novo synthesis, or not, of the cytokine.
The clinical use of IL-8 could be studied. The most probable
routes of administration will be intracervical or intravaginal and either
as a gel or pessary formulation although direct injection of the
cytokine into the cervical tissue may be possible. The German
company Schering are known to be involved in studies of IL-8 in the
guinea pig. They have administered it to these animals and observed
cervical ripening. If IL-8 does prove to be a useful adjunct to obstetric
care in terms of cervical ripening, its use may supersede
prostaglandins for this purpose since it is less likely to affect the
myometrium, the initiation of uterine contractions induced once the
cervix was in a favourable condition.
Conclusion
The human cervix from nonpregnant and early pregnant
women is capable of producing interleukin-8 and prostaglandin E2.
There is some evidence that these two biological mediators are
regulated by separate mechanisms. This was most obvious in terms of
their response to the phosphatase inhibitor, okadaic acid, where PGE2
showed an increase in output when challenged and IL-8 did not show
any significant effect. The differential was also seen with PMA and
PMA + A23187, where less IL-8 was detected in the presence of
A23187 but the ionophore did not block the effect of PMA on PGE2.
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Comparison with the guinea pig study shows that the human
cervix increased its output of PGE2 when exposed to A23187 (in the
presence of PMA) or to TNF, while the guinea pig reduced its
production of the prostaglandin in response to the ionophore and did
not show any response to TNF. The TNF effect may be attributable to
the fact that the cytokine was a recombinant human peptide.
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Immunohistological Studies Using IL-8 Antiserum
Human Cervix
Human cervical tissue was also examined immunohistologically
for evidence of interleukin-8, in an attempt to further examine its
production, investigate the binding sites within the cervix for IL-8 and
possibly show the cellular origins of IL-8 within the cervix.
In the presence of bound rabbit antibodies the tissue should
take on a brown stain when the emyme substrate (DAB) is applied
(see methods, page 4.30). The nuclei were counterstained with
hematoxylin (blue/purple).
Figure 9.1 shows brown staining of the cervical connective
tissue matrix in the sections exposed to the IL-8 antiserum (upper
panel) and the lack of any positive staining in the control Ig incubated
sections (lower panel). Examination of the two photographs shows
that they are of the same area of cervix and from consecutive, or very
nearly consecutive, sections. These particular results were obtained
with sections from nonpregnant women (group 3). However, similar
observations were made in material from women in the first trimester
of pregnancy. Figures 9.2 and 9.3 show sections of cervix from
pregnant women, stained for IL-8 (upper panel), and the same area of
the cervix in consecutive (or very close) sections but under control Ig
conditions (lower panel). The photographs in Figure 9.2 are of tissue
from women given cervagem (group 1), and those in figure 9.3 of
tissue from women not given cervagem (group 2).
The general impression from these sections of all three tissue
groups is of a nonspecific staining of the connective tissue matrix with
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a distinct lack of strongly stained individual cells. The tissue sections
in figures 9.1 and 9.3 contain large luminal structures, probably part
ofmucus glands or arterioles. However there is no evidence of blood in
the lumen and in sections where red blood corpuscles (RBC) have
been identified the vessel wall was much thinner. These "glandular"
structures do not appear to stain positively for IL-8, nor does the
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Figure 9.1 The same region of nonpregnant cervical tissue (group 3)






Figure 9.2 The same region of cervical tissue exposed to the IL-8
antiserum (upper panel) and control Ig (lower panel). This tissue was





Figure 9.3 The same region of cervical tissue exposed to the IL-8
antiserum (upper panel) and control Ig (lower panel). This tissue was
from a pregnant woman not given cervagem (group 2).
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Red blood corpuscles have been claimed to bind IL-8 (Darbonne
et al., 1991). Several sections were found to contain blood vessels with
RBC in the lumen, easily identifiable by their concave surfaces.
However, there was no evidence of IL-8 staining of these corpuscles
despite positive staining of the tissue matrix. Figure 9.4 shows
positively stained matrix in nonpregnant tissue but no brown colour
associated with the RBC (upper panel). As a control for this positively
stained section the lower panel shows another area of nonpregnant
cervix containing RBC, but incubated with control Ig and exhibiting a
lack of staining of the connective tissue matrix. Figure 9.5 is of a
group 1 cervix displaying the same characteristic staining as the
nonpregnant tissue (upper panel shows staining in presence of IL-8
antiserum, lower panel with control Ig).
The photographs in figure 9.6 are of cervix from a nonpregnant
patient incubated with IL-8 antiserum (upper panel) and control Ig
(lower panel). They have been presented here to illustrate the
differences in cell density observed, but do not show consecutive
sections of the same area of the tissue. Some areas were virtually














Figure 9.4 Red blood corpuscles (arrows) within nonpregnant
cervical tissue (group 3) exposed to the IL-8 antiserum (upper panel)





Figure 9.5 Red blood corpuscles (arrows) within cervical tissue
exposed to the IL-8 antiserum (upper panel) and control Ig (lower





Figure 9.6 Nonpregnant cervical tissue (group 3) exposed to the IL-8




The cervix of a pregnant marmoset monkey became available,
courtesy of Dr S F Lunn. The animal was 15 weeks pregnant (term is
21 weeks in this species) and had previously been used in a study of a
vaccine against the oocyte antigen ZP3 approximately one year earlier.
This monkey was sacrificed for immunohistological studies on the
ovarian tissue.
The cervical tissue was fixed and embedded in wax and
sectioned in the same way as the human material and similarly
probed for immunoreactive interleukin-8.
Overall, the results were the same as those observed with the
human tissue. The connective tissue stained positively when treated
with IL-8 antiserum and displayed no staining with the control Ig. The
glandular areas generally did not exhibit binding of the interleukin-8
antiserum (figure 9.7, upper panel shows staining in presence of IL-8
antiserum, lower panel with control Ig). However, where staining did
occur it sometimes appeared to be more localised than it did in the
human cervix (figure 9.8, upper panel with IL-8 antiserum, lower
panel with control Ig). These photographs also show a generally higher
cell density in the monkey tissue than observed in the human cervix.
Figure 9.9 shows the sections where positive staining occurred
and where RBC were present. It revealed a distinct lack of reactivity
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Figure 9.7 The same region of marmoset cervical tissue exposed to





Figure 9.8 The same region of marmoset cervical tissue exposed to
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Figure 9.9 Red blood corpuscles (arrows) within marmoset cervical




The most interesting observation in the marmoset tissue was
the presence of strongly positive individual cells in what seemed to be
a deep, penetrating glandular structure. Figures 9.10 and 9.11 show a
low and high power magnification of these cells following incubation
with the IL-8 antiserum (upper panels). The control Ig incubations,
(the lower panels of the same figures) show that in the absence of the
IL-8 antibodies these same cells did not stain positively. The intense
colour appeared to be specific for those cells and localised within well
defined boundaries, taking on the semblance of cell membranes.
There were very few of these positively stained cells and none were
observed in the human cervical tissue. As can been seen, the majority
of apparently similar cells in the same structure in the marmoset






Figure 9.10 Low power magnification of the same region ofmarmoset
cervical tissue exposed to the IL-8 antiserum (upper panel) and





Figure 9.11 High power magnification of the same region of
marmoset cervical tissue exposed to the IL-8 antiserum (upper panel)
and control Ig (lower panel).
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Nonspecific Binding of IL-8 to Connective Tissue
The immunohistological examination of the cervix, described
previously, appeared to show binding of the interleukin-8 antiserum
in an apparently nonspecific manner to the connective matrix. A
simple experiment was carried out to investigate the possibility that
the collagen in the connective tissue was coated with IL-8.
Insoluble collagen was incubated with some of the radiolabelled
interleukin-8 used in the radioimmunoassay for the cytokine and the
radioactivity that became associated with the collagen was
determined.
The collagen (lOmg) was incubated in a volume of 3ml of
radiolabelled IL-8, diluted from stock with PBGS, for 1 hr at 37°C with
gentle agitation. The collagen IL-8 mixture was then centrifuged twice
at 10,000g (Biofuge) for two minutes each time. An aliquot of 500fil of
the supernatant contained 34,683 cpm of radioactivity while the same
volume of incubation fluid not in contact with collagen contained
43,611 cpm. The pellet produced by centrifugation was associated
with approximately 40,000 cpm of radioactivity, a number which fell
slightly upon washing the pellet in PBGS, possibly through the
contamination of the supernatant with fibres of the insoluble collagen
dislodged when the fluid phase was removed.
A further experiment was performed overnight under the same
conditions. The results were essentially the same with a slight
increase in the radioactivity associated with the collagen
(approximately 50,000 cpm). Again, washing of the pellet caused the
release of some activity and filtration of the wash supernatant,
through a 0.2|im filter, confirmed that some of it was due to the
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presence of fibres of collagen. Following a third wash in PBGS the
supernatant contained only 6% of the activity measured in the
collagen pellet at this stage compared with 39% after the first PBGS
wash.
Discussion of Immunohistological Results
The immunohistological examination of the cervix showed
staining of the connective tissue that was related to the application of
antibodies directed against interleukin-8. The results suggested that
the connective tissue matrix was either coated with IL-8 or the rabbit
immunoglobulins were reacting with it in a nonspecific manner.
However, the control sections which were incubated with normal
rabbit serum did not show a positive stain, implying that rabbit
proteins were not binding nonspecifically to the tissue.
All three groups of human tissue exhibited basically the same
pattern of positive staining. The tissue culture study showed that the
cervix, in vitro at least, produces IL-8 without provocation, although
this may have been the result of the trauma of dissection. Thus, its
presence in the cervical tissue would be expected and was apparently
detected. However, there was a distinct lack of any focal production,
except for a few cells in the marmoset tissue which lay outwith the
connective tissue matrix. The general lack of positive staining of the
glandular-like areas, especially in the human cervix, and the epithelial
cells suggests that there was some degree of differential binding of the
antiserum and the reaction was not entirely nonspecific.
The possibility that the connective tissue may bind IL-8 was
investigated by looking for an interaction between collagen and a
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radiolabeled form of the cytokine. This work suggested that the
collagen and IL-8 may in fact bind together.
Of particular interest in this area is the recent proposal that a
concentration gradient in a moving fluid phase would be impossible to
sustain and that a chemoattractant would be more likely to be
effective if immobilised (Rot, 1992; Tanaka et al., 1993).
The migration of leucocytes from the blood to the interstitium
seems to be a multi-stage process whereby the cells become attached
to the endothelium via molecules called selectins. The attachment of
the cells at this stage is relatively weak and they are capable of
'rolling' along the blood vessel wall. A signalling event causes a change
in the integrins found on the leucocytes, their adherence becomes
stronger and they are no longer able to drift along the endothelium.
This is followed by the change in shape and passage of these cells
between those of the endothelial layer (Rot, 1992; MacKay and Imhof,
1993). IL-8 has been identified as a chemoattractant that can produce
the change from 'rolling' attachment of neutrophils to the strong
attachment via the integrins (Rot, 1992).
The manner in which IL-8 is immobilised has been suggested to
involve proteoglycans protruding into the blood stream from the
endothelial cells (Tanaka et al., 1993). These authors propose that
IL-8 bound to the proteoglycans would effectively 'attract' the 'rolling'
leucocytes and thus stimulate migration across the endothelial wall.
Proteoglycan molecules attached to the lumenal surfaces of blood
vessels are normally present and act in the prevention of
inappropriate clotting of the blood and may be involved in lipid
metabolism (Tanaka et al., 1993).
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Thus, the apparent binding of IL-8 to the connective tissue in
the cervical sections examined in this thesis may lend support to the
theory that this molecule binds to proteoglycans. Such an action
would presumably also permit the IL-8 to retain its activating
properties, with regard to degranulation, as well as its
chemoattractant properties.
Despite the indication that collagen and IL-8 can become
associated with each other it is also possible that the IL-8 antiserum
may contain antibodies which cross react with connective tissue. A
more extensive immunohistological study of the cervix would be
required to clarify the situation. The use of antiserum from several
sources and the preincubation of the antisera with IL-8 prior to
application to the tissue as alternative controls could be examined.
The few positively stained cells in the marmoset tissue appeared
to be a real effect, as indicated by the intensity of the stain within
apparent cytoplasmic boundaries (cell membranes) and the lack of
any staining in the absence of the antiserum. This tissue was taken
from a pregnant animal in the last third of her pregnancy.
Examination of the human tissue did not provide evidence of similar
focal production but the human material was all from first trimester
or nonpregnant women. It is possible that the appearance of this
staining is indicative of changes in cervical biology associated with
increasing gestation. The collagenase found in cervical tissue at the
end of pregnancy has been shown to be of polymorphonuclear origin.
The activation of cells producing IL-8 in later gestation would provide
a mechanism whereby neutrophils would be attracted into the cervix.
The reason that few cells were observed in the marmoset tissue may
be that this sample was taken in the early stages of stimulated IL-8
9.20
Chapter 9 Immunohistochemistry
production, and that tissue collected at a later stage of the pregnancy
would provide evidence of significantly more focal production of the
chemokine.
It has been claimed that red blood corpuscles bind IL-8 and
may remove it from the circulation in order to maintain the
concentration gradient around its source and to limit the stimulation
of neutrophils (Darbonne et al., 1991). This removal of IL-8 from the
circulation may be of importance since it has been shown that when
neutrophils have undergone shape change and shedding of selectin
molecules before adhering to a vessel wall then they are subsequently
unable to attach to the lumenal surface (Rot, 1992). This appears to
be a fail-safe mechanism preventing generalised neutrophil activation
and migration into the interstitium. However, none of the RBC
observed in either the human or marmoset material reacted with the
IL-8 antiserum despite its reactivity with the connective tissue. Since,
as already mentioned, the cervix produces IL-8 at a basal level it
would then be expected that any captive RBC in the tissue explant
would bind the cytokine produced therein, unless of course it was
internalised by them. The size of RBCs (2|im 'thick' and 7gm in
diameter) would allow whole corpuscles to be present in the sectioned
material since each section was 4|im thick.
The similarities between the three groups of human material
coincides with their similar production of IL-8 observed in the tissue
culture experiments. This evidence of IL-8 in the connective tissue, as
shown in the preceding figures, and the production of IL-8 by the
tissue in culture may raise questions concerning the source of the
IL-8 measured in the culture medium. The possibility does exist that
the treatments used in the experimental system caused the release of
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IL-8 from the connective tissue. The apparent constitutive production
by the cervix in culture may indicate dissociation of IL-8 from the
connective tissue or that tissue necrosis is taking place and thereby
releasing IL-8 into the medium. However, the consistent production
over three days (see Chapter 7) indicates that the tissue remains
viable and that significant necrosis is not occurring. This consistency
of production also suggests that the IL-8 measured is produced by the
tissue on stimulation rather than the release of 'stored' material.
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Main Findings and Suggestions for FurtherWork
The following pages summarise the main findings of the work
presented and contain suggestions for other studies in this area.
The antiprogestin RU486, given in vivo, did not appear to affect
the production of PGE2 or PGF2a by pregnant guinea pig cervical cells
in culture, nor did it influence the stimulatory properties of LPS, PMA
or okadaic acid. The effect of LPS, PMA and okadaic acid supports the
proposals that cervical ripening could be an inflammatory based
process, showing that cervical production of prostaglandins can be
modulated. The effect of LPS also provides further indications that
microbial infections may induce preterm labour/cervical ripening by
stimulating an inflammatory response. The most obvious effect
associated with RU486 treatment of the guinea pigs was that seen
with the calcium ionophore A23187. Most studies using A23187
report a stimulatory action of the ionophore, however, in experiments
carried out for this thesis there was a distinct inhibitory response. The
inhibitory effects of this material were attenuated in cultures derived
from animals that were given the antiprogestin prior to sacrifice. This
implies that RU486 may regulate calcium concentrations in its
ripening action.
Additional RU486, introduced into the culture medium, again
did not affect the actions of LPS, PMA, and okadaic acid, and only
produced a slight increase in prostaglandin production by cells from
RU486 pretreated animals.
The inclusion of progesterone in the culture medium seemed to
have a slight inhibitory effect on basal prostaglandin synthesis, an
effect that was blocked where the guinea pigs were given RU486.
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Progesterone generally had no effect on the other treatments applied
in vitro and in the instances where it did the responses were
inconsistent and showed no particular pattern. Prostaglandins and
inflammation are regarded as important regulators of the condition of
the cervix. Progesterone and RU486 are considered to be important
factors in cervical ripening, despite the apparent lack of any major
effect on prostaglandins in these experiments. However, it is possible
that progesterone could restrain cervical ripening through indirect
mechanisms, such as maintenance of the quiescence of the uterus.
In the guinea pig experiments the cytokines IL-1 and TNF did
not affect the production of prostaglandins.
The human study showed that cervical tissue from women can
produce the cytokine interleukin-8 and that its synthesis can be
upregulated by LPS, PMA and TNF. The tissue from postmenopausal
women did not respond to PMA in the same way as the other tissues.
The absence of an increase in IL-8 output from these samples
suggesting some form of hormonal control may be operative. The
production of this cytokine by the cervix may be significant with
regard to its ability to direct its own remodelling during pregnancy,
especially at term where rapid changes are crucial.
The pattern of PGE2 production by human cervix was similar to
that of IL-8, except when challenged by okadaic acid and by A23187.
This suggests different control mechanisms for the two mediators.
Again, there appeared to be some element of hormonal control evident
by the lack of an effect of PMA on the postmenopausal tissue. The
human tissue also responded to TNF by increasing its output of PGE2.
The immunohistological work provided evidence of the presence
of IL-8 associated with the connective tissue of the human cervix.
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However, there was little indication for a cellular source of the
cytokine.
With regard to further work, it would be of great interest to
determine whether or not the results obtained when working with
cervical material from postmenopausal women are repeatable. If this
proved to be the case then the effects of hormone replacement therapy
in such women should be studied.
It would also be useful to examine tissue from women at the
end of their pregnancy and to probe for differences in the responses of
tissue from the different groups of women, for example the term
pregnant versus the early pregnant or the non pregnant.
Another study looking at the effect of RU486 on the production
of IL-8 would be of interest. However, the sampling procedure would
have to be modified.
The immunohistochemical study could be repeated,
incorporating further controls to refine the results already presented,
and to identify the source of the IL-8.
The use of IL-8 to produce cervical ripening has the potential to
offer a major step forward in the induction of cervical maturation and
clinical studies on its effects are required. Should it prove to be a
significant factor in cervical ripening and in preterm cervical ripening,
then the development of compounds able to block its effects may allow






Tissue/Cell Culture and Assay Reagents/Buffers
BSA/tween Buffer
BSA-tween buffer was used in the interleukin-8 assay and was
designed to block the adherence of IL-8 to the assay tubes and
improve assay reliability. It contained the following (per litre),
12.1g Tris(hydroxymethyl)methylamine
5.0g BSA (Bovine Serum Albumin)
l.Og SodiumAzide
0.02% Tween 80
Tris, BSA and sodium azide were dissolved in 900ml purified
water. Tween 80 is a very thick detergent and difficult to dispense in
small volumes, therefore it was dissolved in warm water to give a 1%
solution and 20ml of this (2ml 1% tween 80 per 100ml buffer) added
to the main buffer volume. The pH was adjusted to 7.6 and the
volume topped up to 1 litre with water. Sodium azide is included as
an antimicrobial agent.
Complete Culture Medium
The medium used for culturing cells and tissue is described as
Complete Culture Medium and contained the following,
500ml RPMI1640





t 5000 international units penicillin/ml, 5000|ig streptomycin/ml
ft 30mg glutamine/ml
§ 50mg gentamicin/ml
RPMI1640 is widely accepted as a medium capable of
supporting growth of most mammalian cells and has been used
successfully in this laboratory for some time with a variety of human
and guinea pig culture systems.
Glutamine is an essential component of medium for the
maintenance of tissue in culture. It is unstable above -10°C and was
therefore stored at -20°C and added to the stock RPMI1640 (stored at
4°C) when complete medium was required.
Penicillin-streptomycin and gentamicin were included in the
medium in order to reduce the risk of bacterial and mycoplasma




The collagenase-DNAse solution used for the main digestion
process of the guinea pig cervix dispersal was identified as digestion
medium and was composed of the following,






Once the lyophilised enzymes had dissolved in warmed
RPMI1640 it was sterilised by filtration through 0.22|im filters.
Collagenase initiated the digestion of the collagen matrix and
because the collagenase preparation was impure and also contained
other proteases, further, less specific, proteolytic degradation of the
connective tissue took place. DNAse was present to breakdown any
DNA that was inevitably released into the solution by dead or over
digested cells and thereby prevent it from causing clumping of the
dispersed cells.
Methyloximating Solution (MOX)
The antisera used in this work were raised against
methyloximated prostaglandins and therefore the samples of culture





These materials were combined and once the solids had
dissolved the pH was adjusted to 5.8.
The methyloximation process (moxing) was carried out by
adding half the sample volume ofMOX (i.e. 2 parts culture medium +
1 part MOX) to the harvested medium. The two were mixed and left at
room temperature overnight for the methyloximation to occur. This
converts more than 95% of the PGs present to their methlyoxime
derivatives (Kelly et al., 1986a). The addition of a methyloxime group




Phosphate Buffered Gelatine Saline (PBGS)
Phosphate buffered gelatine saline (PBGS) was a general
purpose buffer used in several preparations. It was produced in
batches of 4 litres as follows,
36.0g Sodium Chloride
34.4g di-Sodium Hydrogen Orthophosphate Anhydrous
24.3g Sodium di-Hydrogen Orthophosphate
4.0g Sodium Azide
4.0g Gelatine
The above compounds, except for the gelatine, were dissolved in
approximately 3.75 litres of purified water. Gelatine is relatively
insoluble in cold water and was dissolved in about 100-150ml warm
water (less than 100°C). The gelatine was then added to the main
volume of buffer and the pH adjusted to 7.8 with sodium hydroxide.
Finally, the total volume was made up to 4 litres and the buffer stored
at 4°C.
PurifiedWater
The water used in this work was purified using a RoStill™
apparatus which removed salts from the water supply by reverse
osmosis.
Radiolabelling Using Chloramine T Oxidation
Chloramine T was used to oxidise sodium iodide to produce free
iodine. The iodine (125I) reacted with the tyrosine group of the
Pro-Gly-Tyr peptide conjugated to the prostaglandins. To remove any
free iodine, once the reaction had taken place between it and the
peptide, sodium bisulphite was added to the mixture. This also
removed any chloramine T present.
Standards Buffer (IL-8 assay)
The standards for the IL-8 assay were reconstituted and diluted
with buffer composed of 50% BSA/tween buffer and 50% PBGS. This









t 5000 international units penicillin/ml, 5000|ig streptomycin/ml
The antibiotics were present to reduce the chances ofmicrobial
contamination.
Treatment Media
The media used to treat the cells in culture were prepared by
aliquotting complete medium into 10ml lots and the appropriate
volume of stock solution added to the vial using an accurate delivery,
positive displacement pipette. The volumes added varied between 2
and 5|il per 10ml and the solvents used were PBS, ethanol or
dimethylformamide. For the cells seeded in progesterone containing
medium the treatment media were prepared using complete medium
with 10~6M progesterone. Progesterone stock was a lOmg/ml solution
in ethanol, ofwhich 3.15|il was added to 100ml medium.
Trypan Blue Exclusion
Cell viability assessment was performed by combining equal
volumes of cell suspension and 0.4% trypan blue solution. The two
were mixed and left for 2 minutes then the cells were examined using
a haemocytometer and the proportions of viable and non viable cells
determined.
Trypsin Pre-Digestion Solution
The trypsin pre-digestion solution used in the first stage of the




The above solution was sterilised by filtration through 0.22|im
filters.
The dispersal system used was derived from that of Rajabi et al
(Rajabi et al., 1991) however, they do not indicate their reason for
including trypsin. It may be the case that this enzyme was used to
cleave any of the pro form of collagenase contained in the cervix
(Cawston and Tyler, 1979) and possibly in an attempt to "loosen" the
connective tissue matrix and allow easier dispersal of the individual
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cells by degrading any other proteins that may be present in the
cervix or between cells.
EDTA was present in order to sequester any calcium and
magnesium and the PBS used did not contain either metal. Trypsin is
more active in the absence of calcium and magnesium.
Trypsinisation Solution
Tiypsinisation of cells already growing in culture dishes was
carried out using XI0 trypsin diluted by a factor of ten with PBS.
The medium supporting cell growth was removed and the cells
washed at least once with PBS to flush away any fetal bovine serum
and thus remove any enzyme inhibitors present. The trypsin was then
added to the culture flask, sufficient to coat the surface of the vessel,
and any excess decanted. The cells were then replaced in the
incubator for 2-3 minutes to promote the action of the trypsin,
followed by gentle agitation of the flask to dislodge the cells. Complete
medium was added to the trypsinised cells to inhibit the enzyme and
the mixture gently drawn up and down a pipette several times to
disperse the cells.
For the assessment of cell numbers in cluster plate wells
stronger trypsin solutions were used but in these cases there was no
further use for the cells and therefore a more severe digestive
treatment was not as unacceptable.
Wash Buffer
Prostaglandin assays incorporated a wash stage where the
second antibody precipitate was resuspended in buffer to reduce the
NSB values. This buffer was prepared as follows,
100ml PBGS





Tissue fixation for immunohistochemical analysis was
performed with 4% formaldehyde. The stock of 40% was diluted 1 in
10 with phosphate buffer, pH 7.6.
The tissues involved in this work were all small and 24 hours
was adequate time for the fixation process.
Tris Buffered Saline (TBS)
The main buffer used in the immunohistological staining was
tris buffered saline (TBS) which contained the following,
6.05g Tris(hydroxymethyl)methylamine
9.00g Sodium chloride
The tris and sodium chloride were dissolved in almost a litre of
water, the pH adjusted to 7.6 and then the volume made up to one
litre. Two litres was generally enough for the whole staining process.
Endogenous Peroxidase Blocking Solution
Mammalian tissues contain endogenous peroxidase activity
and therefore this must be blocked before the substrate is applied to
sections. This was done by treating the tissue with a solution of 3%
hydrogen peroxide in methanol, made up as follows,
30ml 30% Hydrogen peroxide
270ml Methanol
Normal Swine Serum (NSS)
Normal swine serum (DAKO) was used to block any sites on the
tissue that would non specifically bind the second antiserum, which
was raised in swine, and therefore reduce the chances of false positive
results. The normal swine serum was diluted with TBS, 1 part normal
swine serum plus 4 parts TBS, to produce the reagent referred to as
NSS
Primary Antiserum
The primary antiserum used in this study was directed against
synthetically produced IL-8 (human amino acid sequence) and was
raised by Dr R.W. Kelly in rabbits. It was diluted 1 in 25 with NSS.
Normal Rabbit Serum
Normal rabbit serum was used as a control for the rabbit
primary antiserum and was diluted with NSS to the same
concentration as the primary antiserum (1 in 25).
A.6
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Swine Anti-Rabbit Second Antiserum
The second antiserum (DAKO) was raised in swine against
rabbit immunoglobulins. It was diluted with NSS to 1 part in 40. Its
function was to act as a bridge between the primary antiserum and
the PAP complex.
Peroxidase Anti-Peroxidase Complex
The peroxidase anti-peroxidase (PAP) complex (DAKO) was a
rabbit antiserum complexed with horseradish peroxidase and diluted
to 1 part in 100 with NSS. The PAP complex bound to the swine anti
rabbit second antiserum and acted as an amplification step in the
staining procedure by virtue of the fact that each antibody was linked
to more than one peroxidase molecule.
DAB Peroxidase Substrate
The peroxidase substrate was diaminobenzidine (DAB). It was
dissolved in tris/hydrogen peroxide buffer as follows. The tris was
made up similarly to the TBS but without sodium chloride. DAB
(5mg) was dissolved in 10ml of the 0.05M tris buffer (pH 7.6) plus
3.3|il 30% hydrogen peroxide.
1% Acid Alcohol
A 1% solution of hydrochloric acid in 70% methanol was
employed to differentiate the hematoxylin. This step removes the
hematoxylin from the tissue but preferentially from the cytoplasm first
leaving the nuclei stained.
Scott's Tap Water
Scott's tap water contained (per litre),
lg Potassium Hydrogen Carbonate
lOg Magnesium Sulphate
The above were dissolved in water and the purpose of this
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Material Published as a Consequence of Work in this Thesis
A. 12
leukin-8 production by the human cervix
G. Barclay, BSc," Janet E. Brennand, MB, ChB,a Rodney W. Kelly, PhD,b and
A. Calder, MD"
, Scotland
'ES: Our purpose was (1) to determine whether the human cervix is capable of producing
-8 in vitro and to examine the possibility of stimulating an increase in any such output and (2)
3 the concomitant production of prostaglandins.
-ESIGN: Cervical tissue was obtained from 48 women, 29 pregnant women undergoing surgical
l of pregnancy (20 of whom were treated with the prostaglandin analog Cervagem), 14
tnt, premenopausal women, and three postmenopausal women. Explants were cultured and
m was assayed for interleukin-8 and prostaglandin E2. Analysis of variance and Newman-Keuls
;ests were used.
: Significant quantities of interleukin-8 were produced by the tissue, and the data indicate that
:plants from pregnant and nonpregnant women behave in a similar way when challenged by
lyristate acetate but that the postmenopausal cervix loses its capacity for interleukin-8
l.
SIONS: Human cervix is capable of producing large amounts of interleukin-8 in vitro, and it may
ced by the steroid hormones. Thus interleukin-8 could be an excellent candidate for a prime
Jtrophil-mediated cervical ripening. (Am J Obstet Gynecol 1993;169:625-32.)
ds: Interleukin-8, cervical ripening, neutrophils
ll ripening is the process by which the cervix
from a rigid, closed structure designed to
; uterine contents to one that becomes soft and
date to accommodate the passage of the fetus.
;rvix consists mainly of connective tissue the
of which, about 70%, is type I collagen.1
muscle cells constitute about 10% of the cer-
:reas collagen-producing fibroblasts are the
lular component.3 Changes in the connective
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tissues occur throughout pregnancy,1 but this remodel¬
ing of the collagen does not greatly alter the rigidity of
the cervix. Only in the very last stages can its mechan¬
ical strength be permitted to change in such a dramatic
manner as to permit fetal expulsion.
It has been suggested that this process is similar to an
inflammatory reaction,4 and Junqueira et al.3 and Rath
et al.5 have shown that neutrophil invasion of the cervix
occurs in labor. Others have proposed that the break¬
down of the collagen matrix in the final stages of
pregnancy is caused by collagenase and elastase pro¬
duced not only by leukocytes, as would be found in an
inflammatory reaction, but also by the fibroblasts of the
cervix, which are known to produce collagenase.1 Col¬
lagenase produced by granulocytes, such as neutro¬
phils, selectively degrades type I collagen,6 whereas
collagenase produced by fibroblasts degrades type I
and type III collagen equally. Because type III collagen
625
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still represents a significant percentage of cervical col¬
lagen (30%),'' 7 this would tend to support the idea that
collagenolysis in the cervix is a multienzyme process.
The interleukins may play an important role in such
a process because they are chemotactic for neutrophils
and may represent the signal for the commencement of
cervical ripening.
Interleukin-8 (IL-8) was initially identified by several
laboratories and given a different name by each on the
basis of where it was isolated and the experiments that
were carried out. Some of the names assigned to it
include monocyte-derived neutrophil chemotactic fac¬
tor, neutrophil-activating factor, and neutrophil-activat-
ing or attracting protein or peptide. In addition, T
lymphocyte chemotactic factor was also found to have
the same amino acid sequence.8 Because it appears to
be a multipotent compound acting on several cell types,
agreement was reached that this compound should be
renamed "interleukin-8."9
IL-8 is a 72 amino acid peptide belonging to a
supergene family of peptides.8, 10 It attracts neutrophils
and causes them to release their specific granule con¬
tents, which include collagenase, and may also under
some circumstances stimulate the release of elastase
from the azurophil granules."
Several human cell types have been shown to produce
IL-8, including dermal fibroblasts and, more relevant to
this work, chorion and decidual cells.12 Both these cell
types were shown to produce IL-8 and, under the
influence of phorbol myristate acetate or lipopolysac-
charide, to be capable of augmenting their IL-8 output.
There is evidence that other cytokines may be involved
in the regulation of IL-8 synthesis. In particular, inter-
leukin-1 (IL-1) and tumor necrosis factor (TNF) were
shown by Matsushima et al.'3 and Larsen et al.14 to
cause rapid induction of IL-8 messenger ribonucleic
acid expression. IL-1 and TNF have also been found to
promote prostaglandin and collagenase production in
many cell types,15"19 and prostaglandins are inflamma¬
tory mediators known to be involved in cervical ripen¬
ing.20 Additionally, IL-8 and prostaglandin E2 (PGE2)
have been found to act synergistically, PGE2 reducing
the concentration of IL-8 required to cause neutrophil
invasion of rabbit skin.21
In this paper we report, for the first time, the ability
of human cervical explants to secrete large amounts of
IL-8 in vitro.
Material and methods
Tissue. Tissue was divided into four categories.
Group 1 (n = 14) was from women undergoing surgical
termination of pregnancy who were given a 1 mg
pessary of the prostaglandin E analog Cervagem (16,
16-dimethyl A2-prostaglandin E, methyl esterf 2 to 3
hours before the procedure. Group 2 (n — 9) was from
women undergoing surgical termination of
but not pretreated with Cervagem. Cervage
to ease the dilatation of the cervix in
women. Group 3 (n = 8) was from pren
nonpregnant patients with no disease of
undergoing hysterectomy. These women wi
ous stages of the menstrual cycle. There was
data to show stage-specific differences. Grou
was tissue from postmenopausal patients h
for curettage for investigation of postn
bleeding.
Biopsy specimens were obtained from gr
and 4 with a Tru-cut needle. The tissue
nonpregnant women (group 3) was obtained
Forty-nine samples were obtained, but one
was discarded because of discrepancies in
weights.
This study had the approval of the local e
mittee.
Tissue culture. The needle biopsy speci
proximately 10 to 15 mg in weight, 10 to
length, and 1 to 2 mm in diameter, were
saline solution at 4° C. The tissue was cut
sections and placed in 250 pi of culture
(RPMI1640, Northumbria Biologicals, Cra
U.K.) supplemented with penicillin (50 IU/ml
mycin (50 pg/ml, Gibco), gentamicin (20 pg/r
St. Louis), L-glutamine (0.3 mg/ml, Northun
logicals), and 10% fetal bovine serum (Noi
Biologicals) in a 48-well plate (Costar).
The needle biopsies gave four pieces of
culture, two ofwhich were used as controls. E;
3 cervix provided more pieces, thus allowir
treatments to be tested per biopsy. Every I
used with this group of cervices was applied t
four separate samples.
The treatments used were phorbol myristal
(Sigma) at 10~7 mol/L, okadaic acid (S
5 x 10~8 mol/L dissolved in dimethylforma
popolysaccharide (Sigma) at 4 pg/ml, anc
(Boehringer, Mannheim, Germany) at 100
The effect of progesterone was also examinee
mol/L; this concentration was chosen beca
higher than circulating levels and because tl
concentration of progesterone adjacent to th
ductive organs is unknown but assumed to
because it is produced locally.
All the tissue was incubated in 95% air and 5<
dioxide under humid conditions at 37° C.
Medium was changed at 24-hour intervals, I
medium containing the same additives as the
The harvested medium was split into two porti
frozen at — 20° C and later assayed for inter



































Fig. 1. Effect of phorbol myristate acetate (PMA) on IL-8 and PGE2 production by human cervix
(mean ± SE). Asterisk, Significantly different from control, p < 0.01; no significant differences
between IL-8 controls; dagger, significantly different from control, p < 0.02; no significant differences
between PGE2 controls; P Cgem, group 1; NP, group 3; PM, group 4.
i. For the IL-8 radioimmunoassay a polyclonal
n (ICN Flow) was used with recombinant IL-8
rative Biomedical) labeled with iodine 125
am) by means of chloramine T oxidation. A
: second antibody separation technique was
>es had 100 pi of 100 mmol/L Tris buffer with
bovine serum albumin and 0.2% Tween 80.
lent for the antiserum and the label was a
containing phosphate saline buffer,
andards were stored as freeze-dried aliquots
nstituted in standard buffer (50% phosphate-
saline solution, 50% bovine serum albu-
en buffer) just before assay (range 0.097 to 25
The sensitivity of the assay was 0.2 ng of IL-8 per
milliliter. Assayed medium contained <0.2 ng/ml. The
recovery of known amounts of IL-8 in incubation me¬
dium gave a correlation coefficient of 0.998 when com¬
pared with the expected values, and the sequential
dilution of cervix culture medium (up to eightfold
dilution) also gave a good correlation with the expected
values (coefficient 0.994). The radioimmunoassay was
compared with a commercially available enzyme-linked
immunosorbent assay kit for IL-8 (Quantikine), and the
results from the measurement of cervix-conditioned
medium were closely matched, having a correlation
coefficient of 0.968.
The intraassay coefficient for the IL-8 assay was 5.9%,
and the interassay coefficient was 12.4%.





























□ NP, No Prog
NP, Prog (1|iM)
(n=6)
Control PMA (0.1 p-M)
Fig. 2. Effect of progesterone on stimulation by phorbol myristate acetate (PMA) (mean ± SE).
Progesterone (Prog) had no measurable effect on phorbol myristate acetate-evoked stimulation of
IL-8. IL-8 output was stimulated significantly above control, p < 0.05. PGE2 output was only
significantly stimulated by phorbol myristate acetate in cultures where no progesterone was present
(dagger, p < 0.05); however, no statistical differences were observed between two control levels or two
phorbol myristate acetate—treated levels. NP, Group 3.
PGE2 was assayed as its methyloxime derivative as
previously described.22 The intraassay coefficient for the
PGE2 assay was 6.7%, and the interassay coefficient was
7.6%.
Each sample was assayed in duplicate, and in cases
where there was >10% variation between the results
the sample was reassayed.
Statistical analysis. Analysis of variance was used in
association with the Newman-Keuls test to assign sig¬
nificance.
Results
Interleukin-8 production. Cervix explants from
groups 1, 2, and 3 produced similar basal amounts of
IL-8. Although group 4 showed reduced production, it
was not significantly different (Fig. 1). This expression
could be increased by treatment with the protein kinase
C activator phorbol myristate acetate in grot
and 3 but not in group 4 (groups 1, 2, and 3
significantly different from each other but sigi
different from group 4, p < 0.05).
Progesterone was studied with group 3 samf
2), and statistically there was no difference
stimulation evoked by phorbol myristate acet;
progesterone was present.
Comparison of group 1 and group 3 outpu
under the influence of the phosphatase inhib
daic acid (Fig. 3) indicated no stimulation
curred, and, although the graph may suggest tl
was in fact a decrease in IL-8 levels in group 3,
not reach significance. No statistical different
measurable between these groups.
Fig. 4 shows the results from group 3 tissue
with okadaic acid, lipopolysaccharide, TNF,
•9, Number 3
et Gynecol
















M P Cgem (n=6)
□ NP (n=6)
Control OA (50nM)
Fig. 3. Effect of okadaic acid on IL-8 and PGE2 production by human cervix (mean ± SE). No
significant differences in IL-8 levels were found. Okadaic acid stimulated PGE2 output in both groups
(groups 1 and 3) (dagger, p < 0.05). No differences in PGE2 were observed between groups. P Cgem,
Group 1; NP, group 3.
ormamide, the vehicle used for okadaic acid,
introl, dimethylformamide, and okadaic acid
nts were indistinguishable. Lipopolysaccharide
sIF treatments were significantly higher than
(lipopolysaccharide p s 0.05, TNF p < 0.01).
relation coefficient of 0.93 between the first and
days of production indicates that IL-8 produc-
inges were maintained for at least 48 hours. The
for IL-8 were all based on data obtained from
: 24-hour incubation period,
aglandin production. Each group of tissue was
of producing PGE2, and again there was no
int difference between the basal levels (Fig. 1).
I myristate acetate only increased the output of
gnificantly above the baseline in group 1.
I shows the effect of progesterone on phorbol
myristate acetate action on group 3 tissue. The control
level was unchanged in the presence of progesterone, as
was the level on treatment with phorbol myristate ace¬
tate. Although this was the case, only the tissue that did
not get progesterone had a significant rise in its output
of PGE2.
Okadaic acid treatment significantly stimulated PGE2
production by groups 1 and 3 (p < 0.05) (Fig. 3).
No difference between the control and dimethylfor-
mamide-treated explants was seen in group 3 tissue
(Fig. 4). Okadaic acid caused PGE2 levels to rise signif¬
icantly above all the other treatments in this experi¬
ment (p < 0.01), whereas lipopolysaccharide and TNF
only reached a significance value of p < 0.05 when
compared with control.
Again there was no significant difference between the



























Fig. 4. Effect of okadaic acid (OA), lipopolysaccharide (LPS), and TNF on nonpregnant human
cervix (mean ± SE). Okadaic acid vehicle dimethylformamide (DMF) and okadaic acid were indistin¬
guishable from the control with regard to IL-8 production. Asterisk, Lipopolysaccharide stimulated
IL-8 output over control (p < 0.05); two asterisks, TNF stimulated IL-8 output over control (p < 0.01).
PGE2 levels in control and dimethylformamide treatments were same. Okadaic acid provoked
significant increase in PGE2 output over all other treatments, (dagger, p < 0.01). Two daggers,
Lipopolysaccharide and TNF caused PGE2 levels to rise significantly above control (p < 0.05).
production of PGE2 on the first and second days of
culture; the correlation coefficient was 0.91. The figures
for PGE2 were all based on data obtained from the first
24-hour incubation period.
Comment
The results show, for the first time, that human
uterine cervix explants are capable of producing IL-8
and that the cervix can increase its output of IL-8 when
stimulated by phorbol myristate acetate. Similarly, PGE2
output can also be stimulated by phorbol myristate
acetate.
The ability of the cervix to produce IL-8 ant
may be hormonally dependent because tissui
postmenopausal women apparently lost its
ity to respond to a challenge from phorbol nr
acetate.
Although it has been shown the IL-8 gene con
glucocorticoid-progestin response element10 an
progesterone at 10-6 mol/L has an inhibitory ef
IL-8 production in choriodecidual cells,22 the
from the experiments reported here show a hi
tween-patient variation in basal and stimulated p
don of IL-8, which may explain why the diffc
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in the presence of progesterone did not reach
nee.
s have shown that lipopolysaccharide and TNF
e IL-8 production in various cell types,24 and
ilts here indicated that human cervix is also
ed by these compounds. Lipopolysaccharide
rF seemed to have a similar effect on PGE2 to
IL-8.
naintenance of IL-8 and PGE2 production dur-
second 24 hours in culture indicated that the
ontinued to be viable. In addition to the data
described, some of the cultures were prolonged
irther 24 hours, and levels appeared to remain
those stimulated with phorbol myristate acetate,
ibility of the cervix to produce large amounts of
iuld account for neutrophil influx seen in two
e studies by Junqueira et al.3 and Rath et al.5
erefore the presence of leukocyte collagenase
d by Osmers et al.25 The ripening effect of
;landins on the cervix, the fact that both prosta-
i and collagenase production are influenced by
ytokines (e.g., IL-1 and TNF), together with this
ita concerning the inflammatory mediator IL-8
: cervix, draws us again to the conclusion that the
i of cervical ripening is an inflammatory one.
em is an analog of prostaglandin E, but it does
ect the level of PGE2 or IL-8 when compared
e other groups. However, it is worth considering
le proved role of PGE2 in promoting cervical
ig may be through its synergistic interaction with
augh we have shown that phorbol myristate ace-
mulates IL-8 production by the human cervix,
ysiologic control mechanism for its stimulation in
gan remains unknown. However, the interaction
:r inflammatory cytokines such as IL-1 and TNF,
f which act to stimulate IL-8 in other situations,
likely.
cent report that the origin of a chemotactic factor
abbit cervix was from fibroblasts suggests that the
i cervical source of IL-8 may in fact also be the
asts.26
her work is required in respect of postmeno-
cervical tissue. More samples of such tissue
1 be studied, and tissue from women taking hor-
replacement therapy should be examined to
nine if the capacity to induce IL-8 returns. Im-
ltly, it is necessary to assess the usefulness of early
tpregnant cervix (premenopausal) as a model for
rm cervical state with regard to IL-8 production.
1 has a dual function, to induce neutrophil migra-
nto tissues and to cause degranulation of the
: granules that contain collagenase.11 Therefore
nay be useful clinically when cervical ripening is
ogressing satisfactorily. Administration of IL-8 in
a gel or pessary formulation may be a safer alternative
to prostaglandins for effecting cervical ripening, be¬
cause any myometrial contractions are likely to be
secondary to neutrophil influx.
REFERENCES
1. Uldbjerg N, Ulmsten U, Ekman G. The ripening of the
human uterine cervix in terms of connective tissue bio¬
chemistry. Clin Obstet Gynecol 1983;26:14-26.
2. Danforth DN. The morphology of the human cervix. Clin
Obstet Gynecol 1983;26:7-13.
3. Junqueira LCU, Zugaib M, Montes GS, Toledo OMS,
Krisztan RM, Shigihara KM. Morphologic and histochem-
ical evidence for the occurrence of collagenolysis and for
the role of neutrophilic polymorphonuclear leukocytes
during cervical ripening. Am J Obstet Gynecoi. 1980; 138:
273-81.
4. Liggins GC. Cervical ripening as an inflammatory reac¬
tion. In: Ellwood DA, Anderson ABM, eds. The cervix in
pregnancy and labour, clinical and biochemical investiga¬
tions. Edinburgh: Churchill Livingstone, 1981:1-9.
5. Rath W, Osmers R, Adelmann-Gril BC, Stuhlsatz HW,
Szeverenyi M, Kuhn W. Biophysical and biochemical
changes of cervical ripening. In: Egarter C, Husslein P,
eds. Prostaglandins for cervical ripening and/or induction
of labour. Vienna: Facultas Universitatsverlag, 1988:32-41.
6. Horwitz AL, Hance AJ, Crystal RG. Granulocyte
collagenase: selective digestion of type I relative to type III
collagen. Proc Natl Acad Sci U S A 1977;74:897-901.
7. Uldbjerg N, Ekman G, Malmstrom A, Olsson K, Ulmsten
U. Ripening of the human uterine cervix related to
changes in collagen, glycosaminoglycans, and col-
lagenolytic activity. Am J Obstet Gynecol 1983;147:662-6.
8. Matsushima K, Oppenheim JJ. Interleukin 8 and MCAF:
novel inflammatory cytokines inducible by IL-1 and TNF.
Cytokine 1989;1:2-13.
9. Westwick J, Li SW, Camp R. Novel neutrophil-stimulating
peptides. Immunol Today 1989;10:146-7.
10. Baggiolini M, Sorg C, eds. Interleukin-8 (NAP-1) and
related chemotactic cytokines. Basel: Karger, 1991.
11. Peveri P, Walz A, Dewald B, Baggiolini M. A novel neu-
trophil-activating factor produced by human mononuclear
phagocytes. J Exp Med 1988;167:1547-59.
12. Kelly RW, Leask R, Calder AA. Choriodecidual production
of interleukin-8 and mechanism of parturition. Lancet
1992;339:776-77.
13. Matsushima K, Morishita K, Yoshimura T, et al. Molecular
cloning of a human monocyte-derived neutrophil chemo¬
tactic factor (MDNCF) and the induction of MDNCF
mRNA by interleukin 1 and tumour necrosis factor. J Exp
Med 1988;167:1883-93.
14. Larsen G, Anderson AO, Oppenheim JJ, Matsushima K.
Production of interleukin-8 by human dermal fibroblasts
and keratinocytes in response to interleukin-1 or tumour
necrosis factor. Immunology 1989;68:31-6.
15. Goshowaki H, Ito A, Mori Y. Effects of prostaglandins on
the production of collagenase by rabbit uterine cervical
fibroblasts. Prostaglandins 1988;36:107-114.
16. Pfeilschifter J, Pignat W, Vosbeck K, Marki F. Interleukin 1
and tumour necrosis factor synergistically stimulate pros¬
taglandin synthesis and phospholipase A2 release from rat
mesangial cells. Biochem Biophys Res Commun 1989; 159:
385-94.
17. Endo H, Akahoshi T, Kashiwazaki S. Additive effects of
IL-1 and TNF on induction of prostacyclin synthesis in
human vascular endothelial cells. Biochem Biophys Res
Commun 1988;156:1007-14.
18. Dinarello CA. Biology of interleukin 1. FASEB J 1988;2:
108-15.
19. Elias JA, Gustilo K, Baeder W, Freundlich B. Synergistic
stimulation of fibroblast prostaglandin production by re-
Kniss et al. Septen
Am J Obste
combinant interleukin 1 and tumour necrosis factor.
J Immunol 1987;138:3812-6.
20. Uldberg N, Ulmsten U. The physiology of cervical ripen¬
ing and cervical dilatation and the effect of abortifacient
drugs. Baillieres Clin Obstet Gynaecol 1990;4:263-82.
21. Colditz IG. Effects of exogenous prostaglandin E2 and
actinomycin D on plasma leakage induced by neutrophil-
activating peptide-l/interleukin-8. Immunol Cell Biol
1990;68:397-403.
22. Kelly RW, Graham BJM, O'Sullivan MJ. Measurement of
PGE2 as the methyl oxime by radioimmunoassay using a
novel iodinated label. Prostaglandins Leukot Essent Fatty
Acids 1989;37:187-91.
23. Cohen P, Holmes CFB, Tsukitani Y. Okadaic aci
probe for the study of cellular regulation. TIBS
98-102.
24. Matsushima K, Baldwin ET, Mukaida N. Interleul
MCAF: novel leukocyte recruitment and activat
kines. In: KishimotoT, ed. Interleukins: molecula
and immunology. Basel: Karger, 1992:236-65.
25. Osmers R, Rath W, Adelmann-Grill BC, et al. (
cervical collagenase during parturition. Am J Of
necol 1992;166:1455-60.
26. Uchiyama T, Ito A, Ikesue A, Nakagawa H,
Chemotactic factor in the pregnant rabbit uterin




Aderem, AA, Albert, KA, Keum, MM, Wang, JKT, Greengard, P and Cohn, ZA Stimulus-
dependent myristoylatlon of a major substrate for protein kinase C. Nature 332:362-
364, 1988.
Aggarwal, BB, Eessalu, TE and Hass, PE. Characterization of receptors for human
tumour necrosis factor and their regulation by y-interferon. Nature 318:665-666, 1985.
Alberts, B, Bray, D, Lewis, J, Raff, M, Roberts, K andWatson, JD. Molecular biology of
the cell. New York: Garland Publishing, Inc., 1993.
Anderson, ABM and Tumbull, AC. Relationship between length of gestation and
cervical dilatation, uterine contractility, and other factors during pregnancy. Am J
Obstet Gynecol 105:1207-1214, 1969.
Anderson, PJB, Hancock, KW and Oakey, RE. Non-protein-bound oestradiol and
progesterone in human peripheral plasma before labour and delivery. J Endocrinol
104:7-15, 1985.
Andrews, AE, Barcham, GJ, Brandon, MR and Nash, AD. Molecular cloning and
characterisation of ovine IL-la and IL-1(J. Immunology 74:453-460, 1991.
Anthony, GS, Fisher, J, Coutts, JRT and Calder, AA The effect of exogenous hormones
on the resistance of the early pregnant human cervix. Br J Obstet Gynaecol 91:1249-
1253, 1984.
Ashendel, CL, Staller, JM and Boutwell, RK. Identification of a calcium- and
phospholipid- dependent phorbol ester binding activity in the soluble fraction ofmouse
tissues. Biochem Biophys Res Commun 111:340-345, 1983.
Atad, J, Bomstein, J, Calderon, I, Petrikovsky, M, Sorokin, Y and Abramovici, H.
Nonpharmaceutical ripening of the unfavorable cervix and induction of labor by a
novel double balloon device. Obstet Gynecol 77:146-152, 1991.
Atkins, E. Pathogenesis of fever. Physiol Rev 40:580-646, 1960.
Auron, PE, Webb, AC, Rosenwasser, LJ, et al. Nucleotide sequence of human monocyte
interleukin 1 precursor cDNA Proc Natl Acad Sci USA 81:7907-7911, 1984.
Bacic, M, de Casparis, AW and Diczfalusy, E. Failure of large doses of ethinyl estradiol
to interfere with early embryonic development in the human species. Am J Obstet
Gynecol 107:531-534, 1970.
Bacon, KB, Westwick, J and Camp, RDR. Potent and specific inhibition of IL-8, IL-la and
IL-lb induced in vitro human lymphocyte migration by calcium channel antagonists.
Biochem Biophys Res Commun 165:349-354, 1989.
Baggiolini, M, Dewald, B and Moser, B. Interleukin-8 and related chemotactic
cytokines—CXC and CC chemokines. Adv Immunology 55:97-179, 1994.
Baggiolini, M, Imboden, P and Detmers, P. Neutrophil activation and the effects of
interleukin-8/neutrophil-activating peptide 1 (IL-8/NAP-1). In: Interleukin-8 (NAP-1)
and related chemotactic cytokines. Edited by Baggiolini, M and Sorg, C. Basel: Karger,
4th Ed: pp. 1-17. 1992.
Bakhle, YS. Synthesis and catabolism of cyclo-oxygenase products. Br Med Bull 39:214-
218, 1983.
Balkwill, FR and Burke, F. The cytokine network. Immunol Today 10:299-304, 1989.
Barath, P, Fishbein, MC, Cao, J, Berenson, J, Helfant, RH and Forrester, JS. Tumor
necrosis factor gene expression In human vascular intimal smooth muscle cells
detected by in situ hybridization. Am J Pathol 137:503-509, 1990.
Barr, W and Nalsmith, WCMK. Oral prostaglandins in the Induction of labour. Br Med J
2:188-191, 1972.
Basset, EG. Gestational changes In connective tissue In the ewe. Nature 181:196-197,
1958.
Bassett, JM, Oxborrow, TJ, Smith, ID and Thorburn, GD. The concentration of
progesterone in the peripheral plasma of the pregnant ewe. J Endocrinol 45:449-457,
1969.
Batista, MC, Bristow, TL, Mathews, J, Stokes, WS, Loriaux, DL and Nieman, LK. Dally
administration of the progesterone antagonist RU486 prevents implantation in cycling
guinea pig. Am J Obstet Gynecol 165:82-86, 1991.
Baulieu, E-E. Contragestation with RU486: A new appraoch to postovulatoiy fertility
control. Acta Obstet Gynecol Scand 149:5-8, 1989.
Baulieu, E-E. Steroid hormone antagonists at the receptor level. A role for the heat-
shock protein MW 90,000 (hsp 90). J Cell Biochem 35:161-174, 1987.
Besemer, J, Hujber, A and Kuhn, B. Specific binding, internalization, and degradation
of human neutrophil activating factor by human polymorphonuclear leukocytes. J Biol
Chem 264:17409-17415. 1989.
Bialojan, C and Takai, A. Inhibitory effect of a marine-sponge toxin, okadaic acid, on
protien phosphatases. Biochem J 256:283-290, 1988.
Bigazzi, M, Nardi, E, Bruni, P and Petrucci, F. Relaxin in human decidua. J Clin
Endocrinol Metab 51:939-941, 1980.
Bignold, LP, Rogers, SD, Siaw, TM and Bahnisch, J. Inhibition of chemotaxis of
neutrophil leukocytes to interleukin-8 by endotoxins of various bacteria. Infection and
Immunity 59:4255-4258, 1991.
Blackwell, GJ and Flower, RJ. Inhibition of phospholipase. Br Med Bull 39:260-264,
1983.
Bornstein, P and Sage, H. Structurally distinct collagen types. Ann Rev Biochem
49:957-1003, 1980.
Bosc, MJ, Germain, G, Nicolle, A, Mouren, M, Philibert, D and Baulieu, E-E. Control of
birth in rats by RU486, an antiprogesterone compound. J Reprod Fertil 79:1-8, 1987.
Bowman, WC and Rand, MJ. Textbook of pharmacology. Oxford: Blackwell Scientific
Publications, 2nd Ed: 1980.
Brindley, BA and Sokol, RJ. Induction and augmentation of labor: Basis and methods
for current practice. Obstet Gynecol Surv 43:730-743, 1988.
Brown, MS and Goldstein, JL. Lipid metabolism In the macrophage: Implications for
cholesterol deposition In atheroscleosis. Ann Rev Biochem 52:223-261, 1983.
Buster, JE and Simon, JA. Placental hormones, hormonal preparation for and control
of parturition, and hormonal diagnosis of pregnancy. In: Part X - Endocrinology of
Pregnancy, pp.2043-2073. 190.
Bygdeman, M and Swahn, M-L. Progesterone receptor blockage: Effect on uterine
contractility and early pregnancy. Contraception 31:28-32, 1985.
Cabrol, D, Carbonne, B, Bienkiewicz, A, Dallot, E, Alj, AE and Cedard, L. Induction of
labor and cervical maturation using mifepristone (RU486) in the late pregnant rat.
Influence of a cyclooxygenase inhibitor (Diclofenac). Prostaglandins 42:71-79, 1991.
Cabrol, D, Dallot, E, Bienkienwicz, A, El Alj, A, Sedbon, E and Cedard, L.
Cyclooxygenase and lipoxygenase inhibitors - Induced changes in the distribution of
glycosaminoglycans in the pregnant rat uterine cervix. Prostaglandins 39:515-523,
1990.
Cabrol, D, Dubois, P, Sedbon, E, et al. Prostaglandin E2 induced changes in the
distribution of glycosaminoglycans in the isolated rat uterine cervix. Eur J Obstet
Gynecol Reprod Biol 26:359-365, 1987.
Calder, AA, Embrey, MP and Tait, T. Ripening of the cervix with extra-amniotic
prostaglandin E2 in viscous gel before induction of labour. Br J Obstet Gynaecol 84:264-
268, 1977.
Calder, AA, Hillier, K and Embrey, MP. Prostaglandin therapy for the cervical ripening
prior to induction of labour. Adv Prostaglandin Thromboxane Res 2:993, 1976.
Calder, AA. Cervical ripening. In: Prostaglandins and their inhibitors in clinical
obstetrics and gynaecology. Edited by Bygdeman, M, Berger, S and Keith, LG. Lancaster:
MTP Press Ltd, pp. 145-164. 1986.
Calder, AA. Pharmacological management of the unripe cervix in the human. In:
Dilatation of the uterine cervix. Edited by Naftolin, F and Stubblefield, PG. New York:
Raven Press, pp.317-333. 1980.
Calder, AA. Prostaglandins as therapy for labour induction or therapeutic abortion.
Reprod Fertil Dev 2:553-556, 1990.
Calder, AA. The human cervix in pregnancy: a clinical perspective. In: The cervix in
pregnancy and labour. Edited by Ellwood, DA and Anderson, ABM. Edinburgh:
Churchill Livingstone, pp.103-122. 1981.
Cameron, IT, Michie, AF and Baird, DT. Therapeutic abortion in early pregnancy with
antiprogestin RU486 alone or in combination with prostaglandin analogue
(Gemeprost). Contraception 34:459-468, 1986.
Cannon, JG and Dinarello, CA. Increased plasma interleukin-1 activity in women after
ovulation. Science 227:1247-1249, 1985.
Carsten, ME and Miller, JD. Prostaglandin-specific binding to several microsomal
fractions from bovine myometrium. Adv Prostaglandin Thromboxane Leukotriene Res
6:401-405, 1980.
Casey, ML, Cox, SM, Beutler, B, Milewich, L and MacDonald, PC. Cachectin/tumor
necrosis factor-a in human decidua. Potential role of cytokines in infection-induced
preterm labor. J Clin Invest 83:430-436, 1989.
Casey, ML, Cutrer, SI and Mitchell, MD. Origin of prostanoids in human amniotic fluid:
The fetal kidney as a source of amniotic fluid prostanoids. Am J Obstet Gynecol
147:547-551, 1983a.
Casey, ML, MacDonald, PC and Mitchell, MD. Characterization of prostaglandin
formation by human amnion cells in monolayer culture. Prostaglandins 27:421-427,
1984.
Casey, ML, MacDonald, PC and Mitchell, MD. Stimulation of prostaglandin E2
production in amnion cells in culture by a substance(s) in human fetal and adult urine.
Biochem Biophys Res Commun 114:1056-1063, 1983b.
Castagna, M, Takai, Y, Kaibuchi, K, Sano, K, Kikkawa, U and Nishizuka, Y. Direct
activation of calcium-activated, phospholipid dependent protein kinase by tumor-
promoting phorbol esters. J Biol Chem 257:7847-7851, 1982.
Cawston, TE and Tyler, JA. Purification of pig synovial collagenase to high specific
activity. Biochem J 183:647-656, 1979.
Challis, JRG and Olson, DM. Parturition. In: The physiology of reproduction. Edited by
Knobil, E, Neill, J and et al, . New York: Raven Press, pp.2177-2216. 1988.
Challis, JRG and Vaughan, M. Steroid synthetic and prostaglandin metabolizing
activity is present in different cell populations from human fetal mambranes and
decidua Am J Obstet Gynecol 157:1474-1481, 1987.
Cheah, SH and Sherwood, OD. Target tissues for relaxin in the rat: Tissue distribution
of injected 125I-labeled relaxin and tissue changes in adenosine 3',5'-monophosphate
levels after in vitro relaxin incubation. Endocrinology 106:1203-1209, 1980.
Cherouny, PH, Pankuch, GA, Botti, JJ and Appelbaum, PC. The presence of amniotic
fluid leukoattractants accurately identifies histologic chorioamnionitis and predicts
tocolytic efficacy in patients with idiopathic preterm labor. Am J Obstet Gynecol
167:683-688, 1992.
Christensen, NJ and Green, K. Bioconversion of arachidonic acid in human pregnant
reproductive tissue. Biochem Med 30:162-180, 1983.
Christensen, NJ, Belfrage, P, Bygdeman, M, FLoberg, J, Miszuhashi, N and Green, K.
Bioconversion of arachidonic acid in human pregnant uterine cervix. Acta Obstet
Gynecol Scand 64:259-265, 1985.
Chwalisz, K and Elger, W. Induction of labour with antigestagens in the rat and guinea
pig. J Steriod Biochem Suppl 25:13IS, 1986.(Abstract)
Chwalisz, K, Shi Shao, Q, Neef, G and Elger, W. The effect of antigestagen ZK98.299 on
the uterine cervix. Acta Endocrinol Suppl 114:113-114, 1987.
Clark, IM and Cawston, TE. Fragments of human fibroblast collagenase - Purification
and characterisation. Biochem J 263:201-206, 1989.
Clark-Lewis, I, Schumacher, C, Baggiolini, M and Moser, B. Structure-activity
relationships of interleukin-8 determined using chemically synthesized analogs.
Critical role of NH2-terminal residues and evidence for uncoupling of neutrophil
chemotaxis, exocytosis, and receptor binding activities. J Biol Chem 266:23128-23134,
1991.
Clore, GM and Gronenborn, AM. NMR and X-ray analysis of the three-dimensional
structure of interleukin-8. In: Interleukin-8 (NAP-1) and related chemotactic cytokines.
Edited by Baggiolini, M and Sorg, C. Basel: Karger, 4th Eld: pp. 18-40. 1992.
Cohen, DK, Craig, DA, Strickland, DC, McCubbin, JH and Mitchell, MD. Prostaglandin
biosynthesis stimulatory and inhibitory substances in human amniotic fluid during
pregnancy and labor. Prostaglandins 30:13-20, 1985.
Cohen, P, Holmes, CFB and Tsukitani, Y. Okadaic acid: a new probe for the study of
cellular regulation. TIBS 15:98-102, 1990.
Cohen, P. The structure and regulation of protein phosphatases. Ann Rev Blochem
58:453-508, 1989.
Colditz, IG. Effects of exogenous prostaglandin E2 and actlnomycin D on plasma
leakage induced by neutrophil-activating peptide-1/interleukin-8. Immunol Cell Biol
68:397-403, 1990.
Coleman, RA, Humphrey, PPA, Kennedy, I and Lumley, P. Prostanoid receptors- the
development of a working classification. TIPS 5:303-306, 1984.
Coleman, RA, Humphrey, PPA, Kennedy, I, Levy, GP and Lumley, P. Preliminary
characterisation of three types of prostanoid receptor mediating smooth muscle
contraction. Br J Pharmacol 69:265-266, 1980.
Coleman, RA, Kennedy, I, Humphrey, PPA, Bunce, K and Lumley, P. Prostanoids and
their receptors. In: Comprehensive medicinal chemistry. Edited by Hansch, C, Sammes,
PG and Taylor, JB. Oxford: Pergamon Press, pp.643-714. 1990.
Collins, E and Turner, G. Maternal effects of regular salicylate ingestion in pregnancy.
Lancet 2:335-338, 1975.
Conrad, JT and Ueland, K. Physical characteristics of the cervix. Clin Obs Gyn 26:27-36,
1983.
Couzinet, B, Le Strat, N, Ulmann, A, Baulieu, E-E and Schaison, G. Termination of early
pregnancy by the progesterone antagonist RU486 (Mifepristone). N Engl J Med
315:1565-1570, 1986.
Crankshaw, DJ, Romaniuk, E and Branda, LA. Identification and characterization of
receptors for oxytocin in the myometrium of the pregnant ewe. Gynecol Obstet Invest
14:202-213, 1982.
Crawford, MA. Background to essential fatty acids and their prostanoid derivatives. Br
Med Bull 39:210-213, 1983.
Csapo, AI, Pulkkinen, MO, Ruttner, B, Sauvage, JP and Wiest, WG. The significance of
the human coprus luteum in pregnancy maintenance. I. Preliminary studies. Am J
Obstet Gynecol 112:1061-1067, 1972.
Csapo, AI. The seesaw theory of the regulatory mechanism of pregnancy. Am J Obstet
Gynecol 121:578-581, 1975.
Dabbous, MK, Walker, R, Haney, L, Nicolson, GL and Woolley, DE. Mast cells and matrix
degradation at sites of tumour invasion in rat mammary adenocarcinoma. Br J Cancer
54:459-465, 1986.
Dinarello, CA, Goldin, NP and Wolff, SM. Demonstration and characterization of two
distinct leukocytic pyrogens. J Exp Med 139:1369-1381, 1973.
Dinarello, CA. Biology of lnterleukin 1. FASEB J 2:108-115, 1988.
Dingle, JT, Blow, AMJ, Barrett, AJ and Martin, PEN. Proteoglycan degrading enzymes.
A radiochemical assay method and the detection of a new enzyme, cathepsin F.
Blochem J 167:775-785, 1977.
Doebber, TW, Wu, MS, Robbins, JC, Choy, BM, Chang, MN and Shen, TY Platelet
activating factor (PAF) Involvement In endotoxin induced hypotension in rats. Studies
with PAF-receptor antagonist kadsurenone. Biochem Biophys Res Commun 127:799-
808, 1985.
Dower, SK, Kronheim, SR, Hopp, TP, et al. The cell surface receptors for interleukln-1 a
and interleukln-ip are identical. Nature 324:266-268, 1986.
Downing, SJ and Sherwood, OD. The physiological role of relaxin in the pregnant rat.
II. The Influence of relaxin on uterine contractile activity. Endocrinology 116:1206-
1214, 1985.
Downing, SJ and Sherwood, OD. The physiological role of relaxin in the pregnant rat.
IV. The Influence of relaxin on cervical collagen and glycosaminoglycans.
Endocrinology 118:471-479, 1986.
Dubois, C, Ulmann, A and Baulieu, E-E. Contragestation with late luteal
administration of RU486 (Mifepristone). Fert Sterll 50:593-596, 1988.
Duchesne, MJ, Thaler-Dao, H and Crastes de Paulet, A. Prostaglandin synthesis In
human placenta and fetal membranes. Prostaglandins 15:19-42, 1978.
Eades, DK, Comeius, P and Pekala, PH. Characterization of the tumor necrosis factor In
human placenta. Placenta 9:247-251, 1988.
Eddie, LW, Bell, RJ, Lester, A, et al. Radioimmunoassay of relaxin in pregnancy with an
analogue of human relaxin. Lancet 1:1344-1346, 1986.
Eeckhout, Y and Vaes, G. Further studies on the activation of procollagenase, the latent
precursor of bone collagenase. Effects of lysosomal cathepsin B, plasmin and
kallikrien, and spontaneous activation. Biochem J 166:21-31, 1977.
Eichner, E, Herman, I, Kritzer, L, Platock, GM and Rubinstein, L. The effects of relaxin
on term and premature labor. Ann NY Acad Sci 75:1023-1032, 1958.
Ekman, G, Forman, A, Marsal, K and Ulmsten, U. Intravaginal versus intracervlcal
application of prostaglandin E2 in viscous gel for cervical priming and induction of
labor at term in patients with an unfavourable cervical state. Am J Obstet Gynecol
147:657-601, 1983.
Ekman, G, Malmstrom, A, Uldbjerg, N and Ulmsten, U. Cervical collagen: An important
regulator of cervical function In term labor. Obstet Gynecol 67:633-636, 1986.
Elder, MG. Intravaginal prostaglandins for cervical ripening and induction of labour.
In: Prostaglandins for cervical ripening and/or induction of labour. Edited by Egarter,
C and Husslein, P. Vienna: Facultas Universit&tsverlag, pp.46-52. 1988.
Elgendy, H and Hausman, RE. Prostaglandin-dependent phosphatidylinositol
signaling during embryonic chick myogenesis. Cell Differ Dev 32:109-116, 1990.
Elger, W and Hasan, SG. Studies on the mechanism of action of antifertile PG in animal
models. Acta Physiologica Hungarica 65:415-432, 1985.
Elger, W, Fahnrich, M and Kosub, B. Evidence that progesterone stimulates uterine PG-
liberation. Acta Endocrinol Suppl 114:6-7, 1987b.
Elger, W, Fahnrich, M, Beier, S, Qing, SS and Chwalisz, K. Endometrial and myometrial
effects of progesterone antagonists in pregnant guinea pigs. Am J Obstet Gynecol
157:1065-1074, 1987a.
Elger, W. Pharmacology of parturition and abortion. An Rep Sci 2:133-148, 1979.
Elias, J. Tumour Necrosis Factor interacts with Interleukin-1 and Interferons to
inhibit fibroblast proliferation via fibroblast prostaglandin-dependent and -
independent mechanisms. Am Rev Respir Dis 138:652-658, 1988.
Elias. JA, Gustilo, K and Freundlich, B. Human alveolar macrophage and blood
monocyte inhibition of fibroblast proliferation Evidence for synergy between
interleukin-1 and tumour necrosis factor. Am Rev Res Dis 138:1595-1603, 1988a.
Elias, JA, Gustilo, K, Baeder, W and Freundlich, B. Synergistic stimulation of fibroblast
prostaglandin production by recombinant interleukin 1 and tumour necrosis factor. J
Immunol 138:3812-3816, 1987.
Elias, JA, Krol, RC, Freundlich, B and Sampson, PM. Regulation of human lung
fibroblast glycosaminoglycan production by recombinant interferons, tumour necrosis
factor, and lymphotoxin. J Clin Invest 81:325-333, 1988b.
Ellwood, DA, Mitchell, MD, Anderson, ABM and Tumbull, AC. A significant increase in
the in vitro production of prostaglandin E by ovine cervical tissue at delivery. J
Endocrinol 81:133P-134P, 1979.
Ellwood, DA, Mitchell, MD, Anderson, ABM and Turnbull, AC. The in vitro production
of prostanoids by the human cervix during pregnancy: preliminary observations. Br J
Obstet Gynaecol 87:210-214, 1980.
Embrey, MP and Anselmo, JF. The effects of intravenous oxytocin on uterine
contractility. J Obstet Gynaecol Br Commonw 69:918-923, 1962.
Embrey, MP, Calder, AA and Hillier, K. Extra amniotic prostaglandins in the
management if intrauteruine fetal death, anencephaly and hydatidiform mole. J Obstet
Gynaecol Br Commonw 81:47-51, 1974.
Endo, H, Akahoshi, T and Kashiwazaki, S. Additive effects of IL-1 and TNF on
induction of prostacyclin synthesis in human vascular endothelial cells. Biochem
Biophys Res Commun 156:1007-1014, 1988.
Evans, MI, Dougan, M-B, Moawad, AH, Evans, WJ, Bryant-Greenwood, GD and
Greenwood, FC. Ripening of the human cervix with porcine ovarian relaxin. Am J
Obstet Gynecol 147:410-414, 1983.
Evequoz, V, Schynder, J, Trechsel, U, Baggiolinl, M and Fleisch, H. Influence of
macrophage products on the release of plasminogen activator, collagenase, p-
glucuronidase and prostaglandin E2 by articular chondrocytes. Blochem J 219:667-677,
1984.
Falkay, G, Herczeg, J and Sas, M. Prostaglandin synthesis and metabolism in the
human uterus and mldtrimester fetal tissues. J Reprod Fertil 59:525-529, 1980.
Faris, IB and Kahlenberg, B. Intravenous pitocin by the drip method In the induction of
labour. J Obstet Gynaecol Br Empire 61:96-102, 1954.
Feigen, LP and Chapnick, BM. Evidence for separate PGD2 and PGF201 receptors in the
canine mesenteric vascular bed. Prostaglandins 18:221-233, 1979.
Fields, PA and Larkln, LH. Enhancement of uterine cervix extensibility In oestrogen-
primed mice following administration of relaxln. J Endocrinol 87:147-152, 1980a.
Fields, PA and Larkln, LH. Purification and immunohistochemical localization of
relaxin in human term placenta. J Clin Endocrinol Metab 52:79-85, 1980b.
Fitzpatrick, RJ and Dobson, H. Softening of the ovine cervix at parturition. In: The
cervix in pregnancy and labour: Clinical and biochemical investigations. Edited by
Ellwood, DA and Anderson, ABM. London: Chuchill Livingstone, pp.40-56. 1981.
Flatman, S, Hurst, JS, McDonald-Gibson, RG, Jonas, GEG and Slater, TF. Biochemical
studies on a 12-lipoxygenase in human uterine cervix. Biochim Biophys Acta 883:7-14,
1986.
Flower, RJ. Lipocortln and the mechanism of action of the glucocorticoids. Br J
Pharmacol 94:987-1015, 1988.
Fosang, AJ and Handley, CJ. Connective tissue remodelling in the ovine cervix during
pregnancy and at term. Connect Tissue Res 17:277-285, 1988.
France, JT and Liggins, GC. Placental sulfatase deficiency. J Clin Endocrinol Metab
29:138-141, 1969.
France, JT, Sneddon, RJ and Liggins, GC. A study of a pregnancy with low estrogen
production due to placental sulfatase deficiency. J Clin Endocrinol Metab 36:1-9, 1973.
Frieden, EH and Hisaw, FL. The mechanism of symphyseal relaxation. The distribution
of reducing groups, hexosamine and proteins in symphyses of normal and relaxed
guinea pigs. Endocrinology 48:88-97, 1951.
Frydman, R, Fernandez, H, Pons, J-C and Ulmann, J. Mifepristone (RU486) and
therapeutic late pregnancy termination: a double-blind study of two different doses.
Human Reprod 3:803-806, 1988.
Fuchs, A-R, Fuchs, F, Husslein, P and Soloff, MS. Oxytocin receptors in the human
uterus during pregnancy and parturition. Am J Obstet Gynecol 150:734-41, 1984.
Fuchs, A-R, Fuchs, F, Husslein, P, Soloff, MS and Fernstrom, MJ. Oxytocin receptors
and human parturition: a dual role for oxytocin In the imitiation of labour. Science
215:1396, 1982.
Fuchs, A-R, Goeschen, K, Hussleln, P. Rasmussen, AB and Fuchs, F. Oxytocin and the
initiation of human parturition: III. Plasma concentrations of oxytocin and 13,14-
dihydro-15-keto-prostaglandin F2« in spontaneous and oxytocln-induced labor at
term. Am J Obstet Gynecol 147:497-502, 1983b.
Fuchs, A-R, Hussleln, P and Fuchs, F. Oxytocin and the Initiation of human
parturition: II. Stimulation of prostaglandin production In the human decidua by
oxytocin. Am J Obstet Gynecol 141:694-697, 1981.
Fuchs, A-R, Periyasamy, S, Alexandrova, M and Soloff, MS. Correlation between
oxytocin receptor concentration and responsiveness to oxytocin in pregnant rat
myometrium: Effects of ovarian steroids. Endocrinology 113:742-749, 1983a.
Galanos, C, Luderitz, O, Rietschel, ET, et al. Synthetic and natural Escherichia coli free
lipid A express identical endotoxlc activities. European Journal of Biochemistry 148:1-
5, 1985.
Gant, NF, Hutchinson, HT, Siiterl, PK and MacDonald, PC. Study of the metabolic
clearance of dehydrepiandrosterone sulfate In pregnancy. Am J Obstet Gynecol
111:555-563,1971.
Garfield, RE, Gase, JM and Baulieu, E-E. Effect of the antiprogesterone RU486 on
preterm birth in the rat. Physiology and Behaviour 157:1281, 1987.
Garfield, RE, Kannan, MS and Daniel, EE. Gap junction formation in myometrium:
control by estrogens, progesterone and prostaglandins. Am J Physiol 238:C81-C89,
1980.
Garfield, RE, Sims, SM, Kannan, MS and Daniel, EE. Possible role of gap junctions in
activation ofmyometrium during parturition. Am J Physiol 235:C168-C179, 1978.
Gates, GS, Flynn, JJ, Ryan, RJ and Sherwood, OD. In vivo uptake of 125I-relax±n in the
guinea pig. Biol Reprod 25:549-554, 1981.
Giannopoulos, G, Jackson, K, Kredentser, K and Tulchinsky, D. Prostaglandin E and
F2a receptors in human myometrium during the menstrual cycle and In pregnancy and
labor. Am J Obstet Gynecol 153:904-910, 1985.
Gibb, DMF, Cardozo, LD, Studd, JWW and Cooper, DJ. Prolonged pregnancy: Is
induction of labour Indicated? A prospective study. Br J Obstet Gynaecol 89:292-295,
1982.
Gibb, W, Lavoie, J-C and Roux, JF. 3(3-hydroxysteroid dehydrogenase activity In human
fetal membranes. Steroids 32:365, 1978.
Gillespie, A. Prostaglandin-oxytocin enhancement and potentiation and their clinical
applications. Br Med J 1:150-152, 1972.
Goeschen, K, Fuchs, A-R, Fuchs, F, Rasmussen, AB, Rehnstrbm, JV and Saling, E. Effect
of ff-mimetic tocolysis on cervical ripening and plasma prostaglandin F2« metabolite
after endocervical application of prostaglandin E2. Obstet Gynecol 65:166-171, 1985.
Gollchowski, A. Cervical stromal interstitial polysaccharide metabolism In
pregnancy. In: Dilatation of the uterine cervix. Edited by Naftolin, F and Stubblefield,
PG. New York: Raven Press, pp.98-112. 1980.
Gooneratne, AD, Bryant-Greenwood, G, Maule Walker, F, Nottage, HM and Hartmann,
PE. Pre-partum changes in the plasma concentrations of progesterone, relaxin,
prostaglandin F-2a and 13,14-dihydro-15-keto prostaglandin F-2a in meclofenamic
acid-treated sows. J Reprod Fertil 68:33-40, 1983.
Gordon, AJ and Calder, AA. Oestradiol applied locally to ripen the unfavourable cervix.
Lancet 2:1319-1321, 1977.
Gordon, AJ. Comparison of oestradiol and prostaglandin E2 vaginal gel for ripening the
unfavourable cervix. Br Med J 282:1394-1395, 1981.
Goshowaki, H, Ito, A and Mori, Y. Effects of prostaglandins on the production of
collagenase by rabbit uterine cervical fibroblasts. Prostaglandins 36:107-114, 1988.
Goureau, O, Tanfin, Z, Marc, S and Harbon, S. Diverse prostaglandin receptors activat
distinct signal transduction pathways in rat myometrium. Am J Physiol 263:C257-
C265, 1992.
Green, K, Christensen, N and Bygdeman, M. The chemistry and pharmacology of
prostaglandins, with reference to human reproduction. J Reprod Fert 62:269-281, 1981.
Grimshaw, R Mitchell, BF and Challis, JRG. Steroid modulation of pregnenolone to
progesterone conversion by human placental cells in vitro. Am J Obstet Gynecol
145:234-238, 1983.
Grob, PM, David, E, Warren, TC, DeLeon, RP, Farina, PR and Homan, CA.
Characterization of a receptor for human monocyte-derived neutrophil chemotactic
factor/interleukin 8. J Biol Chem 265:8311-8316, 1990.
Hale, RW and Pion, RJ. Laminaria: an under-utilized clinical adjunct. Clin Obs Gyn
15:829-850, 1972.
Halme, J and Woessner, JFJr. Effect of progesterone on collagen breakdown and tissue
collagenolytic activity in the involuting rat uterus. J Endocrinol 66:357-361, 1975.
Haluska, GJ, Stanczyk, FZ, Cook, MJ and Novy, MJ. Temporal changes in uterine
activity and prostaglandin response to RU486 in rhesus macaques in late gestation. Am
J Obstet Gynecol 157:1487-1495, 1987.
Hammarstrom, M. Autonomic nervous control of cervical secretion in the guinea-pig.
Acta Physiol Scand 135:367-371, 1989.
Hampton, RY, Golenbock, DT and Raetz, CRH. Lipid A binding sites in membranes of
macrophage tumor cells. J Biol Chem 263:14802-14807, 1988.
Hansen, HS. 15-hydroxyprostaglandin dehydrogenase, a review. Prostaglandins
12:647-679, 1976.
Hanssens, MCAJA, Selby, C and Symonds, EM. Sex steroid hormone concentrations in
preterm labour and the outcome of treatment with ritodrine. Br J Obstet Gynaecol
92:698-702, 1985.
Hauth, JC, Goodman, MT, Gilstrap, LC and Gilstrap, JER Post-term pregnancy. I. Obstet
Gynecol 56:467-470, 1980.
Haystead, TAJ, Sim, ATR Carling, D, et al. Effects of the tumour promoter okadaic acid
on intracellular protein phosphorylation and metabolism. Nature 337:78-81, 1989.
Heap, RB and Deanesly, R Progesterone levels in intact and ovariectomized pregnant
guinea pigs. Proceedings of the Society for Endocrinology. J Endocrinol 30:ii-iii, 1964.
Hecker, M, Ullrich, V, Fischer, C and Meese, CO. Identification of novel arachidonic
acid metabolites formed by prostaglandin H synthase. European Journal of
Biochemistry 169:113-123, 1987.
Hegele-Hartung, C, Chwalisz, K, Beier, HM and Elger, W. Ripening of the uterine cervix of
the guinea-pig after treatment with the progesterone antagonist onapristone (ZK
98.299): an electron microscopic study. Human Reprod 4:369-377, 1989.
Heidvall, K, Radestad, A and Christensen, NJ. Production of 12-
hydroxyeicosatetraenoic acid in early pregnant uterine cervix - Lack of correlation to
mifepristone-induced cervical ripening. Prostaglandins 43:473-482, 1992.
Hill, NOW, Selinger, M, Ferguson, J, Lopez Bemal, A and MacKenzie, IZ. The
physiological and clinical effects of progesterone inhibition with RU38.486 in the
second trimester. 7th International Conference on Prostaglandins and Relateed
Compounds,Florence 160, 1990. (Abstract)
Hillier, K and Coad, N. Synthesis of prostaglandins by the human uterine cervix in
vitro during passive mechanical stretch. J Pharm Pharmacol 34:262-263, 1982.
Hillier, K and Karim, SMM. The human isolated cervix: A study of its spontaneous
motility and responsiveness to drugs. Br J Pharmacol 40:576-577, 1970.
Hillier, K and Wallis, RM. Prostaglandins, steroids and the human cervix. In: The
cervix in pregnancy and labour. Edited by Ellwood, DA and Anderson, ABM. Edinburgh:
Chuchill Livingstone, pp. 144-162. 1981.
Hirata, F. The regulation of lipomodulin, a phospholipase inhibitory protein, in rabbit
neutrophils by phosphorylation. J Biol Chem 256:7730-7733, 1981.
Hiro, D, Ito, A, Matsuta, K and Mori, Y. Hyaluronic acid is an endogenous inducer if
interleukin-1 production by human monocytes and rabbit macrophages. Biochem
Biophys Res Commun 140:715-722, 1986.
Hofmeier, M. Das untere uterinsegment in anatomischer und physiologischer
beziehung. In: Der schwangere und kreisende uterus. Edited by Schroeder, K. Bonn:
pp.48. 1886.
Hopkins-Sibley, CH, Terry, A and Raetz, CRH. Induction of k light chain synthesis in
70Z/3 Blymphoma cells by chemically defined lipid A precursors. J Biol Chem
263:5098-5103, 1988.
Horton, EW and Poyser, NL. Elongation of oestrus cycle in the guinea-pig following
subcutaneous or intra-uterine administration of indomethacin. Br J Pharmacol 49:98-
105, 1973.
Horwitz, AL, Hance, AJ and Crystal, RG. Granulocyte collagenase: Selective digestion of
type I relative to type III collagen. Proc Natl Acad Sci USA 74:897-901, 1977.
Horwitz, AL, Kelman, JA and Crystal, RG. Activation of alveolar macrophage
collagenase by a neutral protease secreted by the same cell. Nature 264:772-774, 1976.
Hughesdon, PE. The fibromuscular structure of the cervix and its changes during
pregnancy and labour. J Obstet Gynaecol Br Empire 59:763-776, 1952.
Hulka, JF and Higgins, G. Trauma to the internal cervical os during dilatation for
diagnostic curettage. Am J Obstet Gynecol 82:913-919, 1961.
Hulka, JF, Lefte, HJJr, Aglone, A and Lachenbruch, PA. A nonelectronic force monitor
to measure factors influencing cervical dilation for vacuum curettage. Am J Obstet
Gynecol 120:166-173, 1974.
Hunninghake, GW, Glazier, AJ, Monick, MM and Dinarello, CA. Interleukin-1 is a
chemotactic factor for human T-lymphocytes. Am Rev Respir Dis 135:66-71, 1987.
Husslein, P, Fuchs, A-R and Fuchs, F. Oxytocin and the initiation of human
parturition. I. Prostaglandin release during induction of labor by oxytocin. Am J Obstet
Gynecol 141:688-692, 1981.
Husslein, P, Kofler, K, Rasmussen, AB, Sumulong, L, Fuchs, A-R and Fuchs, F. Oxytocin
and the initiation of human parturition IV. Plasma concentrations of oxytocin and
13,14-dihydro-15-keto-prostaglandin F2a during induction of labor by artificial
rupture of the membranes. Am J Obstet Gynecol 147:503-507, 1983.
Hutchins, CJ and Parkin, EN. PZ-peptidase activity in the pregnant and non pregnant
human cervix. Br J Obstet Gynaecol 88:150-152, 1981.
Hwang, JJ, Shanks, RD and Sherwood, OD. Monoclonal antibodies specific for rat
relaxin. IV. Passive immunization with monoclonal antibodies during the antepartum
period reduces cervical growth and extensibility, disrupts birth and reduces pup
survival in intact rats. Endocrinology 125:260-266, 1989.
Illingworth, DV and Challis, JRG. Concentrations of oestrogens and progesterone in the
plasma of ovariectomized and ovariectomized norgestrel-treated pregnant guinea-pigs.
J Reprod Fertil 34:289-296, 1973.
Insull, GM, Cooke, I and MacKenzie, IZ. Tocolysis during cervical ripening with vaginal
PGE2. Clin Endocrinol Metab 96:179-182, 1989.
Irvine, RF. How is the level of free arachidonic acid controlled in mammalian cells?
Biochem J 204:3-16, 1982.
Ito, A, Hiro, D, Ojima, Y and Mori, Y. Spontaneous production of interleukin-1-like
factors from pregnant rabbit uterine cervix. Am J Obstet Gynecol 159:261-265, 1988.
Ito, A, Hiro, D, Sakyo, K and Mori, Y. The role of leukocyte factors on uterine cervical
ripening and dilation. Biol Reprod 37:511-517, 1987.
Ito, A, Ihara, H and Mori, Y. Partial purification and characterization of a novel
neutral proteinase from human uterine cervix. Biochem J 185:443-450, 1980.
Ito, A, Kitamura, K, Mori, Y and Hirakawa, S. The change in solubility of type I collagen
in the human uterine cervix in pregnancy at term. Biochem Med 21:262-270, 1979.
Jaattela, M, Kuusela, P and Saksela, E. Demonstration of tumor necrosis factor in
human amniotic fluids and supematants of placental and decidual tissues. Lab Invest
58:48-52, 1988.
Jeffrey, JJ, Coffey, RJ and Eisen, AZ. Studies on uterine collagenase in tissue culture. II.
Effect of steroid hormones on enzyme production. Biochim Biophys Acta 252:143-149,
1971.
Johnson, N. Intracervical tents: Usage and mode of action. Obs Gyn Sun/ 44:410-420,
1989.
Johnstone, FD, Beard, RJ, Boyd, IE and McCarthy, TG. Cervical diameter after suction
termination of pregnancy. Br Med J 1:68-69, 1976.
Johnstone, FD, Boyd, IE, McArthy, TG and McClure-Brown, JC. The diameter of the
uterine Isthmus during the menstrual cycle, pregnancy and the peurperlum. J Obstet
Gynaecol Br Commonw 81:558-562, 1974.
Jones, SA, Brooks, AN and Challis, JRG. Steroids modulate cortlcotropin-releasing
hormone production in human fetal membranes and placenta. J Clin Endocrinol
Metab 68:825-830, 1989.
Joseph, NR. Engel, MB and Catchpole, HR Interaction of Ions and connective tissue.
Biochlm Blophys Acta 8:575-587, 1952.
Jue, D-M, Sherry, B, Leudke, C, Manogue, KR and Ceraml, A. Processing of newly
synthesized cachectln/tumor necrosis factor In endotoxln-stlmulated macrophages.
Biochemistry 29:8371-8377, 1990.
Junqueira, LCU, Bignolas, G and Brentani, RR Picroslrius staining plus polarization
microscopy, a specific method for collagen detection In tissue sections. Histochemical
Journal 11:447-455, 1979.
Junqueira, LCU, Zugaib, M, Montes, GS, Toledo, OMS, Krlsztan, RM and Shigihara, KM.
Morphologic and histochemical evidence for the occurrence of collagenolysis and for
the role of neutrophilic polymorphonuclear leukocytes during cervical ripening. Am J
Obstet Gynecol 138:273-281, 1980.
Kaibuchl, K, Sano, K, Hoshijima, M, Takai, Y and Nishizuka, Y. Phosphatidylinositol
turnover in platelet activation; calcium mobilization and protein phosphorylation.
Cell Calcium 3:323-335, 1982.
Kaibuchi, K, Takai, Y and Nishizuka, Y. Cooperative roles of various membrane
phospholipids in the activation of calcium-activated, phospholipid-dependent protein
kinase. J Biol Chem 256:7146-7149, 1981.
Kaibuchi, K, Takai, Y, Sawamura, M, Hoshijima, M, Fujikura, T and Nishizuka, Y.
Synergistic functions of protien phosphorylation and calcium mobilization In platelet
activation. J Biol Chem 258:6701-6704, 1983.
Kanayama, N and Terao, T. The relationship between granulocyte elastase-like activity
of cervical mucus and cervical maturation. Acta Obstet Gynecol Scand 70:29-34, 1991.
Karim, SMM and Sharma, SD. Therapeutic abortion and induction of labour by the
intravaglnal administration of prostaglandins E and F2a■ 3 Obstet Gynaecol Br
Commonw 78:294-300, 1971.
Kasahara, T, Mukaida, N, Yamashita, K, Yagisawa, H, Akahoshi, T and Matsushima, K.
II-1 and TNFa induction of IL-8 and monocuyte chematactic and activating factor
(MCAF) mRNA expression in a human astrocytoma cell line. Immunology 74:60-67,
1991.
Kauma, S, Matt, D, Strom, S, Eirman, D and Turner, T. Interleukin-ip, human
leukocyte antigen HLA-DRa, and transforming growth factor-P expression in
endometrium, placenta and placental membranes. Am J Obstet Gynecol 163:1430-1437,
1990.
Kawakami, M, Ishibashi, S, Ogawa, H, Murase, T, Takaku, F and Shlbata, S.
Cachectin/TNF as well as Interleukin-1 induces prostacyclin synthesis In cultured
vascular endothelial cells. Biochem Blophys Res Commun 141:482-487, 1986.
Keirse, MJNC, Flint, APF and Tumbull, AC. F prostaglandins In amniotic fluid during
pregnancy and labour. J Obstet Gynaecol Br Commonw 81:131-135, 1974.
Keirse, MJNC, Hicks, BR, Kendall, JZ and Mitchell, MD. Comparison of Intrauterine
prostaglandin metabolism during pregnancy In man, sheep and guinea pig. Eur J Obstet
Gynecol Reprod Biol 8:195-203, 1978.
Keirse, MJNC, Hicks, BR, Mitchell, MD and Turnbull, AC. Increase of the prostaglandin
precursor, arachidonic acid, in amniotic fluid during spontaneous labour. Br J Obstet
Gynaecol 84:937-940, 1977a.
Keirse, MJNC, Mitchell, MD and Turnbull, AC. Changes in prostaglandin F and 13,14-
dihydro-15-keto-prostaglandin F concentrations in amniotic fluid at the onset of and
during labour. Br J Obstet Gynaecol 84:743-746, 1977b.
Keirse, MJNC, Thiery, M, Parewijck, W and Mitchell, MD. Chronic stimulation of
uterine prostaglandin synthesis during cervical ripening before the onset of labor.
Prostaglandins 25:671-682, 1983.
Keirse, MJNC. Biosynthesis and metabolism of prostaglandins In the pregnant human
uterus. Adv Prostaglandin Thromboxane Res 4:87-102, 1978.
Keirse, MJNC. Endogenous prostaglandins in human parturition. In: Human
parturition. Boerhaave series for postgraduate medical education. Vol 15. Edited by
Keirse, MJNC, Anderson, ABM and Bennebroek Gravenhorst, J. Leiden: Leiden
University Press, pp.101-142. 1979.
Keiser, H, Greenwald, RA, Feinstein, G and Janoff, A. Degradation of cartilage
proteoglycans by human leukocyte granule neutral proteases-A model of joint injury
II. Degradation of isloated bovine nasal cartilage proteoglycan. J Clin Invest 57:625-
632, 1976.
Kelly, JV and Posse, N. The hormone relaxin in labor. Tocometric studies of its effect on
uterine contractions at term. Obstet Gynecol 8:531-535, 1956.
Kelly, RW and Abel, MH. A comparison of the effects of 4-catechol oestrogens and 2-
pyrogallol oestrogens on prostaglandin synthesis by the rat and human uterus. J
Steroid Biochem 14:787-791, 1981.
Kelly, RW and Abel, MH. Catechol oestrogens stimulate and direct prostaglandin
synthesis. Prostaglandins 20:613-626, 1980.
Kelly, RW, Deam, S, Cameron, MJ and Seamark, RF. Measurement by
radioimmunoassay of prostaglandins as their methyl oximes. Prostaglandins Leukot
Med 24:1-14, 1986b.
Danforth, DN and Buckingham, JC. The effects of pregnancy and labor on the amino
acid composition of the human cervix. In: The biology of the cervix. Edited by Blandau,
RJ and Moghissi, K. Chicago: University of Chicago, pp.351-355. 1973.
Danforth, DN and Evanston, MD. The distribution and functional activity of the
cervical musculature. Am J Obstet Gynecol 68:1261-1271, 1954.
Danforth, DN, Buckingham, JC and Roddick, JWJr. Connective tissue changes incident
to cervical efifacement. Am J Obstet Gynecol 80:939-945, 1960.
Danforth, DN, Friedman, EA, Ferenc2y, A, et al. Dilatation of the uterine cervix. New
York: Raven Press, 1980.
Danforth, DN, Veis, A, Breen, M, Weinstein, HG, Buckingham, JC and Manalo, P. The
effect of pregnancy and labor on the human cervix: Changes in collagen, glycoproteins,
and glycosaminoglycans. Am J Obstet Gynecol 120:641-651, 1974.
Danforth, DN. The fibrous nature of the human cervix, and its relation to the isthmic
segment in gravid and nongravid uteri. Am J Obstet Gynecol 53:541-560, 1947.
Danforth, DN. The morphology of the human cervix. Clin Obs Gyn 26:7-13, 1983.
Daniel-Issakani, S, Spiegel, AM and Strulovici, B. Lipopolysaccharide response is
linked to the GTP binding protein Gi2 in the promonocytic cell line U937. J Biol Chem
264:20240-20247, 1989.
Darbonne, WC, Rice, GC, Hohler, MA, et al. Red blood cells are a sink for interleukin 8, a
leukocyte chemotaxin. J Clin Invest 88:1362-1369, 1991.
Das, NP, Khan-Dawood, FS and Dawood, MY. The effects of steroid hormones and
gonadotropins on in vitro placental conversion of pregnenolone to progesterone. J
Steroid Biochem 23:517-522, 1985.
Dayer, JM, Beutler, B and Cerami, A. Cachectin/tumor necrosis factor stimulates
collagenase and prostaglandin E2 production by human synovial cells and dermal
fibroblasts. J Exp Med 162:2163-2168, 1985.
Dayer, JM, de Rochemonteix, B, Burrus, B, Demczuk, S and Dinarello, CA. Human
recombinant interleukin 1 stimulates collagenase and prostaglandin E2 production by
human synovial cells. J Clin Invest 77:645-648, 1986.
Dean, DD and Woessner, JFJr. Extracts of human articular cartilage contain an
inhibitor of tissue metalloproteinases. Biochem J 218:277-280, 1984.
Decker, WH, Thwaite, W, Bordat, S, Kayser, R, Harami, T and Campbell, J. Some effects
of relaxin in obstetrics. Obstet Gynecol 12:37-46, 1958.
DeFranco, AL. Molecular aspects of B-lymphocyte activation. Arm Rev Cell Biol 3:143-
178, 1987.
Dembele-Duchesne, MJ, Thaler-Dao, H, Chavis, C and Crastes de Paulet, A. Some new
prospects in the mechanism of control of arachidonate metabolism in human placenta
and amnion. Prostaglandins 22:979-1002, 1981.
Dennis, EA. Regulation of eicosanoid production: role of phospholipases and
inhibitors. Biotechnology 5:1294-1300, 1987.
Kelly, RW, Graham, BJM and O'Sulllvan, MJ. Measurement of PGE2 as the methyl
oxime by radioimmunoassay using a novel iodlnated label. Prostaglandins
Leukotrlenes and Essential Fatty Acids 37:187-191, 1989.
Kelly, RW, Healy, DL, Cameron, MJ, Cameron, IT and Baird, DT. RU486 stimulation of
PGF2a production in Isolated endometrial cells In short term culture. In: The
antiprogestin steroid RU486 and human fertility control. Edited by Baulieu, E-E and
Segal. SJ. New York: Plenum Press, pp.259-262. 1985.
Kelly, RW, Healy, DL, Cameron, MJ, Cameron, IT and Baird, DT. The stimulation of
prostaglandin production by two antlprogesterone steroids In human endometrial
cells. J Clin Endocrinol Metab 62:1116-1123, 1986a.
Kelly, RW, Leask, R and Calder, AA. Choriodecidual production of interleukin-8 and
mechanism of parturition. Lancet 339:776-777, 1992.
Kelly, RW. Antiprogestins and prostaglandins. Prostaglandins Leukotrlenes and
Essential Fatty Acids 33:231-237, 1988.
Kennedy. I, Coleman, RA, Humphrey, PPA and Lumley, P. Studies on the
characterisation of prostanoid receptors. Adv Prostaglandin Thromboxane
Leukotriene Res 11:327-332, 1983.
Kennedy, I, Coleman, RA, Humphrey, PPA, Levy, GP and Lumley, P. Studies on the
characterisation of prostanoid receptors: a proposed classification. Prostaglandins
24:667-689, 1982.
Kennedy, TG. Does prostaglandin F2a (PGF2a) mediate the effect of relaxin on cervical
tone in the rat? Proc Can Fed Biol Soc 19:273, 1976.(Abstract)
Kikkawa, U, Takai, Y, Tanaka, Y, Miyake, R and Nishizuka, Y. Protein kinase C as a
possible receptor of tumor-promoting phorbol esters. J Biol Chem 258:11442-11445,
1983.
Kilian, PL, Kaffka, KL, Stern, AS, et al. Interleukin la and interleukin lb bind to the
same receptor on T cells. J Immunol 136:4509-4514, 1986.
Killick, SR, Williams, CAV and Elstein, M. A comparison of prostaglandin E2 pessaries
and laminaria tents for ripening the cervix before termination of pregnancy. Br J
Obstet Gynaecol 92:518-521, 1985.
Kishimoto, A, Takai, Y, Mori, T, Kikkawa, U and Nishizuka, Y. Activation of calcium
and phospholipid-dependent protein kinase by diacylglycerol, its possible relation to
phosphatidylinositol turnover. J Biol Chem 255:2273-2276, 1980.
Kitamura, K, Ito, A and Mori, Y. The existing forms of collagenase in the human uterine
cervix. J Biochem 87:753-760, 1980.
Kitamura, K, Ito, A, Mori, Y and Hirakawa, S. Changes in the human uterine cervical
collagenase with special reference to cervical ripening. Biochem Med 22:332-338, 1979.
Kleissl, HP, Van Der Rest, M, Naftolin, F, Glorieux, FH and De Leon, A. Collagen changes
in the human uterine cervix at parturition. Am J Obstet Gynecol 130:748-753, 1978.
Klempner, MS and Dinarello, CA. Stimulation of neutrophil oxygen-dependent
metabolism by human leukocytic pyrogen. J Clin Invest 64:996-1002, 1979.
Klempner, MS, Dinarello, CA and Gallin, JI. Human leukocytic pyrogen induces release
of specific granule contents from human neutrophils. J Clin Invest 61:1330-1336, 1978.
Koay, ESC, Bryant-Greenwood, GD, Yamamoto, SY and Greenwood, FC. The human
fetal membranes: A target tissue for relaxin. J Clin Endocrinol Metab 62:513-521, 1986.
Koay, ESC, Too, CKL, Greenwood, FC and Bryant-Greenwood, GD. Relaxin stimulates
collagenase and plasminogen activator secretion by dispersed human amnion and
chorion cells in vitro. J Clin Endocrinol Metab 56:1332-1334, 1983.
Kokenyesi, R and Woessner, JFJ. Relationship between dilatation of the rat uterine
cervix and a small dermatan sulphate proteoglycan. Biol Reprod 42:87-97, 1990.
Koob, TJ and Ryan, KJ. Collagen dynamics and extensibility in the female reproductive
tract. In: Dilatation of the uterine cervix. Edited by Naftolin, F and Stubblefleld, PG.
New York: Raven Press, pp.45-58. 1980.
Kozawa, O, Tokuda, H, Miwa, M, Kotoyori, J and Oiso, Y. Cross-talk regulation between
cyclic AMP production and phosphoinosotide hydrolysis induced by prostaglandin E2
in osteoblast-like cells. Exp Cell Res 198:130-134, 1992.
Kraft, AS, Anderson, WB, Cooper, HL and Sando, JJ. Decrease In cytosolic
calcium/phospholipid-dependent protein kinase activity following phorbol ester
treatment of EL4 thymoma cells. J Biol Chem 257:13193-13196, 1982.
Krane, SM, Dayer, J-M, Simon, LS and Byrne, S. Mononuclear cell-conditioned
medium containing mononuclear cell factor (MCF), homologous with interleukin 1,
stimulates collagen and fibronectln synthesis by adherent rheumatoid synovial cells:
effects of prostaglandin E2 and indomethacln. Collagen Rel Res 5:99-117, 1985.
Krohn, PL. The effect of steroid hormones on the survival of skin homografts in the
rabbit. J Endocrinol 11:78-82, 1954.
Kulmacz, RJ. Biosynthesis of prostaglandins. In: CRC Handbook of eicosanoids:
Prostaglandins and related lipids. Volume I Chemical and biochemical aspects. Part A.
Edited by Willis, AL. Boca Raton, Florida: CRC Press, pp. 163-174. 1987.
Kunkel, SL, Strieter, RM, Chensue, SW, et al. Tumor necrosis factor-alpha, interleukin-
8 and chemotactic cytokines. In: Cytokines and lipocortins in inflammation and
differentiation. Edited by Melli, M and Parente, L. New York: Wiley-Liss, pp.433-444.
1990.
Kurt-Jones, EA, Kiely, J-M and Unanue, ER Conditions required for expression of
membrane IL 1 on B cells. J Immunol 135:1548-1550, 1985.
Kurzrok, R and Lieb, CC. Biochemical studies of human semen: II. The action of semen
on the human uterus. Proc Soc Exp Biol Med 28:268-272, 1930.
Lamont, RF, Anthony, F, Myatt, L, Booth, L, Furr, PM and Taylor-Robinson, D.
Production of prostaglandin E2 by human amnion in vitro in response to addition of
media conditioned by microorganisms associated with chorioamnionitis and preterm
labor. Am J Obstet Gynecol 162:819-825, 1990.
Larkin, LH, Pardo, RJ and Renegar, RH. Sources of relaxin and morphology of relaxin
containing cells. In: Biology of Relaxin and its Role in the Human. Edited by Bigazzi, M,
Greenwood, FC and Gasparri, F. Amsterdam: Excerpta Medica, pp. 191-205. 1983.
Larsen, CG, Anderson, AO, Appella, E, Oppenheim, JJ and Matsushlma, K. The
neutrophil-actlvatlng protein (NAP-1) is also chemotactic for T lymphocytes. Science
243:1464-1466, 1989a.
Larsen, G, Anderson, AO, Oppenheim, JJ and Matsushima, K. Production of
interleukin-8 by human dermal fibroblasts and keratinocytes in response to
interleukin-1 or tumour necrosis factor. Immunology 68:31-36, 1989b.
Le, J and Vilcek, J. Biology of disease. Tumor necrosis factor and interleukin 1:
cytokines with multiple overlapping biological activities. Lab Invest 56:234-248, 1987.
Leach, KL, James, ML and Blumberg, PM. Characterization of a specific phorbol ester
aporeceptor in mouse brain cytosol. Proc Natl Acad Sci USA 80:4208-4212, 1983.
Ledger, WL, Webster, M, Harrison, LP, Anderson, ABM and Turnbull, AC. Increase in
cervical extensibility during labor induced after isolation of the cervix from the uterus
in pregnant sheep. Am J Obstet Gynecol 151:397-402, 1985.
Ledger, WL, Webster, MA, Anderson, ABM and Turnbull, AC. Effect of inhibition of
prostaglandin synthesis on cervical softening and uterine activity during ovine
parturition resulting from progesterone withdrawal induced by epostane. J Endocrinol
105:227-233, 1984.
Lefebvre, Y, Proulx, L, Elie, R, Poulin, O and Lanza, E. The effects ofRU-38486 on
cervical ripening. Am J Obstet Gynecol 162:61-65, 1990.
Lei, M-G and Morrison, DC. Specific endotoxic lipopolysaccharide-binding proteins on
murine splenocytes I. Detection of lipopolysaccharide-binding sites on splenocytes and
splenocyte subpopulations. J Immunol 141:996-1005, 1988.
Leppert, PC, Keller, S, Ceretta, J and Mandl, I. Conclusive evidence for the presence of
elastin in the human and monkey cervix. Am J Obstet Gynecol 142:179-182, 1982.
Leppi, T,J. and Kinnison, PA. The connective tissue ground substance in the mouse
uterine cervix: An electron microscopic histochemical study. Anat Rec 170:97-117,
1971.
Lewis, RB and Schulman, JD. Influence of acetylsalicylic acid, an inhibitor of
prostaglandin synthesis, on duration of human gestation and labour. Lancet 2:1159-
1161,1973.
Liggins, GC. Cervical ripening as an inflammatory reaction. In: The cervix in
pregnancy and labour. Edited by Ellwood, DA and Anderson, ABM. Edinburgh:
Churchill Livingstone, pp. 1-9. 1981.
Liggins, GC. Initiation of spontaneous labour. Clin Obs Gyn 26:47-55, 1983.
Liggins, GC. Ripening of the Cervix. Semin Perinatol 2:261-271, 1978.
Lin, Y-M and Jarabak, J. Isolation of two proteins with 9-ketoprostaglandin reductase
and NADP-linked 15-hydroxyprostaglandin dehydrogenase activities and studies on
their inhibition. Biochem Biophys Res Commun 81:1227-1234, 1978.
Lindahl, U and Ho6k, M. Glycosaminoglycans and their binding to biological
macromolecules. Ann Rev Biochem 47:385-411, 1978.
Lindley, I, Aschauer, H, Seifert, JM, et al. Synthesis and expression in Escherichia coli
of the gene encoding monocyte-derived neutrophil-activating factor: Biological
equivalence between natural and recombinant neutrophil-activating factor. Proc Natl
Acad Sci USA 85:9199-9203, 1988.
Lindley, IJD, Westwick, J and Kunkel, SL. Nomenclature announcement-the
chemokines. Immunology Today 14:24, 1993.
Luque, EH and Montes, GS. Progesterone promotes a massive infiltration of the rat
uterine cervix by the eosinophilic polymorphonuclear leukocytes. Anat Rec 223:257-
265, 1989.
Luther, ER, Roux, J, Popat, R, et al. The effect of estrogen priming on induction of labor
with prostaglandins. Am J Obstet Gynecol 137:351-357, 1980.
Lyndrup, J, Nickelsen, C, Guldbaek, E and Weber, T. Induction of labor by prostaglandin
E2: Intracervical gel or vaginal pessaries? Eur J Obstet Gynecol Reprod Biol 42:101-109,
1991.
MacKay, CR and Imhof, BA. Cell adhesion in the immune system. Immunology Today
14:99-102, 1993.
MacKenzie, IZ and Embrey, MP. A comparison of PGE2 and PGF20C vaginal gel for
ripening the cervix before induction of labour. Br J Obstet Gynaecol 86:167-170, 1979.
MacKenzie, IZ and Embrey, MP. Cervical ripening with intravaginal PGE2 gel. Br Med J
2:1381-1384, 1977.
MacKenzie, IZ. Clinical studies on cervical ripening. In: The cervix in pregnancy and
labour. Edited by Ellwood, DA and Anderson, ABM. Edinburgh: Churchill Livingstone,
pp. 163-186. 1981.
MacLennan, AH and Green, RC. Cervical ripening and induction of labour with
intravaginal prostaglandin F2a- Lancet 1:117-119, 1979.
MacLennan, AH, Green, RC, Bryant-Greenwood, GD, Greenwood, FC and Seamark, RF.
Ripening of the human cervix and induction of labour with purified porcine relaxin.
Lancet February 2:220-223, 1980.
MacLennan, AH, Green, RC, Grant, P and Nicolson, R. Ripening of the human cervix and
induction of labor with intracervical purified porcine relaxin. Obstet Gynecol 68:598-
601, 1986.
MacLennan, AH, Katz, M and Creasy, MD. The morphologic characteristics of cervical
ripening induced by the hormones relaxin and prostaglandin F2a in a rabbit model.
Am J Obstet Gynecol 152:691-696, 1985.
MacLennan, AH. Cervical ripening and the induction of labour by vaginal
prostaglandin F2a and relaxin. In: The cervix in pregnancy and labour. Edited by
Ellwood, DA and Anderson, ABM. Edinburgh: Chuchill Livingstone, pp.187-195. 1981.
Madden, JD, Siiteri, PK, MacDonald, PC and Gant, NF. The pattern and rates of
metabolism ofmaternal plasma dehydroepiandrosterone sulfate in human pregnancy.
Am J Obstet Gynecol 125:915-920, 1976.
Male, D, Champion, B and Cooke, A. Advanced Immunology. London: Gower Medical
Publishing, 1987.
Manabe, Y, Manabe, A and Takahashl, A. Effect of indomethacin on stretch-Induced
uterine activity In the post-partum. Prostaglandins 25:653-659, 1983.
March, CJ, Mosley, B, Larsen, A, et al. Cloning, sequence and expression of two distinct
human interleukin-1 complementary DNAs. Nature 315:641-647, 1985.
Margolis, AJ and Goldsmith, S. Second trimester abortion after vaginal termination of
pregnancy. Lancet 2:431, 1972.
Matsushlma, K and Oppenheim, JJ. Interleukin 8 and MCAF: Novel Inflammatory
cuytoklnes Inducible by IL-1 andTNF. Cytokine 1:2-13, 1989.
Matsushlma, K, Baldwin, ET and Mukaida, N. Interleukln-8 and MCAF: Novel
leukocyte recruitment and activating cytokines. In: Interleukins: Molecular biology
and Immunology. Edited by Kishimoto, T. Basel: Karger, 51st Ed: pp.236-265. 1992.
Matsushlma, K, Morishita, K, Yoshlmura, T, et al. Molecular cloning of a human
monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of
MDNCF mRNA by Interleukin 1 and tumour necrosis factor. J Exp Med 167:1883-1893,
1988.
Matsushlma, K, Morishita, K, Yoshlmura, T, et al. Molecular cloning of a human
monocyte-derived neutrophil chemotactic factor (MDNCF) and the Induction of
MDNCF mRNA by Interleukin 1 and tumour necrosis factor. J Exp Med 167:1883-1893,
1988.
Mazzone, A, Baiguera, R Rossini, S, et al. Pharmacological effect of hyaluronic acid
(HA) on phagocytosis: Hypothesis for an HA-induced monocyte chemotactic factor for
neutrophils. Clinical Therapeutics 8:527-536, 1986.
McCall, JL, Yun, K, Funamoto, S and Parry, BR In vivo immunohistochemical
identification of tumor necrosis factor/cachetin in human lymphoid tissue. Am J
Pathol 135:421-425, 1989.
McCarthy, JJ, Erving, HW and Laufe, LE. Preliminary report on the use of relaxin in the
management of threatened premature labor. Am J Obstet Gynecol 74:134-138, 1957.
McDonald, JK and Schwabe, C. Relaxin-induced elevations of cathepsin B and
dipeptidyl peptidase I In the mouse pubic symphysis, with localization by flourescence
enzyme histochemistry. Ann NY Acad Sci 380:178-186, 1982.
McGaughey, HS, Corey, EL and Thornton, WN. An evaluation of the action of relaxin on
isolated human uterine muscle and cervical tissues in vitro. Am J Obstet Gynecol 75:23-
27, 1958.
McGregor, JA. Prevention of preterm birth: New initiatives based on microbial-host
interactions. Obstet Gynecol Surv 43:1-14, 1988.
Mclnnes, CJ. Current research on ovine cytokines. B Veterinary J 149:371-386, 1993.
Medawar, PB and Sparrow, EM. The effects of adrenocortical hormones,
adrenocorticotrophic hormone and pregnancy on skin transplantation immunity in
mice. J Endocrinol 14:240-256, 1956.
Mercado-Slmmen, RC, Goodwin, B, Ueno, MS, Yamamoto, SY and Bryant-Greenwood,
GD. Relaxin receptors in the myometrium and cervix of the pig. Biol Reprod 26:120-128,
1982.
Mercer, E, Cawston, TE, DeSilva, M and Hazleman, BL. Purification of a
metalloproteinase inhibitor from human rheumatoid synovial fluid. Biochem J
231:505-510, 1985.
Michelet, C, Coffe, C, Schaal, JP, Chapuis, P and Colette, C. La maturation artiflcielle du
col gravide par action locale de leucocytes maternels. Rev Fr Gynecol Obstet 81:137-142,
1986.
Milewich, L, Gant, NF, Schwarz, BE, Chen, GT and MacDonald, PC. Initiation of human
parturition. VIII. Metabolism of progesterone by fetal membranes of early and late
human gestation. Obstet Gynecol 50:45, 1977.
Minamoto, T, Aral, K, Hirakawa, S and Nagai, Y. Immunohistochemical studies on
collagen types in the uterine cervix in pregnant and nonpregnant states. Am J Obstet
Gynecol 156:138-144, 1987.
Mitchell, B, Cruikshank, B, McLean, D and Challis, J. Local modulation of progesterone
production in human fetal membranes. J Clin Endocrinol Metab 55:1237-1239, 1982.
Mitchell, MD and Grzyboski, CF. Arachidonic acid metabolism by lipoxygenase
pathways in intrauterine tissues of women at term of pregnancy. Prostaglandins
Leukot Med 28:303-312, 1987.
Mitchell, MD, Flint, APF and Turnbull, AC. Stimulation by oxytocin of prostaglandin
F levels in uterine venous effluent in pregnant and peurperal sheep. Prostaglandins
9:47-56, 1975.
Mitchell, MD, Flint, APF, Bibby, J, et al. Rapid increases in plasma prostaglandin
concentrations after vaginal examination and amniotomy. Br Med J 2:1183-1185,
1977.
Mochizuki, M and Tojo, S. Effect of dehydroepiandrosterone sulfate on softening and
dilatation of the uterine cervix in pregnant women. In: Dilatation of the uterine cervix.
Edited by Naftolin, F and Stubblefield, PG. New York: Raven Press, pp.267-286. 1980.
Mori, Y, Ito, A, Hirakawa, S and Kitamura, K. Proteinases in the human and rabbit
cervix. In: The cervix in pregnancy and labour. Edited by Ellwood, DA and Anderson,
ABM. Edinburgh: Churchill Livingstone, pp. 136-143. 1981.
Morrison, DC and Ryan, JL. Endotoxins and disease mechanisms. Ann Rev Med 38:417-
432, 1987.
Morrison, DC. C3H/HeJ mouse strain role in elucidation of host response to bacterial
endotoxins. In: Microbiology. Edited by Leive, L. Washington: ASM Publications, pp.23-
28. 1986.
Mukaida, N and Matsushima, K. Regulation of IL-8 production and the characteristics
of the receptors for IL-8. In: Interleukin-8 (NAP-1) and related chemotactic cytokines.
Edited by Baggiolini, M and Sorg, C. Basel: Karger, 4th Ed: pp.41-53. 1992.
Mukaida, N, Hishinuma, A, Zachariae, COC, Oppenheim, JJ and Matsushima, K.
Regulation of human interleukin 8 gene expression and binding of several other
members of the intercrine family to receptors for interleukin 8. Adv Exp Med Biol
305:31-38, 1991.
Mukaida, N, Mahe, Y and Matsushima, K. Cooperative interaction of nuclear factor-K-
B- and cis-regulatory enhancer binding protein-like factor binding elements in
activating the interleukin-8 gene by pro-inflammatory cytokines. J Biol Chem
265:21128-21133,1990.
Mukaida, N, Morita, M, Ishikawa, Y, et al. Novel mechanism of glucocorticoid-
mediated gene repression. Nuclear factor-KB is target for glucocorticoid-mediated
interleukin 8 gene repression. J Biol Chem 269:13289-13295, 1994a.
Mukaida, N, Okamoto, S-i, Ishikawa, Y and Matsushima, K. Molecular mechanism of
interelukin-8 gene expression. J Leukoc Biol 56:554-558, 1994b.
Murato, S-I, Abe, M and Otsuka, K. Stimulatory effect of prostaglandins on the
production of hexosamine-containing substances by cultured fibroblasts (3) Induction
of hyaluronic acid synthetase by prostaglandin F2a- Prostaglandins 14:983-991, 1977.
Murphy, G, Cawston, TE and Reynolds, JJ. An inhibitor of collagenase from human
amniotic fluid. Purification, characterization and action on metalloproteinases.
Biochem J 195:167-170, 1981.
Najak, Z, Hillier, K and Karim, SMM. The action of prostaglandins on the human
isolated non-pregnant cervix. J Obstet Gynaecol Br Commonw 77:701-709, 1970.
Nishizuka, Y. The role of protein kinase C in cell surface signal transduction and
tumour promotion. Nature 308:693-698, 1984.
Nissenson, R, Flouret, G and Hechter, O. Opposing effects of estradiol and progesterone
on oxytocin receptors in rabbit uterus. Proc Natl Acad Sci USA 75:2044-2048, 1978.
Norstrom, A and Wiqvist, I. Relaxin induced changes in 3',5'-monophosphate levels in
the human cervix. Acta Endocrinol 109:122-125, 1985.
Norstrom, A. Influence of prostaglandin E2 on the biosynthesis of connective tissue
constituents in the pregnant human cervix. Prostaglandins 23:361-367, 1982.
Novak, E. Textbook of Gynecology. Baltimore: Williams &Wilkins Co., 2nd Ed: pp.
13.1944.
Novy, MJ and Walsh, SW. Dexamethasone estradiol treatment in pregnant rheseus
macaques: Effects on gestational length, maternal plasma hormones and fetal growth.
Am J Obstet Gynecol 145:920-931, 1983.
O'Brien, WF, Knuppel, RA and Cohen, GR. Plasma prostaglandin metabolite levels after
use of prostaglandin E2 gel for cervical ripening. Am J Obstet Gynecol 155:1037-1040,
1986.
O'Day, MB, Winn, RJ, Easter, RA, Dziuk, PJ and Sherwood, OD. Hormonal control of the
cervix in pregnant gilts. II. Relaxin promotes changes in the physical properties of the
cervix in ovariectomised hormone-treated pregnant gilts.. Endocrinology 125:3004-
3010, 1989.
Obrink, B. A study of the interactions between monomeric tropocollagen and
glycosaminoglycans. Eur J Biochem 33:387-400, 1973.
Ohno, T, Imai, A and Tamaya, T. Possible evidence that dehydroepiandrosterone
sulfate (DHA-S) stimulates cervical ripening by a membrane-mediated process: specific
binding-sites in plasma membrane from human uterine cervix. Research
Communications in Chemical Pathology and Pharmacology 72:117-120, 1991.
Okamoto, S-i, Mukaida, N, Yasumoto, K, et al. The interleukin-8 AP-1 and xB-like sites
are genetic end targets of FK506-sensitive pathway accompanied by calcium
mobilization. J Biol Chem 269:8582-8589, 1994.
Okamura, K, Yonemoto, Y, Hamazaki, Y, Higashiiwai, H and Yajima, A. Nitroblue
tetrazolium reduction by leukocytes in the cervix of pregnant women. Am J Obstet
Gynecol 159:417-420, 1988.
Okazaki, T, Casey, ML. Okita, JR. MacDonald, PC and Johnston, JM. Initiation of
human parturition: XII. Biosynthesis and metaboism of prostaglandins in human fetal
membranes and uterine decidua. Am J Obstet Gynecol 139:373-381, 1981.
Oliveira, IC, Sciavolino, PJ, Lee, TH and Vilcek, J. Downregulation of interleukin 8 gene
expression in human fibroblasts: Unique mechanism of transcriptional inhibition by
interferon. Proc Natl Acad Sci USA 89:9049-9053, 1992.
Olson, DM, Skinner, K and Challis, JRG. Estradiol-17b and 2-hydroxyestradiol-17(3-
induced differential production of prostaglandins by cells dispersed from human
intrauterine tissues at parturition. Prostaglandins 25:639-651, 1983b.
Olson, DM, Skinner, K and Challis, JRG. Prostaglandin output in relation to
parturition by cells dispersed from human intrauterine tissues. J Clin Endocrinol
Metab 57:694-699, 1983a.
Olund, A, Jonasson, A, Kindahl, H, Fianu, S and Larrson, B. The effect of cervical
dilatation by laminaria on the plasma levels of 15-keto-13,14-dihydro-PGF2a-
Contraception 30:23-27, 1984.
Osmers, R, Rath, W, Adelmann-Grill, BC, et al. Origin of cervical collagenase during
parturition. Am J Obstet Gynecol 166:1455-1460, 1992.
Osmers, R, Rath, W, Adelmann-Grill, BC, Fittkow, C, Severenyi, M and Kuhn, W.
Collagenase activity in the cervix of non-pregnant and pregnant women. Arch Gynecol
Obstet 248:75-80, 1990.
Owen, J and Hauth, JC. Oxytocin for the induction or augmentation of labor. Clin Obs
Gyn 35:464-475, 1992.
Oxholm, A, Oxholm, P, Staberg, B and Brendtzen, K. Immunohistological detection of
interleukin 1-like molecules and tumour necrosis factor in human epidermis before
and after UVB-irradation in vivo. Br J Dermatol 118:369-376, 1988.
Papaevangelou, G, Vrettos, AS, Papadatos, C and Alexiou, D. The effect of spontaneous
and induced abortion on prematurity and birthweight. J Obstet Gynaecol Br Commonw
80:418-422, 1973.
Parker, CR, Leveno, K, Carr, BR, Hauth, J and MacDonald, PC. Umbilical cord plasma
levels of dehydroepianrosterone sulfate during human gestation. J Clin Endocrinol
Metab 54:1216-1220, 1982.
Parry, DM and Ellwood, DA. Ultrastructural aspects of cervical softening In the sheep.
In: The cervix In pregnancy and labour. Edited by Ellwood, DA and Anderson, ABM.
Edinburgh: Churchill Livingstone, pp.74-84. 1981.
Pedersen, S, Petersen, JM and Aegldius, J. Comparison of oestradiol and prostaglandin
E>2 vaginal gel for ripening the unfavourable cervix. Br Med J 282:1395, 1981.
Peers, SH, Moon, D and Flower, RJ. Reversal of the anti-inflammatory effects of
dexamethasone by the glucocorticoid antagonist RU 38486. Biochem Pharmacol
37:556-557, 1988.
Petersen, LK, Svane, D, Uldbjerg, N and Forman, A Effects of human relaxin on
isolated rat and human myometrium and uteroplacental arteries. Obstet Gynecol
78:757-762, 1991.
Peveri, P, Walz, A, Dewald, B and Baggiolini, M. A novel neutrophil-activating factor
produced by human mononuclear phagocytes. J Exp Med 167:1547-1559, 1988.
Pfeilschlfter, J, Pignat, W, Vosbeck, K and Marki, F. Interleukln 1 and tumour necrosis
factor synergistically stimulate prostaglandin synthesis and phospholipase A2 release
from rat mesangial cells. Biochem Biophys Res Commun 159:385-394, 1989.
Pickering, RM and Forbes, JF. Risks of preterm delivery and small for gestational age
infants following abortion: a population study. Br J Obstet Gynaecol 92:1106-1112,
1985.
Pinto, RM, Fisch, L, Schwarcz, RL and Montouri, E. Action of estradiol-17(1 upon uterine
contractility and the milk-ejecting effect in the pregnant woman. Am J Obstet Gynecol
90:99-106, 1964.
Pinto, RM, Rabow, W and Votta, RA. Uterine cervix ripening in term pregnancy due to
the action of estradiol-17(3, a histological and histochemical study. Am J Obstet
Gynecol 92:319-324, 1965.
Platz-Christensen, JJ, Brandberg, A and Wiqvist, N. Increased prostaglandin
concentrations in the cervical mucus of pregnant women with bacterial vaginosis.
Prostaglandins 43:133-141, 1992.
Pnatelkis, SN, Papadimitriou, GG and Doxiadis, SA Influence of induced and
spontaneous abortion on the outcome of subsequent pregnancies. Am J Obstet Gynecol
116:799-805, 1973.
Poole, AR. Proteinases of connective tissues. In: Dilatation of the uterine cervix. Edited
byNaftolin, F and Stubblefleld, PG. New York: Raven Press, pp.113-131. 1980.
Porto, M. The unfavorable cervix: Methods of cervical priming. Clin Obs Gyn 32:262-
268, 1989.
Poyser, NL. Prostaglandin F2a ls the luteolytic hormone in the guinea pig: The evidence
reviewed. Adv Prostaglandin Thromboxane Res 2:633-643, 1976.
Puri, CP and Garfield, RE. Changes in hormone levels and gap junctions in the rat
uterus during pregnancy and parturition. Biol Reprod 27:967-975, 1982.
Quagliarello, J, Lustig, DS, Steinetz, BG and Weiss, G. Absence of a prelabor relaxin
surge in women. Biol Reprod 22:202-204, 1980.
RAdestad, A, Bygdeman, M and Green, K. Induced cervical ripening with mifepristone
(RU486) and byconversion of arachidonic acid In human pregnant uterine cervix in the
first trimester. Contraception 41:283-292, 1990.
RAdestad, A, Christensen, NJ and Strdmberg, L. Induced cervical ripening with
mifepristone in first trimester abortion: A double-blind randomized blomechanical
study. Contraception 38:301-312, 1988.
Raetz, CRH. Biochemistry of endotixins. Ann Rev Biochem 59:129-170, 1990.
Rajabi, M, Solomon, S and Poole, AR Hormonal regulation of Interstitial collagenase
In the uterine cervix of the pregnant guinea pig. Endocrinology 128:863-871, 1991a.
Rajabi, MR, Dean, DD, Beydoun, SN andWoessner, JFJr. Elevated tissue levels of
collagenase during dilation of uterine cervix in human parturition. Am J Obstet
Gynecol 159:971-976, 1988.
Rajabi, MR, Dodge, GR Solomon, S and Poole, AR Immunochemical and
immunohistochemical evidence of estrogen-mediated collagenolysis as a mechanism
of cervical dilatation in the guinea pig at parturition. Endocrinology 128:371-378,
1991b.
Rath, W, Adelmann-Grill, BC, Osmers, R and Kuhn, W. Enzymatic collagen degradation
in the pregnant guinea pig cervix during physiological maturation of the cervix and
after local application of prostaglandins. Eur J Obstet Gynecol Reprod Biol 32:199-204,
1989.
Rath, W, Adelmann-Grill, BC, Pieper, U and Kuhn, W. The role of collagenases and
proteases In prostaglandin-induced cervical ripening. Prostaglandins 34:119-127,
1987.
Rath, W, Adelmann-Grill, BC, Pieper, U, Kuhn, W and Osmers, R Collagenase activity in
cervical tissue of the non-pregnant and pregnant human cervix. Acta Physiologica
Hungarica 71:491-495, 1988b.
Rath, W, Kuhnle, H, Theobald, P and Kuhn, W. Objective demonstration of cervical
softening with a prostaglandin F2a gel during first trimester abortion. Int J Gynaecol
Obstet 20:195, 1982.
Rath, W, Osmers, R Adelmann-Grill, BC, Stuhlsatz, HW, Szeverenyi, M and Kuhn, W.
Biophysical and biochemical changes of cervical ripening. In: Prostaglandins for
cervical ripening and/or Induction of labour. Edited by Egarter, C and Husslein, P.
Vienna: Facultas Universitatsverlag, pp.32-41. 1988a.
Raynes, JG, Anderson, JC, Fitzpatrick, RJ and Dobson, H. Increased collagenase
activity is not detectable in cervical softening in the ewe. Collagen Rel Res 8:461-469,
1988a.
Raynes, JG, Clarke, FA, Anderson, JC, Fitzpatrick, RJ and Dobson, H. Collagenase
inhibitor concentration In cultured cervical tissue of sheep is increased In late
pregnancy. J Reprod Fert 83:893-900, 1988b.
Reddi, K, Kambaran, SR Norman, RJ, Joubert, SM and Philpott, RH. Abnormal
concentrations of prostaglandins in amniotic fluid during delayed labour In
multigravid patients. Br J Obstet Gynaecol 91:781-787, 1984.
Rehnstrom, J, Ishikawa, M, Fuchs, F and Fuchs, A-R. Stimulation ofmyometrial and
decidual prostaglandin production by amniotic fluid from term, but not midtrimester
pregnancies. Prostaglandins 26:973-981, 1983.
Riemer, RK, Goldflen, AC, Goldfien, A and Roberts, JM. Rabbit uterine oxytocin
receptors and in vitro contractile response: Abrupt changes at term and the role of
eicosanoids. Endocrinology 119:699-709, 1986.
Rimmer, DM. The effect of pregnancy on the collagen of the uterine cervix of the mouse.
J Endocrinol 57:413-418, 1973.
Roberts, JM, Insel, PA and Goldfien, A. Regulation of myometrial adrenoreceptors and
adrenergic response by sex steroids. Mol Pharmacol 20:52-58, 1981.
Roberts, JS, McCracken, JA, Gavagan, JE and Soloflf, MS. Oxytocln-stimulated release
of prostaglandin F2a from ovine endometrium in vitro: Correlation with estrus cycle
and oxytocin-receptor binding. Endocrinology 99:1107-1114, 1976.
Robertson, RP. Characterization and regulation of prostaglandin and leukotriene
receptors: an overview. Prostaglandins 31:395-411, 1986.
Romero, R, Brody, DT, Oyarzun, E, et al. Infection and labor. III. Interleukin-1: a signal
for the onset of parturition. Am J Obstet Gynecol 160:1117-1123, 1989c.
Romero, R, Ceska, M, Avila, C, Mazor, M, Behnke, E and Lindley, I. Neutrophil
attractant/activating peptide-l/interleukin-8 in term and preterm parturition. Am J
Obstet Gynecol 165:813-820, 1991.
Romero, R, Emamian, M, Wan, M, Grzyboski, C, Hobbins, JC and Mitchell, MD.
Increased concentrations of arachidonic acid lipoxygenase metabolites in amniotic
fluid during parturition. Obstet Gynecol 70:849-851, 1987a.
Romero, R, Manogue, KR, Mitchell, MD, et al. Infection and labor. IV. Cachetin-tumor
necrosis factor in the amniotic fluid of women with intraamniotic infection and
preterm labor. Am J Obstet Gynecol 161:336-341, 1989d.
Romero, R, Quintero, R, Emamian, M, et al. Arachidonate lipoxygenase metabolites in
amniotic fluid of women with intra-amniotic infection and preterm labor. Am J Obstet
Gynecol 157:1454-1460, 1987b.
Romero, R, Rolansky, P, Oyarzun, E, et al. Labor and infection. II. Bacterial endotoxin
in amniotic fluid and its relationship to the onset of preterm labor. Am J Obstet
Gynecol 158:1044-1049, 1988.
Romero, R, Wu, YK, Brody, DT, Oyarzun, E, Duff, GW and Durum, SK. Human decidua: a
source of interleukln-1. Obstet Gynecol 73:31-34, 1989b.
Romero, R, Wu, YK, Mazor, M, Oyarzun, E, Hobbins, JC and Mitchell, MD. Amniotic
fluid arachidonic lipoxygenase metabolites in preterm labor. Prostaglandins
Leukotrienes and Essential Fatty Acids 36:69-75, 1989a.
Rorie, DK and Newton, M. Histologic and chemical studies of the smooth muscle in the
human cervix and uterus. Am J Obstet Gynecol 99:466-469, 1967.
Rosen, A, Nairn, AC, Greengard, P, Cohn, ZA and Aderem, A. Bacterial
lipopolysaccharide regulates the phosphorylation of the 68K protein kinase C substrate
in macrophages. J Biol Chem 264:9118-9121, 1989.
Rosoff, PM and Cantley, LC. Lipopolysaccharide and phorbol esters induce
differentiation but have opposite effects on phosphatidylinositol turnover and Ca2+
mobilization in 70Z/3 pre-B lymphocytes. J Biol Chem 260:9209-9215, 1985.
Rot, A. Chemotactic potency of recombinant human neutrophil attractant/activation
protein-1 (interleukin-8) for polymorphonuclear leukocytes of different species.
Cytokine 3:21-27, 1991.
Rot, A. Endothelial cell binding of NAP-1/IL-8: role in neutrophil emigration. Immunol
Today 13 (8):291-294, 1992.
Roughley, PJ and Barratt, AJ. The degradation of cartilage proteoglycans by tissue
proteinases. Biochem J 167:629-637, 1977.
Roughley, PJ. The degradation of cartilage proteoglycans by tissue proteinases.
Proteoglycan heterogeneity and the pathway of proteolytic degradation. Biochem J
167:639-646, 1977.
Ruco, LP, Stoppacciaro, A, Pomponi, D, et al. Immunoreactivity for IL-1 beta and TNF
alpha in human lymphoid and non lymphoid tissues. Am J Pathol 135:889-897, 1989.
Saeed, SA and Mitchell, MD. Formation of arachidonate lipoxygenase metabolites by
human fetal membranes, uterine decidua vera and placenta. Prostaglandins Leukot
Med 8:635-640, 1982b.
Saeed, SA and Mitchell, MD. New aspects of arachidonic acid metabolism in the human
uterine cervix. Eur J Pharmacol 81:515-516, 1982a.
Saeed, SA, Strickland, DC, Young, DC, Dang, A and Mitchell, MD. Inhibition of
prostaglandin synthesis by human amniotic fluid: Acute reduction in inhibitory
activity of amniotic fluid obtained during labor. J Clin Endocrinol Metab 55:801-803,
1982.
Saito, Y, Takahashi, S and Maki, M. Effects of conjugated estrogens on ripening of
uterine cervix in nonpregnant castrated and pregnant rats. Acta Obst Gynaec Jpn 33
(2):292-300, 1981.
Sakyo, K, Ito, A and Mori, Y. Dehydroepiandrosterone sulfate stimulates collagenase
synthesis without affecting the rates of collagen and noncollagen protein synthesis by
rabbit uterine cervical fibroblasts. Biol Reprod 36:277-281, 1987.
Sakyo. K, Ito, A and Mori, Y. Effects of dehydroepiandrosterone sulphate on the
production of collagenase and gelatinolytic metalloproteinase by rabbit uterine
cervical cells in primary cultures. J Pharmacobio-Dyn 9:276-286, 1986.
Sakyo, K, Ito, A, Ogawa, C and Mori, Y. Hormonal control of collagenase inhibitor
production in rabbit uterine cervical fibroblast-like cells. Biochim Biophys Acta
883:517-522, 1986.
Salamonsen, LA, Hampton, AL, Clements, JA and Findlay, JK. Regulation of gene
expression and cellular localization of prostaglandin synthase by oestrogen and
progesterone in the ovine uterus. J Reprod Fert 92:393-406, 1991.
Samanta, AK, Oppenheim, JJ and Matsushima, K. Identification and characterization
of specific receptors for monocyte-derived neutrophil chemotactic factor (MDNCF) on
human neutrophils. J Exp Med 169:1185-1189, 1989.
Sanborn, BM, Held, B and Kuo, HS. Hormonal action in human cervix II: specific
progestagen binding proteins in human cervix. J Steroid Biochem 7:665-672, 1976.
Sanborn, BM, Held, B and Kuo, HS. Specific estrogen binding proteins In human cervix.
J Steriod Biochem Suppl 6:1107-1112, 1975.
Sanborn, BM, Kuo, HS and Held, B. Estrogen and progestagen binding site
concentrations In human endometrium and cervix throughout the menstrual cycle and
in tissue from women taking oral contraceptives. J Steriod Biochem Suppl 9:951-955,
1978.
Sando, JJ and Young, MC. Identification of high-affinity phorbol ester receptor In
cytosol of EL4 thymoma cells: Requirement for calcium, magnesium and
phospholipids. Proc Natl Acad Sci USA 80:2642-2646, 1983.
Sapolsky, AI, Howell, DS and Woessner, JFJr. Neutral proteases and cathepsin D In
human atricular cartilage. J Clin Invest 53:1044-1053, 1974.
Sapolsky, AI, Keiser, H, Howell, DS and Woessner, JFJr. Metalloproteases of human
articular cartilage that digest cartilage proteoglycans at neutral and acid pH. J Clin
Invest 58:1030-1041, 1976.
Sariban, E, Imamura, K, Luebbers, R and Kufe, D. Transcriptional and
posttranscriptional regulation of tumor necrosis factor gene expression in human
monocytes. J Clin Invest 81:1506-1510, 1988.
Satin, AJ and Hankins, GDV. Induction of labor in the postdate fetus. Clin Obs Gyn
32:269-277, 1989.
Sauder, DN, Mounessa, NL, Katz, SI, Dinarello, CA and Gallin, JI. Chemotactic
cytokines: The role of leukocyte pyrogen and epidermal cell thymocyte-activating
factor in neutrophil chemotaxis. J Immunol 132:828-832, 1984.
Schlaepfer, DD and Haigler, HT. Characterisation of Ca2+-dependent phospholipid
binding and phosphorylation of lipocortin 1. J Biol Chem 262:6931-6937, 1987.
Schmid, J and Weissmann, C. Induction ofmRNA for a serine protease and a (1-
thromboglobulin-like protein in mitogen-stimulated human leukocytes. J Immunol
139:250-256, 1987.
Schr6der, J-M, Mrowietz, U, Morita, E and Christophers, E. Purification and partial
biochemical characterisation of a human monocyte-derived, neutrophil-activating
peptide that lacks interleukin 1 activity. J Immunol 139:3474-3483, 1987.
Schwalm, H and Dubrauszky, V. The structure of the musculature of the human uterus -
muscles and connective tisssue. Am J Obstet Gynecol 94:391-404, 1966.
Scott, JE and Orford, CR Dermatan sulphate-rich proteoglycan associates with rat tail
tendon collagen at the d band in the gap region. Biochem J 197:213-216sl, 1981.
Sellers, SM, Hodgson, HT, Mitchell, MD, Anderson, ABM and Turnbull, AC. Release of
prostaglandins after amniotomy is not mediated by oxytocin. Br J Obstet Gynaecol
87:43-46, 1980.
Seron-Ferre, M, Taylor, NF, Rotten, D, Koritnik, DR and Jaffe, RB. Changes in fetal
rhesus monkey plasma dehydroepiandrosterone sulfate: Relationship to gestational
age, adrenal weight and preterm delivery. J Clin Endocrinol Metab 57:1173-1178, 1983.
Shepherd, J, Sims, C and Craft, I. Extra-amniotic prostaglandin E2 and the
unfavourable cervix. Lancet 709-710, 1976.
Sherwood, OD. Relaxin. In: The Physiologt of Reproduction. Edited by Knobil, E, Neill, J
and et al, . New York: Raven Press, pp.585-673. 1988.
Shime, J, Gare, DJ, Andrews, J, Bertrand, M, Salgado, J and Whillans, G. Prolonged
pregnancy: Surveillance of the fetus and the neonate and the course of labor and
delivery. Am J Obstet Gynecol 148:547-552, 1984.
Sica, A, Matsushima, K, Van Damme, J, et al. IL-1 transcriptionally activates the
neutrophil chemotactic factor/IL-8 gene in endothelial cells. Immunology 69:548-553,
1990.
Siiteri, PK and MacDonald, PC. Placental estrogen biosynthesis during human
pregnancy. J Clin Endocrinol Metab 26:751-761, 1966.
Siiteri, PK, Febres, F, Clemens, LE, Chang, RJ, Gondos, B and Stites, D. Progesterone
and maintenance of pregnancy: Is progesterone nature's immunosuppressant? Ann NY
Acad Sci 286:384-397, 1977.
Simmons, RL, Price, AL and Ozerkis, AJ. The immunologic problem of pregnancy. V.
The effect of estrogen and progesterone on allograft survival. Am J Obstet Gynecol
100:908-911,1968.
Skinner, KA and Challis, JRG. Changes in the synthesis and metabolism of
prostaglandins by human fetal membranes and decidua at labor. Am J Obstet Gynecol
151:519-523, 1985.
Smit, DA, Essed, GGM and de Haan, J. Predictive value of uterine contractility and the
serum levels of progesterone and oestrogens with regard to preterm labour. Gynecol
Obstet Invest 18:252-263, 1984.
Smith, WL. Prostaglandin biosynthesis and its compartmentalisation in vascular
smooth muscle and endothelial cells. Ann Rev Physiol 48:251-262, 1986.
Soloff, MS. Uterine receptor for oxytocin: effects of estrogen. Biochem Biophys Res
Commun 65:205-212, 1975.
Souka, AR, Karson, O, Shams, A and Toppozada, M. Role of endogenous prostaglandins
in pregnancy termination by 15-methyl PGF2a- Prostaglandins 25:711-714, 1983.
Spriggs, D, Imamura, K, Rodriguez, C, Horiguchi, J and Kufe, DW. Induction of tumor
necrosis factor expression and resistance in a human breast tumor cell line. Proc Natl
Acad Sci USA 84:6563-6566, 1987.
Stander, HJ. Textbook ofObstetrics. New York: D Appleton-Centuiy Co., pp. 18.1945.
Standiford, TJ, Strieter, RM, Allen, RM, Burdick, MD and Kunkel, SL. IL-7 up-regulates
the expression of IL-8 from resting and stimulated human blood monocytes. J Immunol
149:2035-2039, 1992.
Staples, LD, Heap, RB, Wooding, FBP and King, GJ. Migration of leucocytes into the
uterus after acute removal of ovarian progesterone during early pregnancy in the sheep.
Placenta 4:339-350, 1983.
Steinetz, BG and Manning, JP. Influence of growth hormone, steroids and relaxln on
acid phosphatase activity of connective tissue. Proc Soc Exp Biol Med 124:180-184,
1967.
Steinetz, BG, Manning, JP, Butler, M and Beach, V. Relationships of growth hormone,
steroids and relaxln In the transformation of pubic joint cartilage to ligament In
hypophysectomised mice. Endocrinology 76:876-882, 1965.
Stewart, P, Kennedy, JH, Barlow, DH and Calder, AA. A comparison of oestradiol and
prostaglandin E2 for ripening the cervix. Br J Obstet Gynaecol 88:236-239, 1981.
Stiemer, B and Elger, W. Cervical ripening of the rat in dependence on endocrine milieu;
effects of antigestagens. J Perinat Med 18:419-429, 1990.
Stieve, H. Der halstell des menschlichen gebcirmutter, etc. Leipzig: Akademische
Verlagsgesellschaft M.B.H., 1927.
Stites, DP and Siiteri, PK. Steroids as immunosuppresants in pregnancy.
Immunological Rev 75:117-138, 1983.
Strickland, DC, Saeed, SA, Casey, ML and Mitchell, MD. Stimulation of prostaglandin
biosynthesis by urine of the human fetus may serve as a trigger for parturition. Science
220:521-522, 1983.
Stricklin, GP and Welgus, HG. Human skin fibroblast collagenase inhibitor.
Purification and biochemical characterization. J Biol Chem 258:12252-12258, 1983.
Strieter, RM, Kunkel, SL, Showell, HJ, et al. Endothelial cell gene expression of a
neutrophil chemotactic factor by TNFa, LPS and IL-ip. Science 243:1467-1469, 1989.
Strittmatter, W, Weckesser, J, Salimath, PV and Galanos, C. Nontoxic
lipopolysaccharide from Rhodopseudomonas sphaeriodes ATCC 17023. J Bacterid
155:153-158, 1983.
Stryer, L and Bourne, HR G-proteins: A family of signal transducers. Ann Rev Cell Biol
2:391-420, 1986.
Stryer, L. Biochemistry. New York: W.H. Freeman and Company, 2nd Ed: 1980.
Stubblefield, PG. Present techniques for cervical dilatation. In: Dilatation of the
uterine cervix. Edited by Stubblefield, PG and Naftolin, F. New York: Raven Press,
pp.335-342. 1980.
Stys, SJ, Clewell, WH and Meschia, G. Changes in cervical compliance at parturition
Independent of uterine activity. Am J Obstet Gynecol 130:414-418, 1978.
Suganuma, M, Fujiki, H, Suguri, H, et al. Okadaic acid: An additional non-phorbol-12-
tetradecanoate-13-acetate-type tumor promoter. Proc Natl Acad Sci USA 85:1768-1771,
1988.
Swahn, ML and Bygdeman, M. The effect of the antiprogestin RU486 on uterine
contractility and sensitivity to prostaglandin and oxytocin. Br J Obstet Gynaecol
95:126-134, 1988.
Szlachter, N, O'Byrne, E, Goldsmith, L, Steinetz, BG andWeiss, G. Myometrial
inhibiting activity of relaxin-containing extracts of human corpora lutea of pregnancy.
Am J Obstet Gynecol 136:584-586, 1980.
Tabibzadeh, S, Kaffka, KL, Satyaswaroop, PG and Kilian, PL. Interleukln-1 regulation
of human endometrial function: Presence of IL-1 receptor correlates with IL-1-
stimulated prostaglandin E2 production. J Clin Endocrinol Metab 70:1000-1006, 1990.
Tabibzadeh, S. Cytokine regulation of human endometrial function. Ann NY Acad Scl
622:89-98, 1991b.
Tabibzadeh, S. Human endometrium: An active site of cytokine production and action.
Endocrine Reviews 12:272-290, 1991a.
Tachlbana, K, Scheuer, PJ, Tsukitani, Y, et al. Protein phosphatases come of age. J Am
ChemSoc 103:2469-2471, 1981.
Takacs, L, Kovacs, EJ, Smith, MR, Young, HA and Durum, SK. Detection of IL-1 a and IL-
lb gene expression by in situ hybridization. Tissue localization of IL-1 mRNA In the
normal C57BL/6 mouse. J Immunol 141:3081-3095, 1988.
Takahashi, GW, Andrews, DF.III, Lilly, MB, Singer, JW and Alderson, MR Effect of
granulocyte-macrophage colony-stimulating factor and interleukin-3 on interleukin-8
production by human neutrophils and monocytes. Blood 81:357-364, 1993.
Takai, A, Blalojan, C, Troschka, M and Ruegg, JC. Smooth muscle myosin phosphatase
inhibition and force enhancement by black sponge toxin. FEBS Lett 217:81-84, 1987.
Takai, Y, Kishlmoto, A, Iwasa, Y, Kawahara, Y, Mori, T and Nishizuka, Y. Calcium-
dependent activation of a multifunctional protein kinase by membrane phospholipids.
J Biol Chem 254:3692-3695, 1979a.
Takai, Y, Kishimoto, A, Kikkawa, U, Mori, T and Nishizuka, Y. Unsaturated
diacylglycerol as a possible messenger for the activation of calcium-activated,
phosphollpid-dependent protein kinase system. Biochem Biophys Res Commun
91:1218-1224, 1979b.
Takayama, K, Quershi, N, Beutler, B and Kirkland, TN. Diphosphoryl lipid A from
Rhodopeudomonas sphaeroides ATCC 17203 blocks induction of cachectin in
macrophages by llpopolysaccharide. Infection and Immunity 57:1336-1338, 1989.
Takenaka, A, Soga, H, Miyamoto, K, Kasahara, K and Yoshida, Y. An enzyme (fi-D-N-
acetylglucosaminidase) released from the decidua to maternal plasma prior to the onset
of labor. Acta Obstet Gynecol Scand 70:469-473, 1991.
Tamatani, T, Tsunoda, H, Iwasaki, H, Kaneko, M, Hashimoto, T and Onozaki, K.
Existence of both IL-1a and b In normal human amniotic fluid: unique high molecular
weight form of IL-1 (5. Immunology 65:337, 1988.
Tanaka, M, Morita, I, Hirakawa, S and Murota, S. Increased prostacyclin synthesizing
activity In human ripening uterine cervix. Prostaglandins 21:83, 1981.
Tanaka, Y, Adams, DH and Shaw, S. Proteoglycans on endothelial cells present
adhesion-inducing cytokines to leukocytes. Immunology Today 14:111-115, 1993.
Taniguchi, T, Matsuzaki, N, Kameda, T, et al. The enhanced production of placental
interleukin-1 during labor and intrauterine infection. Am J Obstet Gynecol 165:131-
137, 1991.
Taylor, MJ, Webb, R Mitchell, MD and Robinson, JS. Effect of progesterone withdrawal
In sheep during late preganncy. J Endocrinol 92:85-93, 1982.
Thelen, M, Peveri, P, Kemen, P, Von Tscharner, V, Walz, A and Baggiolini, M.
Mechanism of neutrophil activation by NAF, a novel monocyte-derived peptide
agonist. FASEB J 2:2702-2706, 1988.
Thiery, M, DeGezelle, H, Van Kets, H, et al. Extra-amniotic oestrogens for the
unfavourable cervix. Lancet 2:835-836, 1978.
Toriyama, K, Morita, I and Murota, S. The existence of distinct classes of prostaglandin
E2 receptors mediating adenylate cyclase and phospholipase C pathways in osteoblastic
clone MC3T3-E1. Prostaglandins Leukotrienes and Essential Fatty Acids 46:15-20,
1992.
Toriyama, K, Morita, I, Seyama, Y, Yamashita, S and Murota, S. Prostaglandin E2
evokes intracellular calcium rise in mouse osteoblastic cell line MC3T3-E1.
Eicosanoids 3:157-160, 1990.
Townsley, JD and Pepe, GJ. Serum dehydroepiandrosterone and
dehydroepiandrosterone sulfate in baboon (Papio papio) pregnancy. Acta Endocrinol
85:415-421, 1977.
Townsley, JD. Inhibition of placental 3(3-hydroxy-steroid dehydrogenase by naturally
occurring steroids. A potential mechanism regulating oestrogen synthesis from
conjugated precursors. Acta Endocrinol 79:740-748, 1975.
Trofatter, KF. Cervical ripening. Clin Obs Gyn 35:476-486, 1992.
Tromans, PM, Beazley, JM and Shenouda, PI. Comparative study of oestradiol and
prostaglandin E2 vaginal gel for ripening the unfavourable cevix before induction of
labour. Br Med J 282:679-681, 1981.
Tulchinsky, D and Korenman, SG. The plasma estradiol as an index fetoplacental
function. J Clin Invest 50:1490-1497, 1971.
Tulchinsky, D, Hobel, CJ, Yeager, E and Marshall, JR. Plasma estrone, estradiol,
estriol, progesterone and 17-hydroxyprogesterone in human pregnancy. I. Normal
pregnancy. Am J Obstet Gynecol 112:1095-1100, 1972.
Turnbull, AC, Patten, PT, Flint, APF, Keirse, MJNC, Jeremy, JY and Anderson, ABM.
Significant fall in progesterone and rise in oestradiol levels in human peripheral
plasma before onset of labour. Lancet 1:101-103, 1974.
Uchiyama, T, Ito, A, Ikesue, A, Nagakawa, H and Mori, Y. Chemotactic factor in the
pregnant rabbit uterine cervix. Am J Obstet Gynecol 167:1417-1422, 1992.
Uldbjerg, N and Danielsen, CC. A study of the interaction in vitro between type-I
collagen and a small dermatan sulphate proteoglycan. Biochem J 251:643-648, 1988.
Uldbjerg, N and Ulmsten, U. The physiology of cervical ripening and cervical dilatation
and the effect of abortifacient drugs. Bailliere's Clin Obstet Gynaecol 4:263-282, 1990.
Uldbjerg, N, Carlstedt, I, Ekman, G, MalmstrSm, A, Ulmsten, U andWingerup, L.
Deimatan sulphate and mucin glycopeptides from the human uterine cervix. Gynecol
Obstet Invest 16:199-209, 1983c.
Uldbjerg, N, Ekman, G, Malmstrdm, A, Olsson, K and Ulmsten, U. Ripening of the
human uterine cervix related to changes In collagen, glycosaminoglycans, and
collagenolytic activity. Am J Obstet Gynecol 147:662-666, 1983a.
Uldbjerg, N, Ekman, G, MalmstrQm, A, Sporrong, B, Ulmsten, U and Wlngerup, L.
Biochemical and morphological changes of the human cervix after local application of
prostaglandin E2 In pregnancy. Lancet 267-268, 1981.
Uldbjerg, N, Malmstrom, A, Ekman, G and Ulmsten, U. The Integrity of cervical
collagen during pregnancy and labor. Gynecol Obstet Invest 20:68-73, 1985.
Uldbjerg, N, Ulmsten, U and Ekman, G. The ripening of the human utreine cervix In
terms of connective tissue biochemistry. Clin Obs Gyn 26:14-26, 1983b.
Ulmann, A and Dubois, C. Clinical trials with RU486 (Mifepristone): An update. Acta
Obstet Gynecol Scand Suppl 149:9-11, 1989.
Ulmsten, U, Wingerup, L and Ekman, G. Local application of prostaglandin E2 for
cervical ripening or Induction of term labor. Clin Obs Gyn 26:95-105, 1983.
Ulmsten, U. Intracervical application of prostaglandin E2. In: Prostaglandins for
cervical ripening and/or Induction of labour. Edited by Egarter, C and Husslein, P.
Vienna: Facultas Universitatsverlag, pp.42-45. 1988a.
Ulmsten, U. Some physical and pharmacological aspects of cervical ripening in term
pregnancy. Eur J Obstet Gynecol Reprod Biol 28:90-94, 1988b.
Ulmsten, U. The cervix. In: Prostaglandins and their inhibitors in clinical obstetrics
and gynaecology. Edited by Bygdeman, M, Berger, S and Keith, LG. Lancaster: MTP Press
Ltd, pp.29-57. 1986.
Vaes, G. The release of collagenase as an inactive proenzyme by bone explants in
culture. Biochem J 126:275-289, 1972.
Valentine, BH. Intravenous oxytocin and oral prostaglandin E2 for ripening of the
unfavourable cervix. Br J Obstet Gynaecol 84:846-854, 1977.
Van Damme, J, Rampart, M, Conings, R, et al. The neutrophil-activating proteins
interleukin 8 and (3-thromboglobulin: In vitro and in vivo comparison of NH2-
terminally processed forms. Eur J Immunol 20:2113-2118, 1990.
Van Damme, J, Van Beeumen, J, Conings, R, Decock, B and Billiau, A. Purification of
granulocyte chemotctic peptide/interleukin-8 reveals N-terminal sequence
heterogeneity similar to that of beta-thromboglobulin. Eur J Biochem 181:337-344,
1989.
Van den Bosch, H. Intracellular phospholipases A. Biochim Biophys Acta 604:191-246,
1980.
Vater, CA, Mainardi, CL and Harris, EDJr. Inhibitor of human collagenase from
cultures of human tendon. J Biol Chem 254:3045-3053, 1979.
Veis, A. Cervical dilatation: A proteolytic mechanism for loosening the collagen fiber
network. In: Dilatation of the uterine cervix. Edited by Naftolin, F and Stubblefield, PG.
New York: Raven Press, pp. 195-202. 1980.
Vilcek, J and Lee, TH. Tumor necrosis factor. New insights into the molecular
mechanisms of its multiple actions. J Biol Chem 266:7313-7316, 1991.
Von Euler, US. Uber die speziflsche blutdrucksenkende substanz des menschlichen
prostata- und samenblasensekretes. KlinWochenschr 14:1182-1183, 1935.
von Maillot, K and Zimmermann, BK. The solubility of collagen of the uterine cervix
during pregnancy and labour. Arch Gyn&kol 220:275-280, 1976.
von Maillot, K, Stuhlsatz, HW, Mohanaradhakrishnan, V and Greiling, H. Changes in
the gylcosaminoglycans distribution pattern in the human uterine cervix during
pregnancy and labor. Am J Obstet Gynecol 135:503-506, 1979.
Vukajlovich, SW, Hoffman, J and Morrison, DC. Activation of human serum
complement by bacterial lipopolysaccharides: Structural requirements for antibody
independent activation of the classical and alternative pathways. Mol Immunol
24:319-331. 1987.
Wakeling, AE and Wyngarden, LJ. Prostaglandin receptors in human, monkey and
hamster uterus. Endocrinology 95:55-64, 1974.
Wallis, RM and Hillier, K. Regulation of collagen dissolution in the human cervix by
oestradiol-17|3 and progesterone. J Reprod Fert 62:55-61, 1981.
Wallis, RM and Hillier, K. The effect of arachidonic acid and prostanoids on collagen
dissolution in human uterine cervix in vitro. Prostaglandins 24:377-385, 1982.
Walsh, SW, Behr, MJ and Allen, NH. Placental prostacyclin production in normal and
toxemic pregnancies. Am J Obstet Gynecol 151:110-115, 1985.
Walz, A and Baggiolini, M. Generation of the neutrophil-activating peptide NAP-2 from
platelet basic protein or connective tissue-activating peptide III through monocyte
proteases. J Exp Med 171:449-454, 1990.
Watanabe, K, Yoshida, R, Shimizu, T and Hayaishi, O. Enzymatic formation of
prostaglandin F2a from prostaglandin H2 and D2. J Biol Chem 260:7035-7041, 1985.
Watnick, AS and Russo, RA. Survival of skin homografts in uteri of pregnant and
progesterone-estrogen treated rats. Proc Soc Exp Biol Med 128:1, 1968.
Weiss, G, O'Byrne, EM and Steinetz, BG. Relaxin: A product of the human corpus luteum
of pregnancy. Science 194:948-949, 1976.
Weiss, TJ and Bryant-Greenwood, GD. Localization of relaxin binding sites in the rat
uterus and cervix by autoradiography. Biol Reprod 27:673-679, 1982.
Welgus, HG and Stricklin, GP. Human skin fibroblast collagenase inhibitor.
Comparative stiudies in human connective tissue, serum and amniotic fliud. J Biol
Chem 258:12259-12264, 1983.
Werb, Z, Mainardi, CL, Vater, CA and Harris, EDJr. Endogenous activation of latent
collagenase by rheumatoid synovial cells. Evidence for a role of plasminogen activator.
NEnglJ Med 296:1017-1023, 1977.
Westphal, O. Handbook of endotoxin: Vol I, chemistry of endotoxin. Amsterdam:
Elsevier, 1984.
Westwick, J, Li, SW and Camp, R Novel neutrophil-stlmulating peptides. Immunology
Today 10:146-147, 1989.
Wightman, PD and Raetz, CRH. The activation of protein kinase C by biologically active
lipid moieties of lipopolysaccharide. J Biol Chem 259:10048-10052, 1984.
Williams, JK, Lewis, ML, Cohen, GR and O'Brien, WF. The sequential use of estradiol and
prostaglandin E2 topical gels for cervical ripening in high-risk term pregnancies
requiring induction of labor. Am J Obstet Gynecol 158:55-58, 1988.
Wilson, PD. A comparison of four methods of ripening the unfavourable cervix. Br J
Obstet Gynaecol 85:941-944, 1978.
Wiqvist, I, Norstr5m, A and Wiqvist, N. Induction of labor by intra-cervical PGE2 in
viscous gel. Acta Obstet Gynecol Scand 65:485-492, 1986.
Wiqvist, I, Norstrom, A, O'Byrne, E and Wiqvist, N. Regulatory influence of relaxin on
human cervical and uterine connective tissue. Acta Endocrinol 106:127-132, 1984.
Woessner, JFJr. Total, latent and active collagenase during the course of post-partum
involution of the rat uterus. Effect of oestradiol. Biochem J 180:95-102, 1979.
Yamanishi, J, Takai, Y, Kaibuchi, K, Sano, K, Castagna, M and Nishizuka, Y.
Synergistic functions of phorbol ester and calcium in serotonin release from platelets.
Biochem Biophys Res Commun 112:778-786, 1983.
Yasumoto, K, Okamoto, S-i, Mukaida, N, Murakami, S, Mai, M and Matsushima, K.
Tumor necrosis factor a and interferon 7 synergist!cally induce interleukin 8
production in a human gastric cancer cell line through acting concurrently on AP-1 and
NF-x-B-like binding sites of the interleukin 8 gene. J Biol Chem 267:22506-22511, 1992.
Ye, BL, Yamamoto, K and Tyson, JE. Functional and biochemical aspects of laminaria
used in first trimester pregnancy termination. Am J Obstet Gynecol 142:36-39, 1982.
Yoshida, Y and Manabe, Y. Different characteristics of amniotic and cervical
collagenous tissue during pregnancy and delivery: Amoprphologic study. Am J Obstet
Gynecol 162:190-193, 1990.
Yoshimura, T, Matsushima, K, Oppenheim, JJ and Leonard, EJ. Neutrophil chemotactic
factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear
leukocytes: Partial characterization and separation from interleukin 1 (IL 1). J
Immunol 139:788-793, 1987a.
Yoshimura, T, Matsushima, K, Tanaka, S, et al. Purification of a human monocyte-
derived neutrophil chemotactic factor that has peptide sequence similarity to other
host defense cytokines. Proc Natl Acad Sci USA 84:9233-9237, 1987b.
Yoshimura, T, Robinson, EA, Appella, E, et al. Three forms of monocyte-derived
neutrophil chemotactic factor (MDNCF) distinguished by different lengths of the
amino-terminal sequence. Mol Immunol 26:87-93, 1989.
Zarrow, MX and Yochim, J. Dilation of the uterine cervix of the rat and accompanying
changes during the estrous cycle, pregnancy and following treatment with estradiol,
progesterone and relaxin. Endocrinology 69:292-304, 1961.
Zarrow, MX, Neher, GM, Sikes, D, Brennan, DM and Bullard, JF. Dilatation of the
uterine cervix of the sow following treatment with relaxin. Am J Obstet Gynecol 72:260-
264, 1956.
Zuidema, LJ, Khan-Dawood, F, Dawood, MY and Work, BAJ. Hormones and cervical
ripening: Dehydroepiandrosterone sulfate, estradiol, estriol and progesterone. Am J
Obstet Gynecol 155:1252-1254, 1986.
